Citrus Sinensis ID: 005907
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.964 | 0.76 | 0.503 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.895 | 0.766 | 0.508 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.967 | 0.765 | 0.491 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.946 | 0.777 | 0.518 | 1e-179 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.949 | 0.742 | 0.478 | 1e-179 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.961 | 0.763 | 0.495 | 1e-177 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.947 | 0.762 | 0.470 | 1e-171 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.947 | 0.751 | 0.468 | 1e-166 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.952 | 0.747 | 0.480 | 1e-165 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.947 | 0.754 | 0.437 | 1e-157 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/675 (50%), Positives = 451/675 (66%), Gaps = 29/675 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K+ VWVANR P++ S G L I+ + NLV+ QS+ VWS L+ +V++P+V +
Sbjct: 73 KAISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAE 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN VLRD + + WQSFD+P+DTLLP MKLGWD KTG R + SWKS DDPS
Sbjct: 132 LLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF + +E + PE+ +W + YR+GPWNG+RFS P ++P F+F ++ E+
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y+F IT V SR+ ++ + ++R F W + Q+W + P+DQCD Y CG YG C
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQR-FTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDS 310
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SPVC C+KGFKP++ G D S GCVR L+ DGF++ ++KLPD T++ V
Sbjct: 311 NTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVD 370
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + +KEC + CL + +C A+ N+DIRG GSGC W GEL D+R++ GGQD Y+R++A+
Sbjct: 371 RGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAAT 430
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLI-RKRRRNIAEKT--------------- 408
++ K + KI+ I + LL + I +L RK++R+I +T
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 409 ----ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
+ R +EN DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DG
Sbjct: 491 EVVISSRRHISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDG 548
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QE+AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLD
Sbjct: 549 QEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLD 608
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
S +FD++R + L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668
Query: 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644
DFG+ R FG DETE NT +VVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+S K+N+
Sbjct: 669 DFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNK 728
Query: 645 GFYRSDTKVNLIGHV 659
GFY SD +NL+G V
Sbjct: 729 GFYNSDRDLNLLGCV 743
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/653 (50%), Positives = 441/653 (67%), Gaps = 53/653 (8%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGF---KPKSGGYVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF P++ D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
Query: 367 GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLE 426
++++ +SR+ ++E DLE
Sbjct: 429 ETLQRESSRV---------------------------------SSRKQEEE------DLE 449
Query: 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 486
LP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+AVKRLS+ S QG++E KNE
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNE 509
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ RR LDW +R II
Sbjct: 510 IKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIK 569
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL RT GGDETE NT RVVG
Sbjct: 570 GIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVG 629
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHV 659
TYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF + K+NL+GH
Sbjct: 630 TYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHA 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 635 bits (1637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/672 (49%), Positives = 439/672 (65%), Gaps = 24/672 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTE-------------- 409
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNE 488
Query: 410 --NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
+ + E++ LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 489 LVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668
Query: 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647
+ R FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY
Sbjct: 669 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 728
Query: 648 RSDTKVNLIGHV 659
S+ +NL+G V
Sbjct: 729 NSNRDLNLLGFV 740
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1623), Expect = e-179, Method: Compositional matrix adjust.
Identities = 344/664 (51%), Positives = 452/664 (68%), Gaps = 30/664 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPV----VLQL 69
P VVWVANR NP+ + GFL ++ G+L L + +WS+ S + +L++
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKI 131
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPSP
Sbjct: 132 SCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSP 187
Query: 130 GDFIWAIERQDNPEVVMWKG--SRKFYRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDVE 185
GDF +++ + P++++ K S YR G WNGL F+ AP++ R N +F + F S+ E
Sbjct: 188 GDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQE 247
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +C
Sbjct: 248 VNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304
Query: 246 IIG--QSPVCQCLKGFKPKSGGYVDRSQG---CVRSKPLNYSRQDGFIKFTELKLPDATS 300
I +P C CL+GFKPKSG + S+G CV P N ++D F+KF LKLPD +
Sbjct: 305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364
Query: 301 SW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD Y
Sbjct: 365 SWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVY 424
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQEN 418
IRM ++I KG +VV + A++ VV+ A + + +R + EN R+ +E
Sbjct: 425 IRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKR---YRGENFRKGIEEE 481
Query: 419 EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ 478
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S Q
Sbjct: 482 -----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQ 536
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDW 538
G++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LDW
Sbjct: 537 GVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDW 596
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++E
Sbjct: 597 KKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSE 656
Query: 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 658
+TNRVVGTYGYM PEYA DG FS+KSDVFSFG+L+LEI++GK NRGF +D +NL+GH
Sbjct: 657 SSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGH 716
Query: 659 VSKM 662
V KM
Sbjct: 717 VWKM 720
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 320/669 (47%), Positives = 449/669 (67%), Gaps = 33/669 (4%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQLLDSGNLV 76
VWVANR NP++++ G L I+ NLVL SN VW L++ ++PVV +LL +GN V
Sbjct: 83 VWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFV 141
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAI 136
+RD + D+ Y WQSFDYP+DTLLP MKLG++LKTGL R +TSW+S DDPS G+F + +
Sbjct: 142 MRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKL 201
Query: 137 ERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNK 195
E Q PE + + + +R+GPWNG+RFS P + ++F+ N+ E+ YTF +TN
Sbjct: 202 ETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN 261
Query: 196 AVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRD-QCDTYGLCGAYGICIIGQSPVCQ 254
+ SR+ + Y +R W + + W + P D QCDTY +CG Y C + SPVC
Sbjct: 262 SFYSRLTLISEGYFQR-LTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCN 320
Query: 255 CLKGFKPKSGGYVDR---SQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKE 311
C++GF P++ D+ + GC+R L+ S DGF + ++KLP+ T + V +S+ +KE
Sbjct: 321 CIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKE 379
Query: 312 CREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGG---GQDFYIRMSASEIGA 368
C++ C+ + +C A+ N+DIR GGSGC +W L D+R++ GQD Y+R++A++I
Sbjct: 380 CKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK 439
Query: 369 KGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI----- 423
K + KI+ + + + LL +++ + + KR++ A+ + S Q N++ +
Sbjct: 440 KRNASGKIISLTVGVSVLLLLIM---FCLWKRKQKRAKASAISIANTQRNQNLPMNEMVL 496
Query: 424 -------------DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+LELPL E+ T+ AT+NFS NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 497 SSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVK 556
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK S QG E NEV L ++LQH NLV++LGCCI+G+EK+LIYE++ N SLDS++F +
Sbjct: 557 RLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGK 616
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TRR+ L+W++RF I G ARGLLYLHQDSR RIIHRDLK SN+LLD++M PKISDFG+ R
Sbjct: 617 TRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMAR 676
Query: 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
F DETE NT +VVGTYGYM+PEYA G FS KSDVFSFG+++LEIVSGKKNRGFY D
Sbjct: 677 IFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLD 736
Query: 651 TKVNLIGHV 659
+ +L+ +V
Sbjct: 737 YENDLLSYV 745
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 623 bits (1606), Expect = e-177, Method: Compositional matrix adjust.
Identities = 333/672 (49%), Positives = 444/672 (66%), Gaps = 28/672 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN------------- 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLIND 484
Query: 411 ---SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 485 VVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647
+ R FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724
Query: 648 RSDTKVNLIGHV 659
S+ +NL+G V
Sbjct: 725 NSNRDLNLLGFV 736
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 603 bits (1555), Expect = e-171, Method: Compositional matrix adjust.
Identities = 316/671 (47%), Positives = 446/671 (66%), Gaps = 36/671 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNI--VVWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N ++WS +S + P +V L D G
Sbjct: 68 IVWVANRDHPINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLG 127
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SFD+P+DT LP M+LG+ K GL+R +TSWKS DP GD I
Sbjct: 128 NLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLI 184
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ER+ P+++++KG ++R G W G R+S P + IF+ SFV+N+ E+ +T+ +
Sbjct: 185 LRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGV 244
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPV 252
T+ +VI+R ++N+T + R F W + W + VP++QCD Y CG G C S
Sbjct: 245 TDASVITRTMVNETGTMHR-FTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKT 303
Query: 253 --CQCLKGFKPKSGGY---VDRSQGCVRSKPLNY-SRQDGFIKFTELKLPDATSSWVSKS 306
C CL GF+PK + D S GC + K + S +DGF+K +K+PD + + V +
Sbjct: 304 FECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMN 363
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC++ CL+N SC+AY ++ + + G GC W G ++D R + GQDFYIR+
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKE 423
Query: 365 EI------GAKGEPTTKIVVI-VISTAALLAVVLIAGYLIRKRRRNIAEKTENSR----- 412
E+ G G+ +++I +I+ LL V+L ++R+RR++ ++ ++
Sbjct: 424 ELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFC--VVRERRKSNRHRSSSANFAPVP 481
Query: 413 ----ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+ + +D+ + ELPLF+L TI AT+NFS NKLG GGFGPVYKG L + EIA
Sbjct: 482 FDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIA 541
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSLD FIF
Sbjct: 542 VKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIF 601
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +R LDW +R I+ G ARG+LYLHQDSRLRIIHRDLKASN+LLD +M PKISDFG+
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661
Query: 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648
R FGG++ EG T+RVVGT+GYMAPEYA +GQFSIKSDV+SFG+L+LEI++GKKN F+
Sbjct: 662 ARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE 721
Query: 649 SDTKVNLIGHV 659
+ NL+GH+
Sbjct: 722 ESS--NLVGHI 730
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 586 bits (1510), Expect = e-166, Method: Compositional matrix adjust.
Identities = 317/676 (46%), Positives = 449/676 (66%), Gaps = 41/676 (6%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIV--VWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N +WS + +Q P +V +L D G
Sbjct: 71 IVWVANRDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLG 130
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SF++P++TLLP MK G+ ++G++R +TSW+S DP G+
Sbjct: 131 NLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNIT 187
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ IER+ P+++M+KG ++RTG W G R+S P + IF+ SFV+N E+ T+ +
Sbjct: 188 YRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGV 247
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC--IIGQS 250
+ +V +R+V+N+T ++R F WN + W + P D+CD Y CG G C +
Sbjct: 248 LDASVTTRMVLNETGTLQR-FRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEK 306
Query: 251 PVCQCLKGFKPKSGG---YVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
C CL G++PK+ D S GC R K + ++GF K +K+P+ ++ V +
Sbjct: 307 FECSCLPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMN 366
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC + CL+N SC+AY ++ + + G GC W G ++D R + GQDFY+R+ S
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKS 426
Query: 365 EI------GAKGEPTTKIVVIVISTAALLAVVLIA--GYLIRKRRRNIAEKTENSRETD- 415
E+ GA G+ ++V+I+IS A++ ++LI+ YL ++R+R + + + +
Sbjct: 427 ELARWNGNGASGK--KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484
Query: 416 ------------QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
+E ED++ ELPLFEL+TIA AT+NF+ NKLG GGFGPVYKG L +
Sbjct: 485 PSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQN 544
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G EIAVKRLSK S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSL
Sbjct: 545 GMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSL 604
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
D FIF + +R LDW +R II G RG+LYLHQDSRLRIIHRDLKASNVLLD +M PKI
Sbjct: 605 DYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKI 664
Query: 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643
+DFGL R FGG++ EG+TNRVVGTYGYM+PEYA DGQFSIKSDV+SFG+L+LEI++GK+N
Sbjct: 665 ADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRN 724
Query: 644 RGFYRSDTKVNLIGHV 659
FY + +NL+ H+
Sbjct: 725 SAFY--EESLNLVKHI 738
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1496), Expect = e-165, Method: Compositional matrix adjust.
Identities = 319/664 (48%), Positives = 424/664 (63%), Gaps = 26/664 (3%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVL 77
VWVANR P+++ G L I+ NLV+ S+ VWS L+ V++ VV +LLD+GN VL
Sbjct: 83 VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141
Query: 78 RDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIE 137
R +S+ + WQSFD+P+DTLLP MKLG D K GL R VTSWKS DPS G F++ +E
Sbjct: 142 RGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLE 201
Query: 138 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELYYTFNITNKA 196
PE + + YR+GPW+GLRFS ++ ++F N E+ YTF +T+
Sbjct: 202 TLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHN 261
Query: 197 VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCL 256
SR+ +N T+ F+W Q W ++ +P+D CD YG+CG Y C + SP C C+
Sbjct: 262 SYSRLTIN-TVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCI 320
Query: 257 KGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKECR 313
KGF+P S D + C R L +D F + +K+P T++ V K + LKEC
Sbjct: 321 KGFQPLSPQDWASGDVTGRCRRKTQLTCG-EDRFFRLMNMKIPATTAAIVDKRIGLKECE 379
Query: 314 EGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEIGAKGEPT 373
E C + +C AY NSDIR GGSGC +W GE D+R++ GQD ++R++A+E G +
Sbjct: 380 EKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 374 TKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTE---NSRETDQE------------- 417
KI+ ++I + +L + I Y K+++ A T R+ QE
Sbjct: 440 GKIIGLIIGISLMLVLSFII-YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGR 498
Query: 418 -NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
+ DLELPL E T+ AT+NFS +N LG GGFG VYKG L+DGQEIAVKRLS++S
Sbjct: 499 RLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMS 558
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT-L 535
QG E KNEV L ++LQH NLV+LL CCI +EK+LIYE++ N SLDS +F+ T+ +
Sbjct: 559 SQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNK 618
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
L+W RF II G ARGLLYLHQDSR +IIHRDLKASNVLLD++M PKISDFG+ R F D
Sbjct: 619 LNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERD 678
Query: 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 655
ETE NT +VVGTYGYM+PEYA +G FS+KSDVFSFG+L+LEIVSGK+NRGF+ S NL
Sbjct: 679 ETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNL 738
Query: 656 IGHV 659
+G+
Sbjct: 739 LGYT 742
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 298/681 (43%), Positives = 422/681 (61%), Gaps = 46/681 (6%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVV-LQLLD 71
P VVWVAN+ +PIND+ G + I + GNL +T N +VWS +S V +QL+D
Sbjct: 79 PIQTVVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMD 138
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
SGNL+L+D + W+SF +P D+ +P M LG D +TG ++TSW S DDPS G+
Sbjct: 139 SGNLMLQDNRNNGE--ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGN 196
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSF-VSNDVELYYTF 190
+ I PE+++WK + +R+GPWNG F + +F F +++D + +
Sbjct: 197 YTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISM 256
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N + + ++ + ++ W+ + ++W + P CD YG CG +G C G++
Sbjct: 257 SYANDSFMYHFNLDPEGIIYQK-DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGEN 315
Query: 251 PVCQCLKGFKPKS-----GGYVDRSQGCVRSKPLNYSRQ------------DGFIKFTEL 293
P C+C+KGF PK+ GG + S GC+R PL RQ DGF+K ++
Sbjct: 316 PPCKCVKGFVPKNNTEWNGG--NWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKM 373
Query: 294 KLP-DATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
K+P A S S+ + C + CL+N SC AY G GC +W G+L+DM+ F G
Sbjct: 374 KVPISAERSEASEQV----CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG 425
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G D +IR++ SE+ I VI + AV ++ RK ++ A + S
Sbjct: 426 SGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLA--CRKYKKRPAPAKDRSA 483
Query: 413 E----------TDQENEDQNIDL-ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 461
E +D E+ I L ELPLFE +A +TD+FS+ NKLG+GGFGPVYKG L
Sbjct: 484 ELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKL 543
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
+GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+GEE++L+YE+MP K
Sbjct: 544 PEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKK 603
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
SLD+++FD ++ +LDW RF+I+ G RGLLYLH+DSRL+IIHRDLKASN+LLD+++NP
Sbjct: 604 SLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNP 663
Query: 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
KISDFGL R F +E E NT RVVGTYGYM+PEYA +G FS KSDVFS G++ LEI+SG+
Sbjct: 664 KISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGR 723
Query: 642 KNRGFYRSDTKVNLIGHVSKM 662
+N ++ + +NL+ + K+
Sbjct: 724 RNSSSHKEENNLNLLAYAWKL 744
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | ||||||
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.971 | 0.793 | 0.646 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.967 | 0.790 | 0.646 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.971 | 0.778 | 0.623 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.911 | 0.777 | 0.621 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.910 | 0.777 | 0.619 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.968 | 0.769 | 0.596 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.961 | 0.791 | 0.594 | 0.0 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.961 | 0.508 | 0.593 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.965 | 0.788 | 0.595 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.913 | 0.776 | 0.572 | 0.0 |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2279), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/662 (64%), Positives = 515/662 (77%), Gaps = 11/662 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+++YR+GPWNG+ FS P LR NP+F F FV + E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQ+ Y R+R+ WN+ Q+W LY++VPRD CDTY LCGAYG CII
Sbjct: 242 YTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCII 301
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVC+CL+ F PKS +D SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 302 SQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 361
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CLEN SCMAYT ++I+ SGCA+WFG+LID+ P GQ+ YIRM+AS
Sbjct: 362 KTMNLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLIDITQLPAAGQEIYIRMNAS 420
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKT----ENSRETDQENED 420
E V I +S ++L+A Y+ +++ + I + T N E DQ +
Sbjct: 421 ESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKVTLTAFSNREENDQIDSG 480
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K S+ S QG+
Sbjct: 481 PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSRSSGQGI 540
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+
Sbjct: 541 NEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGELLDWSK 600
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGN
Sbjct: 601 RFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGN 660
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVS 660
T RVVGTYGYMAPEYA+DG FS+KSDVFSFGIL+LEI+SGKK+RGFY D ++LIGH
Sbjct: 661 TTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDHSLSLIGHAW 720
Query: 661 KM 662
++
Sbjct: 721 RL 722
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/659 (64%), Positives = 515/659 (78%), Gaps = 11/659 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGN VL S +N VVWS+ K Q+ + +
Sbjct: 69 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQS-AMGE 127
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L DSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 128 LQDSGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 187
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NP+F F FV + E+Y
Sbjct: 188 SGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVY 247
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQT Y R+R+ WN+ Q+W LY+ VPRD CDTY LCGAYG CI+
Sbjct: 248 YTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIM 307
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVCQCL+ F P+S +D S+GCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 308 SQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 367
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CL+N SCMAYT ++I+ SGCA+WFG+LID+R F GQ+ YIR++AS
Sbjct: 368 KTMNLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLIDIRQFSAAGQEIYIRLNAS 426
Query: 365 EIGAKGEPTTKIVV-IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI 423
E AK K+ V +S ++L+A Y+ +++ ++I N E DQ +
Sbjct: 427 ESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGG---NREENDQIDSGPKE 483
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K LS+ S QGL E
Sbjct: 484 DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSRSSGQGLNEF 543
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+RF
Sbjct: 544 KNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGKLLDWSKRFS 603
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGNT R
Sbjct: 604 IICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGNTTR 663
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
VVGTYGYMAPEYA+DG FS+KSDVFSFGIL+LEI+SGKK+RGF D ++LIGH ++
Sbjct: 664 VVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPDHSLSLIGHAWRL 722
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2232), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/678 (62%), Positives = 521/678 (76%), Gaps = 27/678 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S +Y WQSFDYPSDT+LPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+V+WKGS K++R+GPWNG+ FS +LR NP+F F FV N E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTL-YVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
YT+N+ NK++I+R+VMNQT ++R+R+ WN+ +Q+WELY+ VPRD CD Y LCGAYG CI
Sbjct: 242 YTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCI 301
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
I QSPVC+CL+ F PKS ++ SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV
Sbjct: 302 ISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWV 361
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K+MNLKECR CL+N SCMAYT +DI+ SGCA+WFG+LID+R FP GGQ+ YIRM+A
Sbjct: 362 NKTMNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPDGGQEIYIRMNA 420
Query: 364 SEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRN------------------IA 405
SE + I +S ++L+A Y+ ++ + ++
Sbjct: 421 SESSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 406 EKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
EKT +RE DQ + D+ELPLF+ TIA AT+ FS+NNK+GEGGFGPVYKGTL DG
Sbjct: 481 EKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDG 540
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPN+SLD
Sbjct: 541 QEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLD 600
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
SFIFDQTR LLDWS+RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKIS
Sbjct: 601 SFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKIS 660
Query: 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644
DFGL R GGD+TEGNT RV+GTYGYMAPEYA+DG FS+KSDVFSFGIL+LEI+SGKK+R
Sbjct: 661 DFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSR 720
Query: 645 GFYRSDTKVNLIGHVSKM 662
GFY D ++L H ++
Sbjct: 721 GFYHPDRSLSLTAHAWRL 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/657 (62%), Positives = 496/657 (75%), Gaps = 46/657 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS GFL I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G+LID+R FP GGQ+ YIRM
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRM---- 429
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
N +E E ++ DQ + +N DL
Sbjct: 430 -------------------------------------NPSESAEMDQQNDQITDGENEDL 452
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 453 ELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKN 512
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 513 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 572
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 573 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 632
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
GTYGYMAPEYA+DG FS+KSDVFSFGI+LLEIV+GKK+RGFY D ++LIG+ ++
Sbjct: 633 GTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRL 689
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/657 (61%), Positives = 495/657 (75%), Gaps = 47/657 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS G L I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+ YIRM+ SE
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPSE 433
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
+E ++ DQ + +N DL
Sbjct: 434 ------------------------------------------SEMDQQNDQITDGENEDL 451
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 452 ELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKN 511
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 512 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 571
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 572 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 631
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
GTYGYMAPEYA+DG FS+KSDVFSFGI+LLEIV+GKK+RGFY D ++LIG+ ++
Sbjct: 632 GTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRL 688
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/686 (59%), Positives = 499/686 (72%), Gaps = 37/686 (5%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQ 68
K+ P +VWVANR NPINDS G L ++ ++VL S +N VVWS+ +K+ +P+ LQ
Sbjct: 65 KNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPI-LQ 123
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRD++DG S WQSFDYP DT+LPGMK+GWDL+ G + R++SWKS DDPS
Sbjct: 124 LLDSGNLVLRDKNDGRS-GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPS 182
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVELY 187
PGDF IER+ NPEVV WKGS+K YR+GPWNG+ FS + ++PNP+F F+FVSN++E+Y
Sbjct: 183 PGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVY 242
Query: 188 YTFNITNKA-VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y FN+ +++ VI+R+V+N T R+ + WN+ TQ+W L VPRD CD YGLCGA CI
Sbjct: 243 YIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCI 302
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
PVCQCL+ FKPKS +D SQGCVR+K L+ + DGFIKF LKLPDAT SWV
Sbjct: 303 FNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWV 362
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K MNLKEC+ CL N SCMAY+N DIRGGGSGCA WFG+L+D+R PGGGQ+ YIRM A
Sbjct: 363 NKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPGGGQELYIRMHA 422
Query: 364 SEIGAK-GEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAE-----KTENSRETDQE 417
SEIG + + KI I + L+ L Y + K + AE +TEN + D
Sbjct: 423 SEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSERTENDWKNDTN 482
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
N Q D+ELPLF + IA+AT+NFS+NNKLGEGGFGPVY+G L DG EIAVKRLS+ S
Sbjct: 483 NGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIAVKRLSRCSG 542
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG E KNEVIL +KLQHRNLVKLLGCC Q EEK+LIYE+MPN+SLD FIFD+T+ LLD
Sbjct: 543 QGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIFDETKGRLLD 602
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
WS+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGL R F D+T
Sbjct: 603 WSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGLARMFVADQT 662
Query: 598 EGNTNRV---------------------VGTYGYMAPEYASDGQFSIKSDVFSFGILLLE 636
EG+T+RV GYMAPEYA+DG FS+KSDVFSFG+LLLE
Sbjct: 663 EGDTSRVTSDSLASSNIPILPLCILTLNASCSGYMAPEYATDGLFSVKSDVFSFGVLLLE 722
Query: 637 IVSGKKNRGFYRSDTKVNLIGHVSKM 662
I+SGKK++GFY D +LIGH ++
Sbjct: 723 IISGKKSKGFYHPDH--SLIGHTWRL 746
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/659 (59%), Positives = 487/659 (73%), Gaps = 15/659 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL+FSA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQFSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
VVGTYGYMAPEYA DGQFSIKSDVFSFGIL+LEI+SG+KNRGF+R + +NLIGH K+
Sbjct: 659 VVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWKL 717
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/659 (59%), Positives = 487/659 (73%), Gaps = 15/659 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL++SA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQYSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
VVGTYGYMAPEYA DGQFSIKSDVFSFGIL+LEI+SG+KNRGF+R + +NLIGH K+
Sbjct: 659 VVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWKL 717
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/658 (59%), Positives = 479/658 (72%), Gaps = 11/658 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPI D+ L IN GN +L +Q+N V+WS + + VV Q
Sbjct: 67 KNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKASL-VVAQ 125
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D + E Y WQSFDYPSDT LPGMK GWDLK GL R +T+WK++DDPS
Sbjct: 126 LLDSGNLVLRDEKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAWKNWDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
GDF R + PE VMWKG+ ++YR+GPW+G +FS +PS+ N I ++S VSN E Y
Sbjct: 186 SGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVVSNKDEFY 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
T+++ +K++ISR+V+NQTLYVR+R WN+ +Q+W + S++P D CD Y CGA+GIC+
Sbjct: 246 ATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCGAFGICVA 305
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNY--SRQDGFIKFTELKLPDATSSW 302
GQ+PVC CL GFKPKS ++ +QGCV ++ + +DGF KF+ LK PD SW
Sbjct: 306 GQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKAPDTERSW 365
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
V+ SM L EC+ C EN SC AY N D+RG GSGCA+WFG+L+D+R P GQD YIR++
Sbjct: 366 VNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRLIPNAGQDLYIRLA 425
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE K + K+VVI ++++A +LI ++ +NI E + NE Q
Sbjct: 426 VSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKEIILGIEV--KNNESQQ 483
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D ELPLF+L +IA ATD+FS +NKLGEGGFGPVYKGTL DG E+AVKRLS+ S QGLKE
Sbjct: 484 EDFELPLFDLVSIAQATDHFSDHNKLGEGGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKE 543
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV+L +KLQHRNLVK+LGCCIQ EKLLIYE+M NKSLD F+FD R LLDW +RF
Sbjct: 544 FKNEVMLCAKLQHRNLVKVLGCCIQENEKLLIYEYMANKSLDVFLFDSDRSKLLDWPKRF 603
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+II ARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGL R GGD+ EG T
Sbjct: 604 YIINRIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGKTR 663
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHV 659
RVVGTYGYMAPEYA DG FSIKSDVFSFG+LLLEIVSGKK NR FY +D NLIGH
Sbjct: 664 RVVGTYGYMAPEYAFDGLFSIKSDVFSFGVLLLEIVSGKKNNRLFYPNDYNNNLIGHA 721
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/660 (57%), Positives = 480/660 (72%), Gaps = 48/660 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMIN-KTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQ 68
+ P VVWVANRLNPINDS G L +N TG LVLT + V+WS + ++PV L
Sbjct: 74 RKIPIQTVVWVANRLNPINDSSGILRMNPSTGTLVLT-HNGTVIWSTASIRRPESPVAL- 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LL+SGNLV+RDE D +SE Y W+SF+YP+DT LP MK GWDL+TGL R++ +WKS DDPS
Sbjct: 132 LLNSGNLVIRDEKDANSEDYLWESFNYPTDTFLPEMKFGWDLRTGLNRKLIAWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
P DF + + + PE M KG +KFYR+GPWNGL S +P ++ NPI+ F FVSN ELY
Sbjct: 192 PSDFSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLHSSGSPQVKANPIYDFKFVSNKDELY 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+++ N ++ISR+V+N T YVR+R++W ++ Q WE+Y+ VP D CD+Y LCGA C+I
Sbjct: 252 YTYSLKNSSMISRLVLNATSYVRKRYVWIESKQRWEVYTSVPLDLCDSYSLCGANANCVI 311
Query: 248 GQSPVCQCLKGFKPK---SGGYVDRSQGCVRSKPLNYS--RQDGFIKFTELKLPDATSSW 302
SPVCQCL+GFKPK + +D S GC+R+K L+ +DGF K T LK PD T SW
Sbjct: 312 SDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKELSCENKNKDGFNKLTLLKTPDTTHSW 371
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
+ +++ L+EC+ CL+N SCMAY NSDI G GSGCAMWFG+LID+R F GGQD Y+R+
Sbjct: 372 LDQTIGLEECKAKCLDNCSCMAYANSDISGQGSGCAMWFGDLIDIRQFAAGGQDVYVRID 431
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
ASE+ E+++ S +++Q + Q
Sbjct: 432 ASEL---------------------------------------ERSDFSIKSNQNSGMQV 452
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D++LP+F+L+TIA AT NF++ NK+GEGGFGPVY+G+L DGQEIAVKRLS S QGL E
Sbjct: 453 DDMDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTE 512
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV L +KLQHRNLVKLLGCC++GEEK+L+YE+M N SLDSFIFD+ R LDWS+RF
Sbjct: 513 FKNEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDWSKRF 572
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+IICG A+GLLYLHQDSRLRIIHRDLKASNVLLD ++NPKISDFG+ R FG D+ EGNT
Sbjct: 573 NIICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIFGVDQQEGNTK 632
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
R+VGTYGYMAPEYA+DG FS+KSDVFSFG+LLLEI+SGK++RG+Y + NLIGH K+
Sbjct: 633 RIVGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHSQNLIGHAWKL 692
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.370 | 0.316 | 0.684 | 7.1e-180 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.944 | 0.776 | 0.518 | 1.8e-174 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.391 | 0.309 | 0.649 | 3e-170 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.371 | 0.295 | 0.674 | 2.6e-169 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.355 | 0.280 | 0.677 | 1.1e-146 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.964 | 0.778 | 0.445 | 4.9e-140 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.947 | 0.789 | 0.438 | 3e-133 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.934 | 0.777 | 0.429 | 7.1e-132 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.914 | 0.757 | 0.435 | 7.1e-132 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.943 | 0.783 | 0.429 | 2.4e-131 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 7.1e-180, Sum P(2) = 7.1e-180
Identities = 171/250 (68%), Positives = 205/250 (82%)
Query: 409 ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+SR + ++ E++ DLELP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+A
Sbjct: 434 ESSRVSSRKQEEE--DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIF
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
D+ RR LDW +R II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648
RT GGDETE NT RVVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 649 SDTKVNLIGH 658
+ K+NL+GH
Sbjct: 672 EEHKLNLLGH 681
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1695 (601.7 bits), Expect = 1.8e-174, P = 1.8e-174
Identities = 345/665 (51%), Positives = 456/665 (68%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAY-----LSKEVQTPVVLQ 68
P VVWVANR NP+ + GFL ++ G+L L + +WS+ SK P+ L+
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPL-LK 130
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
+ SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPS
Sbjct: 131 ISCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186
Query: 129 PGDFIWAIERQDNPEVVMWK-GSRKF-YRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDV 184
PGDF +++ + P++++ K G + YR G WNGL F+ AP++ R N +F + F S+
Sbjct: 187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246
Query: 185 ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGI 244
E+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +
Sbjct: 247 EVNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAV 303
Query: 245 CIIGQ--SPVCQCLKGFKPKSGGY--VDR-SQGCVRSKPLNYSRQDGFIKFTELKLPDAT 299
C I +P C CL+GFKPKSG + R + GCV P N ++D F+KF LKLPD +
Sbjct: 304 CGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTS 363
Query: 300 SSW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDF 357
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD
Sbjct: 364 WSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDV 423
Query: 358 YIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQE 417
YIRM ++I KG ++V +V+ + +AVVL+ + +++ + EN R+ +E
Sbjct: 424 YIRMGFAKIEFKGR---EVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEE 480
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S
Sbjct: 481 E-----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSG 535
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LD
Sbjct: 536 QGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELD 595
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
W +R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++
Sbjct: 596 WKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQS 655
Query: 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 657
E +TNRVVGTYGYM PEYA DG FS+KSDVFSFG+L+LEI++GK NRGF +D +NL+G
Sbjct: 656 ESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLG 715
Query: 658 HVSKM 662
HV KM
Sbjct: 716 HVWKM 720
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 864 (309.2 bits), Expect = 3.0e-170, Sum P(2) = 3.0e-170
Identities = 172/265 (64%), Positives = 208/265 (78%)
Query: 396 LIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFG 454
L+R + + E + SR T +EN+ LELPL E +A AT+NFS +NKLG+GGFG
Sbjct: 478 LVRSQDSLMNELVKASRSYTSKENKTDY--LELPLMEWKALAMATNNFSTDNKLGQGGFG 535
Query: 455 PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
VYKG L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LI
Sbjct: 536 IVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 595
Query: 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
YE++ N SLDS +FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVL
Sbjct: 596 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 655
Query: 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
LD++M PKISDFG+ R FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LL
Sbjct: 656 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 715
Query: 635 LEIVSGKKNRGFYRSDTKVNLIGHV 659
LEI+SGK+N+GFY S+ +NL+G V
Sbjct: 716 LEIISGKRNKGFYNSNRDLNLLGFV 740
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 2.6e-169, Sum P(2) = 2.6e-169
Identities = 168/249 (67%), Positives = 200/249 (80%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 488 SRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVK 547
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ
Sbjct: 548 RLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQ 607
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+ R
Sbjct: 608 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 667
Query: 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY S+
Sbjct: 668 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 727
Query: 651 TKVNLIGHV 659
+NL+G V
Sbjct: 728 RDLNLLGFV 736
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 847 (303.2 bits), Expect = 1.1e-146, Sum P(2) = 1.1e-146
Identities = 162/239 (67%), Positives = 195/239 (81%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP+F L IA AT++F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSLD F+FD+T++ L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+ R FGG++ E NT RVV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664
GTYGYM+PEYA +G FS+KSDV+SFG+LLLEIVSGK+N RS +LIG+ ++T
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLYT 750
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1370 (487.3 bits), Expect = 4.9e-140, P = 4.9e-140
Identities = 305/684 (44%), Positives = 412/684 (60%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL-QLLD 71
P VVWVAN +PINDS G + I+K GNLV+ V WS + V +LL+
Sbjct: 67 PVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLN 126
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLVL + E W+SF++P + LP M L D KTG ++ SWKS DPSPG
Sbjct: 127 TGNLVLLGTTNTGDEI-LWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGR 185
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRF-SAPSL--RPNPIFSFSFVSNDVELYY 188
+ + PE+V+WK +R+GPWNG F P++ R N +F + +S+D
Sbjct: 186 YSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELT-LSSDNRGSV 243
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII- 247
+ + ++ +++ V +R WN A Q W+ + VP +CDTY CG + C
Sbjct: 244 SMSYAGNTLLYHFLLDSEGSVFQRD-WNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFN 302
Query: 248 -GQSPVCQCLKGFKPKSGGYVDR---SQGCVRSKPLNY--------SRQ-DGFIKFTELK 294
G +P C C++GFKP+S + +QGCVR PL SR+ DGF++ ++K
Sbjct: 303 PGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMK 362
Query: 295 LPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354
+P N ++C E CL+N SC AY+ G GC +W G L+DM++F G G
Sbjct: 363 VPHNPQR---SGANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTG 415
Query: 355 QDFYIRMSASEIGAKGEPTTKIVVIVISTAALLA-VVLIAGYLIRKRR-RNIAEKTENSR 412
FYIR++ SE + + I V ++ A L A V++A + I K R +N + N R
Sbjct: 416 VVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNER 475
Query: 413 ETDQENEDQNIDL-------ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ D L ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G
Sbjct: 476 MEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGL 535
Query: 466 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
+IAVKRLS+ S QG++E NEV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD+
Sbjct: 536 DIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDA 595
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
++FD ++ LLDW RF+II G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 596 YLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISD 655
Query: 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645
FGL R F G+E E +T RVVGTYGYMAPEYA G FS KSDVFS G++LLEIVSG++N
Sbjct: 656 FGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSS 715
Query: 646 FYRSDTKVNLIGHVSKMHTTFSSI 669
FY NL + K+ T I
Sbjct: 716 FYNDGQNPNLSAYAWKLWNTGEDI 739
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
Identities = 294/670 (43%), Positives = 411/670 (61%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
P VVWVANR P+ DS +L I+ +G+L+L + + VWS+ ++ + +L DSG
Sbjct: 70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFS-SSGCRAELSDSG 128
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NL + D SE WQSFD+ DTLL L ++L T +R +TSWKS+ DPSPGDF+
Sbjct: 129 NLKVIDNV---SERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFL 185
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL--YYTF 190
I Q + + +GS ++R+GPW RF+ P + + F+ + DV Y T+
Sbjct: 186 GQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFT-LHQDVNGSGYLTY 244
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+SRI + ++ ++ WELY + P+ CD YG CG +G+C++ S
Sbjct: 245 -FQRDYKLSRITLTSEGSIK---MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPS 300
Query: 251 PVCQCLKGFKPKSGGYVDRSQ---GCVRSKPL----NYSRQDG--FIKFTELKLPDATSS 301
P+C+C +GF PKS R GCVR L N + +D F + +K PD
Sbjct: 301 PMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE- 359
Query: 302 WVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRM 361
+ S+N +EC + C+ N SC+A+ I+G GC +W +L+D F G+ IR+
Sbjct: 360 -FASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLVWNQDLMDAVQFSATGELLSIRL 414
Query: 362 SASEI-GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENED 420
+ SE+ G K + T IV ++S + + A + R R +IA ++++ + D + +D
Sbjct: 415 ARSELDGNKRKKT--IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQD 472
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
L F++ TI NAT+NFS++NKLG+GGFG VYKG L DG+EIAVKRLS S QG
Sbjct: 473 VP---GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGK 529
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+E NE++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSLD+F+FD +R +DW +
Sbjct: 530 EEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPK 589
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF II G ARGLLYLH DSRLR+IHRDLK SN+LLD+ MNPKISDFGL R + G E + N
Sbjct: 590 RFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 649
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHV 659
T RVVGT GYM+PEYA G FS KSD++SFG+L+LEI+SG+K +R Y + K LI +
Sbjct: 650 TRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKT-LIAYA 708
Query: 660 SKMHTTFSSI 669
+ + + I
Sbjct: 709 WESWSEYRGI 718
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1293 (460.2 bits), Expect = 7.1e-132, P = 7.1e-132
Identities = 286/666 (42%), Positives = 393/666 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K P VVWVANR P+ S L I+ G+L+L V+WS A+ S +
Sbjct: 62 KKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHA--- 118
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LLD+GN V+ D+ G+ WQSF++ +T+LP L +D G +R +T+WKS D
Sbjct: 119 -ELLDTGNFVVIDDVSGNK---LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSD 174
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVE 185
PSPG+F I Q + ++ +GS ++R GPW RFS S + + + FS V +
Sbjct: 175 PSPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAA 234
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+F+ + + + T + + +W+ +W+L+ +P + CD YG CG YG+C
Sbjct: 235 GTGSFSYSTLRNYNLSYVTLTPEGKMKILWDDGN-NWKLHLSLPENPCDLYGRCGPYGLC 293
Query: 246 IIGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQ----------DGFIKFTE 292
+ P C+CLKGF PKS G + + GCVR L+ + D F + T+
Sbjct: 294 VRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTD 353
Query: 293 LKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
+K PD + +N ++C +GCL N SC A+ G GC +W GEL D F
Sbjct: 354 VKTPDLHQ--FASFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFLS 407
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G+ +IR+++SE+ G KI+V + ++ +++ A ++ + R + +N
Sbjct: 408 SGEFLFIRLASSELA--GSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGF 465
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
E Q+ N FE+ TI AT+NFS +NKLG+GGFGPVYKG LVDG+EI VKRL
Sbjct: 466 ER-QDVSGVNF------FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRL 518
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEFM NKSLD FIFD
Sbjct: 519 ASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCL 578
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LDW +RF+II G ARGLLYLH+DSRLR+IHRDLK SN+LLD MNPKISDFGL R F
Sbjct: 579 KFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMF 638
Query: 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652
G + + NT RVVGT GYM+PEYA G FS KSD++SFG+L+LEI+SGK+ F D
Sbjct: 639 QGTQYQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDES 698
Query: 653 VNLIGH 658
L+ +
Sbjct: 699 KGLLAY 704
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1293 (460.2 bits), Expect = 7.1e-132, P = 7.1e-132
Identities = 284/652 (43%), Positives = 395/652 (60%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K P VVWVANR P+ DS L I+ G+L+L ++++ VVWS +L
Sbjct: 65 KGIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIG-ETFASNGSRAEL 123
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
D+GNLV+ D + G + W+SF++ DT+LP L ++L TG +R +TSWKS DPSP
Sbjct: 124 TDNGNLVVIDNNSGRT---LWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSP 180
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYY 188
GDF I Q + +GS+ ++R+GPW RF+ P + FS + D
Sbjct: 181 GDFTVQITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFS-LQQDTNGSG 239
Query: 189 TFNITNKAV-ISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
+F + +S I++ ++ I+ WEL + P + CD YG CG +GIC++
Sbjct: 240 SFTYFERNFKLSYIMITSEGSLK---IFQHNGMDWELNFEAPENSCDIYGFCGPFGICVM 296
Query: 248 GQSPVCQCLKGFKPKS------GGYVDRSQGCVRSKPL------NYSRQDGFIKFTELKL 295
P C+C KGF PKS G + D GCVR L N +GF +K
Sbjct: 297 SVPPKCKCFKGFVPKSIEEWKRGNWTD---GCVRHTELHCQGNTNGKTVNGFYHVANIKP 353
Query: 296 PDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQ 355
PD + ++ + C + CL N SC+A+ + G GC MW +L+D F GG+
Sbjct: 354 PDFYE--FASFVDAEGCYQICLHNCSCLAFAYIN----GIGCLMWNQDLMDAVQFSAGGE 407
Query: 356 DFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGY-LIR-KRRRNIAEKTEN--S 411
IR+++SE+G G KI+V I + +L ++ A + +R K + ++ K S
Sbjct: 408 ILSIRLASSELG--GNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIAS 465
Query: 412 RET-DQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+E + + E Q++ L FE+ TI ATDNFS++NKLG+GGFG VYKG L DG+EIAVK
Sbjct: 466 KEAWNNDLEPQDVS-GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 524
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLS S QG +E NE++L SKLQH+NLV++LGCCI+GEE+LL+YEF+ NKSLD+F+FD
Sbjct: 525 RLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDS 584
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+R +DW +RF+II G ARGL YLH+DS LR+IHRDLK SN+LLD+ MNPKISDFGL R
Sbjct: 585 RKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLAR 644
Query: 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
+ G E + NT RV GT GYMAPEYA G FS KSD++SFG++LLEI++G+K
Sbjct: 645 MYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEK 696
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1288 (458.5 bits), Expect = 2.4e-131, P = 2.4e-131
Identities = 285/663 (42%), Positives = 395/663 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K P VVWVANR P+ DS L I+ G+L+L + + V WS+ + V +L
Sbjct: 65 KGIIPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSGEAL-VSNGSRAEL 123
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
D+GNL++ D G + WQSFD+ DT+LP L ++L TG ++ ++SWKS+ DPS
Sbjct: 124 SDTGNLIVIDNFSGRT---LWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSV 180
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELYYT 189
GDF+ I Q +V++ KGS +YR+GPW RF+ L + V D +
Sbjct: 181 GDFVLQITPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGS 240
Query: 190 FNITNKAV-ISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
N+ + R ++ T + W+ T W L P CD YG+CG +G+C+
Sbjct: 241 LTYLNRNDRLQRTML--TSKGTQELSWHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKS 297
Query: 249 QSPVCQCLKGFKPKSGGYVDRSQ---GCVRSKPLNYSRQDGFIKFTE-------LKLPDA 298
P C C KGF PK R GCVR L Y + + K+ +K PD
Sbjct: 298 VPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTEL-YCQGNSTGKYANVFHPVARIKPPDF 356
Query: 299 TSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
+ +N++EC++ CL N SC+A+ D G GC MW +L+D F GG+
Sbjct: 357 YE--FASFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGGELLS 410
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLI-RKRRRNIAEKTENSRETDQE 417
IR++ SE+G G K + I + +L+ ++ + R R ++ A+ T ++ +
Sbjct: 411 IRLARSELG--GNKRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQVSWR 468
Query: 418 NEDQNIDLE-LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
N+ + D+ L F++ TI AT+NFSI+NKLG+GGFGPVYKG L DG+EIAVKRLS S
Sbjct: 469 NDLKPQDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSS 528
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL 536
QG +E NE++L SKLQH+NLV++LGCCI+GEEKLLIYEFM N SLD+F+FD +R +
Sbjct: 529 GQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEI 588
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
DW +R II G ARG+ YLH+DS L++IHRDLK SN+LLD+ MNPKISDFGL R + G E
Sbjct: 589 DWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTE 648
Query: 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNL 655
+ NT RVVGT GYMAPEYA G FS KSD++SFG+L+LEI+SG+K +R Y + K L
Sbjct: 649 YQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKT-L 707
Query: 656 IGH 658
I +
Sbjct: 708 IAY 710
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5037 | 0.9641 | 0.76 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000369 | hypothetical protein (820 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 670 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-44 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 4e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-18 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 5e-55
Identities = 81/206 (39%), Positives = 110/206 (53%), Gaps = 18/206 (8%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E ++ E+M L S++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAP 613
IHRDL A N L+ +++ KISDFGL R D + + R G +MAP
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E +G+F+ KSDV+SFG+LL EI +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 2e-54
Identities = 82/206 (39%), Positives = 112/206 (54%), Gaps = 17/206 (8%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKGTL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E +++ E+MP L ++ R L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAP 613
IHRDL A N L+ +++ KISDFGL R D + + +V G +MAP
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E +G+F+ KSDV+SFG+LL EI +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 5e-53
Identities = 77/206 (37%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 446 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500
KLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYGYMAP 613
L + +HRDL A N L+ +D+ KISDFGL R + D T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E DG F+ KSDV+SFG+LL EI +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-51
Identities = 78/210 (37%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 495
+ KLGEG FG VYKGTL ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+LLG C QGE ++ E+MP L F+ + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY----- 610
+HRDL A N L+ +++ KISDFGL R D+ G
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKW 170
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
MAPE DG+F+ KSDV+SFG+LL EI +
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 72/194 (37%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 566 RDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSI 623
RDLK N+LLD D K++DFGL + D++ T +VGT YMAPE G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 624 KSDVFSFGILLLEI 637
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 9e-47
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+L+ + L+ E+ L ++ +R L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YAS 617
IIHRDLK N+LLD++ KI+DFGL + + + VGT YMAPE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLG 172
Query: 618 DGQFSIKSDVFSFGILLLEIVSGK 641
+ K DV+S G++L E+++GK
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-46
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L ++ L+ E+ L + + R + D ++ + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEAR--FYLRQILSALEYLHS-- 115
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
I+HRDLK N+LLD+D + K++DFGL R E VGT YMAPE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+ D++S G++L E+++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LG G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 498 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICGTAR 550
+V+ G E+ L I+ E++ SL S + ++F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL YLH I+HRD+K +N+L+D D K++DFG + G ET T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE ++ +D++S G ++E+ +GK
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-41
Identities = 47/111 (42%), Positives = 71/111 (63%), Gaps = 2/111 (1%)
Query: 154 YRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRR 212
+R+GPWNG+RFS P ++ + ++F N+ E+YYT+ +TN ++ SR+ ++ + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER- 59
Query: 213 FIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263
F W +Q W L+ P+DQCD YG CG YG C + SP C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 7e-41
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I K+G+GGFG VYK G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G ++ +E ++ EF SL + T +TL SQ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL-TESQIAYVCKELLKGLEYLHS--- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
IIHRD+KA+N+LL D K+ DFGL N +VGT +MAPE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
+ K+D++S GI +E+ GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 19/223 (8%)
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE 482
+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
+ NE+++ +H N+V + G+E ++ E+M SL I Q + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE----P 116
Query: 543 HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
I +C +GL YLH +IHRD+K+ N+LL +D + K++DFG F T+
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKE 169
Query: 600 NTNR--VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
+ R VVGT +MAPE + K D++S GI+ +E+ G
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 31/214 (14%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 497
N+ + + +G G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 498 LVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFH------IICGTA- 549
+VK +G I+ + L I E+ N SL I ++F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 550 --RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+GL YLH+ +IHRD+KA+N+L +D K++DFG+ + + VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+MAPE S SD++S G ++E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 57/112 (50%), Positives = 70/112 (62%), Gaps = 6/112 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANRLNP+ DS L++ GNLVL + VVWS+ + + V L D GNLV
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSS-NTSGKGSGCVAVLQDDGNLV 62
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L D +S WQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 63 LYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 69/198 (34%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C GE +I E M SL +F+ + L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
IHRDL A N+L+ +D+ K++DFGL R D + ++ Y + APE AS G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 622 SIKSDVFSFGILLLEIVS 639
S KSDV+SFGILL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/201 (36%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C + E ++ E+M SL F+ + L Q + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYMAPEYASD 618
IHRDL A N+L+ +++ KI+DFGL R DE EG + T APE A+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178
Query: 619 GQFSIKSDVFSFGILLLEIVS 639
G+F+IKSDV+SFGILL EIV+
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 500
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 501 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L Q EEKL L+ E+ P L S + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
L II+RDLK N+LLD D + K++DFGL + + + NT GT Y+APE
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+ D +S G+LL E+++GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 446 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 499
+LGEG FG V L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 500 KLLGCC--IQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
K G C G LI E++P+ SL ++ + LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVGTYGYM 611
YL R IHRDL A N+L++ + KISDFGL + D + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
APE +FS SDV+SFG+ L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 494
D+F +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++KL Q EE L + E+ PN L +I + LD L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV--------- 604
YLH IIHRDLK N+LLD+DM+ KI+DFG + + + +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 605 ---------VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
VGT Y++PE ++ SD+++ G ++ ++++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 73/213 (34%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 448 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIICG 547
LLG C + + +++E++ + L F+ D+T ++ LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVG 606
A G+ YL S +HRDL A N L+ + + KISDFGL R + D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+M PE G+F+ +SD++SFG++L EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I KLGEG +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G + + ++ E+ S+ S I T +TL + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTL-TEEEIAAILYQTLKGLEYLHS--- 117
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
+ IHRD+KA N+LL+++ K++DFG+ T N V+GT +MAPE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
++ K+D++S GI +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+ I ++G+G FG VY DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-------TLLDWSQRFHIICGTAR 550
++K + + ++ E+ L I Q + +LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
L YLH SR +I+HRD+K N+ L + K+ DFG+ + T VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
++PE + ++ KSD++S G +L E+ + K
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 69/195 (35%), Positives = 104/195 (53%), Gaps = 17/195 (8%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G GQ++AVK L K + E + + L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 508 GEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
G ++ E+M SL ++ ++R R ++ +Q+ G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSIK 624
DL A NVL+ +D+ K+SDFGL + E + + G + APE + +FS K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 625 SDVFSFGILLLEIVS 639
SDV+SFGILL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
+ LG+G G VYK G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-----RG 551
+VK G + E ++ E+M SL + + + + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
L YLH IIHRD+K SN+L++ KI+DFG+ + + T N VGT YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYM 167
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+PE +S +D++S G+ LLE GK
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C+Q + ++ E +P SL +F+ + ++ L + + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIK 624
HRDL A N L+ ++ KISDFG+ R G + + APE + G+++ +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 625 SDVFSFGILLLEIVSG 640
SDV+S+GILL E S
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/196 (36%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E M SL ++ R L Q + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYASDGQFSI 623
DL A NVL+ ++ K++DFGL R D E G + APE A +FSI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 624 KSDVFSFGILLLEIVS 639
KSDV+SFGILL EIV+
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 496
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKL L+ E++ SL+ + R+ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGN----TNRVVGTYGYM 611
IIHRD+K N+LLD+D K+ DFGL + + + + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 612 APEYA---SDGQFSIKSDVFSFGILLLEIVSGK 641
APE S S SD++S GI L E+++G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL--LDWSQRFHIICGTA 549
G C +G+ ++++E+M + L+ F + L SQ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
G++YL + +HRDL N L+ D+ KI DFG+ R D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 608 --YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
+M PE +F+ +SDV+SFG++L EI + K + S+ +V
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 448 LGEGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----TLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ + LI + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
R++HRDL A NVL+ + KI+DFGL + DE E + +MA E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 618 DGQFSIKSDVFSFGILLLEIVS-GKK 642
++ KSDV+S+G+ + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 80/215 (37%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 448 LGEGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 497
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLL 553
+VKLLG C+ E + +I E M L S++ D LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 554 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETEGNTNRVVG-- 606
YL Q + IHRDL A N L+ D D KI DFGL R D + + R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEG 173
Query: 607 --TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE DG+F+ +SDV+SFG+L+ EI++
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + ++I E+M N SLD F+ + Q ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
L S + +HRDL A N+L++ ++ K+SDFGL R E T + APE
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
+ +F+ SDV+SFGI++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLLY 554
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH +I+HRD+K+ N+ LD N KI D G+ + + NT +VGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
D ++ KSDV++ G++L E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 446 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYASD 618
+HRDL A NVLL KISDFG+ R G G + + APE +
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINY 172
Query: 619 GQFSIKSDVFSFGILLLEIVS 639
G+FS KSDV+S+G+ L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG V+ G ++ +++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L G C + L++EFM + L ++ + +R + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPE 614
+ +IHRDL A N L+ ++ K+SDFG+ R D+ +T GT + +PE
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPE 171
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
S ++S KSDV+SFG+L+ E+ S K RS+++V
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 494
+ ++GEG +G VYK G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L + +++E+M + L + + SQ + GL
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
YLH + I+HRD+K SN+L++ D K++DFGL R + + TNRV+ T Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
PE Y + D++S G +L E+ GK
Sbjct: 170 PELLLGATRYGP------EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 73/208 (35%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLY 554
+L Q E +I E+M N SL F+ T L+D + + A G+ +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYM 611
+ R IHRDL+A+N+L+ + + KI+DFGL R +E EG + T
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 170
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
APE + G F+IKSDV+SFGILL EIV+
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 499
K+GEG +G VYK + G+ +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KLL + L++EFM + L I + R+ L S + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASD 618
I+HRDLK N+L++ + K++DFGL R+FG T+ VV T Y APE D
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGD 173
Query: 619 GQFSIKSDVFSFGILLLEIVSGK 641
+S D++S G + E++S +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
D++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VK + G+E L+ ++ SL + R LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYGYMAPE 614
+ + IHRD+KA N+LL +D + KI+DFG+ + GGD T VGT +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 615 YASDGQ-FSIKSDVFSFGILLLEIVSGK 641
+ K+D++SFGI +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 499
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + E+M SLD + + R + I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYGYMAPEY 615
+ +IIHRD+K SN+L++ K+ DFG LV + VGT YMAPE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--------VGTSSYMAPER 170
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
+S+KSD++S G+ L+E+ +G+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D ++ LGEG FG V K V +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ + +L F+ D R +Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+ + ARG+ +L + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 448 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 500
LG G FG V+ KG +G E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E +I E+ L F+ ++ + L Q+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
L S R +HRDL A N L+ K+S L + E N ++ ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
+ FS KSDV+SFG+L+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 21/224 (9%)
Query: 447 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+LGEG FG V+ L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL---LDWSQRFHIICGT 548
G C +G L+++E+M + L+ F I L Q I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A G++YL + L +HRDL N L+ Q + KI DFG+ R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652
+M PE +F+ +SD++SFG++L EI + K + S+T+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 447 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIIC 546
LLG + + +I+ + + L F+ D+T ++ L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVV 605
A G+ +L S ++H+DL NVL+ +N KISD GL R + D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+M+PE G+FSI SD++S+G++L E+ S
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 71/228 (31%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILF 490
D+ ++ LG G FG VY+G D E +AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIIC 546
SK H+N+V+L+G + + ++ E M L SF+ + R + L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFGGDETEGNTNR 603
A+G YL ++ IHRD+ A N LL KI+DFG+ R R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-------GKKNR 644
+ +M PE DG F+ K+DV+SFG+LL EI S G+ N+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 74/207 (35%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 496
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL I E KL L++E+ + L ++ R L + I+ RGL Y
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE- 614
H RI+HRDLK N+L+++D K++DFGL R FG T+ VV T Y APE
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEI 169
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
+S D++S G + E+++GK
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 40/213 (18%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 502 LGCCIQGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGTA 549
LG + E+ L I+ E +P SL + I TR+ LL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
GL YLH +HRD+K +N+L+D + K++DFG+ + G+
Sbjct: 114 -GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPY 166
Query: 610 YMAPEY-ASDGQFSIKSDVFSFGILLLEIVSGK 641
+MAPE A G + + +D++S G +LE+ +GK
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C + +I EFM +L ++ + R ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
IHRDL A N L+ ++ K++DFGL R GD + + APE + +F
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKF 182
Query: 622 SIKSDVFSFGILLLEIVS 639
SIKSDV++FG+LL EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 64/215 (29%), Positives = 119/215 (55%), Gaps = 12/215 (5%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + +H N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE + + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 33/222 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 490
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--------QRF 542
+ ++V+LLG G+ L++ E M L S++ ++RR + + Q+F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 543 HIICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R D E +
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDY 174
Query: 602 NRVVGT----YGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R G +MAPE DG F+ KSDV+SFG++L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 447 KLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 501
KLG+G FG V +G +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLH 556
G + + + E P SL + TL D++ + A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYGYMAPE 614
R IHRDL A N+LL D KI DFGL+R D + V + + APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
FS SDV+ FG+ L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L + E +I E+M SL F+ D+ + LL F A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYA 616
R IHRDL+A+NVL+ + + KI+DFGL R +E T R + + APE
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 176
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
+ G F+IKSDV+SFGILL EIV+
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 500
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDS 559
LLG I ++ E M +L +F+ +TR R L+ Q A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+++HRDL A N+L+ +D K+SDFGL R + G N + + APE
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPV-KWTAPEALKHK 172
Query: 620 QFSIKSDVFSFGILLLEIVS 639
+FS KSDV+S+G+LL E+ S
Sbjct: 173 KFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 490
NF I K+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTA 549
+L H N++K L I+ E ++ E L I + ++ L+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
L ++H RI+HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEI 637
YM+PE + ++ KSD++S G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-24
Identities = 35/65 (53%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 283 RQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342
DGF++ +KLPD T++ V +S+ LKEC + CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 343 ELIDM 347
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 73/211 (34%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 492
+N S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+V LLG C G L+I E+ L +F+ + R + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTY 608
+ +L + IHRDL A NVLL KI DFGL R D +GN V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE + ++ +SDV+S+GILL EI S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 495
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHI 544
N++KL+G C + ++I FM + L SF+ + L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETEGNTN 602
A G+ YL S IHRDL A N +L +DM ++DFGL + + GD +G
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
++ ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 176 KM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 500
+G+G FG V++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF----------------HI 544
LLG C G+ L++E+M L+ F+ ++ R S
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 545 IC---GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGN 600
+C A G+ YL S + +HRDL N L+ ++M KI+DFGL R + D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
N + +M PE +++ +SDV+++G++L EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 72/208 (34%), Positives = 109/208 (52%), Gaps = 29/208 (13%)
Query: 448 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 503 GCCIQ-GEEKL-LIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
G C G L L+ E++P SL ++ D R+ LL SQ IC +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQ----IC---KGMEY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG---TYGYM 611
L R +HRDL N+L++ + KI DFGL + D+ E R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
APE ++ +FS+ SDV+SFG++L E+ +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-Q 494
+ T F + +GEG +G VYK GQ +A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 495 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------ 542
H N+ G I+ +++L L+ E S+ + + L +R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG+ D T G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
Query: 603 RVVGTYGYMAPE-----YASDGQFSIKSDVFSFGILLLEIVSGK 641
+GT +MAPE D + +SDV+S GI +E+ GK
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 441 NFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQ 494
N + +LGEG FG V+ L Q+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHI 544
H ++VK G C++G+ ++++E+M + L+ F+ + R L SQ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
A G++YL + +HRDL N L+ +++ KI DFG+ R D + RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 605 VG----TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
G +M PE +F+ +SDV+S G++L EI + K + S+ +V
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 448 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 502
+G+G FG VY GTL+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
G C+ E L++ +M + L +FI +T + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYASDG 619
+ +HRDL A N +LD+ K++DFGL R E N +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 620 QFSIKSDVFSFGILLLEIVS 639
+F+ KSDV+SFG+LL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 65/215 (30%), Positives = 121/215 (56%), Gaps = 12/215 (5%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KNE 486
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ +L++ N+V L + G+E ++ E++ SL D T +D +Q +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE + + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
++ + KLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L + E ++ E+M SL F+ D R L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEY 615
R+ IHRDL+++N+L+ + KI+DFGL R +E T R + + APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEA 174
Query: 616 ASDGQFSIKSDVFSFGILLLEIVS 639
A G+F+IKSDV+SFGILL E+V+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G FG V+ G ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ ++ E+M N L +++ + R+ L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYASDGQFS 622
RDL A N L+ +D K+SDFGL R D+ + GT + PE +FS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFS 179
Query: 623 IKSDVFSFGILLLEIVSGKK 642
KSDV+SFG+L+ E+ S K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E+M SL F+ + L Q + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSIK 624
DL+A+N+L+ +++ K++DFGL R +E T R + + APE A G+F+IK
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 625 SDVFSFGILLLEIVS 639
SDV+SFGILL E+ +
Sbjct: 184 SDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK G A K + SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V L E KL I EF +LDS I + R L Q ++ L +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGL-TEPQIRYVCRQMLEALNF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH ++IHRDLKA N+LL D + K++DFG V + + +GT +MAPE
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFG-VSAKNKSTLQ-KRDTFIGTPYWMAPE 173
Query: 615 YA-----SDGQFSIKSDVFSFGILLLEI 637
D + K+D++S GI L+E+
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
Q + ++ E +P SF+ + ++ L Q A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKS 625
DL A N L+ ++ KISDFG+ R G + ++ + APE + G++S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 626 DVFSFGILLLEIVS 639
DV+S+GILL E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 496
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 497 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+ LG EE L I+ E++P S+ S + R + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVVGTYGYMAP 613
H I+HRDLKA N+L+D D KISDFG+ + D+ N + G+ +MAP
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVFWMAP 179
Query: 614 EY-ASDGQ-FSIKSDVFSFGILLLEIVSGKK 642
E S Q +S K D++S G ++LE+ +G++
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 441 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 493
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI------------FDQTRRTLLDWSQR 541
H +++KL G C Q LLI E+ SL SF+ D R + +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 542 FHIIC---------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ +RG+ YL + ++++HRDL A NVL+ + KISDFGL R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+++ ++ +MA E D ++ +SDV+SFG+LL EIV+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 447 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 500
+LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF--------------DQTRRTLLDWSQRFHIIC 546
LLG Q + +++E++ L F+ D T ++ LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVV 605
A G+ YL S +H+DL A N+L+ + ++ KISD GL R + D ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+M PE G+FS SD++SFG++L EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T G+++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L I TR ++ Q + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGTYGYMAPEYA 616
+IHRD+K+ ++LL D K+SDFG F ++ R +VGT +MAPE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
S + + D++S GI+++E+V G+
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 75/210 (35%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 448 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 498
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 499 VKLLGCCIQGEEK--LLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLY 554
VK GCC + K LI E++P SL ++ LL ++Q+ IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG----- 609
LH IHRDL A NVLLD D KI DFGL + EG+ V G
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVF 175
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ A E + +FS SDV+SFG+ L E+++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 7e-23
Identities = 65/202 (32%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 448 LGEGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP+ L ++ + + LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
R++HRDL A NVL+ + KI+DFGL R GDE E N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
+F+ +SDV+S+G+ + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 497
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTARG 551
+V+ LG + + + E++P S+ LL+ F + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG--NTNR--VVGT 607
L YLH IIHRD+K +N+L+D KISDFG+ + + N R + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+MAPE ++ K+D++S G L++E+++GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 496
+F + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
LV L Q EE + L+ + + L + + + +F IC L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYL 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H IIHRD+K N+LLD+ + I+DF + D T GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGF-YRSDTKVNLIGHVSKMHTTFSS 668
+S+ D +S G+ E + GK R + S T + I +
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQETADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 507 QGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+ + E +P SL + + +T++ ++++ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHD--- 126
Query: 561 LRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+I+HRD+K NVL++ KISDFG + G T GT YMAPE G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKG 184
Query: 620 Q--FSIKSDVFSFGILLLEIVSGK 641
+ +D++S G ++E+ +GK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQR---FHIICGTARGLLYLHQ 557
GC ++ +E L I+ E+MP S+ + + L + R I+ G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGTYGYMAPEYA 616
+ I+HRD+K +N+L D N K+ DFG + + G + V GT +M+PE
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
S + K+DV+S G ++E+++ K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 499
+G+G FG V K V DG+ + K + ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 500 KLLGCCIQGEEKLL-IY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLH 556
+ I + L I E+ L I + R ++ + I+ L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 557 --QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
D ++HRDLK +N+ LD + N K+ DFGL + G D + T VGT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ + KSD++S G L+ E+ +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 498
+++ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 499 VKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V G +KL I E+ SL I+ TR L + Q ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYGYMAP 613
IHRD+K +N+LL +D + K++DFG L T +GT +MAP
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------AKRKSFIGTPYWMAP 170
Query: 614 EYA---SDGQFSIKSDVFSFGILLLEIVSGK 641
E A G + K D+++ GI +E+ +
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 30/233 (12%)
Query: 444 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----------IFDQTRRT--LLDWSQRFHI 544
+VK G C G+ ++++E+M + L+ F + Q R+ L SQ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
A G++YL + +HRDL N L+ ++ KI DFG+ R D + RV
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 605 VG----TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
G +M PE +F+ +SDV+SFG++L EI + K F S+T+V
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-22
Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 278 PLNYSR---QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGG 334
PLN DGF+K ++KLPD ++ +++L+ECRE CL N SC AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 335 SGCAMWFGELIDMRDFPGGGQDFYIR 360
GC +W G L ++R GG Y+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKL 493
+ ++LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 494 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTA 549
+ +VK G + + E+ SLDS I+ + ++ ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVV 605
+GL YLH +IIHRD+K SN+LL + K+ DFG LV + G T
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-------- 164
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT YMAPE +SI SDV+S G+ LLE+ +
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRT----LLDWSQRFHIICGTARGLLY 554
KL + E +I EFM SL F+ D+ + L+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYM 611
+ Q + IHRDL+A+N+L+ + KI+DFGL R +E EG + T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
APE + G F+IKSDV+SFGILL+EIV+
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 441 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F + KLG+G +G VYK L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH 556
++ + G + ++ E+ P L I + +R L+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
+ +I+HRDLK++N+LL + KI D G+ + + +GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
+S KSD++S G LL E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-22
Identities = 62/215 (28%), Positives = 119/215 (55%), Gaps = 12/215 (5%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE + + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F++ +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGTYGYMAPEYAS 617
IHRD+KA+N+LL ++ + K++DFG+ G T + R VGT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGV----SGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 618 DGQFSIKSDVFSFGILLLEIVSGK 641
+ K+D++S GI +E+ G+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDS 559
+ ++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
RI++RDLK NVLLD N +ISD GL V GG + +G GT GYMAPE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQG 168
Query: 619 GQFSIKSDVFSFGILLLEIVSGK 641
+ D F+ G L E+++G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 499
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHIICGTA 549
+ LG C+ + EF+P S+ S + F + + +LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF---GGDETEGNTNRVV- 605
G+ YLH + ++HRD+K +NV+L + K+ DFG R G T N + +
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT +MAPE ++ + KSD++S G + E+ +GK
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+Q LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
R++HRDLK N+L+D K++DFGL R F G T+ VV T Y APE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 621 -FSIKSDVFSFGILLLEIVSGK 641
+S D++S G + E+ + K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-21
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L + E ++ EFM SL F+ + + L Q + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYAS 617
R+ IHRDL+A+N+L+ ++ KI+DFGL R +E T R + + APE A
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
G+F+IKSDV+SFGILL E+V+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 17/201 (8%)
Query: 448 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 502
+G G FG V++G L + G++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--QRFHIICGTARGLLYLHQDSR 560
G + + ++I E+M N +LD ++ D ++S Q ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG--YMAPEYASD 618
+ +HRDL A N+L++ ++ K+SDFGL R D+ EG G + APE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 619 GQFSIKSDVFSFGILLLEIVS 639
+F+ SDV+SFGI++ E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 15/210 (7%)
Query: 447 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLYLHQDSRLRII 564
+ GEE ++ EF+ +L I QTR ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIK 624
HRD+K+ ++LL D K+SDFG D + + +VGT +MAPE S + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 625 SDVFSFGILLLEIVSGKKNRGFYRSDTKVN 654
D++S GI+++E+V G+ Y SD+ V
Sbjct: 198 VDIWSLGIMVIEMVDGEPP---YFSDSPVQ 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 64/205 (31%), Positives = 112/205 (54%), Gaps = 15/205 (7%)
Query: 444 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 498
I +G G FG V +G L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L G + ++I EFM N +LDSF+ + + T++ Q ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG---TYGYMAPE 614
S + +HRDL A N+L++ ++ K+SDFGL R D ++ +G + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
+ +F+ SDV+S+GI++ E++S
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 59/215 (27%), Positives = 118/215 (54%), Gaps = 12/215 (5%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG 178
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE + + K D++S GI+ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K L I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
+PE + ++ KSD++S G LL E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 64/194 (32%), Positives = 100/194 (51%), Gaps = 15/194 (7%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G G ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 508 GEEKLLIY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ L I E+M SL ++ ++R R++L + YL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKS 625
RDL A NVL+ +D K+SDFGL + E + + APE + +FS KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 626 DVFSFGILLLEIVS 639
DV+SFGILL EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 15/207 (7%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 498
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V+L I E KL L++E+M +K L ++ R LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT--NRVVGTYGYMAPEY 615
+ R++HRDLK N+L+++ K++DFGL R FG NT N VV T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDV 171
Query: 616 ASDGQ-FSIKSDVFSFGILLLEIVSGK 641
+ +S D++S G ++ E+++G+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVI 488
IA + D ++++ L EG FG ++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRF 542
L L H+N++ +L CI+ E ++Y +M +L F + + L Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGD-ETEG- 599
H+ A G+ YLH + +IH+D+ A N ++D+++ KI+D L R F D G
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
N NR V +MA E + ++S SDV+SFG+LL E+++
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 500
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 501 LLGCCIQ------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC-GTARGLL 553
G I+ ++ L+ EF S+ I + TL + + IC RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAYICREILRGLS 125
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
+LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G N +GT +MAP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180
Query: 614 EYAS-----DGQFSIKSDVFSFGILLLEIVSG 640
E + D + KSD++S GI +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + + I +LG+G FG VYK + G A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLY 554
+VKLLG + ++ EF P ++D+ + + R + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQY 125
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH ++IIHRDLKA NVLL D + K++DFG+ + +T + +GT +MAPE
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 615 YA-----SDGQFSIKSDVFSFGILLLEI 637
D + K+D++S GI L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 29/206 (14%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 502
+G G +G VY+G V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLL----YL 555
G ++G +I E+ S+ RTL+ ++++ I R +L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H+ +IHRD+KA+N+L+ N K+ DFG+ ++ + VGT +MAPE
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEV 172
Query: 616 ASDGQ-FSIKSDVFSFGILLLEIVSG 640
++G+ + K+D++S GI + E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 71/239 (29%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSF-----IFDQ--TRR---TLLDWSQRFHIICGTARGL 552
G + E+ + E+ +L+ I D+ R LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTY 608
YLH I+HRD+K +N+ LD + K+ DFG L E + + GT
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTP 167
Query: 609 GYMAPEYASDGQFSIK---SDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664
YMAPE + G+ +D++S G ++LE+ +GK R + D + ++ HV H
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHVGAGHK 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 448 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG +Y+ +LV +E+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ L+ E+ +L I + + L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
I+HRD+K N+ L + K+ DFG+ + G + + T VVGT YM+PE ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 622 SIKSDVFSFGILLLEIVSGKK 642
+ KSD+++ G +L E+++ K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 490
+L+ + + F + +G G +G VYKG V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 491 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF 542
K HRN+ G I ++ L+ EF S+ + + L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG+ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 603 RVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSG 640
+GT +MAPE + D + +SD++S GI +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 22/183 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 493
+ I ++GEG G V+K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR--FHIICGTARG 551
QH +VKLL G +L+ E+MP+ L + D+ R L + + ++ +G
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDE-ERPLPEAQVKSYMRMLL---KG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+ Y+H I+HRDLK +N+L+ D KI+DFGL R F +E +++ V T Y
Sbjct: 112 VAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYR 167
Query: 612 APE 614
APE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 447 KLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKELKNEVILF 490
KLGEG FG V+ DGQ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL---------DWSQR 541
S+L++ N+++LLG C+ + +I E+M N L+ F+ + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
++ A G+ YL + L +HRDL N L+ KI+DFG+ R +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R V +MA E G+F+ SDV++FG+ L E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
+PE + ++ KSD++S G LL E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T+ G+ +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L D T ++ Q + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
+IHRD+K+ ++LL D K+SDFG + + +VGT +MAPE S
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190
Query: 619 GQFSIKSDVFSFGILLLEIVSGK 641
+ + D++S GI+++E+V G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V T G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ G+E ++ EF+ +L D T ++ Q + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKS 625
RD+K+ ++LL D K+SDFG + + + +VGT +MAPE S + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199
Query: 626 DVFSFGILLLEIVSGK 641
D++S GI+++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
++ + +++ E+ P +L +I + +LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 562 RIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
I+HRDLK N+LLD+ M KI DFG+ + ++ VVGT Y++PE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177
Query: 621 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK-MHTTFSSI 669
++ KSD+++ G +L E+ S K R+ NL V K M TF+ I
Sbjct: 178 YNQKSDIWALGCVLYELASLK------RAFEAANLPALVLKIMSGTFAPI 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+VKLL I E KL L++EF+ ++ L F+ D + + + + +GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
R++HRDLK N+L++ + K++DFGL R F G T+ VV T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 617 SDGQF-SIKSDVFSFGILLLEIVSGK 641
++ S D++S G + E+V+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 493
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARG 551
H +VK ++ + +I E+ + LD + T +TL + +Q G
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCEWFIQLLLG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+ Y+HQ RI+HRDLKA N+ L ++ KI DFG+ R G T GT YM
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYM 172
Query: 612 APEYASDGQFSIKSDVFSFGILLLEI 637
+PE + KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 499
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L++EFM L+ I D + +L + + T RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE--YAS 617
I+HRDLK +N+L+ D K++DFGL R+FG + T++VV T Y APE + +
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRAPELLFGA 177
Query: 618 DGQFSIKSDVFSFGILLLEIVSGK 641
+ + D++S G + E++
Sbjct: 178 R-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 451 GGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
G +G V+ K T G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
QG++ L L+ E++P L S + D+ D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLV------RTFGGDETEGNTNRVVGTYGYM 611
IIHRDLK N+L+D + + K++DFGL R ++ E R+VGT Y+
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSG 640
APE S D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 73/223 (32%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 440 DNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 490
D + LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTR--RTLL 536
+ +H+N++ LLG C Q +I E+ +L F+ FD T+ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
T+ +MAPE D ++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 438 ATDNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 490
A + +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
+ ++V+LLG QG+ L+I E M L S++ + + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ +M+PE DG F+ SDV+SFG++L EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 23/211 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQH 495
I +G G FG V G L + G+ +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLY 554
N++ L G + + +++ E+M N SLD+F+ + T++ Q ++ G A G+ Y
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG----- 609
L S + +HRDL A N+L++ ++ K+SDFGL R D T R G
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPI 173
Query: 610 -YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE + +F+ SDV+S+GI++ E++S
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 15/208 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQH 495
N + + I +LG+G FG VYK + +A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG-TARGLLY 554
N+VKLL ++ EF ++D+ + + R L + + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTE--PQIRVVCKQTLEALNY 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH++ +IIHRDLKA N+L D + K++DFG+ + T + +GT +MAPE
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 615 Y-----ASDGQFSIKSDVFSFGILLLEI 637
+ D + K+DV+S GI L+E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V G ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C + ++ E+M N L +++ + +R SQ + G+ YL + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYASDGQF 621
HRDL A N L+D K+SDFGL R DE + VG+ + PE +F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 622 SIKSDVFSFGILLLEIVS-GK 641
S KSDV++FG+L+ E+ S GK
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L I + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
R++HRDL A NVL+ + KI+DFGL + G DE E + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
++ +SDV+S+G+ + E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLV 499
LG G F Y+ GTL+ +++ R + SEQ ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
++LG + L E+M S+ + + RGL YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN- 122
Query: 560 RLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF-----GGDETEGNTNRVVGTYGYM 611
+IIHRD+K +N+L+D Q + +I+DFG G E +G +++GT +M
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAFM 175
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGK 641
APE Q+ DV+S G +++E+ + K
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G VYK + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRF-HIICGTARGLLYLHQDS 559
+ L++EF+ K +DS L+ + + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
R++HRDLK N+L+D++ K++DFGL R F G T+ VV T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGS 174
Query: 620 -QFSIKSDVFSFGILLLEIVSGK 641
Q+S D++S G + E+V+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+ G ++G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
R IHRD+KA+NVLL + + K++DFG+ +T+ N VGT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+ K+D++S GI +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP L ++ + R LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
+R++HRDL A NVL+ + KI+DFGL R DETE + + +MA E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
+F+ +SDV+S+G+ + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 498 LVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIIC 546
+++L+G C+Q E ++I FM + L SF+ D L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMT 119
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETEGNTNRV 604
A G+ YL S IHRDL A N +L+++MN ++DFGL + + GD +G ++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
++A E +D ++ KSDV+SFG+ + EI +
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 59/202 (29%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG V+KG Q++ A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E++ S D R D Q ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+ IHRD+KA+NVLL + + K++DFG+ +T+ N VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V+ G ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
C Q + ++ EFM N L +++ + ++ LL Q +C G+ YL ++S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD---VC---EGMEYLERNS- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------YMAPE 614
IHRDL A N L+ K+SDFG+ R DE + G + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPE 171
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKK 642
+ ++S KSDV+SFG+L+ E+ + K
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++ + +I E++ S D LD +Q I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+ IHRD+KA+NVLL + K++DFG+ +T+ N VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG VY V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--IC-GTARGLLYLHQDS 559
GC ++ L+ E+ + D I + ++ L Q I IC G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAYLHSHE 135
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE--YAS 617
R IHRD+KA N+LL + K++D FG N VGT +MAPE A
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLAD------FGSASLVSPANSFVGTPYWMAPEVILAM 186
Query: 618 D-GQFSIKSDVFSFGILLLEIVSGK 641
D GQ+ K DV+S GI +E+ K
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 49/233 (21%)
Query: 447 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEVI 488
KLGEG FG V+ +V+ Q+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD----------- 537
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 538 --------WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
+S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 590 RT-FGGD--ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R + GD +G R V +MA E G+F+ SDV++FG+ L EI+
Sbjct: 186 RNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 448 LGEGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRT--LLDWSQRFHIICGTA 549
G C L E+ P+ +L F+ F T L Q H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G V T G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183
Query: 610 -----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G G V K GT++ + + + S + +Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + EFM SLD +L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
RI+HRD+K SN+L++ K+ DFG+ G+ + VGT YM+PE G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQGG 177
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
++++KSDV+S GI ++E+ GK
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 497
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI---ICGTARGLL 553
LVKLL Q +E L L E++P + + L + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
LH L IHRDLK N L+D + K++DFGL + N VVG+ YMAP
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAP 167
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSG 640
E + D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C Q + ++ E + +F+ +T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM--------APEYA 616
HRDL A N L+ + KISDFG+ R +E +G V + G M APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDG----VYASTGGMKQIPVKWTAPEAL 168
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
+ G++S +SDV+SFGILL E S
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQ 494
++ ++ +GEG FG VY+G + + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + ++ E P L S++ Q + LD + + L Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
L R +HRD+ A NVL+ K+ DFGL R DE+ ++ +MAPE
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPE 178
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS-GKK 642
+ +F+ SDV+ FG+ + EI+ G K
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 6e-18
Identities = 39/80 (48%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP + S L + GNLV+ S VVWS+ + V VL LLD GNLV
Sbjct: 43 VVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS-NTTRVNGNYVLVLLDDGNLV 100
Query: 77 LRDEHDGDSETYFWQSFDYP 96
L D + WQSFDYP
Sbjct: 101 LYD----SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 490
D ++ LGEG FG V + + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDW 538
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 539 SQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
T +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVI 488
D + LGEG FG V + D ++ +AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 489 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLL 536
+ + +H+N++ LLG C Q +I E+ +L ++ ++ T+
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 537 DWSQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 438 ATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 490
++ I KLGEG FG VYK + G+ +A+K++ +E+ L+E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 491 SKLQHRNLVKLLGCCI-----QGEEKLLIYEFMPNKSLD-SFIFDQTRRTLLDWSQRFHI 544
KL+H N+V L+ + ++ +Y P D S + + L I
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL----TESQI 117
Query: 545 ICGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--------- 592
C + G+ YLH++ I+HRD+KA+N+L+D KI+DFGL R +
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 593 -GGDETEGNTNRVVGTYGYMAPEY-ASDGQFSIKSDVFSFGILLLEIVSGK 641
GG T TN VV T Y PE + +++ D++ G + E+ + +
Sbjct: 175 GGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 36/213 (16%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 501
+G G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRF--HIICGTARGLLYLH 556
G + + + E M + SLD F +++ + + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYGYMA 612
++ L+IIHRD+K SN+LLD++ N K+ DFG LV + R G YMA
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-------KTRDAGCRPYMA 175
Query: 613 PE----YASDGQFSIKSDVFSFGILLLEIVSGK 641
PE A DG + ++SDV+S GI L E+ +GK
Sbjct: 176 PERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILF 490
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
++V+LLG +G+ L++ E M + L S++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ A G+ YL+ + +HRDL A N ++ D KI DFG+ R D E + R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYR 176
Query: 604 VVGT----YGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G +MAPE DG F+ SD++SFG++L EI S
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 74/227 (32%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 489
L ++ + TD + I +G+G +G VYK T DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 490 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-- 542
S H N+VK G + G + L+ E S+ + + LL QR
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 543 ----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 599 GNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSG 640
NT+ VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK 500
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 501 LLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI-ICGTARGLLYLHQ 557
G C + LI EF+P+ SL ++ + L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTNRVVGTYGYMAP 613
SR + +HRDL A NVL++ + KI DFGL + D+ + + + V Y AP
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---AP 181
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E +F I SDV+SFG+ L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 501
+++G G FG VY T E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
GC ++ L+ E+ + D + + L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY---ASD 618
+IHRD+KA N+LL + K++D FG N VGT +MAPE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLAD------FGSASKSSPANSFVGTPYWMAPEVILAMDE 194
Query: 619 GQFSIKSDVFSFGILLLEIVSGK 641
GQ+ K DV+S GI +E+ K
Sbjct: 195 GQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFI---------FDQTRRTLLDWSQ 540
N++KL+G ++ K ++I FM + L +F+ F +TL+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETE 598
RF I A G+ YL S IHRDL A N +L+++M ++DFGL + + GD +
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G +++ ++A E +D ++ SDV++FG+ + EI++
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
F+ ++G G FG VY V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY-- 615
+ +IHRD+KA N+LL + K++D FG N VGT +MAPE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLAD------FGSASIASPANSFVGTPYWMAPEVIL 194
Query: 616 -ASDGQFSIKSDVFSFGILLLEIVSGK 641
+GQ+ K DV+S GI +E+ K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 37/79 (46%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP++DS L + GNLVL VVWS+ + VL LLD GNLV
Sbjct: 42 VVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS-NTTGANGNYVLVLLDDGNLV 99
Query: 77 LRDEHDGDSETYFWQSFDY 95
+ D + WQSFDY
Sbjct: 100 IYD----SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-17
Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 378 VIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLEL---PLFELAT 434
I + A L + L+A + R RN E ENED +L+ + + T
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKR------VENEDGTWELQFFDSKVSKSIT 684
Query: 435 IANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
I + + N + G G YKG ++ +G + VK ++ ++ +E+ KL
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
QH N+VKL+G C + LI+E++ K+L + + L W +R I G A+ L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALR 794
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
+LH ++ +L +++D P + L D ++ Y+AP
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAP 847
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSGK 641
E + KSD++ FG++L+E+++GK
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C G L+ + P SL + + R LD + + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
R++HR+L A N+LL D +I+DFG+ D+ + + +MA E G++
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 622 SIKSDVFSFGILLLEIVS 639
+ +SDV+S+G+ + E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLD-WSQRFHIICGTARGLLYLHQDSRL 561
+ ++ + ++ E+ L + + D R L D ++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVV-LAFEYLH---NR 112
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
II+RDLK N+LLD + K+ DFG + + T GT Y+APE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 622 SIKSDVFSFGILLLEIVSGK 641
D +S GILL E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
FS ++G G FG VY V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY-- 615
+ +IHRD+KA N+LL + K+ DFG N VGT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 616 -ASDGQFSIKSDVFSFGILLLEIVSGK 641
+GQ+ K DV+S GI +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCI-QGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGT 548
GC + E+ L I+ E+MP S+ +S TR+ L
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL------------- 116
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGT 607
G+ YLH + I+HRD+K +N+L D N K+ DFG + G R V GT
Sbjct: 117 -EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+M+PE S + K+DV+S G ++E+++ K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 447 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
+LG G FG V KG + Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
G C + E +L+ E L+ F+ ++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--GYMAPEYASDGQ 620
+HRDL A NVLL KISDFGL + G D++ R G + + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 621 FSIKSDVFSFGILLLEIVS-GKK 642
FS +SDV+S+GI + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 441 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 497 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V Q +L I E+ L I Q R L Q + GL ++
Sbjct: 60 NIVTFFAS-FQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
H +I+HRD+K+ N+ L ++ M K+ DFG+ R D E VGT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME-LAYTCVGTPYYLSPE 172
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ ++ K+D++S G +L E+ + K
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 66/228 (28%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELKNEVI 488
KLGEG FG V+ Q+ AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFDQT---------RRT 534
+ S+L N+ +LLG C +I E+M N L+ F T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FG 593
LL ++ A G+ YL L +HRDL N L+ ++ KI+DFG+ R +
Sbjct: 132 LL------YMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 594 GD--ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
D +G R +MA E G+F+ KSDV++FG+ L EI++
Sbjct: 183 SDYYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 498
++GEG +G VYK L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 499 VKLLGCC--IQGEEKL---LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
V+LL C + + +L L++E + ++ L +++ + + L ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
+LH RI+HRDLK N+L+ D KI+DFGL R + T+ VV T Y AP
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-TLWYRAP 175
Query: 614 E------YASDGQFSIKSDVFSFGILLLEI 637
E YA+ D++S G + E+
Sbjct: 176 EVLLQSSYAT------PVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFD--------QTRRTLLDWSQRFHIICGTARGL 552
Q + L L+ M L I++ R +Q II G L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG----L 110
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYGY 610
+LHQ RII+RDLK NVLLD D N +ISD GL G +T+G GT G+
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG----YAGTPGF 163
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
MAPE ++ D F+ G+ L E+++ +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 497
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFD----------QTRRTLLDWSQRF 542
++ LL + + S + F + + ++ + L D ++
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
+ RGL YLH +IHRDLK SN+L++ + + KI DFGL R DE E
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 601 TNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
T VV T Y APE S +++ D++S G + E+++ K
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 447 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + +AVK L + + LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ F+ T + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----YGYMAPEYAS 617
+HRDL A NVLL KISDFGL + G DE N + + APE +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171
Query: 618 DGQFSIKSDVFSFGILLLEIVS-GKK 642
+FS KSDV+SFG+L+ E S G+K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
D + K+GEG +G VYK V + IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L + E++L L++E++ K +DS D + L + + I+ RG+
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSP-DFAKNPRLIKTYLYQIL----RGI 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
Y H R++HRDLK N+L+D+ N K++DFGL R F G T+ VV T Y
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYR 170
Query: 612 APE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
APE +S D++S G + E+V+ K
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 492
++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ +L ++ FD + +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+ + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V + + DG ++ A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQR 541
H N++ LLG C + E+ P +L +F + + L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
A G+ YL S + IHRDL A NVL+ +++ KI+DFGL R G+E
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV---- 171
Query: 602 NRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
V T G +MA E + ++ KSDV+SFG+LL EIVS
Sbjct: 172 -YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 40/220 (18%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHR 496
F N++GEG +G VY+ G+ +A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF------DQTRRTLLD-------WSQRFH 543
N+V+L E + K LDS IF +Q +LLD SQ
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
++ RGL YLH++ IIHRDLK SN+LL KI+DFGL RT+ G + T +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPK 168
Query: 604 VVGTYGYMAPE--YASDGQFSIKSDVFSFGILLLEIVSGK 641
VV T Y APE + D+++ G +L E+++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC E+ L E MP S I DQ T ++++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRV 604
G+ YLH + I+HRD+K +N+L D N K+ DFG + G V
Sbjct: 116 ---LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT +M+PE S + K+D++S G ++E+++ K
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 39/213 (18%)
Query: 446 NKLGEGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
N++G G G VYK T G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDS-------FIFDQTRRTLLDWSQRFHIICGTARGLL 553
E ++ EFM SL+ F+ D R+ L G+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
YLH R I+HRD+K SN+L++ N KI+DFG+ R +T N VGT YM+P
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSP 237
Query: 614 EYA----SDGQFS-IKSDVFSFGILLLEIVSGK 641
E + G + D++S G+ +LE G+
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 33/228 (14%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 501
+GEG +G V K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRFHIICGTARGLLY 554
+ + + L++EF+ + LD + R+ L F I+ RG+ +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL------FQIL----RGIEF 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
H + IIHRD+K N+L+ Q K+ DFG RT E T+ V T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTD-YVATRWYRAPE 170
Query: 615 Y-ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
D ++ D+++ G L+ E+++G+ + D+ ++ + H+ K
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEP---LFPGDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILF 490
+ + + +GEG +G V T G ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 491 SKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ +H N++ +L + ++ E M D + +T+ D Q F +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--L 112
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV- 604
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGL R D +T +
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 605 --VGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
V T Y APE + ++ D++S G +L E++S +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 440 DNFSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLK 481
+ KLGEG FG V+ K +D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRR 533
+ E+ + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-F 592
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG+ R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 593 GGD--ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
GD +G R V +M+ E G+F+ SDV++FG+ L EI++
Sbjct: 182 SGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC EEK L E+MP S I DQ T ++++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRV 604
+G+ YLH + I+HRD+K +N+L D N K+ DFG + G V
Sbjct: 116 ---LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT +M+PE S + K+DV+S ++E+++ K
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 440 DNFSIN--NKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSK 492
DN SI LG G FG + +G L +E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L G +G +++ E+M N +LDSF+ + L Q ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGM 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG--NTNRVVGTYGY 610
YL S + +H+ L A VL++ D+ KIS F ++ D++E T +
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLW 174
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
APE FS SDV+SFGI++ E++S
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 503 GCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQRFHIICGTA 549
G C L E+ P+ +L +F + + L Q H A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R G E
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 7e-16
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 499
+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + +E ++E+M +L + D+ + S II +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH--- 116
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-----VVGTYGYMAPE 614
+ HRDLK N+L+ KI+DFGL R E +R V T Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAPE 168
Query: 615 -YASDGQFSIKSDVFSFGILLLEIVSGK 641
+S D+++ G ++ E+ + +
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLV 499
LG+G FG V KGT + AVK L K + + ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L C Q +++L + E++ L I Q + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYGYMAPEYAS 617
II+RDLK NVLLD + + KI+DFG+ + G T T+ GT Y+APE S
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILS 169
Query: 618 DGQFSIKSDVFSFGILLLEIVSGK 641
+ D ++ G+LL E+++G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 14/227 (6%)
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
++ E++D + D +P + A A+ +++ L G G V+ T GQ V +
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--V 95
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
KI ++G + E +L + H +++++ + G ++ +P+ S D + + R
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
L Q I GL YLH RIIHRD+K N+ ++ I D G +
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF- 206
Query: 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ GT APE + +++ K+D++S GI+L E+++
Sbjct: 207 --PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 440 DNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 492
D+F LG G FG V +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR- 550
++H LV L G Q + L L+ E++P L F R+ S RF AR
Sbjct: 58 IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPE--PVARF 105
Query: 551 -------GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
L YLH L I++RDLK N+LLD D KI+DFG + +G T
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYT 157
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
+ GT Y+APE + D ++ GIL+ E+++G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ + +LG G +G V K V G +AVKR+ + ++ Q K L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRFHIICGTARGLL 553
V G + + + E M + SLD F ++D+ D + I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRVV-----GT 607
YLH S+L +IHRD+K SNVL++++ K+ DFG+ G + V G
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI---------SGYLVDSVAKTIDAGC 166
Query: 608 YGYMAPEY----ASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE + + +KSDV+S GI ++E+ +G+
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH 495
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V G ++ ++ + EF SL I+ T L SQ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H + +HRD+K +N+LL + + K++DFG+ T +GT +MAPE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEV 177
Query: 616 AS---DGQFSIKSDVFSFGILLLEI 637
A+ G ++ D+++ GI +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ EFM SLD ++ + +L I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKS 625
RD+K SN+L++ K+ DFG+ VGT YMAPE S Q+ I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 626 DVFSFGILLLEIVSGK-------KNRGF 646
DV+S GI +E+ G+ KN+G
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 484
T+ T+ + +G G FG V + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF- 542
L L+H N++ L I E + + E + D +R + Q F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFL 114
Query: 543 -HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGL R +
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162
Query: 602 NRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGK 641
V T Y APE Q + ++ D++S G + E++ GK
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 34/209 (16%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 497
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGL 552
LV L C Q E+ + + E+ L I F + R F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-------AVFYAAC-VVLGL 114
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYGYM 611
YLH++ +I++RDLK N+LLD + KI+DFGL + G + T+ GT ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSG 640
APE ++ ++ D + G+L+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 34/218 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 493
+ I KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 494 -QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+VKLL I+ E IY E+M L + I R +L+ + +I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLL 117
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV----V 605
+ L Y+H S +IHRDLK SN+LL+ D K++DFGL R+ + E N V V
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYV 173
Query: 606 GTYGYMAPE--YASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE S +++ D++S G +L E++ GK
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 448 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
L+ M L I++ R L + + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
I++RD+K NVLLD N ++SD GL +T + GT GYMAPE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 622 SIKSDVFSFGILLLEIVSGK 641
S D F+ G + E+V+G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 441 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 487
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRF---- 542
I+ +L+H N+V+ ++ + ++ + + L + F +L + QRF
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN------SLKEKKQRFTEER 114
Query: 543 --HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+I L YLH++ R I+HRDL +N++L +D I+DFGL + E
Sbjct: 115 IWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESK 169
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
VVGT Y PE + + K+DV++FG +L ++ +
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
RI++RDLK N+LLD + +ISD GL V G +G VGT GYMAPE +
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNE 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+++ D ++ G LL E+++G+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
++RDLK N+LLD + +ISD GL V+ G+ G VGT GYMAPE ++
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQ 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
++++ D + G L+ E++ G+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 49/230 (21%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D F I ++GEG +G VYK D G+ +A+K++ +E+ ++E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKL----------LIYEFMPN-------KSLDSFIFDQTR--- 532
L HRN+V L ++ L L++E+M + L F D +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LL+ GL Y H+ + L HRD+K SN+LL+ K++DFGL R +
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 593 GGDETEGNTNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
+E+ TN+V+ T Y PE + ++ DV+S G +L E+ + K
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 447 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVK 500
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ ++ ++ L I Q +LDW F IC L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHV 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H +I+HRD+K+ N+ L +D K+ DFG+ R T +GT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
+ ++ KSD+++ G +L E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQ 494
N ++ + ++G G +G VYK + E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V G + E+ + E+ SL I+ T L Q ++ T +GL Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH ++ HRD+K +N+LL + + K++DFG+ T +GT +MAPE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPE 176
Query: 615 YAS---DGQFSIKSDVFSFGILLLEI 637
A+ +G ++ D+++ GI +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 49/233 (21%)
Query: 444 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 484
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+ ++++H N++ L+ ++G+ L+ + M S + D R+ L SQ I
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCI 124
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD--------- 595
+ GL LH+ +HRDL +N+ ++ KI+DFGL R +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 596 ----ETEGNTNRVVGTYGYMAPEY---ASDGQFSIKSDVFSFGILLLEIVSGK 641
E T++VV T Y APE A F++ D++S G + E+++GK
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 6/92 (6%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
RGL YL + + +I+HRD+K SN+L++ K+ DFG+ G + N VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRS 163
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
YM+PE ++++SD++S G+ L+E+ G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 45/215 (20%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQHRNLVK 500
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 501 LL-------GCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L C+ G+ K IY FD+ R I CG
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----AAEITCG 114
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVG 606
L LH R RI++RDLK N+LLD + +ISD GL V G+ G VG
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VG 163
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T GYMAPE + +++ D + G L+ E++ GK
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 494
+ + + +GEG +G V K G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L + L++E++ L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
H IIHRD+K N+L+ + K+ DFG R T+ V T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 615 -YASDGQFSIKSDVFSFGILLLEIVSG 640
D + DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 47/217 (21%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHR--NLV 499
+G G G VYK G +AVK++ + + +E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-------HIICGTARGL 552
K G I + + E M S D+ LL Q + + L
Sbjct: 78 KCYGYFITDSDVFICMELM------STCLDK----LLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTY 608
YL + +IHRD+K SN+LLD N K+ DFG LV +++ T R G
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV------DSKAKT-RSAGCA 178
Query: 609 GYMAPEY----ASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE + ++ I++DV+S GI L+E+ +G+
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 49/217 (22%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVKL- 501
LG+G FG V L E +K LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 502 --------LGCCIQGEEKLL-IYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFH---I 544
L C Q +E L + E++ L S FD+ R RF+ I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEI 105
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
ICG L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +T
Sbjct: 106 ICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--F 156
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT Y+APE +++ D +SFG+LL E++ G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 22/203 (10%)
Query: 448 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHRNL 498
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
VKL Q E KL LI +F+ L + + + T D +F++ A L +LH
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYL-AELALALDHLH- 115
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
L II+RDLK N+LLD++ + K++DFGL + + E GT YMAPE +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 618 DGQFSIKSDVFSFGILLLEIVSG 640
+ +D +SFG+L+ E+++G
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 47/202 (23%)
Query: 442 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 495
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD--------------QTRRTLLD---- 537
N+V L+ ++ +K + +FD Q +R +
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFG 593
S + I+ G+ YLH + ++HRDLK +N+L+ + KI D GL R F
Sbjct: 111 KSLLWQILN----GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 594 GD-ETEGNTNRVVGTYGYMAPE 614
+ + + VV T Y APE
Sbjct: 164 APLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 446 NKLGEGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 499
+++G G FG V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRRTLLDWSQRFHIICGTARG 551
+ LG CI+ LL+ EF P L +++ + L + C A G
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASG 112
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYGY 610
LL+LHQ IH DL N L D++ KI D+GL + D V +
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRW 168
Query: 611 MAPEYASDGQFSI-------KSDVFSFGILLLEI 637
+APE + KS+++S G+ + E+
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 39/233 (16%)
Query: 447 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 499
++GEG +G V+K + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 500 KLLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA----- 549
+L C E KL L++E + DQ T LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 550 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
RGL +LH R++HRDLK N+L+ K++DFGL R + + VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHV 659
T Y APE ++ D++S G + E+ + + +R + V+ +G +
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 451 GGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCC 505
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRII 564
+ L+ E++ S I +T L DW++++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIK 624
HRD+K N+L+DQ + K++DFGL R G E + + VGT Y+APE
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPETILGVGDDKM 173
Query: 625 SDVFSFGILLLEIVSG 640
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ + L ++ E+ L I Q T+L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H+ R++HRD+K+ N+ L Q+ K+ DFG R T VGT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI 171
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
+ ++ KSD++S G +L E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 461 LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 519 PNKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
P KSL+ F + D Q + LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSD 626
DLK SN+++ D KI DFGL RT G T VV Y Y APE + D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVD 199
Query: 627 VFSFGILLLEIVSGK 641
++S G ++ E++ G
Sbjct: 200 IWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQH 495
D+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 496 RNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
+++L + +++ L + E++P L S++ + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--- 113
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
L YLH I++RDLK N+LLD++ + K++DFG + + T + GT Y
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+APE + D ++ GIL+ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 45/195 (23%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNL 498
K+G+G FG V+K Q +A+K++ +E+ L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 499 VKLLGCC---IQGEEK-----LLIYEF--------MPNKSLDSFIFDQTRRTLLDWSQRF 542
V L+ C + L++EF + NK++ F + ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMK------ 126
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
++ GL Y+H R +I+HRD+KA+N+L+ +D K++DFGL R F +
Sbjct: 127 MLL----NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 601 -TNRVVGTYGYMAPE 614
TNRVV T Y PE
Sbjct: 180 YTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
CC Q ++L + EF+ L I Q R + RF+ T+ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
II+RDLK NVLLD + + K++DFG+ + G T+ GT Y+APE + +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 622 SIKSDVFSFGILLLEIVSG 640
D ++ G+LL E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V K I ++L + + ++N++I ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + + +R + + I RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
+ + +I+HRD+K SN+L++ K+ DFG+ G + N VGT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPER 173
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
+S++SD++S G+ L+E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKL 501
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 502 LGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+GE+ LL + F L + +Q + L + +Q A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK- 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
I+HRDLK NV L + K+ D G+ R +T ++GT YM+PE S+
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNK 177
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
++ KSDV++ G + E+ + K
Sbjct: 178 PYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 74/270 (27%), Positives = 107/270 (39%), Gaps = 76/270 (28%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL---SKISEQG--LKELKNEVI 488
D + LG G FG V + + ++ +AVK L + SE + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---I 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLI------------------YEFMPNKS-------- 522
L H N+V LLG C + L++ F P ++
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 523 ---------LDS-----------FIFDQTRRTLL------DWSQRF----HIICGT---A 549
LDS FI D++ + + + +I + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
RG+ +L SR + IHRDL A N+LL ++ KI DFGL R D
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 448 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLV 499
LG+G FG V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 500 KLLGCCIQGEEKLL-IYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLL 553
L C Q +E L + E++ L I FD R T IICG L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQ 110
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYGYMA 612
+LH I++RDLK N+LLD D + KI+DFG+ + GD T GT Y+A
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIA 164
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE +++ D +SFG+LL E++ G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K I + + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQD 558
C Q +E L + EF+ L I D+ R L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVGTYGYMAPEYA 616
II+RDLK NV+LD+D + KI+DFG+ + FG + + GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEIL 168
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
+++ D +SFG+LL E++ G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 46/151 (30%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
+ ++KL L++E+ ++ L + FD + D + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++HRDLK N+L++++ K++DFGL R FG
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVK 500
+G G +G V + +++A+K+++ + + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 501 LLGCCI-----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRFHIICGTARGLLY 554
+ + ++YE M + L I ++ +TL D Q F + RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYF--LYQLLRGLKY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
+H + ++HRDLK SN+LL+ + + KI DFGL RT E V T Y APE
Sbjct: 124 IHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPE 178
Query: 615 Y---ASDGQFSIKSDVFSFGILLLEIVSGK 641
S+ +I DV+S G + E++ K
Sbjct: 179 LLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
I +E L ++E+M + L ++ Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY---ASDGQ 620
+HRDLK N+L+ K++DFGL R ++ ++ VV T Y P+ A+D
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATD-- 180
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
+S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + L++E+ + L+ ++ R + + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNC 121
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY-ASDGQFS 622
IHRD+K N+L+ + K+ DFG R G + V T Y APE D Q+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 623 IKSDVFSFGILLLEIVSG 640
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E+ L L++E++ +K L ++ D + + F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 621
++HRDLK N+L+++ K++DFGL R T+ +N VV T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 622 SIKSDVFSFGILLLEIVSGK 641
S + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ + CG L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGTYGYMAPEYASDG 619
RI++RDLK N+LLD + +ISD GL EG T R VGT GYMAPE ++
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEVINNE 176
Query: 620 QFSIKSDVFSFGILLLEIVSGK 641
+++ D + G L+ E++ G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-12
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 282 SRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMW 340
D F++ KLP S V +L+EC CL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 341 -FGELIDMRDFPGGGQDFYIR 360
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/199 (32%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +++ L F Q R L+ RF+ A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYA-AEVASAIGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
II+RDLK N+LLD + ++DFGL + G E E T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 622 SIKSDVFSFGILLLEIVSG 640
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ L++E++ +K L ++ D + + F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQFS 622
+HRDLK N+L+++ K++DFGL R T+ +N VV T Y P+ ++S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 623 IKSDVFSFGILLLEIVSGK 641
+ D++ G + E+ SG+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 441 NFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + ++ + T + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYI----AEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+L L +L II+RD+K N+LLD + + ++DFGL + F +E E GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 612 APEY--ASDGQFSIKSDVFSFGILLLEIVSG 640
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 490
+ + +LG+G +G V T + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 491 SKLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--- 544
H+N+ L I +L +YE + L I ++ + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTN 602
I GL Y+H + ++HRDLK N+L++ D KI DFGL R F E G
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 603 RVVGTYGYMAPEYASDGQFSIKS-DVFSFGILLLEIVSGK 641
V T Y APE Q K+ DV+S G +L E++ K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF----------------IFDQTRRTLLDWSQRFHIICGT 548
F P SL+ F I + L D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQI 127
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
RGL Y+H IIHRDLK SN+ +++D KI DFGL R T+ V T
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATR 179
Query: 609 GYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGK 641
Y APE + ++ D++S G ++ E+++GK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
+ +D + I +G+G +G V+K +G + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 495 HRNLVKLLGC-----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------H 543
H N+VK G G++ L+ E S+ + + L +R +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAY 128
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
I+ GL +LH + + IHRD+K +N+LL + K+ DFG+ NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 604 VVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSG 640
VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 440 DNFSINNKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
D + ++LG+G +G VYK G + +EI RL + E ++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+V G + E+M SLD + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYG 609
+L ++ IIHRD+K +NVL++ + K+ DFG LV + TN +G
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL------AKTN--IGCQS 166
Query: 610 YMAPEYASDG------QFSIKSDVFSFGILLLEIVSGK 641
YMAPE G ++++SDV+S G+ +LE+ G+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R+ + RF+ A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
II+RDLK N+LLD + ++DFGL + G E T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 622 SIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651
D + G +L E++ G FY DT
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP--FYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVG 606
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y+APE + + D ++FG+LL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKL 501
K+GEG F V K + G+ A+K + K + L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 502 LGCCIQGEEK--LLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ + L++E M D +++ + R+ L + + + L ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE--TEGNTNRVVGTYGYMAPE- 614
+ I HRD+K N+L+ D K++DFG R TE + T Y APE
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-----YISTRWYRAPEC 169
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
+DG + K D+++ G + EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL---- 555
C C+ Y F L SFI D L + H + A Y
Sbjct: 56 CPFIVCMS-------YAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 556 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H +R +++RDLK +N+LLD+ + +ISD GL F + + VGT+GYM
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 612 APEYASDG-QFSIKSDVFSFGILLLEIVSG 640
APE G + +D FS G +L +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVK 500
+G G FG V+ T DG+ +A+K++ + ++ +ELK + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 501 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLL 553
L EE ++ E M L I + D + F I+ RGL
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVFLYQIL----RGLK 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
YLH I+HRD+K N+L++ + KI DFGL R DE++ T VV Y Y AP
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAP 173
Query: 614 EYASDGQ-FSIKSDVFSFGILLLEIVSGK 641
E + ++ D++S G + E++ +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + + + R Q I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+L L +L II+RD+K N+LLD + + ++DFGL + F DE E GT YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 612 APEY--ASDGQFSIKSDVFSFGILLLEIVSG 640
AP+ DG D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLL 536
++H N++ LL F P +SL+ F ++ T + L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D +F +I RGL Y+H IIHRDLK SN+ +++D KI DFGL R DE
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 173
Query: 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGK 641
G V T Y APE + ++ D++S G ++ E+++G+
Sbjct: 174 MTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 38/220 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQ 494
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FI----FDQTRRTLLD-WSQRFHI---- 544
H N+V + E + +LD ++ + ++L++ Q F
Sbjct: 63 HPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
Query: 545 --ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ G+ +LH + I+HRDLK SN+LL+ KI DFGL R +G
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYT 164
Query: 603 RVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
++V T Y APE ++S D++S G + E+++ K
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 55/238 (23%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 497
+ I +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD--WSQR-------------- 541
+V + C G+ +Y MP +I T ++LL W +
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 542 ----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
FH IC T Y+H S+ ++HRDLK N+LL I D+G +E
Sbjct: 115 FLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 598 E------GNTN----------RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ N ++VGT YMAPE S +D+++ G++L ++++
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHR 496
D + K+GEG +G VYK G+ +A+K+ ++ E+G+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 497 N-LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFIFDQTRR---TLLDWSQRFHIIC 546
+V+LL EEK L++E++ + L F+ D R L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVV 605
+G+ + H + ++HRDLK N+L+D+ KI+D GL R F + T+ +V
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV 173
Query: 606 GTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSG 640
T Y APE +S D++S G + E+
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V+K + I ++L + + ++N++I ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLL 553
+V G E + E M SLD + R +L + +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
YL + + +I+HRD+K SN+L++ K+ DFG+ G + N VGT YM+P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSP 171
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSGK 641
E +S++SD++S G+ L+E+ G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 447 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSR 560
G C + LL+ EF P L ++ + L+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
IH DL N LL D+ KI D+GL
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 47/220 (21%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 500
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 501 LLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLL--------------DWSQR 541
L+ C E K+ L++E + DQ RT L D ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
F RGL +LH + I+HRDLK N+L+ K++DFGL R + +
Sbjct: 117 F------LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMAL 164
Query: 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
VV T Y APE ++ D++S G + E+ K
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSF 630
SN+++ D KI DFGL RT G T V T Y APE + D++S
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 631 GILLLEIVSGK 641
G ++ E++ G
Sbjct: 212 GCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 497
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V LL I +E L L++E++ + L ++ + + F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-Y 615
Q I+HRDLK N+L+ K++DFGL R + +N VV T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVL 175
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSG 640
++S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 50/142 (35%), Positives = 68/142 (47%), Gaps = 18/142 (12%)
Query: 519 PNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
++S DS + T + LD A+G+ +L + IHRD+ A NVLL
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTD 247
Query: 578 DMNPKISDFGLVRTFGGDET---EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
KI DFGL R D +GN V +MAPE D ++++SDV+S+GILL
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILL 304
Query: 635 LEIVS-GKK-------NRGFYR 648
EI S GK N FY+
Sbjct: 305 WEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 462 VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
V G +AVK+LS+ ++ K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 520 NKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567
KSL+ F + D Q LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDV 627
LK SN+++ D KI DFGL RT + T VV Y Y APE + D+
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDI 205
Query: 628 FSFGILLLEIVSG 640
+S G ++ E+V G
Sbjct: 206 WSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 41/100 (41%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 543 HIICGT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
+IC + A+G+ +L SR + IHRDL A N+LL ++ KI DFGL R D
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE D ++I+SDV+SFG+LL EI S
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L E+ A+K L K + + + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQ-RFHIICGTARGLLYLHQDSR 560
CC Q +++L + E++ L +F R D + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
+I+RDLK N+LLD + + K++DFG+ + G T GT Y+APE + +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
+ D ++ G+L+ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 448 LGEGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
LG+G F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G C+ G+E +++ E++ SLD+++ + + L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 560 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+ H ++ A NVLL + NP K+SD G+ T E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 612 APEYASDGQ-FSIKSDVFSFGILLLEIVSG 640
PE + Q S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLG- 503
+G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 504 --CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ G+E Y MP D + L + +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-Q 620
IIHRDLK N+ +++D KI DFGL R + T V T Y APE +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILNWMH 191
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
++ D++S G ++ E+++GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 448 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ + K TLV AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKS----LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ I E ++ M S L + + + F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AF-ILKDVLNALDYIHS 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG-------- 609
IHR +KAS++LL D +S + G RVV +
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLP 173
Query: 610 YMAPE--YASDGQFSIKSDVFSFGILLLEIVSG 640
+++PE + ++ KSD++S GI E+ +G
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 39/211 (18%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQR-----------FHIICGTARGL 552
I ++ L L++E++ D + +D F ++ RGL
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
Y HQ R++HRDLK N+L+ + K++DFGL R ++ +N VV T Y
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRP 171
Query: 613 PEY---ASDGQFSIKSDVFSFGILLLEIVSG 640
P+ +++ +S D++ G + E+ +G
Sbjct: 172 PDVLLGSTE--YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL--- 555
C C + Y F P+K FI D L + H + Y
Sbjct: 56 CPFIVC-------MTYAFHTPDKL--CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 556 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
H +R +++RDLK +N+LLD+ + +ISD GL F + + VGT+GY
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 611 MAPEYASDGQ-FSIKSDVFSFGILLLEIVSG 640
MAPE G + +D FS G +L +++ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSR 560
C Q +L L+ E++ L Q +R L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ 620
II+RDLK NVLLD D + K++D+G+ + G T+ GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 621 FSIKSDVFSFGILLLEIVSGK 641
+ D ++ G+L+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +F+ L F Q R+ + RF+ A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
I++RDLK N+LLD + ++DFGL + G T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 622 SIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651
D + G +L E++ G FY D
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP--FYCRDV 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSF 630
SN+++ D KI DFGL RT G T V T Y APE + D++S
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 631 GILLLEIVSGK 641
G ++ E+V K
Sbjct: 205 GCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q E KL LI +++ + + ++ R + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFY----SGEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+L L +L I++RD+K N+LLD + + ++DFGL + F +E E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 612 APEYA-SDGQFSIKSDVFSFGILLLEIVSG 640
APE G D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 39/91 (42%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
ARG+ +L SR + IHRDL A N+LL ++ KI DFGL R D
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 493
+F + LG G FG V +KGT G+ A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTR---RTLLDWSQRFHIICGTA 549
H +V ++ C Q E ++ + EF+ L F R R D ++ +H A
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH-----A 125
Query: 550 RGLL---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+L YLH II+RDLK N+LLD + K++DFG F + T + G
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPD-RTFTLCG 177
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
T Y+APE D ++ G+LL E ++G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLLDWSQRFHIICGTAR 550
F P S+++F ++ T + L D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
GL Y+H IIHRDLK SNV +++D +I DFGL R DE G V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWY 181
Query: 611 MAPEYASDG-QFSIKSDVFSFGILLLEIVSGK 641
APE + ++ D++S G ++ E++ GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E L L++E++ + L ++ L+ + RGL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 621
I+HRDLK N+L+++ K++DFGL R T+ +N VV T Y P+ ++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 622 SIKSDVFSFGILLLEIVSGK 641
S D++ G +L E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 66/242 (27%), Positives = 103/242 (42%), Gaps = 57/242 (23%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
D+F + +G G FG V+ LV GQ A+K L K +K +N++
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51
Query: 496 RN---------LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
R+ +VKL Q EE L L+ E+MP L + + + + + RF+I
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYI- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL----------------- 588
A +L L +L IHRD+K N+L+D D + K++DFGL
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 589 --------VRTFGGDETEGNTNR--VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638
V D + VGT Y+APE + ++ D +S G++L E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 639 SG 640
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 38/91 (41%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
ARG+ +L + +HRDL A NVLL Q KI DFGL R D +
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE D ++ SDV+S+GILL EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 57/229 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISE------QGLKELKNEVILF 490
+ +G G +G V +D G+++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL--DSF-IFDQTRRTLLDWSQRFHIICG 547
+H N++ + P + D + + D L S HII
Sbjct: 59 RHFKHDNIIAIRDI------------LRPPGADFKDVYVVMD------LMESDLHHIIHS 100
Query: 548 TA---------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
RGL Y+H + +IHRDLK SN+L+++D +I DFG+ R
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 593 GGDETEGNT--NRVVGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIV 638
TE V T Y APE S +++ D++S G + E++
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
++F+ LG G FG V T + +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG---TARG 551
H V L G L+ EF+ +F+ RR ++RF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RR-----NKRFPNDVGCFYAAQI 140
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+L L I++RDLK N+LLD+D K++DFG + + T + GT Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSG 640
APE + +D ++ GI + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-VGT 607
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G T R GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGT 164
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE + + D +++G+LL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 35/79 (44%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---EGNTNRVVGTYGYMAPEYASDGQ 620
IHRDL A N+LL KI DFGL R D +GN V +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 621 FSIKSDVFSFGILLLEIVS 639
++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-VGTYGY 610
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
+APE D + D + G+++ E++ G+ FY D
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 448 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRF------HIICGTARG 551
F P+ SLD F F T L ++ ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
L Y+H IIHRDLK N+ +++D KI DFGL R +T+ V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYR 182
Query: 612 APEYASDG-QFSIKSDVFSFGILLLEIVSGK 641
APE + ++ D++S G ++ E+++GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTL 535
++ + ++ E +F + + + L C Q E +L + E++ L Q +R L
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 93
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
+ RF+ + L YLH+ II+RDLK NVLLD + + K++D+G+ + G
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GL 147
Query: 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T+ GT Y+APE + D ++ G+L+ E+++G+
Sbjct: 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 46/222 (20%)
Query: 448 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 505 CIQGEEKLLIYE--FMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTA------ 549
+YE L + T + ++ + G
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 550 -------RGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD-ETEGN 600
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGL R +G
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 601 TNRVVGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
+ + T Y +P S ++ D+++ G + E+++GK
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLV 499
LG+GG+G V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR--TLLDWSQRFHIICGTARGLLYLHQ 557
L+ G + LI E++ L F R ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVVGTYGYMAPEY 615
II+RDLK N+LLD + K++DFGL + + T+ GT YMAPE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSG 640
D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 464 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 519
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 576
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 577 QDMNPKISDFGLVRTFGGDE-----TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFG 631
+ K+ DFG+ G T T V+GT Y APE + SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 632 ILLLEIVSGK 641
++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 496
LG+G F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+LVKL G C++ +E +++ E++ LD F+ + L W + + A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLVRTFGGDETEGNTNRVVGTYG 609
+++H ++ N+L+ + K+SD G+ T E V
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIP 169
Query: 610 YMAPEYASDGQFSIKS--DVFSFGILLLEIVSGKK 642
++APE +GQ S+ D +SFG LLEI S +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R L+ RF+ A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
I++RDLK N+LLD + ++DFGL + E G T+ GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 622 SIKSDVFSFGILLLEIVSG 640
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 39/263 (14%)
Query: 419 EDQNIDLELPLFE-----LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL 472
+++NID L +E + + +++ + +G G FG V Q++ A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 473 SKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF 526
SK S+ + +++ F+ + V L C Q ++ L ++ E+MP L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 527 I--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
+ +D + W++ + TA +L L + +IHRD+K N+LLD+ + K++
Sbjct: 134 MSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 585 DFGLVRTFGGDETEG-NTNRVVGTYGYMAPEY----ASDGQFSIKSDVFSFGILLLEIVS 639
DFG DET + VGT Y++PE DG + + D +S G+ L E++
Sbjct: 185 DFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242
Query: 640 GKKNRGFYRSDTKVNLIGHVSKM 662
G + FY +L+G SK+
Sbjct: 243 G--DTPFYAD----SLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A GL +LH II+RDLK NV+LD + + KI+DFG+ + D T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE + + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 31/91 (34%), Positives = 52/91 (57%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
LL +H +IHRD+K++N+LL + K+ DFG + + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
APE +S K+D+FS G+LL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 46/206 (22%)
Query: 459 GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
GTLV + + L +E+ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 519 ----PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
N L ++ + L+ +I+ G RGL YLHQ+ IHR++KAS++L
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 575 LDQDMNPKISDFGLVRTFGGDE-----TEGNTNRVVGTYGYMAPEYASDGQ--------- 620
+ D GLV G G +VV Y P++++
Sbjct: 134 ISGD--------GLVSLSGLSHLYSLVRNGQKAKVV----YDFPQFSTSVLPWLSPELLR 181
Query: 621 -----FSIKSDVFSFGILLLEIVSGK 641
+++KSD++S GI E+ +G+
Sbjct: 182 QDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQD 558
L C Q E +L + EF+ L Q +R L + RF+ I L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEIS---LALNFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
II+RDLK NVLLD + + K++D+G+ + G T+ GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 619 GQFSIKSDVFSFGILLLEIVSGK 641
+ D ++ G+L+ E+++G+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 67/235 (28%), Positives = 99/235 (42%), Gaps = 55/235 (23%)
Query: 447 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLV 499
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYL 555
L Q E L L+ ++ P L + Q + L + RF+ ++ L YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL--------------------------- 588
H L I++RDLK N+LL + + +SDF L
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 589 -VRTFGGDETEGNTNRVVGTYGYMAPEYAS-DGQ-FSIKSDVFSFGILLLEIVSG 640
TF +E +N VGT Y+APE S DG ++ D ++ GILL E++ G
Sbjct: 177 PSETFS-EEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNLV 499
++G G FG V + +A VK L + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-DQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ LG C++ LL++E+ L S++ +Q R + C A G+ ++H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYGYMAPEYAS 617
+ +H DL N L D+ K+ D+G+ + + D E ++ V ++APE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 618 ---DGQFSIK----SDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
G + + S+V++ G+ L E+ + SD +V + HV K
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--LNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
L YLH +++RD+K N++LD+D + KI+DFGL + G GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
APE D + D + G+++ E++ G+ FY D
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 31/172 (18%)
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLD----SFIFDQTRRT 534
+L+NE++ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 535 LLDWS------QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
DW Q I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 589 VRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVS 639
F E E VGT +PE A DG I +D++S G++LL+++S
Sbjct: 314 AMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
L YLH + +++RDLK N++LD+D + KI+DFGL + G + GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEY 162
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
+APE D + D + G+++ E++ G+ FY D
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
L YLH +I++RDLK N++LD+D + KI+DFGL + G GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEY 161
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
+APE D + D + G+++ E++ G+ FY D
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 492
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L+ N+V+L + + L++E++ L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
+ H++ I+HRD+K N+L+ + K+ DFG R + + N V T Y +
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE + D++S G +L E+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G+G FG V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q EKL L+ F+ L + FD +R RF+ TA L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR-------ARFY----TAELLCALEN 108
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
+ +I+RDLK N+LLD + + DFGL + D+ + TN GT Y+APE
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLL 166
Query: 618 DGQFSIKSDVFSFGILLLEIVSG 640
++ D ++ G+LL E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 501
+G+G FG VY+ D + I A+K LSK KE+ + +++ + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L Q + L L+ ++M L F Q + +F+I A +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYGYMAPEYASDG 619
I++RDLK N+LLD + + DFGL + ++T TN GT Y+APE D
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDE 171
Query: 620 Q-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652
+ ++ D +S G+L+ E+ G FY DT+
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP--FYAEDTQ 203
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 70/245 (28%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFSKLQHRNLV 499
+G G FG V LV G A+K+L K SE KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL Q E L LI E++P + D+F ++TR F+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR---------FYI----AET 110
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD----------ETEGNT 601
+L + +L IHRD+K N+LLD + K+SDFGL +
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 602 NR--------------------------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLL 635
VGT Y+APE ++ + D +S G+++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 636 EIVSG 640
E++ G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 17/235 (7%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRT-----LLDWSQRFHIICGTARGLLYLHQD 558
+ ++ L++++ + F + + L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGD-ETEGNTNRVVGTYGYMAP 613
++HRDLK +N+L+ + KI+D G R F + + + VV T+ Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 614 EYASDGQFSIKS-DVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667
E + K+ D+++ G + E+++ + + D K + H ++ FS
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 31/76 (40%), Positives = 41/76 (53%)
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSI 623
+HRDL A NVL+ + KI DFGL R D + +MAPE + ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 624 KSDVFSFGILLLEIVS 639
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTY 608
R L Y+H + + HRDLK N+L + D KI DFGL R F T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 609 GYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGK 641
Y APE +++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 448 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 494
LG G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H+++V L G C++ E +++ EF+ LD F+ ++ +L +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 555 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGLVRTFGGDETEGNTNRVVGT 607
L +D L +H ++ N+LL D + P K+SD G+ T + V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ------ECVER 171
Query: 608 YGYMAPEYASDGQ-FSIKSDVFSFGILLLEI 637
++APE D + SI +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/249 (23%), Positives = 114/249 (45%), Gaps = 34/249 (13%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
E++ N+ + E+E++ ID ++ + ++ + N +G G FG VY+ +D
Sbjct: 39 ERSHNNNAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 466 E-IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLL----IYE 516
E +A+K++ + + +EL ++ L H N++ L C + EK + + E
Sbjct: 92 EKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 517 FMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
F+P +K + + + L + +C R L Y+H I HRDLK N+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNL 201
Query: 574 LLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA-SDGQFSIKSDVFSFG 631
L+D + + K+ DFG + + + + + Y APE ++ D++S G
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 632 ILLLEIVSG 640
++ E++ G
Sbjct: 259 CIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 54/261 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQ 494
+ + + K+G G FG V+ QE + IS +GLKE L EV + +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 495 HRNLVKLLGCCI-QGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICG 547
H+N+V+ + + + +KL I EF L R + + F H I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLS--------RNIQKCYKMFGKIEEHAIVD 122
Query: 548 TARGLL----YLHQ----DSRLRIIHRDLKASNVLLD-------------QDMN----PK 582
R LL Y H + R++HRDLK N+ L ++N K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA--SDGQFSIKSDVFSFGILLLEIVSG 640
I DFGL + G E + VGT Y +PE + KSD+++ G ++ E+ SG
Sbjct: 183 IGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 641 KKNRGFYRSDTKVNLIGHVSK 661
K F++++ LI + +
Sbjct: 240 KTP--FHKANNFSQLISELKR 258
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
L S++ H +L + G C++G E +++ EF+ + LD + + R + W + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVL-----LDQDMNP--KISDFGLVRTFGGDETEGNT 601
A L YL + ++H ++ A N+L L + +P K+SD G+ +F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREERV 181
Query: 602 NRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEI 637
R+ ++APE G S +D +SFG LLEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-----LHQD 558
+ ++ L++++ + F + + + + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGD-ETEGNTNRVVGTYGYMAP 613
++HRDLK +N+L+ + KI+D G R F + + + VV T+ Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 614 EYASDGQFSIKS-DVFSFGILLLEIVSGK 641
E + K+ D+++ G + E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 440 DNFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+F + + +G G FG V K T G A+K + K ++++ + + E + S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHIICGTA 549
+ +L + L+ E+ P L S + DQ + +F++ A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYL----A 109
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
+L +H ++ +HRD+K NVL+D+ + K++DFG ++ N+ VGT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPD 168
Query: 610 YMAPEY------ASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE G + ++ D +S G++ E++ G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKELKNEVIL 489
++ + ++F + +G G FG V +++ A+K LSK + +K +++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIK--RSDSAF 89
Query: 490 FSK----LQHRN--LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI--FDQTRRTLLDWSQ 540
F + + H N + L Q ++ L ++ E+MP L + + +D W+
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWA- 144
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF+ TA +L L + IHRD+K N+LLD+ + K++DFG +
Sbjct: 145 RFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-R 199
Query: 601 TNRVVGTYGYMAPEY----ASDGQFSIKSDVFSFGILLLEIVSG 640
+ VGT Y++PE DG + + D +S G+ L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 31/193 (16%)
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E + + H ++++L G + LI +P D + + +R + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI--------AI 181
Query: 546 C-------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
C R + YLH++ RIIHRD+KA N+ ++ + + DFG F D
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA 237
Query: 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR--------SD 650
GT APE + + D++S GI+L E+ + + F + SD
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC-HDSLFEKDGLDGDCDSD 296
Query: 651 TKVNLIGHVSKMH 663
++ LI S H
Sbjct: 297 RQIKLIIRRSGTH 309
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 56/248 (22%), Positives = 94/248 (37%), Gaps = 21/248 (8%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATD----NFSINNKLGEGGFGPVYKGTL- 461
+ D+E+ D+ E + ++ ++I + L G G V+ T
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH 114
Query: 462 --VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
+++ VK ++ G K E+ + + HR ++ L+ K + MP
Sbjct: 115 GDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAY---RWKSTVCMVMP 166
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579
D F + R L Q I L YLH IIHRD+K N+ LD+
Sbjct: 167 KYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPE 222
Query: 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
N + DFG GT +PE + + K+D++S G++L E+
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 640 GKKNRGFY 647
KN +
Sbjct: 283 --KNVTLF 288
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF+I A +L +H +L +HRD+K NVLLD + + +++DFG D T
Sbjct: 105 RFYI----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159
Query: 601 TNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGK 641
++ VGT Y++PE G++ + D +S G+ + E++ G+
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 22/156 (14%)
Query: 513 LIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
++ E+MP L + + +D + W+ RF+ TA +L L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WA-RFY----TAEVVLALDAIHSMGFIHRDVKP 170
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY----ASDGQFSIKSD 626
N+LLD+ + K++DFG + + VGT Y++PE DG + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 627 VFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
+S G+ L E++ G + FY +L+G SK+
Sbjct: 230 WWSVGVFLYEMLVG--DTPFYAD----SLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 24/78 (30%), Positives = 46/78 (58%)
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
+++HRDLK++N+ L K+ DFG + + + + GT Y+APE ++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 622 SIKSDVFSFGILLLEIVS 639
S K+D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV----------------RTFGGDETEG 599
+L IHRD+K N+LLD + K+SDFGL + D T
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 600 NTN-----------------RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
N N VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 62/260 (23%), Positives = 96/260 (36%), Gaps = 75/260 (28%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHII 545
+V L + LI EF+P L D+F D TR F++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR---------FYM- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-------------VRTF 592
A +L + +L IHRD+K N+L+D+ + K+SDFGL +
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
Query: 593 GGDE-TEGNTNR-------------------------------VVGTYGYMAPEYASDGQ 620
G NR VGT Y+APE
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224
Query: 621 FSIKSDVFSFGILLLEIVSG 640
+ + D +S G ++ E + G
Sbjct: 225 YGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF++ A +L + +L +HRD+K NVLLD++ + +++DFG D T
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159
Query: 601 TNRVVGTYGYMAPEY-----ASDGQFSIKSDVFSFGILLLEIVSGK 641
+N VGT Y++PE G++ + D +S G+ + E++ G+
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV-------RT-FGGDETEG-------- 599
+L IHRD+K N+LLD + K+SDFGL RT F + T
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 600 --NTNR---------------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
N+ R VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 492
DN LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEF 517
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 63/245 (25%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q ++ L + +++P + S IF++ RF+I A +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------ARFYI----AELTCAIES 116
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-----------GG----------DE 596
++ IHRD+K N+L+D+D + K++DFGL F G +E
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 597 TEGNTNR--------------------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLE 636
+VGT Y+APE ++ D +S G++L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 637 IVSGK 641
++ G+
Sbjct: 237 MLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 25/87 (28%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS-- 617
+L +HRD+K N+L+D + + +++DFG D T ++ VGT Y++PE
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAM 178
Query: 618 ---DGQFSIKSDVFSFGILLLEIVSGK 641
G++ + D +S G+ + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 42/200 (21%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 456 VYKGTLVDGQEIAVKRLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508
+YKG + +E+ ++ K + + E+KN ++ N++K+ G I
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKN----LRRIDSNNILKIYGFIIDI 90
Query: 509 EEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRI 563
+ L LI E+ L + + L + + + +GL L++ ++
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNK--- 144
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD--GQF 621
+++L + + L+ ++ KI GL + + N N +V Y + + +D ++
Sbjct: 145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEY 199
Query: 622 SIKSDVFSFGILLLEIVSGK 641
+IK D++S G++L EI +GK
Sbjct: 200 TIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 55/243 (22%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + +++P + S + + RF+I A L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYI----AELTLAIESVHKMGF 122
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFG------------------------------ 593
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 594 ---GDETEGNTNR------------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638
GD + R +VGT Y+APE ++ D +S G++L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 639 SGK 641
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 19/125 (15%)
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR----TFGGDETEGNTNR 603
T L YLH I+HRDLK N+L+ + K++DFGL + + + EG+ +
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 604 ---------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVN 654
V GT Y+APE + D ++ GI+L E + G F+ DT
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP--FF-GDTPEE 223
Query: 655 LIGHV 659
L G V
Sbjct: 224 LFGQV 228
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 44/172 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE--------- 486
+ F I + G FG VY G + + AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 487 ---VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDW 538
V L+ LQ N V L+ E++ + S + FD+ +
Sbjct: 64 PFIVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDE------EM 105
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ++ I A L YLH+ IIHRDLK N+L+ + + K++DFGL +
Sbjct: 106 AVKY--ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ 465
D+F + KLGEG FG VYK +LV+ Q
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQ 157
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLGC 504
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E++ ++LD + ++ I A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 565 HRDLKASNVLLDQDMNPKISDFG 587
H DL N+L+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+E L +L H ++ LL + G L+ +P D + + R L +Q
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 545 ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+ AR LL Y+H + IIHRD+K NVL++ + + DFG G +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLE 636
+ GT APE + ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 45/127 (35%)
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF----------GGDETEGNT-------- 601
++ IHRD+K N+L+D+D + K++DFGL F GD ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 602 ---------------------------NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
+ +VGT Y+APE ++ D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 635 LEIVSGK 641
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 40/128 (31%), Positives = 58/128 (45%), Gaps = 24/128 (18%)
Query: 535 LLDW-------SQRF--HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPK 582
LLDW S R II T L Y H + L ++H DLK N+L+ D ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 583 IS-----DFGLVRT--FGG--DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGIL 633
+ D VR GG DE T +V T Y +PE + +D++S G +
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334
Query: 634 LLEIVSGK 641
+ E+ +GK
Sbjct: 335 IYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.98 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.8 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.45 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.43 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.93 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.02 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.96 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.73 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| PLN02236 | 344 | choline kinase | 96.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.18 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=363.19 Aligned_cols=212 Identities=30% Similarity=0.517 Sum_probs=185.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
...+|.+.+.||+|+||+||+|+++. +..||||.+.+. ..+..+.+..|+++|+.++|||||+|++++..++..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34678889999999999999999854 789999998764 666778889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC------CceEEEeecC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGL 588 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGl 588 (670)
||||.+|+|.+||+... .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999996543 5899999999999999999999998 9999999999999875 4589999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
||.+... ......+|+|-|||||++...+|+.|+|+||+|+|||||++|+.||. .....+++..+++
T Consensus 162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~---a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD---AETPKELLLYIKK 228 (429)
T ss_pred hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc---ccCHHHHHHHHhc
Confidence 9998533 33445899999999999999999999999999999999999999965 3334444444443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=376.85 Aligned_cols=234 Identities=48% Similarity=0.835 Sum_probs=201.6
Q ss_pred cCCcccHHHHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEE
Q 005907 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (670)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (670)
....|.+.++..++++|...+.||+|+||.||+|.+.+++.||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45568999999999999999999999999999999999999999988764432156799999999999999999999999
Q ss_pred EeCC-eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 506 IQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 506 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
.+.+ +.+||||||++|+|.++|+..... .++|..+++||.++|+||+|||+...++||||||||.|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999765443 78999999999999999999999887789999999999999999999999
Q ss_pred eecCceecCCCcccCCcccc-ccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhce
Q 005907 585 DFGLVRTFGGDETEGNTNRV-VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~ 662 (670)
|||+|+........ .... .||.+|+|||.+..+..+.|+|||||||+|.||+||+++.+.-.......+.++++..
T Consensus 220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999665321111 1112 7999999999999999999999999999999999999997755544445566655443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=349.74 Aligned_cols=215 Identities=29% Similarity=0.424 Sum_probs=189.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|+++++||+|+||+||.++.++ ++.+|+|++++ ......+..++|..+|.+++||+||+++..|++.+.+++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999999865 78899999976 234466788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|+||+.||.|..+|..+ ..+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++.-.
T Consensus 103 Vld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999543 44888888889999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
. ....+...+||+.|||||++.+..|+..+|+||+|++||||++|.+|| ..++...+++.|.+..
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF---~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPF---YAEDVKKMYDKILKGK 241 (357)
T ss_pred c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCC---cCccHHHHHHHHhcCc
Confidence 2 223345589999999999999999999999999999999999999995 4455667777777766
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=356.29 Aligned_cols=218 Identities=27% Similarity=0.430 Sum_probs=194.5
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.+|...+.||+|||+.||+++. ..|+.||+|++.+ ......+.+.+|++|.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 6799999999865 34556778899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|+|++++|..++. ++..+++.++..++.||+.||.|||+++ |+|||||..|++|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4567999999999999999999999998 999999999999999999999999999998755
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
..... +.||||.|+|||++....++..+||||+|||||-||.|++||+ .+...+.+..|+...-++|+
T Consensus 172 ~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe---tk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 172 GERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE---TKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred ccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc---cchHHHHHHHHHhcCccccc
Confidence 44443 4899999999999999999999999999999999999999965 44455666666666666654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.56 Aligned_cols=204 Identities=37% Similarity=0.612 Sum_probs=175.4
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-eeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~ 517 (670)
.+.+.+.||+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+|+|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344556799999999999999544449999997632 222669999999999999999999999999887 79999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 596 (670)
|++|+|.++|+.. .+..+++..+++++.+||+||+|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45669999999999999999999999863 99999999999999997 99999999998764322
Q ss_pred ccCCccccccccCcccccccC--CCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYAS--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||+....
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 1222267999999999999 56999999999999999999999999875544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.09 Aligned_cols=217 Identities=28% Similarity=0.398 Sum_probs=193.8
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|+..+.||.|+||.|.+++.+. |.-+|+|++++. .-++.+...+|..+|+.+.||+++++.+.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3578899999999999999999854 778999999763 345566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||++||.|.++|++..+ +++....-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+....
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999976443 788899999999999999999988 99999999999999999999999999998642
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.+-+.||||.|+|||++..+.|+.++|+|||||++|||+.|.+||...+ ...+.+.|.+....||+-
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~---~~~iY~KI~~~~v~fP~~ 263 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN---PIQIYEKILEGKVKFPSY 263 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC---hHHHHHHHHhCcccCCcc
Confidence 2556899999999999999999999999999999999999999964333 378889999998888864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=333.01 Aligned_cols=212 Identities=30% Similarity=0.385 Sum_probs=185.9
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-eeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e 516 (670)
.+++..+.||+|..|+||+++++. ++.+|+|.+.. ..+...+++.+|++++++.+||+||+++|+|.... ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 356667899999999999999864 77899999843 45566789999999999999999999999999988 5999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||++|+|+.++... +.+++...-.++.++++||.|||+ .+ ||||||||.||||+..|+|||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998654 348999999999999999999996 44 999999999999999999999999999887543
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC--CCcccchHhhhhhc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY--RSDTKVNLIGHVSK 661 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~--~~~~~~~l~~~i~~ 661 (670)
..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ......+++..|-.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 334578999999999999999999999999999999999999998753 33466777777765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=332.31 Aligned_cols=219 Identities=26% Similarity=0.408 Sum_probs=180.7
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccch-------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
..+.|.+.+.||+|+||.|-+|.. ++++.||||++++..- .......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999986 4589999999976211 11234569999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEee
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 586 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DF 586 (670)
..||||||++||.|.+++-.+ +.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998543 34666777789999999999999998 9999999999999876 67999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ---FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
|+|+..+.. ....+.||||.|.|||++.+.. +..++|+||+||+||-+|+|.+||..... ...+.++|.+..
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQILKGR 398 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHhcCc
Confidence 999987522 2344589999999999997664 33588999999999999999999753332 244667777665
Q ss_pred eecC
Q 005907 664 TTFS 667 (670)
Q Consensus 664 ~~~~ 667 (670)
-.|.
T Consensus 399 y~f~ 402 (475)
T KOG0615|consen 399 YAFG 402 (475)
T ss_pred cccc
Confidence 5443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.91 Aligned_cols=218 Identities=33% Similarity=0.538 Sum_probs=185.5
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
..+.+.+.||+|.||.|+.|.+.....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345667899999999999999987789999999754 4455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
.|+|.+||+. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+||....+.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 33456888999999999999999999987 9999999999999999999999999999665544433
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhcee
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
.. ...-+..|.|||.+....|+.|||||||||+||||+| |+.||+.....+..+.++.=-||.
T Consensus 361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 32 2334678999999999999999999999999999999 899977655555555544444443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.11 Aligned_cols=218 Identities=27% Similarity=0.460 Sum_probs=185.7
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEE-EEEeCCe-eEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV 514 (670)
.+|+++++||+|.||+||++.. .+|..+|.|.+.- .+.+..+.+..|+.+|++|+|||||++++ -+.++.. +.+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999985 6799999998863 45566778899999999999999999998 4444444 7899
Q ss_pred EEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 515 YEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
|||+.+|+|..++.. ...+..++++.+++++.|++.||.++|++- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999854 234566899999999999999999999842 234999999999999999999999999999998
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhce
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~ 662 (670)
.+..... ...+|||.||+||.+.+..|+.||||||+||++|||+.-++||. .+.-.++..+|.+.
T Consensus 179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~---g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY---GDNLLSLCKKIEQG 243 (375)
T ss_pred cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc---cccHHHHHHHHHcC
Confidence 6544433 33789999999999999999999999999999999999999965 33566777777765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.60 Aligned_cols=215 Identities=33% Similarity=0.543 Sum_probs=185.7
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
..+....+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 356677789999999999999863 2467999999875554 788999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR-----------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
+||+|||..|+|.+||..... ..+++..+.+.||.|||.||+||-++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999964211 334888999999999999999999887 999999999999999999
Q ss_pred eEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHh
Q 005907 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLI 656 (670)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~ 656 (670)
|||+|||++|.+...++........-..+|||||.|..++|+.+||||||||+|||++| |+-||..+..++..+.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999998877666554433445789999999999999999999999999999999 99998765555443333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.75 Aligned_cols=220 Identities=25% Similarity=0.351 Sum_probs=186.2
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++++.||+|+||.||+++.++ |..+|+|++++. ...+.+.++.|-.+|....+|.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56889999999999999999999765 889999999873 45567788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||++||++..+|.. ...+++.....++.+++-|++.||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999854 456889999999999999999999998 9999999999999999999999999985432
Q ss_pred CC----------------------cccC-----Cc------------------cccccccCcccccccCCCCCCccchHH
Q 005907 594 GD----------------------ETEG-----NT------------------NRVVGTYGYMAPEYASDGQFSIKSDVF 628 (670)
Q Consensus 594 ~~----------------------~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~~~~sDvw 628 (670)
.. .... .. ...+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 00 113799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 629 SFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 629 SlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
||||||||||.|.+||.-..+.+.-..|.+....+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l 407 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL 407 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc
Confidence 99999999999999977655555544444444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.21 Aligned_cols=222 Identities=28% Similarity=0.457 Sum_probs=192.9
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
...+|.+.+.||+|+|++|++|+.+. ++++|||++.+ ..+...+-+..|-.+|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45689999999999999999998754 88999999976 3444556677899999999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999654 45889999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccc---------CCc--cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 593 GGDETE---------GNT--NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 593 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
...... ... ..++||..|.+||++.+...+..+|+|+||||||+|+.|++|| +...+--+++.|..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF---ra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF---RAANEYLIFQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC---ccccHHHHHHHHHH
Confidence 533221 111 4478999999999999999999999999999999999999994 55556677778887
Q ss_pred eeeecCC
Q 005907 662 MHTTFSS 668 (670)
Q Consensus 662 ~~~~~~~ 668 (670)
+.-+||.
T Consensus 302 l~y~fp~ 308 (604)
T KOG0592|consen 302 LDYEFPE 308 (604)
T ss_pred hcccCCC
Confidence 7777764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.22 Aligned_cols=220 Identities=27% Similarity=0.458 Sum_probs=194.4
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 511 (670)
...++|.+.++||+|.||+|+++.++. ++.+|||.+++ ...+..+..+.|..|+.... ||.+++++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999865 77899999987 35667788889999988875 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+.||++..+. +...+++..+.-++..++.||.|||+++ |||||||.+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954443 3355899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
-.. ....+.+.||||.|||||++.+..|+..+|+|||||+|||||.|+.| |..++++++.+.|......||-
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~P---F~gddEee~FdsI~~d~~~yP~ 589 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESP---FPGDDEEEVFDSIVNDEVRYPR 589 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCC---CCCCCHHHHHHHHhcCCCCCCC
Confidence 532 33456779999999999999999999999999999999999999999 5567778888988888877774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.45 Aligned_cols=216 Identities=28% Similarity=0.409 Sum_probs=181.6
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (670)
..+.|+.+++||+|.||.||+|+. .+|+.||+|+++... +....-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345788889999999999999986 458999999987643 45566778999999999999999999998876 6899
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
||+|||++ +|.-++.. ....+++.++..++.||+.||+|+|+++ |+|||||..|||||.+|.+||+|||||+.+
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 77777743 2344889999999999999999999998 999999999999999999999999999988
Q ss_pred CCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
........++ .+-|+.|.|||.+.+. .|+.++|+||.||||.||++|++.|. ...+.+.++.|.++-
T Consensus 269 ~~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~---G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 269 TPSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ---GRTEVEQLHKIFKLC 336 (560)
T ss_pred cCCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC---CccHHHHHHHHHHHh
Confidence 6655544444 4559999999999875 79999999999999999999999965 344455555555443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.73 Aligned_cols=217 Identities=29% Similarity=0.465 Sum_probs=191.0
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+. .++..+.+.+|++|+++++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999998754 688999999763 44567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+.+ +|..+|... ..++++.+..++.++..||.|||+.. |+|||+||+|||+...+.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 999999543 34899999999999999999999987 9999999999999999999999999999876533
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
. ....+.|||-|||||...+.+|+..+|.||+|||+|||++|++|| -..+...++..|.+-...+|+
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF---~a~si~~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF---YARSITQLVKSILKDPVKPPS 221 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc---hHHHHHHHHHHHhcCCCCCcc
Confidence 2 233478999999999999999999999999999999999999994 455667788888777666664
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=303.56 Aligned_cols=206 Identities=24% Similarity=0.376 Sum_probs=174.6
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|+.+.++|+|+||.||+.+.++ |+.||||++.... +...+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999866 8999999986532 3344567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++..-|.+. .... ..++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eL-e~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHEL-ERYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHH-Hhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 9987655543 3333 34788999999999999999999988 99999999999999999999999999999863
Q ss_pred ccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~ 653 (670)
........+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+.|....+.+..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 2223334677999999999877 68999999999999999999999997654444433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.43 Aligned_cols=223 Identities=26% Similarity=0.415 Sum_probs=192.1
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc----ch-hchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (670)
...++|.+.+.||+|.||.|++|... .+..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999864 5799999977552 11 33556778999999999 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGl 588 (670)
..++||||+.+|+|.+++.+ ...+.+.....++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999966 344778899999999999999999998 9999999999999999 9999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCC-CC-ccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ-FS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.. .....+...|.+....+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKGEFKI 242 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcCCccC
Confidence 99873 1222334579999999999999987 86 789999999999999999999664 56677888889888888
Q ss_pred CCCC
Q 005907 667 SSIV 670 (670)
Q Consensus 667 ~~~~ 670 (670)
|+.+
T Consensus 243 p~~~ 246 (370)
T KOG0583|consen 243 PSYL 246 (370)
T ss_pred CCCc
Confidence 8753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=324.46 Aligned_cols=201 Identities=30% Similarity=0.501 Sum_probs=179.4
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
...|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+..++.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34677778999999999999986 45889999999765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
|++|+|.+.+. ...+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999983 344899999999999999999999998 99999999999999999999999999998864443
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....+|||.|||||++....|+.|+||||||+|++||+-|++||=..+
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~ 473 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN 473 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence 3345789999999999999999999999999999999999999975433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.99 Aligned_cols=203 Identities=32% Similarity=0.488 Sum_probs=173.1
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e 516 (670)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999999865 8899999986643333677999999999999999999999855444 5889999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCC-
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG- 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~- 594 (670)
|+++|+|.+++.+... .+++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976443 5899999999999999999999998 999999999999999 79999999999988754
Q ss_pred CcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
...........||+.|||||++.++ ....++||||+||++.||+||++||..+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 1122233347899999999999864 3345999999999999999999998865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.07 Aligned_cols=187 Identities=33% Similarity=0.499 Sum_probs=165.8
Q ss_pred ccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005907 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~ 522 (670)
..++-||+|+.|.||+|++ .++.||||+++...+ .+|+-|++|+||||+.|.|+|.....++||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3356899999999999998 688999999865443 36777899999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcc
Q 005907 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602 (670)
Q Consensus 523 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 602 (670)
|...|+. +..+.......+..+||.||.|||.+. |||||||.-||||..+..|||+|||.++.+.... ...
T Consensus 199 L~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkM 269 (904)
T KOG4721|consen 199 LYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKM 269 (904)
T ss_pred HHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhh
Confidence 9999964 334677888899999999999999998 9999999999999999999999999998875432 223
Q ss_pred ccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 603 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.++||..|||||+|++.+.+.|+|||||||+|||||||..||..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 47899999999999999999999999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=289.88 Aligned_cols=199 Identities=31% Similarity=0.460 Sum_probs=173.4
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccch--hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|...++||+|.||.||+|++ ..|+.||||+++.... .......+|++.|+.++|+||+.++++|.+.+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999997 4589999999875322 224567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
||+ .+|...+++ +...+...++..++.++++|++|+|++. |+||||||.|+||+.+|.+||+|||+++.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 589999965 4456889999999999999999999988 9999999999999999999999999999987655
Q ss_pred ccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..... .+-|..|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|..
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 44332 2568999999988764 799999999999999999999988654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.66 Aligned_cols=203 Identities=30% Similarity=0.508 Sum_probs=177.6
Q ss_pred CcccceeeeecCceeEEEEEecC----CcEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
...+.++||.|.||+|++|+++- ...||||.++. ..+++..+|+.|+.||.++.||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678999999999999999853 35799999986 45677889999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|||++|+|+.||+.+. +.+.+.++..++++||.||+||-+.+ +|||||.++|||++.+..+|++|||++|.+..+
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999998754 44888999999999999999999877 999999999999999999999999999988655
Q ss_pred cccCCcccccc--ccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 596 ETEGNTNRVVG--TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 596 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
... ......| ..+|.|||.|...+++.+|||||||++|||.++ |++||.....
T Consensus 785 ~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 785 PEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred CCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 422 2222223 568999999999999999999999999999887 9999764433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.37 Aligned_cols=216 Identities=28% Similarity=0.457 Sum_probs=185.8
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+.+.++++||+|-||+|.+.+...+..||||+++... ....++|..|+++|.+++||||++++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35677889999999999999999778999999998744 34458999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
|++|+|.+||.++.... +......+|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||++|-+...++
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998764433 456677789999999999999987 99999999999999999999999999998877666
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCCCCCcccchHhhhhhc
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS--GKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~p~~~~~~~~~~~l~~~i~~ 661 (670)
.......+-+.+|||||.|..++++.++|||+||++|||+++ .++||+.... ++++++...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~ 755 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGE 755 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhh
Confidence 655555667889999999999999999999999999999866 6778654433 344444433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.48 Aligned_cols=220 Identities=26% Similarity=0.384 Sum_probs=195.0
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..-|++.+.||.|+-|.|-+|++ ..|+.+|||++.+. .......+.+|+.||+.+.|||++++++++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688889999999999999997 45999999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
.||+++|-|.++|.. ++.+++.+..+++.||+.|+.|.|..+ |+||||||+|+|||..+++||+|||+|.+--
T Consensus 91 lEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 999999999999854 455889999999999999999999987 9999999999999999999999999998742
Q ss_pred CcccCCccccccccCcccccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~~ 670 (670)
......+.||.|.|.|||++++.+|. .++||||.|||||.||||+.||+ ++....++..++++..++|+.|
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f~MPs~I 235 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVFEMPSNI 235 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcccCCCcC
Confidence 22334457999999999999999985 89999999999999999999954 7778899999999999999865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=287.38 Aligned_cols=222 Identities=28% Similarity=0.412 Sum_probs=194.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++.+|++|-..|+||||++++++|.+....+|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45789999999999999999999754 668999998652 33445688999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++||..+|.|...|.+.. ...+++.....++.|+|.|+.|+|... ||||||||+|+|++..+..||+|||.+-.-
T Consensus 100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 999999999999997543 334778888899999999999999887 999999999999999999999999987653
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~~ 670 (670)
........|||..|++||...+..++..+|+|++|++.||++.|.+||+ +....+.++.|.+....||+.|
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe---s~~~~etYkrI~k~~~~~p~~i 245 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE---SQSHSETYKRIRKVDLKFPSTI 245 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh---hhhhHHHHHHHHHccccCCccc
Confidence 2334455899999999999999999999999999999999999999965 3447788999999999988765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=343.48 Aligned_cols=209 Identities=36% Similarity=0.583 Sum_probs=181.0
Q ss_pred cCCcccceeeeecCceeEEEEEecC--Cc----EEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.+..+..+.||+|+||.||+|...+ +. .||||.+.+ .+++...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456677899999999999998754 33 489999977 4567778999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 512 LLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
++++|||++|+|..||++.. ....+...+.+.++.+||+|+.||+++. +|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998742 1345889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
+|+.+...++........-..+|||||.+.+..|+.|+|||||||+|||++| |..||..-+..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 9997765555444333344578999999999999999999999999999999 88997644433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.60 Aligned_cols=221 Identities=26% Similarity=0.385 Sum_probs=182.2
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchh--chHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ--GLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
...++|+.++.|++|.||.||+|+++. ++.||+|+++...+. -.-.-.+|+.+|.+++|||||.+-.+..-. +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 345678999999999999999999854 788999999764322 223457899999999999999998887643 568
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++|||||+. +|...+.... ..+...+...++.|+++|++|||... |+||||||+|+|++..|.+||+|||+||.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 999999975 8998886543 45778888899999999999999988 99999999999999999999999999999
Q ss_pred cCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
++..... ....+-|+.|.|||.+.+. .|+...|+||+|||+.||+++++.|. .+.+.+.++.|.++.....+
T Consensus 227 ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~---G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 227 YGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP---GKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred hcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC---CCchHHHHHHHHHHhCCCcc
Confidence 8755332 2335679999999998775 68999999999999999999999954 45556666777666655544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.62 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=173.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+++.. .++.||+|++++. .......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999875 4789999998753 2334457888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998643 34889999999999999999999987 999999999999999999999999998765321
Q ss_pred ccc---------------------------------CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCC
Q 005907 596 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642 (670)
Q Consensus 596 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~ 642 (670)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 005907 643 NRGF 646 (670)
Q Consensus 643 p~~~ 646 (670)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.73 Aligned_cols=215 Identities=24% Similarity=0.330 Sum_probs=181.3
Q ss_pred cCCcccceeeeecCceeEEEEEecC--CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.+.||+|+||.||+|.... +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998644 368999998642 23345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999653 34788999999999999999999988 9999999999999999999999999998763
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+...++..+.+....+|
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~---~~~~~~~~~i~~~~~~~p 248 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA---NEPLLIYQKILEGIIYFP 248 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC---CCHHHHHHHHhcCCCCCC
Confidence 22 2235789999999999998999999999999999999999999753 233344555555444444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=310.34 Aligned_cols=201 Identities=29% Similarity=0.395 Sum_probs=173.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhch-HHHHHHHHHHhcCC-CCceeeEEEEEEeCC-eeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGL-KELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 513 (670)
..++|.++++||.|.||.||+|+.. .+..||||++++.-.... -.=.+|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568999999999999999999864 488999999976322211 22358999999998 999999999999988 8999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||||+ .+|++++.+. +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 5999999664 677999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcccCCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.... .+..+.|..|.|||++. ...|+.+.|+|++|||++|+.+-++.|..-
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 4433 23467899999999874 567999999999999999999999998643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.55 Aligned_cols=214 Identities=22% Similarity=0.316 Sum_probs=180.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 4889999998642 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998643 34788889999999999999999988 999999999999999999999999998865322
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+......++
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~ 218 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---NPFGIYEKILAGKLEFP 218 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCcCCC
Confidence 22356899999999999999999999999999999999999997543 23344444444444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.05 Aligned_cols=215 Identities=24% Similarity=0.346 Sum_probs=181.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357999999999999999999985 4789999998652 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999998653 34788888899999999999999988 99999999999999999999999999987633
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....+...+.+....+|
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~---~~~~~~~~~i~~~~~~~p 235 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLKFP 235 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCcCCC
Confidence 21 235789999999999999999999999999999999999999753 223344444444444443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.79 Aligned_cols=212 Identities=26% Similarity=0.465 Sum_probs=185.9
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++ .+++....+.+|++||..|+||||++++.+|...+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35789999999999999999986 5699999999976 3556667889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||..+|.|++|+.+ +..+++.+..+++.||..|+.|.|.+. ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999965 345899999999999999999999887 99999999999999999999999999988743
Q ss_pred CcccCCccccccccCcccccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhce
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~ 662 (670)
.. ..+++||+|-|.+||++.+.+|. +.+|-|||||+||.|+.|..||..+ +...++.+|.+.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~G 268 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRG 268 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcc
Confidence 33 23458999999999999999884 8899999999999999999996544 344555555543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=301.52 Aligned_cols=198 Identities=34% Similarity=0.575 Sum_probs=170.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc--CCCCceeeEEEEEEeCC----eeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~ 512 (670)
.+..++.++||+|.||.||+|.+ +++.||||++. .+..+.|.+|-.|... ++|+||++|+++-..+. .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34567778999999999999998 56999999985 4556778888888775 58999999999977665 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
||+||.+.|+|.+||.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+++++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999954 4489999999999999999999975 3678999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCC-CC-----ccchHHHHHHHHHHHHcCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ-FS-----IKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvil~elltG~~p~ 644 (670)
|+|..+........+-..+||.+|||||++.+.. +. .+.||||+|.|||||++.-+-.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999998776666666689999999999997653 22 4689999999999999875543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.83 Aligned_cols=209 Identities=28% Similarity=0.408 Sum_probs=180.5
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..+.|++.++||.|..++||+|+. +.++.||||++.-. .....+.+.+|+..++.++||||++.+..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346899999999999999999986 55899999998542 2233789999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
.||.+|++.++++..-..+ +++..+..|.+++++||.|||++| -||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997755433 889999999999999999999998 999999999999999999999999987766433
Q ss_pred ccc--CCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 596 ETE--GNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 596 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
... ...+...||+.|||||++... .|+.|+||||||+...||.+|.-||..|-+-
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 221 111457899999999997543 6899999999999999999999999876543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.97 Aligned_cols=203 Identities=33% Similarity=0.518 Sum_probs=173.3
Q ss_pred CCcccceeeeecCceeEEEEEecCC----cE-EEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDG----QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
++..+.++||+|+||.||+|+++.. .. ||||..+. ..+...++|++|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 4555668999999999999997542 23 89999874 4567788999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++|||+|.||+|.+||.+... .++..+++.++.++|.||+|||+++ +|||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999976443 5889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
-. .+........-+.+|+|||.+....|+.++|||||||++||+++ |..||.....
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 43 11111111124679999999999999999999999999999999 8889764443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.27 Aligned_cols=206 Identities=31% Similarity=0.542 Sum_probs=173.5
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
.++....+.+.+.+.||+|.||+||+|++.+ .||||.+.. ...+..+.|++|+..+++-+|.||+-|+|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3444455667788899999999999999843 589999875 345578899999999999999999999999988777
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.+|..+|+|.+|+.+|+- .+..++....+.|+.||++||.|||.++ |||||||..||++.+++.|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999964 3355888899999999999999999998 9999999999999999999999999986
Q ss_pred ecCCCcccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.-..-.-........|...|||||+++. .+|+..+||||||+++|||+||..||..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 4322111122233457889999999964 4799999999999999999999999863
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.20 Aligned_cols=222 Identities=27% Similarity=0.352 Sum_probs=186.6
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+.|++++.||.|.-|+||++++.+ +..+|+|++.+. .++...+...|-+||+.++||.++.|+..++..+..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467888999999999999999976 478999999763 3445567788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC-
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG- 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~- 594 (670)
|||+||+|...++++. ...+++..+.-++.+++-||+|||..| ||+|||||+||||.++|++-|+||.|+..+..
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999987754 455788888889999999999999988 99999999999999999999999998754311
Q ss_pred --------------------------------C-c--------------------ccCCccccccccCcccccccCCCCC
Q 005907 595 --------------------------------D-E--------------------TEGNTNRVVGTYGYMAPEYASDGQF 621 (670)
Q Consensus 595 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 621 (670)
. . ....+...+||-.|+|||+|++...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0012233579999999999999999
Q ss_pred CccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 622 SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 622 ~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
+.++|+|+|||+|||||.|+.|| ......+.+.+|..-...||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPF---KG~~~~~Tl~NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPF---KGSNNKETLRNIVGQPLKFPE 356 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCc---CCCCchhhHHHHhcCCCcCCC
Confidence 99999999999999999999995 455555666666666666654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=291.29 Aligned_cols=219 Identities=26% Similarity=0.398 Sum_probs=180.5
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch--hchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCC------
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 509 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 509 (670)
..|..+++||+|+||.||+|+.+ .|+.||+|+++-..+ .......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777788999999999999974 588999999875333 24456789999999999999 999999998877
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
..++|+||+ ..+|..|+...... ..++...+..++.||+.||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 56999999764432 34677889999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
|+.+.-.... ....++|..|.|||++.+. .|+...||||+|||+.||++++..|.. +.+.+.+..|.+...+.+
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG---~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG---DSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHHHcCCCC
Confidence 9976422222 3346789999999999887 799999999999999999998888653 334666666666555544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.89 Aligned_cols=193 Identities=24% Similarity=0.323 Sum_probs=167.8
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||+++.. +++.||+|++++. .......+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998753 2334456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCc
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (670)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 999988543 35789999999999999999999988 9999999999999999999999999987542211 122
Q ss_pred cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 602 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 345799999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.10 Aligned_cols=201 Identities=25% Similarity=0.350 Sum_probs=171.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|.+.++||+|+||.||++... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999874 5889999998652 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998543 34788888899999999999999988 999999999999999999999999998643211
Q ss_pred cc------------cC---------------------------------CccccccccCcccccccCCCCCCccchHHHH
Q 005907 596 ET------------EG---------------------------------NTNRVVGTYGYMAPEYASDGQFSIKSDVFSF 630 (670)
Q Consensus 596 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 630 (670)
.. .. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 005907 631 GILLLEIVSGKKNRGF 646 (670)
Q Consensus 631 Gvil~elltG~~p~~~ 646 (670)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (377)
T cd05629 235 GAIMFECLIGWPPFCS 250 (377)
T ss_pred chhhhhhhcCCCCCCC
Confidence 9999999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=309.26 Aligned_cols=198 Identities=28% Similarity=0.422 Sum_probs=174.8
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|+... ++.||+|++.+.. ......+.+|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999864 7899999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999543 34788899999999999999999988 99999999999999999999999999886533
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2233578999999999999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.02 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=172.6
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
|+..+.||+|+||.||++... +++.||+|.+.+.. ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999874 58999999986422 22334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.....
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998875432 234788999999999999999999987 99999999999999999999999999987532221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 123568999999999999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.63 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=172.2
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.|++++.||+|+||.||+|+.. .++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999874 4789999998652 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998643 34788888889999999999999987 9999999999999999999999999976431100
Q ss_pred c---------------------------------------------cCCccccccccCcccccccCCCCCCccchHHHHH
Q 005907 597 T---------------------------------------------EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFG 631 (670)
Q Consensus 597 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 631 (670)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 005907 632 ILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 632 vil~elltG~~p~~~~~ 648 (670)
|++|||++|+.||....
T Consensus 236 ~il~elltG~~Pf~~~~ 252 (381)
T cd05626 236 VILFEMLVGQPPFLAPT 252 (381)
T ss_pred hHHHHHHhCCCCCcCCC
Confidence 99999999999986433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.28 Aligned_cols=207 Identities=31% Similarity=0.466 Sum_probs=171.0
Q ss_pred cCCcccceeeeecCceeEEEEEe------cCCcEEEEEEecccc-hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC-
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE- 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 509 (670)
.++|++.++||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 224679999986532 33456789999999999 8999999999887644
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------------------------------------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 532 (670)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCc
Q 005907 533 --RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610 (670)
Q Consensus 533 --~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 610 (670)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134677888999999999999999987 999999999999999999999999999876433222222234467889
Q ss_pred ccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 611 MAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 611 ~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.92 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=174.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+++.. .++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999975 4889999999653 2334556889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998643 34889999999999999999999988 999999999999999999999999998765321
Q ss_pred cccC------------------------------------CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc
Q 005907 596 ETEG------------------------------------NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639 (670)
Q Consensus 596 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt 639 (670)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 005907 640 GKKNRGFY 647 (670)
Q Consensus 640 G~~p~~~~ 647 (670)
|+.||...
T Consensus 235 G~~Pf~~~ 242 (364)
T cd05599 235 GYPPFCSD 242 (364)
T ss_pred CCCCCCCC
Confidence 99998543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.61 Aligned_cols=193 Identities=24% Similarity=0.329 Sum_probs=167.5
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998753 2334556778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCc
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (670)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 999888543 34788999999999999999999987 99999999999999999999999999875422221 12
Q ss_pred cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 602 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 235689999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.07 Aligned_cols=201 Identities=24% Similarity=0.351 Sum_probs=171.7
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.|++.++||+|+||.||+|+.. .++.+|+|++.+. .......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999874 4788999998653 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998543 34788888899999999999999987 9999999999999999999999999975431100
Q ss_pred ---------------------------------------------ccCCccccccccCcccccccCCCCCCccchHHHHH
Q 005907 597 ---------------------------------------------TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFG 631 (670)
Q Consensus 597 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 631 (670)
........+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001224689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 005907 632 ILLLEIVSGKKNRGFY 647 (670)
Q Consensus 632 vil~elltG~~p~~~~ 647 (670)
|+||||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.27 Aligned_cols=193 Identities=25% Similarity=0.336 Sum_probs=168.0
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998752 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCc
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (670)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 999888543 34789999999999999999999987 9999999999999999999999999987643221 122
Q ss_pred cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 602 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 335789999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.69 Aligned_cols=209 Identities=24% Similarity=0.310 Sum_probs=174.3
Q ss_pred eeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||+++..+ ++.||+|++.+. .......+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999754 788999998652 234456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9998643 34788999999999999999999988 9999999999999999999999999987643222 12234
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
..||+.|+|||++.+..++.++||||+||++|||++|+.||... ....+...+.+....++
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~~~~~~~~~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYRKILQEPLRFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHHHHHHcCCCCCC
Confidence 57999999999999999999999999999999999999997532 23344444444444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.65 Aligned_cols=216 Identities=25% Similarity=0.348 Sum_probs=177.5
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+|++.+.||+|+||.||+|+... ++.+|+|++.+. .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999998754 678999998753 223344567788888777 5899999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999988543 34788999999999999999999987 999999999999999999999999998764322
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...++..+.+....+|
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p 221 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYP 221 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 1 12234578999999999999999999999999999999999999976433 3344455555444444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.88 Aligned_cols=223 Identities=27% Similarity=0.455 Sum_probs=182.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--------------hhchHHHHHHHHHHhcCCCCceeeE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------------EQGLKELKNEVILFSKLQHRNLVKL 501 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l 501 (670)
...+.|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45578999999999999999999974 58899999996521 1123578899999999999999999
Q ss_pred EEEEEeC--CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 502 LGCCIQG--EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 502 ~g~~~~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
+.+..+. +.+|||+|||..|.+... ......+++.+..+++.++..||+|||.++ ||||||||.|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9997654 578999999998877432 122223889999999999999999999998 99999999999999999
Q ss_pred ceEEEeecCceecCCCcc---cCCccccccccCcccccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCCCCCccc
Q 005907 580 NPKISDFGLVRTFGGDET---EGNTNRVVGTYGYMAPEYASDGQ----FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~p~~~~~~~~~ 652 (670)
++||+|||.+........ ........|||.|+|||...++. .+.+.||||+||+||-|+.|+-| |..+..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P---F~~~~~ 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP---FFDDFE 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC---cccchH
Confidence 999999999886632211 11223368999999999987632 35789999999999999999999 566677
Q ss_pred chHhhhhhceeeecCC
Q 005907 653 VNLIGHVSKMHTTFSS 668 (670)
Q Consensus 653 ~~l~~~i~~~~~~~~~ 668 (670)
..+.+.|+.-.-.||+
T Consensus 325 ~~l~~KIvn~pL~fP~ 340 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPE 340 (576)
T ss_pred HHHHHHHhcCcccCCC
Confidence 8888888887777775
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.18 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=172.7
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++..+...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 44689999999999999999999854 788999998642 22334567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998542 3788888999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDG----QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.... .......||+.|+|||++.+. .++.++||||+||+||||++|+.||..
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 3222 122345799999999998654 378899999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.45 Aligned_cols=216 Identities=25% Similarity=0.345 Sum_probs=177.8
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 515 (670)
+|++.+.||+|+||.||+|+..+ ++.||+|++.+. .....+.+..|+.++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999998754 678999998752 234456778899999999765 6888999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988543 34788899999999999999999987 999999999999999999999999998753221
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
. .......||+.|+|||++.+..++.++||||+||++|||+||+.||... ....++..+.+....+|
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~~~~~~~~ 221 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSIMEHNVSYP 221 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence 1 1223457899999999999999999999999999999999999997533 23444555555444444
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=293.90 Aligned_cols=211 Identities=28% Similarity=0.413 Sum_probs=168.0
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----eEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----KLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV 514 (670)
.|...+++|+|+||.||+|.... ++.||||++-...+ .-.+|+.+|+++.|||||+|+-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999999854 68999999854222 22468999999999999999988865432 3489
Q ss_pred EEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCceec
Q 005907 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~ 592 (670)
||||+. +|.++++.. ..+..++...+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 888888642 12344677777789999999999999987 9999999999999987 89999999999998
Q ss_pred CCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeee
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~ 665 (670)
....... ....|.-|.|||.+.+. .|+.+.||||.||+|.||+-|++.|.. ++..+.+..|.++...
T Consensus 177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG---~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG---DSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC---CCHHHHHHHHHHHhCC
Confidence 6555442 23458899999998775 799999999999999999999999765 4444444445444433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.05 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=172.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
+|++.+.||+|+||.||+++.. .++.||+|++.+. .......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999875 4789999998652 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998543 34788888889999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------ccCCccccccccCcccccccCCCCCCccchHHHHHHHHH
Q 005907 597 -----------------------------------------TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLL 635 (670)
Q Consensus 597 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ 635 (670)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011247999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 005907 636 EIVSGKKNRGFYR 648 (670)
Q Consensus 636 elltG~~p~~~~~ 648 (670)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.04 Aligned_cols=193 Identities=28% Similarity=0.409 Sum_probs=166.3
Q ss_pred eeeeecCceeEEEEEec----CCcEEEEEEeccc----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+.||+|+||.||+++.. .++.||+|.+++. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 4788999998752 123345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998543 34678888889999999999999987 99999999999999999999999999875432221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 22335789999999999998999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.97 Aligned_cols=204 Identities=22% Similarity=0.296 Sum_probs=173.7
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
.....++|++.+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 33445789999999999999999999854 788999998642 22334567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999998542 3678888889999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDG----QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 7643221 122346799999999998654 378999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.61 Aligned_cols=196 Identities=28% Similarity=0.426 Sum_probs=167.1
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHH---hcCCCCceeeEEEEEEeCCeeEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
|++.+.||+|+||.||+|... +++.||||++++. .....+.+..|+.++ ..++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999875 4789999998753 223345566666554 567899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988743 34889999999999999999999987 99999999999999999999999999875422
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 11 222346789999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.69 Aligned_cols=203 Identities=26% Similarity=0.360 Sum_probs=174.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 4789999998652 2334567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998543 34788899999999999999999988 999999999999999999999999998755321
Q ss_pred ccc---------------------------------CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCC
Q 005907 596 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642 (670)
Q Consensus 596 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~ 642 (670)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113479999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 005907 643 NRGFYR 648 (670)
Q Consensus 643 p~~~~~ 648 (670)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 986433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.27 Aligned_cols=194 Identities=29% Similarity=0.410 Sum_probs=164.6
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+..+ ++.||+|.++.. .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999754 778999998752 22334455667777665 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999988643 34788899999999999999999987 9999999999999999999999999998653222 22
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 33467899999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.70 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=170.4
Q ss_pred CcccceeeeecCceeEEEEEec----CCcEEEEEEeccc----chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCee
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (670)
+|++.+.||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999763 4788999998652 223345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 34788999999999999999999987 99999999999999999999999999886
Q ss_pred cCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 5332222 22235799999999999765 4788999999999999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.66 Aligned_cols=216 Identities=25% Similarity=0.363 Sum_probs=176.9
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (670)
+|+..+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999875 4789999998752 2334456778888888885 577888999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999998543 34889999999999999999999987 999999999999999999999999998764322
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...++..+.+....+|
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~p 221 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYP 221 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 21 2233568999999999999999999999999999999999999976432 3344444444444443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.35 Aligned_cols=201 Identities=23% Similarity=0.316 Sum_probs=171.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999875 4789999998642 22334567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998542 3678888889999999999999987 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDG----QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 32221 12335799999999998653 478999999999999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.40 Aligned_cols=206 Identities=30% Similarity=0.493 Sum_probs=171.5
Q ss_pred CCcccceeeeecCceeEEEEEecC-----------------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 501 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 501 (670)
++|.+.++||+|+||.||++...+ +..||+|.+... ......++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 336999998653 23345679999999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005907 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565 (670)
Q Consensus 502 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 565 (670)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985421 1134677888999999999999999987 999
Q ss_pred ccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc--CCCC
Q 005907 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS--GKKN 643 (670)
Q Consensus 566 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~p 643 (670)
|||||+|||++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644332222233456789999999988899999999999999999987 5567
Q ss_pred CCCCC
Q 005907 644 RGFYR 648 (670)
Q Consensus 644 ~~~~~ 648 (670)
|....
T Consensus 242 ~~~~~ 246 (304)
T cd05096 242 YGELT 246 (304)
T ss_pred CCcCC
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.68 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=172.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999975 4889999998642 2334456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 234788889999999999999999988 999999999999999999999999998776432
Q ss_pred cccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 221 1223468999999999863 4578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.27 Aligned_cols=211 Identities=23% Similarity=0.357 Sum_probs=173.7
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 789999998753 233445677888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999888543 34788889999999999999999988 99999999999999999999999999876432221 2
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ....++..+.+....+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~---~~~~~~~~i~~~~~~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFESILHDDVLYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence 23356899999999999999999999999999999999999997643 33444455544443333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=299.12 Aligned_cols=210 Identities=27% Similarity=0.382 Sum_probs=172.9
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+.+ +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 4789999998652 233456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999988643 34788999999999999999999987 9999999999999999999999999987642221 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...++..+.+....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCCC
Confidence 233578999999999999999999999999999999999999986433 233444444433333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.95 Aligned_cols=194 Identities=24% Similarity=0.321 Sum_probs=167.1
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998753 2334556788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 999888542 347899999999999999999997 56 99999999999999999999999999876432211 1
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 22356899999999999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=302.51 Aligned_cols=216 Identities=27% Similarity=0.434 Sum_probs=187.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-eEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV 514 (670)
.++|..++++|+|+||.+++++++ +++.+++|++.- ..+...+...+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999999875 477899998754 334445578899999999999999999999999888 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|+|++||+|.+.|.+.. ...++++.+..++.|++.|+.|||+.. |+|||||+.||+++.++.|||.|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997644 567899999999999999999999776 99999999999999999999999999999876
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
.... .....||+.||.||.+.+.+|+.|+|||||||++|||++-+++| +..+...++..|-+..
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF---~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF---KASNMSELILKINRGL 222 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc---CccchHHHHHHHhhcc
Confidence 5423 33478999999999999999999999999999999999999995 4455556666665554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=293.57 Aligned_cols=201 Identities=26% Similarity=0.395 Sum_probs=170.4
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 47899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++ +|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 898888543 234788899999999999999999988 99999999999999999999999999986532221
Q ss_pred cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467899999999865 568999999999999999999999986433
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.88 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=176.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|.+.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999975 5889999998753 2244567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999654 45888999999999999999999987 999999999999999999999999999876433
Q ss_pred c---------------------------ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 E---------------------------TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. .........||+.|+|||.+.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112233568999999999999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.82 Aligned_cols=208 Identities=26% Similarity=0.449 Sum_probs=181.9
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.|...+.||+|.||.||+|... .++.||+|++.- ..+...+++.+|+.++.+++++||.+.++.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 5666789999999999999974 478899999864 45566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
.+|++.+.|.. ...+++..+.-++.+++.|+.|||.++ .+|||||+.|||+..+|.+||+|||++..+......
T Consensus 94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999998843 334477788889999999999999998 999999999999999999999999999887544333
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHh
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 656 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~ 656 (670)
. ..++|||-|||||++....|+.|+||||||++.+||.+|.+|+...++.....+|
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 3 5689999999999999999999999999999999999999999887775544443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.07 Aligned_cols=201 Identities=23% Similarity=0.316 Sum_probs=172.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+++.. .++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 4778999998652 2233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999653 234788888999999999999999987 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 221 1223568999999999875 4678899999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.72 Aligned_cols=203 Identities=20% Similarity=0.271 Sum_probs=176.1
Q ss_pred CcccceeeeecCceeEEEEEecC--CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.|.+.+.||+|+||.||+|.... ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48899999999999999998643 5678888775545555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 519 PNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 519 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
++|+|.++|... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988542 23445788999999999999999999987 99999999999999999999999999987654333
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 2233446799999999999999999999999999999999999999753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.00 Aligned_cols=201 Identities=21% Similarity=0.316 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.++||+|+||.||+++... ++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478899999999999999999755 678999998642 2233456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 234788888999999999999999987 999999999999999999999999998765332
Q ss_pred cccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 22 1222357999999999986 34688999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=292.13 Aligned_cols=225 Identities=27% Similarity=0.379 Sum_probs=194.3
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..+.|..-++||+|+||.||-.+.. .|+-+|.|++.+ ..++.....++|-.||.+++.+.||.+-..+...+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999988765 488899998854 234555677899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|+..|.||+|.-+|..... ..+++..++-++.+|+-||++||... ||+|||||+|||+|+.|+++|+|+|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999977654 56899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccc-hHhhhhhceeeecCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV-NLIGHVSKMHTTFSSI 669 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~i~~~~~~~~~~ 669 (670)
...... ..+||.+|||||++.+..|+...|+||+||+||||+.|+.||..+...... ++-+.+.....+||+.
T Consensus 339 ~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~k 412 (591)
T KOG0986|consen 339 EGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDK 412 (591)
T ss_pred CCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccc
Confidence 544432 248999999999999999999999999999999999999999776665443 5556777777777653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.55 Aligned_cols=201 Identities=27% Similarity=0.387 Sum_probs=170.1
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999985 58899999986532 2234467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6787777543 344788889999999999999999988 9999999999999999999999999987653222
Q ss_pred ccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223567899999999865 46889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=298.11 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=166.1
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4788999998753 233445677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9999888543 34789999999999999999999987 9999999999999999999999999987542211 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2335789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=292.77 Aligned_cols=202 Identities=22% Similarity=0.343 Sum_probs=172.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999985 4788999998653 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998877655422 235788899999999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.. ......|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 21 2223568999999999999899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=298.07 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=167.2
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+++.. +++.||+|++++. .....+.+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 4789999999752 233445688899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9999888543 34889999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2346789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.79 Aligned_cols=199 Identities=27% Similarity=0.375 Sum_probs=174.1
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||+++.. .+..+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999975 4778999988653 33445679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999998653 34788899999999999999999853 4999999999999999999999999998765322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12235689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.55 Aligned_cols=210 Identities=28% Similarity=0.381 Sum_probs=171.1
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+.. +++.||+|.+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999985 47899999987531 23345667787777754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999988553 34788899999999999999999987 9999999999999999999999999987532111 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... +...+...+......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~~~~~~~~~~~~~~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRVDTPHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCC
Confidence 23357899999999999999999999999999999999999997533 2334444444333333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.13 Aligned_cols=194 Identities=29% Similarity=0.395 Sum_probs=164.9
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+..+ ++.||+|+++.. .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 788999998753 12334556677777776 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 9999998643 34788889999999999999999987 9999999999999999999999999987542211 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 23357899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=280.96 Aligned_cols=201 Identities=25% Similarity=0.344 Sum_probs=176.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|..+++||+|.||.|.+++-+ .++.+|+|++++ ...+....-..|-.+|+..+||.+..|-..|+..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578999999999999999999865 488999999987 344455566788999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||..||.|.-+|.. ...+++.....+-.+|..||.|||+++ ||+||||.+|.|+|++|++||+|||+++.-.
T Consensus 246 VMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999888743 445778888888999999999999987 9999999999999999999999999998632
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+...||||.|+|||++.+..|+.++|+|.+||+||||++|+.||..
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 233455678999999999999999999999999999999999999999643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.52 Aligned_cols=193 Identities=27% Similarity=0.339 Sum_probs=162.7
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|+.. +++.+|+|++.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 47889999986522 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 9998888542 34778888899999999999999987 999999999999999999999999998753222 122
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 3345789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.26 Aligned_cols=194 Identities=26% Similarity=0.399 Sum_probs=167.3
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999753 233456688899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9999888543 34889999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 23467899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.13 Aligned_cols=210 Identities=27% Similarity=0.345 Sum_probs=173.9
Q ss_pred eeeeecCceeEEEEEe----cCCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 446 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
+.||+|+||.||+++. ..++.+|+|++.+.. ......+..|+.++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5899999999999875 247899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 99999998543 34789999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||... +....+..+.+....+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i~~~~~~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHHHcCCCCC
Confidence 223357899999999999889999999999999999999999997543 2333444444433333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=288.01 Aligned_cols=195 Identities=30% Similarity=0.435 Sum_probs=168.0
Q ss_pred eeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||++... +++.+|+|++.+.. ....+.+..|+.++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 57899999986522 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcc
Q 005907 524 DSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602 (670)
Q Consensus 524 ~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 602 (670)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98875422 3345889999999999999999999987 999999999999999999999999999876433221 22
Q ss_pred ccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 603 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 357899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.22 Aligned_cols=193 Identities=26% Similarity=0.338 Sum_probs=163.4
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|... +++.||+|++.+.. ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999985 58899999986522 222344555544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999988543 34788889999999999999999988 9999999999999999999999999987542211 22
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 2345789999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.08 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=173.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+++.. +++.+|+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 5889999998753 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999654 235888999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccC------CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS------DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 222 222346899999999986 45678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=288.01 Aligned_cols=201 Identities=30% Similarity=0.431 Sum_probs=172.8
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999874 58899999986422 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886432 235789999999999999999999987 9999999999999999999999999988753222
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1 123468999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.59 Aligned_cols=193 Identities=28% Similarity=0.380 Sum_probs=166.3
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|+... ++.||+|++++. .......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 778999998753 233455677888888887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9999988543 24889999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....+|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 2335689999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=282.11 Aligned_cols=217 Identities=28% Similarity=0.421 Sum_probs=176.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe-----CCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 510 (670)
...|...+.||+|+||.|..+..+ +|+.||||++.. ......++..+|+.+|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666789999999999999874 589999999873 344556788899999999999999999998865 346
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++|+|+| ..+|...|..+ ..++......++.||+.||.|+|+.+ |+||||||.|+|++.+..+||+|||+||
T Consensus 101 vYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 67999998543 33888899999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCcccCCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeee
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~ 665 (670)
...........+..+-|..|.|||++. ...|+.+.||||.||||.||++|++.|..-+ ....+..|..+.++
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d---~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD---YVHQLQLILELLGT 246 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc---hHHHHHHHHHhcCC
Confidence 886442222223456799999999875 4689999999999999999999999976443 34444444444433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.36 Aligned_cols=193 Identities=25% Similarity=0.338 Sum_probs=162.0
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHH-HHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+++... ++.+|+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999754 6789999986522 22233444444 456789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|.+++... ..+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 9999998643 34677888889999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 3346799999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=294.17 Aligned_cols=218 Identities=26% Similarity=0.392 Sum_probs=186.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccch---hchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 511 (670)
...+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||++.+.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678999999999999999999876 89999999976333 24568999999999998 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CceEEEeec
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFG 587 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFG 587 (670)
++|||++.||.|.+.|... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999665 2899999999999999999999988 9999999999999644 479999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.... .......|.+....|+
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~---~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET---EFEIFLAILRGDFDFT 258 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC---hhHHHHHHHcCCCCCC
Confidence 9998754 334456899999999999999999999999999999999999999975433 3333345665555544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.24 Aligned_cols=207 Identities=34% Similarity=0.489 Sum_probs=171.9
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (670)
.++|++.+.||+|+||.||+|... ++..||+|+++.. .......+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457899999999999999998742 2357999998653 233456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC----------------------------------------------------------
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 532 (670)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 533 ---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 533 ---------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
...+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123678888999999999999999987 99999999999999999999999999987643322111222
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 335678999999999999999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.07 Aligned_cols=193 Identities=27% Similarity=0.347 Sum_probs=163.6
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+++.. +++.+|+|++.+. ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999874 5889999998652 2233345555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 9999888542 34789999999999999999999988 9999999999999999999999999987542211 12
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 2345789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=285.40 Aligned_cols=194 Identities=27% Similarity=0.483 Sum_probs=162.3
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc--CCCCceeeEEEEEEeCC----ee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EK 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~ 511 (670)
......+.+.||+|.||+||+|++ .|+.||||++...++ +.+.+|.+|.+. |+|+||+.|++.-..+. ++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345788899999999999999999 689999999976443 456677777765 69999999999876543 57
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
+||.+|.+.|+|.+||.+ ..++....++++..+|.||++||. ++++.|.|||||+.|||+.+++.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999954 458999999999999999999995 57899999999999999999999999999
Q ss_pred cCceecCCCc--ccCCccccccccCcccccccCCCC----C--CccchHHHHHHHHHHHHc
Q 005907 587 GLVRTFGGDE--TEGNTNRVVGTYGYMAPEYASDGQ----F--SIKSDVFSFGILLLEIVS 639 (670)
Q Consensus 587 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlGvil~ellt 639 (670)
|||-...... .....+..+||.+|||||++.... + -..+||||||+||||+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9998765432 223345578999999999986542 2 146999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=287.87 Aligned_cols=191 Identities=20% Similarity=0.357 Sum_probs=165.0
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhc---hHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeEEEEEcc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 518 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 518 (670)
..||+|+++.||+|.. +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5899999999999998 78999999997643322 4678899999999999999999999877 34678999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999653 3478889999999999999999984 5 8899999999999999999999999988653321
Q ss_pred cCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 12457899999999976 689999999999999999999999987543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.02 Aligned_cols=220 Identities=25% Similarity=0.386 Sum_probs=188.7
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (670)
..+|.++.+||+|+||.|.++..+. .+.+|||++++ ...+..+--+.|-++|+.. +-|.+++++.+++.-+.+++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3478899999999999999998765 46799999987 2344455556777888776 46899999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+.||+|-..|+...+ +-+..+.-++.+||-||-+||+++ ||+||||.+|||++.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888854333 556677789999999999999998 9999999999999999999999999998532
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.....+.+.+|||.|+|||++...+|+..+|+|||||+|||||.|+.| |+.+++.++.+.|.....+||..
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpP---FdGeDE~elF~aI~ehnvsyPKs 572 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP---FDGEDEDELFQAIMEHNVSYPKS 572 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCC---CCCCCHHHHHHHHHHccCcCccc
Confidence 223345668999999999999999999999999999999999999999 56778889999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=270.77 Aligned_cols=222 Identities=25% Similarity=0.403 Sum_probs=184.4
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-----ch---hchHHHHHHHHHHhcC-CCCceeeEEEE
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SE---QGLKELKNEVILFSKL-QHRNLVKLLGC 504 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~ 504 (670)
.......|.-.+.||.|..+.|.+..++ .|++.|+|++... .+ ...++-..|+.||+++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445567888899999999999888764 5889999988532 11 1234456799999998 69999999999
Q ss_pred EEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 505 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
+......++|+|.|+.|.|.+||-+ ...+++++..+|+.|+++|++|||..+ ||||||||+|||++++.++||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 9999999999999999999999943 456899999999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccC------CCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhh
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 658 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 658 (670)
|||.+..+..... ....||||+|+|||.+. ...|+..+|+|++|||||.|+.|.+||.. .. ..-++..
T Consensus 166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--Rk-QmlMLR~ 239 (411)
T KOG0599|consen 166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RK-QMLMLRM 239 (411)
T ss_pred ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HH-HHHHHHH
Confidence 9999998854433 34589999999999984 34688999999999999999999999743 22 3455677
Q ss_pred hhceeeecCC
Q 005907 659 VSKMHTTFSS 668 (670)
Q Consensus 659 i~~~~~~~~~ 668 (670)
|.+.+-+|.+
T Consensus 240 ImeGkyqF~s 249 (411)
T KOG0599|consen 240 IMEGKYQFRS 249 (411)
T ss_pred HHhcccccCC
Confidence 7777766654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.50 Aligned_cols=213 Identities=23% Similarity=0.328 Sum_probs=178.4
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCC-C-----CceeeEEEEEEeCCeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 513 (670)
+|++.+.||+|.||.|.++.+.. ++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999998754 899999999753 344566678999999997 4 489999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--CceEEEeecCcee
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRT 591 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~ 591 (670)
|+|.+ ..+|+++|..+. ...++...+..++.||++||.+||+.+ |||+||||+||||.+- ..+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 569999997654 445889999999999999999999988 9999999999999754 4799999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
...... ....+.-|.|||+|.+.+|+.+.|+||||||+.||++|.+.|. .+.+.+.+..|......+|
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp---G~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP---GDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC---CCCHHHHHHHHHHHhCCCC
Confidence 543322 2456788999999999999999999999999999999987754 4455555555555555443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.50 Aligned_cols=200 Identities=25% Similarity=0.420 Sum_probs=166.9
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eeE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (670)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999875 5889999998642 2233457889999999999999999999886432 479
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||++ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6898888543 34789999999999999999999988 999999999999999999999999999865
Q ss_pred CCCccc-CCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 322211 11223568999999999866 67899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=308.37 Aligned_cols=207 Identities=24% Similarity=0.326 Sum_probs=176.1
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 509 (670)
...++|.+.+.||+|+||.||+++.. +++.||||++... .+.....+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34569999999999999999999864 5899999998642 3445567889999999999999999988775432
Q ss_pred ----eeEEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 510 ----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 510 ----~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
..++||||+++|+|.++|.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3579999999999999986532 2345889999999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|||+++.+.............||+.|+|||.+.+..++.++|||||||+||||++|+.||..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999876543333333446799999999999999999999999999999999999999753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.97 Aligned_cols=206 Identities=33% Similarity=0.456 Sum_probs=171.8
Q ss_pred cCCcccceeeeecCceeEEEEEe------cCCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (670)
.++|++.+.||+|+||.||+|.. ..+..||||+++.. .....+.+.+|+.++..+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999964 23568999998643 233456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC----------------------------------------------------------
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 532 (670)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 533 --------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 533 --------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124678889999999999999999987 999999999999999999999999999876443322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 22222345678999999999999999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.84 Aligned_cols=214 Identities=30% Similarity=0.489 Sum_probs=183.8
Q ss_pred cccceeeeecCceeEEEEEe-cCC----cEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTL-VDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
....++||+|+||+||+|.+ ++| -+||+|++.. ...+..+++++|+.+|.+++|||+++|+|+|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457999999999999986 344 3689998865 45566789999999999999999999999998665 78999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
+||+.|+|.+|++.+ +..+-.+..+.+..|||+||.|||++. ++||||.++||||.+-..+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999774 445778999999999999999999887 999999999999999999999999999999877
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~ 661 (670)
..+.......-.+.|||-|.+....|+.++|||||||.+||++| |.+||..-..++.-++++.--|
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 76666555556788999999999999999999999999999999 9999876666665555554444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=272.83 Aligned_cols=219 Identities=26% Similarity=0.441 Sum_probs=183.1
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..+.|++.+.||+|.|+.|++... ..|+.+|+|++.. ......+++.+|+.|.+.|+||||++|.+........++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788889999999999998875 4588899988743 3445788999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~ 591 (670)
+|+|.|++|-.-|-. +-..++...-+.+.||+++|.|.|..+ |||||+||+|+|+-.. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999655422 234677888889999999999999998 9999999999999543 4589999999999
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
++..... -...|||+|||||+++..+|+..+|||+.|||||-||.|..||. .++...+++.|++..-.++.
T Consensus 163 l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~---~~~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 163 VNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW---DEDQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred eCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC---CccHHHHHHHHhccccCCCC
Confidence 8733222 23679999999999999999999999999999999999999964 34556677777776555543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.64 Aligned_cols=200 Identities=26% Similarity=0.375 Sum_probs=173.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999986 4778899987643 33345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++... ..+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999998643 34788888999999999999999752 3999999999999999999999999998765322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..-
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122356899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.10 Aligned_cols=193 Identities=21% Similarity=0.292 Sum_probs=166.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
...+|++.++||+|+||.||++... .++.||+|... ...+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3468999999999999999999874 47889999753 2356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
++. ++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 164 ~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 6888887543 34788999999999999999999987 9999999999999999999999999987542211
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 11223357999999999999999999999999999999999999885
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.01 Aligned_cols=204 Identities=28% Similarity=0.451 Sum_probs=175.5
Q ss_pred cccceeeeecCceeEEEEEe-cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CeeEE
Q 005907 442 FSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 513 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 513 (670)
+...+.||+|+||.||+|+. ..|+.||||.+++. .....+...+|++++++++|||||++++.-... ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567999999999999995 45999999999763 334456778999999999999999999885543 35689
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCC--ceEEEeecCc
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGLV 589 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla 589 (670)
|||||.+|+|+..|.+-.+...+++.+.+.+...+..||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777778999999999999999999999988 99999999999983 323 3599999999
Q ss_pred eecCCCcccCCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
+.+..+. ......||+.|++||... .+.|+..+|.|||||++||..||..||..+....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 9986544 334478999999999998 4889999999999999999999999998777664
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=283.96 Aligned_cols=203 Identities=29% Similarity=0.436 Sum_probs=171.1
Q ss_pred CCcccceeeeecCceeEEEEEec----CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|.+. .+..||+|.++.. .......+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999763 3568999998753 233456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 235789999999999999999999987 99999999999999999999999998765422
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 211 11112335678999999999999999999999999999875 999986443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=286.05 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=165.9
Q ss_pred CCcccceeeeecCceeEEEEEec--CCcEEEEEEecccc--hhchHHHHHHHHHHhcC---CCCceeeEEEEEEe-----
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----- 507 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 507 (670)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36789999886422 22334566777777665 69999999999853
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 68999886533 234788999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99876432 22234568999999999998899999999999999999999999976433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=285.91 Aligned_cols=208 Identities=33% Similarity=0.568 Sum_probs=175.5
Q ss_pred CCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
++|++.+.||+|+||.||+|.... ...||+|.+... ......++.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 257999988643 2334567899999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
++|||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965321 145788899999999999999999987 99999999999999999
Q ss_pred ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999987644333222333456889999999998999999999999999999998 99998654443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.46 Aligned_cols=202 Identities=30% Similarity=0.506 Sum_probs=169.9
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc----EEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.+|++.+.||+|+||.||+|.+.. ++ .||+|.++.. .....+++.+|+.+++.++||||+++++++... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468999999999999999998643 33 4899998653 334557889999999999999999999998764 5679
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999996533 34788899999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
............++..|+|||.+.+..++.++|||||||++|||++ |+.||+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 4333222222334678999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=284.36 Aligned_cols=203 Identities=39% Similarity=0.636 Sum_probs=169.0
Q ss_pred ccceeeeecCceeEEEEEec-----CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 443 SINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35679999999999999986 2568999999653 33457899999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.++|... ....+++..++.++.||++||+|||+.+ ++|++|+++||+++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999775 2345889999999999999999999987 9999999999999999999999999998873332
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
.............|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222223456788999999999999999999999999999999 6889765533
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=313.20 Aligned_cols=204 Identities=22% Similarity=0.323 Sum_probs=173.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.++||+|+||.||+|... .++.||+|++... .+...+++.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 4889999998652 2233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 516 EFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
||+++++|.+++..... ....++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123556778899999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcc----------------cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDET----------------EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9987621110 0011124699999999999999999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=280.26 Aligned_cols=201 Identities=30% Similarity=0.504 Sum_probs=179.4
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
-|.++.+||+|+||.||++.++. |+.+|||++.. +...+++..|+.++++.+.|++|+.+|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 47788999999999999998854 89999999853 4567899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
.|+..++++. +++++.+.++..++...++||+|||... -||||||+.|||++.+|.+||+|||.+..+. +.-.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMA 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMA 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHH
Confidence 9999999965 5567999999999999999999999876 8999999999999999999999999998763 2333
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
..+.+.|||-|||||++..-.|+.++||||||+...||..|++||..-++-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM 235 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM 235 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence 345588999999999999999999999999999999999999998754443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.10 Aligned_cols=226 Identities=23% Similarity=0.339 Sum_probs=193.3
Q ss_pred HHHHHHhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 005907 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (670)
Q Consensus 432 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (670)
..++.-..++|.++++||+|+||.|..++.+. ++.||+|++++ .......-|..|-.+|..-+.+-|++++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34455566899999999999999999999865 77899999987 445566789999999999999999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
..++|+|||||+||+|-.+|.+.. .+++.-+..++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999986543 4788888889999999999999887 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccC----C-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhce
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYAS----D-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~ 662 (670)
.|-.+..+... .....+|||.|++||++. + +.|+..+|+||+||++|||+.|..|| -.+.-+..+..|.++
T Consensus 221 sClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF---YadslveTY~KIm~h 296 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF---YADSLVETYGKIMNH 296 (1317)
T ss_pred hHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc---hHHHHHHHHHHHhch
Confidence 99887644333 344578999999999984 3 67999999999999999999999995 355567777788777
Q ss_pred --eeecC
Q 005907 663 --HTTFS 667 (670)
Q Consensus 663 --~~~~~ 667 (670)
...||
T Consensus 297 k~~l~FP 303 (1317)
T KOG0612|consen 297 KESLSFP 303 (1317)
T ss_pred hhhcCCC
Confidence 44444
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.34 Aligned_cols=197 Identities=29% Similarity=0.425 Sum_probs=165.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|+..++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35667789999999999999875 5889999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 2456778889999999999999987 99999999999999999999999999987643221
Q ss_pred cCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223578999999998743 234568999999999999999999987433
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=284.00 Aligned_cols=205 Identities=31% Similarity=0.545 Sum_probs=174.5
Q ss_pred CCcccceeeeecCceeEEEEEecC------CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999998764333 4578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 513 LIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996532 1244778889999999999999999987 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999986543322222223345788999999999999999999999999999999 99997543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.32 Aligned_cols=207 Identities=32% Similarity=0.445 Sum_probs=173.2
Q ss_pred hcCCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (670)
..++|.+.++||+|+||.||+|.... +..||||++... .....+.+.+|+.+++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45689999999999999999998532 346999999653 2334567899999999996 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------------------------------------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 532 (670)
..++||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 533 ------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 533 ------------------------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
...+++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 123677888899999999999999987 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999987643332222233456788999999999999999999999999999997 99997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.73 Aligned_cols=206 Identities=30% Similarity=0.383 Sum_probs=173.9
Q ss_pred cCCcccceeeeecCceeEEEEEecCC-cEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEE-EEe------CC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIQ------GE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~ 509 (670)
..++++.+.|.+|||+.||+|....+ .++|+|++-..++...+.+++|+.+|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34678889999999999999998776 999999987778899999999999999997 9999999993 221 13
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
+.+|.||||++|.|-+++....... +++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999997544433 899999999999999999999984 78999999999999999999999999988
Q ss_pred eecCCCcccCCc-------cccccccCccccccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDETEGNT-------NRVVGTYGYMAPEYA---SDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
............ -...-|+-|+|||.| .+..++.|+|||+|||+||-|+....||+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 653222211100 012358999999987 678999999999999999999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.33 Aligned_cols=200 Identities=30% Similarity=0.448 Sum_probs=171.8
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.+.||+|+||.||++..+++..+|+|.+... ......+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999888889999987642 2335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999986432 34788999999999999999999987 9999999999999999999999999988654322221
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 112335668999999998899999999999999999999 8999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=280.49 Aligned_cols=195 Identities=30% Similarity=0.424 Sum_probs=166.2
Q ss_pred eeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||+++.. +++.+|+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 48899999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98885533 234788888999999999999999987 99999999999999999999999999887643221 123
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
..|++.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4689999999999988999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=282.86 Aligned_cols=205 Identities=32% Similarity=0.529 Sum_probs=172.7
Q ss_pred CCcccceeeeecCceeEEEEEe-----cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.+.||+|+||.||+|.. ..+..+|+|.+... ......++.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999984 24578999998743 33445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 514 IYEFMPNKSLDSFIFDQTR--------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
||||+++++|.+++..... ...+++...+.++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 234788889999999999999999987 99999999999999999
Q ss_pred ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987643332222233445778999999988889999999999999999999 99897543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=298.14 Aligned_cols=216 Identities=30% Similarity=0.462 Sum_probs=183.5
Q ss_pred eeeecCceeEEEEEecCC-cEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005907 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~ 525 (670)
+||+|.||+||.|++.+. ..+|||.+........+-+.+|+.+.++|+|.|||+.+|.+.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 899999999999998665 4689999977666777889999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCCCcccCCcc
Q 005907 526 FIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTN 602 (670)
Q Consensus 526 ~l~~~~~~~~~--~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 602 (670)
+|+.. -+++ ++..+-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||.++++..- ...+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 99653 3344 67777788999999999999987 999999999999975 689999999999988543 33455
Q ss_pred ccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 603 RVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 603 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
++.||+.|||||+|..+ .|+.++|||||||.+.||.||++||-...+........-+-+.++++|+-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEE 803 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHH
Confidence 68899999999999765 58999999999999999999999986555554444444566677777653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.05 Aligned_cols=199 Identities=22% Similarity=0.293 Sum_probs=170.9
Q ss_pred cCCcccceeeeecCceeEEEEEecC---CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..+|.+.+.||+|+||.||++...+ +..||+|.+... +...+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997532 567999987542 24568999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|++. ++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 688888832 345889999999999999999999987 999999999999999999999999999876544
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 333333346799999999999999999999999999999999999999854433
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.34 Aligned_cols=207 Identities=29% Similarity=0.493 Sum_probs=172.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
..++|++.+.||+|+||.||+|... .+..+|+|++... ......++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467999999999999999999753 2467999988643 22345678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 233577888999999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999886643332222222345778999999998899999999999999999999 68887543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.45 Aligned_cols=205 Identities=32% Similarity=0.551 Sum_probs=174.8
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999752 245689999876655666789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 514 IYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234889999999999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986643332222223345778999999998999999999999999999999 89997543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=285.15 Aligned_cols=202 Identities=25% Similarity=0.404 Sum_probs=170.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|.+.++||+|+||.||+|+.. .++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999875 47789999986532 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 888887543 334788889999999999999999987 99999999999999999999999999876533222
Q ss_pred cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
. .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||.....
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 222457899999998865 4688999999999999999999999865443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.31 Aligned_cols=209 Identities=24% Similarity=0.303 Sum_probs=175.5
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----ee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 511 (670)
..++|.+.++||+|||+-||+++. .+++.+|+|++.....++.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 456899999999999999999984 568899999997766677889999999999999999999998875443 47
Q ss_pred EEEEEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
+++++|...|+|.+.+..... +..+++.+.++|+.+|.+||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999866443 447999999999999999999999985 579999999999999999999999999887
Q ss_pred ecCCCcccC-------CccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 591 TFGGDETEG-------NTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 591 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
...-..... .-.....|..|.|||.+. +...+.++|||||||+||+|+.|..||+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 542111100 011124688999999984 556789999999999999999999999743
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=277.99 Aligned_cols=202 Identities=34% Similarity=0.504 Sum_probs=174.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578999999999999999999888889999988643 234578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986532 334788888999999999999999987 999999999999999999999999999876432221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
. .....++..|+|||.+....++.++|||||||++|||+| |+.||..
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 1 122345678999999988889999999999999999999 9999754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=275.48 Aligned_cols=202 Identities=34% Similarity=0.488 Sum_probs=173.9
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688999999999999999998778899999986532 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..+..++.+++.|+.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986533 235789999999999999999999987 999999999999999999999999999887532221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.......+..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 1111223457999999998999999999999999999999 9999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.52 Aligned_cols=191 Identities=26% Similarity=0.339 Sum_probs=159.7
Q ss_pred eeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcC---CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
||+|+||.||+|+.. .++.||+|++.+.. ......+..|..++.+. +||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 48899999986421 22233455566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 9999988543 34788999999999999999999988 99999999999999999999999999876432221 2
Q ss_pred ccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 2346799999999998764 489999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=278.69 Aligned_cols=199 Identities=28% Similarity=0.416 Sum_probs=171.4
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 58899999986532 22345578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886532 235889999999999999999999987 99999999999999999999999999876532211
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 12346899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=297.57 Aligned_cols=198 Identities=22% Similarity=0.391 Sum_probs=161.6
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 508 (670)
..++|.+.+.||+|+||.||+|... .++.||||++... .....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999875 4789999988542 12345799999999999999999886432
Q ss_pred CeeEEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEee
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF 586 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DF 586 (670)
...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999975 676666432 23355889999999999999999999988 99999999999999665 7999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|++||..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99987643221 2235689999999998764 689999999999999999999999754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=276.36 Aligned_cols=203 Identities=30% Similarity=0.458 Sum_probs=173.5
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|.+.+.||+|+||.||+|...++..+|+|.+... .....++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999998877778999988643 2335678999999999999999999999998888999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999986532 25789999999999999999999987 999999999999999999999999998876433221
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 1112335678999999988889999999999999999999 9999865443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=281.82 Aligned_cols=205 Identities=31% Similarity=0.529 Sum_probs=174.6
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.+|.+.+.||+|+||.||+|... +...+++|.+........+.+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999753 345689999876555556789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
||||+++++|.+++.... ....+++..++.++.||+.|++|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1234788999999999999999999988 999999999999999999
Q ss_pred eEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999886643332222223456788999999999999999999999999999999 99997543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.66 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=168.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eeE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (670)
+|++.++||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 5889999998642 2234567889999999999999999999998776 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 578777743 235889999999999999999999988 999999999999999999999999999875
Q ss_pred CCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
...... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 432221 12224578999999998774 57899999999999999999999986544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=277.86 Aligned_cols=199 Identities=30% Similarity=0.432 Sum_probs=170.9
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
|+..+.||+|+||.||++... .++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999875 47899999986532 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885432 234788899999999999999999987 99999999999999999999999999876532221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....|++.|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 12246899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=278.92 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=168.5
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc----EEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.+.||+|+||.||+|.... ++ .+++|.+.... .....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467888999999999999998743 44 47777775322 234467788888999999999999999875 456778
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999653 345889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 4333222333557788999999998899999999999999999998 999986443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=277.86 Aligned_cols=196 Identities=30% Similarity=0.416 Sum_probs=173.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 4789999998652 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..++...+..++.|+++||+|||+.+ |+|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998653 34788999999999999999999987 999999999999999999999999998876433
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2235688999999999888889999999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=276.12 Aligned_cols=203 Identities=30% Similarity=0.486 Sum_probs=173.1
Q ss_pred CCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|.... ...||+|.++.. ......++.+|+.++++++||||+++++.+...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998743 357999988653 334456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ |+|+||||+|||+++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986532 35789999999999999999999987 99999999999999999999999999988752
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 222222222345678999999999999999999999999999998 99997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=294.71 Aligned_cols=194 Identities=23% Similarity=0.310 Sum_probs=167.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..+|.+.+.||+|+||.||++.... ++.||||... ...+.+|+.++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999854 7889999642 23457899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+. ++|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888887543 235899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
........||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999988764
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=277.91 Aligned_cols=206 Identities=28% Similarity=0.480 Sum_probs=173.9
Q ss_pred cCCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|.+.+.||+|+||.||+|.... +..+|+|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578899999999999999998743 368999998643 234456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234678899999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|||+++.+.............++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 9999887644332222233456789999999988889999999999999999998 89997543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=280.32 Aligned_cols=206 Identities=32% Similarity=0.521 Sum_probs=171.6
Q ss_pred CcccceeeeecCceeEEEEEecC------CcEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
+|.+.++||+|+||.||+|...+ ++.||+|+++.... ...+.+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 47778899999999999998643 47899999875332 234678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||.|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234778888999999999999999987 999999999999999999
Q ss_pred eEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999887643332222223446789999999988889999999999999999998 8888765433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=288.66 Aligned_cols=223 Identities=29% Similarity=0.455 Sum_probs=186.9
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++-...+.....+||-|-||.||.|.++. .-.||||.++. +....++|+.|+.+|+.++|||+|+|+|+|.....+||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33344466778899999999999999865 67899999965 45567899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|.|||.+|+|.+||++.. +..++...++.++.||+.||+||..+. +|||||..+|+|+.++..+|++|||+++++.
T Consensus 341 iTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999998754 345677888999999999999999877 9999999999999999999999999999986
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhcee
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
.+.+.... ...-.+.|.|||.+.-..++.|+|||+|||+|||+.| |-.||..-+-...-.++++--||.
T Consensus 417 gDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 417 GDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD 486 (1157)
T ss_pred CCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence 65544322 1223678999999999999999999999999999988 888976544444444554444443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=275.22 Aligned_cols=201 Identities=27% Similarity=0.432 Sum_probs=164.5
Q ss_pred eeeeecCceeEEEEEecC---CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 3578999886532 233457889999999999999999999999988999999999999
Q ss_pred CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 522 ~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965321 234567778889999999999999987 9999999999999999999999999987654333222
Q ss_pred CccccccccCcccccccCCC-------CCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDG-------QFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
......+++.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 22335578899999998542 35789999999999999996 9999875543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=286.85 Aligned_cols=205 Identities=31% Similarity=0.469 Sum_probs=170.1
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEecccc-hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 509 (670)
.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999642 24689999986432 23345678899999999 899999999988654 5
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------------------------------------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 532 (670)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcc
Q 005907 533 -RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611 (670)
Q Consensus 533 -~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 611 (670)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125788999999999999999999987 9999999999999999999999999998764333222223345677899
Q ss_pred cccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 612 APEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 612 aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=275.11 Aligned_cols=194 Identities=29% Similarity=0.409 Sum_probs=169.4
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.++||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 45788999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997653 2578888899999999999999988 9999999999999999999999999988654221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 22357899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=279.18 Aligned_cols=200 Identities=27% Similarity=0.499 Sum_probs=174.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
...+|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3468999999999999999999864 588999999876555556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999853 23788899999999999999999987 9999999999999999999999999987653322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 11 1224688999999999988899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=267.37 Aligned_cols=218 Identities=25% Similarity=0.339 Sum_probs=182.1
Q ss_pred eeeeecCceeEEEEE-ecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
+.||+|+++.|--.. +..|.++|||++.+.......++.+|++++.+.+ |+||++|+++|.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999998776 4679999999999887778889999999999985 99999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEEeecCceecCCC-----
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFGGD----- 595 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~----- 595 (670)
..+|.+. ..+++.+.-++..+|+.||.+||.++ |.||||||+|||-..-. -+||+||.+..-+...
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999654 34889999999999999999999998 99999999999986554 4799999886543211
Q ss_pred cccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCCC------------CcccchHhhh
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR------------SDTKVNLIGH 658 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~~------------~~~~~~l~~~ 658 (670)
.........+|+..|||||+.. ...|+.+.|.||||||||-||+|..||.... ......+++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1112223467899999999862 2368899999999999999999999994221 2234578899
Q ss_pred hhceeeecCCC
Q 005907 659 VSKMHTTFSSI 669 (670)
Q Consensus 659 i~~~~~~~~~~ 669 (670)
|+..+-+||+.
T Consensus 318 IQEGkYeFPdk 328 (463)
T KOG0607|consen 318 IQEGKYEFPDK 328 (463)
T ss_pred HhccCCcCChh
Confidence 99999999974
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=274.19 Aligned_cols=199 Identities=25% Similarity=0.426 Sum_probs=171.7
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++||||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999997 45788999998754444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||+++.+.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988542 34788999999999999999999987 99999999999999999999999999987642221
Q ss_pred cCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
......|++.|+|||.+. ...++.++||||+||++|||++|+.||.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 122346888999999884 4457889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=287.48 Aligned_cols=198 Identities=29% Similarity=0.363 Sum_probs=167.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (670)
..++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999874 4889999998642 2334567889999999999999999999986543
Q ss_pred -eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 510 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
..++||||+++ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 56655522 2678888899999999999999988 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 87643221 122356899999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=277.80 Aligned_cols=204 Identities=31% Similarity=0.523 Sum_probs=173.6
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.+|.+.++||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 356789999877666667789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 514 IYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134788999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999886643322222222345788999999999999999999999999999998 8999743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=274.69 Aligned_cols=198 Identities=27% Similarity=0.461 Sum_probs=172.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
++|.+.+.||+|+||.||+|... +++.+|+|.++.........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999874 47899999987654455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999998543 34789999999999999999999987 9999999999999999999999999988764322
Q ss_pred CCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.......|++.|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 1223356899999999974 4568899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=278.73 Aligned_cols=210 Identities=24% Similarity=0.365 Sum_probs=180.7
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.-|.+.+.||+|.|..|-+|++ -.|..||||++.+.. .-....+..|+.-|+.++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999986 369999999997743 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE-cCCCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~ 595 (670)
.=.+|+|.+||.++.. .+.+....+++.||+.|+.|.|+.. +|||||||+||.+ .+-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999977554 4888899999999999999999887 9999999999876 45689999999998877543
Q ss_pred cccCCccccccccCcccccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhh
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 657 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~ 657 (670)
. .....||.+.|.|||++.+..|+ +++||||||||||-|+.|+.||+.-+..+...+|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm 232 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM 232 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence 3 23457999999999999999997 68999999999999999999997665555555543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=272.55 Aligned_cols=198 Identities=29% Similarity=0.461 Sum_probs=166.3
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 5889999987643 334456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 234789999999999999999999987 99999999999999999999999999876543211111111
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 123457999999998899999999999999999998 888876443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=272.83 Aligned_cols=202 Identities=29% Similarity=0.461 Sum_probs=171.5
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
.+|++.+.||+|+||.||++..+.+..+|+|.+.+. ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357888999999999999999877778999988642 2234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999986533 35789999999999999999999988 9999999999999999999999999988764322111
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 111224567999999998999999999999999999999 899986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=276.15 Aligned_cols=203 Identities=32% Similarity=0.457 Sum_probs=174.5
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3578899999999999999999754 789999998776666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|..++.... ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999998875432 34789999999999999999999987 9999999999999999999999999987643221
Q ss_pred cCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.......+++.|+|||.+. ...++.++|||||||++|||++|+.||...+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 1122356788999999984 3457889999999999999999999986543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=278.99 Aligned_cols=198 Identities=27% Similarity=0.371 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|+||.||++... .+..+|+|.+... ......++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 4778888887643 333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999653 34788899999999999999999742 3999999999999999999999999998765322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 12235688999999999888899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=275.93 Aligned_cols=203 Identities=34% Similarity=0.563 Sum_probs=177.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
..+|++.++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34688899999999999999999889999999997765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..+......
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996543 345788999999999999999999987 999999999999999999999999999876432222
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 1 12345678999999988899999999999999999998 89997543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=290.76 Aligned_cols=210 Identities=27% Similarity=0.445 Sum_probs=173.6
Q ss_pred ccceeeeecCceeEEEEEec-CCcEEEEEEec--c--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe--eEEEE
Q 005907 443 SINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--K--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY 515 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 515 (670)
.+..+||+|+|-+||+|.+. .|.+||--.++ . ..+...+.|..|+.+|+.|+||||++++..+.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34569999999999999874 36677643322 2 345556899999999999999999999999987665 67899
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 594 (670)
|.|..|+|..|+.++.+ ++.+.+..+++||++||.|||++. ++|||||||.+||+|+.+ |.|||+|+|||..+..
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999977554 788899999999999999999986 789999999999999865 8999999999998743
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
... ....|||.|||||... ..|+..+||||||+.|+||.|+..||..- ...+++++.+-++.
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC--~n~AQIYKKV~SGi 260 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC--TNPAQIYKKVTSGI 260 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh--CCHHHHHHHHHcCC
Confidence 322 2278999999999886 88999999999999999999999996422 22356666665544
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=274.65 Aligned_cols=199 Identities=26% Similarity=0.414 Sum_probs=161.0
Q ss_pred eeeeecCceeEEEEEecC---CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
++||+|+||.||+|...+ ...+|+|.+... .......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997644 346888877543 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 522 ~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999966432 223467778899999999999999987 9999999999999999999999999987643322222
Q ss_pred CccccccccCcccccccC-------CCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYAS-------DGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
......+++.|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 222344577899999874 3456889999999999999999 78887543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=276.16 Aligned_cols=203 Identities=30% Similarity=0.490 Sum_probs=169.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCc----EEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.++||+|+||.||+|... +++ .||+|.++.. .....+++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 57888999999999999999853 344 4899988642 33445678899999999999999999999875 45679
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998653 235789999999999999999999987 9999999999999999999999999998774
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 3322211222334678999999998999999999999999999998 899976443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=270.28 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=175.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|++|.||+|... +++.+++|.+.. ......+++.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 578999998754 2344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 345888999999999999999999987 99999999999999999999999999887653322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. .....|++.|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2 22346789999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=271.96 Aligned_cols=205 Identities=29% Similarity=0.427 Sum_probs=171.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4455555679999999999999865 467899999876555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 595 (670)
|+++++|.+++.........+...+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999965322212277888889999999999999987 999999999999986 679999999998766432
Q ss_pred cccCCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 22 12224578999999998654 3789999999999999999999998543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=274.63 Aligned_cols=198 Identities=34% Similarity=0.555 Sum_probs=171.1
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecccchhch--HHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
|++.+.||+|+||.||+++... ++.+|+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5778999999999999999865 56899999976433322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.. ...+++..+..++.|+++||++||+.+ |+|+||||+||+++.++.++|+|||.+..+. ...
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 99999999962 334789999999999999999999988 9999999999999999999999999988651 122
Q ss_pred CCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2233456899999999998 888999999999999999999999998755
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.67 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=171.7
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6777899999999999999754 678899988765556677889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 9999887542 245889999999999999999999987 99999999999999999999999999876532211 2
Q ss_pred ccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....+++.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 22356889999999983 4567889999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=275.82 Aligned_cols=206 Identities=32% Similarity=0.504 Sum_probs=171.1
Q ss_pred cCCcccceeeeecCceeEEEEEecC------CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578899999999999999998754 4678999876432 33345789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 584 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 584 (670)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 135789999999999999999999987 99999999999998765 58999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999987643322221222234568999999998999999999999999999997 99997643
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=277.02 Aligned_cols=201 Identities=28% Similarity=0.506 Sum_probs=175.8
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999986 45889999998765445567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|..++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998853 24789999999999999999999988 99999999999999999999999999886543322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223467889999999998889999999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=276.44 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=174.3
Q ss_pred cCCcccceeeeecCceeEEEEEecC-----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 511 (670)
.++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999865 678999988653 34446778899999999999999999998876 4678
Q ss_pred EEEEEccCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654322 45889999999999999999999987 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 99987643332222222345778999999998899999999999999999999 99997543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.33 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=172.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58899999876421 1234578899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998643 34788888999999999999999987 9999999999999999999999999988764
Q ss_pred CCcccCC-ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGN-TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 3221111 1234578899999999999999999999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=279.99 Aligned_cols=205 Identities=32% Similarity=0.487 Sum_probs=171.1
Q ss_pred cCCcccceeeeecCceeEEEEEecC--------CcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (670)
.++|.+.+.||+|+||.||+++... ...+|+|.+... ......++.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999997532 346999998753 234456788999999999 799999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 234788999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
+.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 9999999999999876643222222222234578999999998899999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=273.09 Aligned_cols=203 Identities=28% Similarity=0.471 Sum_probs=168.5
Q ss_pred cccceeeeecCceeEEEEEecC----CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (670)
|.+.+.||+|+||.||+|.... +..||+|+++.. .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998743 367999998642 23345678999999999999999999999876554
Q ss_pred -eEEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 511 -KLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 511 -~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2245788999999999999999999987 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99987654333222222335678999999988899999999999999999999 88887543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=274.43 Aligned_cols=200 Identities=30% Similarity=0.452 Sum_probs=170.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|++|.||+|+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 5889999998643 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
++ ++|.+++........+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865444456889999999999999999999987 99999999999999999999999999886543221
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 11223568899999988654 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.27 Aligned_cols=198 Identities=27% Similarity=0.354 Sum_probs=167.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (670)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999874 4788999998652 233456788999999999999999999987543
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
...++||||+++ +|..++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356899999965 67776632 2678888999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98653321 122356899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=281.79 Aligned_cols=209 Identities=28% Similarity=0.443 Sum_probs=174.2
Q ss_pred ceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
.++||+|-||+||-|+++ .|+.||||++.+ ...+....+++|+.||++++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 379999999999999874 599999999976 3445567899999999999999999999999999999999999955
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEeecCceecCCCccc
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 598 (670)
+..+.|... .++.+++.....++.||+.||+|||.++ |+|+||||+|||+... -++||+|||.||.++.....
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 554544332 2344788877888999999999999988 9999999999999765 37899999999998754433
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
...+|||.|+|||+++++.|+..-|+||.|||+|--|+|..||. ..++..+.|+++.=|.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMy 783 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMY 783 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhcccccc
Confidence 23789999999999999999999999999999999999999974 3334445555544443
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.64 Aligned_cols=206 Identities=31% Similarity=0.466 Sum_probs=171.3
Q ss_pred hcCCcccceeeeecCceeEEEEEec------CCcEEEEEEecccc-hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (670)
..++|.+.++||+|+||.||+|++. .+..||+|+++... ....+.+++|+.++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456788899999999999999853 24679999997532 333457889999999997 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------------------------------------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 532 (670)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999964321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 533 --------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 533 --------------------------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123667788899999999999999887 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999987543222112222456789999999998889999999999999999998 8899754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=276.17 Aligned_cols=205 Identities=29% Similarity=0.506 Sum_probs=170.2
Q ss_pred hcCCcccceeeeecCceeEEEEEecC------CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34689999999999999999997532 4579999876432 2334567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
.++||||+++++|.+++..... ....++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 234567788899999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCC
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRG 645 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~ 645 (670)
+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999886543322222222345678999999998999999999999999999999 788874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=295.49 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=162.7
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCC------CceeeEEEEEEeC-
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQG- 508 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~- 508 (670)
...++|++.++||+|+||.||+|... .++.||||+++... ....++..|+.++++++| ++++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34678999999999999999999875 47789999986432 233455667777777654 4588999888764
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCC--------
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM-------- 579 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~-------- 579 (670)
.+.++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ + ||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 4688999988 67888888543 3488899999999999999999974 6 99999999999998765
Q ss_pred --------ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 580 --------NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 580 --------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999875422 112346799999999999999999999999999999999999999865443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=276.82 Aligned_cols=200 Identities=28% Similarity=0.493 Sum_probs=175.6
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
...+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346899999999999999999986 4689999999876555556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999853 34788899999999999999999987 9999999999999999999999999988754332
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 2234678899999999998999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=288.36 Aligned_cols=192 Identities=32% Similarity=0.501 Sum_probs=166.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch---hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
-|.-++.||.|+||.||-|+.. +.+.||||+++-... .....+..|+..|++++|||++.+-||+......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667789999999999999974 477899999865333 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
||- |+-.++|.- .++++-+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|.....
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 566666632 3456888899999999999999999998 99999999999999999999999999876532
Q ss_pred ccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.+.++|||.|||||+|. .+.|+-|+||||||++..||.-.++|+
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 23478999999999984 578999999999999999999999994
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=276.31 Aligned_cols=204 Identities=34% Similarity=0.487 Sum_probs=170.1
Q ss_pred CcccceeeeecCceeEEEEEecC------CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
+|++.+.||+|+||.||+|.... ...+++|.+.... .....++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998632 3568888876532 2345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 005907 514 IYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~N 572 (670)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1134778899999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 573 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543322222223345678999999988899999999999999999999 99997543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.77 Aligned_cols=200 Identities=31% Similarity=0.479 Sum_probs=171.4
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecccc------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999988788999999875321 22345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999653 24688888999999999999999987 99999999999999999999999999876532
Q ss_pred Ccc----cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DET----EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 111 1112234688999999999988999999999999999999999999854
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=272.27 Aligned_cols=202 Identities=31% Similarity=0.500 Sum_probs=172.5
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.+|.+.+.||+|+||.||+|...+ ++.+|+|.+... .....++.+|+.++++++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357888999999999999998754 788999998653 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986533 345788999999999999999999987 999999999999999999999999998876433221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1 112234668999999999999999999999999999998 99997643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=275.20 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=164.3
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcC---CCCceeeEEEEEEe-----CC
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ-----GE 509 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 509 (670)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999875 47899999986522 22233556677776665 79999999998864 24
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++ +|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999974 8888885432 234789999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+.+..... .....||+.|+|||++.+..++.++||||+||++|||++|++||....
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 87643221 223467899999999999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=276.37 Aligned_cols=202 Identities=26% Similarity=0.435 Sum_probs=171.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|+||.||++... .++.+|+|.++.. .......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 5889999988642 334456888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|..++........+++..+..++.+++.||.|||++. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999865433346899999999999999999999742 39999999999999999999999999987653221
Q ss_pred cCCccccccccCcccccccCCC------CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG------QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 2224578899999998544 3578999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=279.96 Aligned_cols=195 Identities=24% Similarity=0.411 Sum_probs=159.4
Q ss_pred eeeeecCceeEEEEEec---CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|+.. .++.+|+|.+... .....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 58999999999999864 3578999998643 223467889999999999999999998864 456789999986
Q ss_pred CCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCceEEEeecCce
Q 005907 521 KSLDSFIFDQT------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (670)
Q Consensus 521 g~L~~~l~~~~------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~ 590 (670)
++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 47887774321 1234788899999999999999999988 9999999999999 456789999999998
Q ss_pred ecCCCccc-CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETE-GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 76433221 22234578999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=272.28 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=173.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|+.. +++.||||.+.. ........+.+|+.++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999874 588999998754 22344557889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999885422 2345788899999999999999999987 99999999999999999999999999887643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... .....+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 2221 122457889999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=278.37 Aligned_cols=205 Identities=31% Similarity=0.493 Sum_probs=172.3
Q ss_pred cCCcccceeeeecCceeEEEEEec--------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (670)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888899999999999999742 2457999988643 234457789999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
...++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999965321 234778889999999999999999987 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
+.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999987754333322333445678999999998899999999999999999999 7888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=275.24 Aligned_cols=202 Identities=30% Similarity=0.450 Sum_probs=174.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457999999999999999999875 5789999998766556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999998653 235889999999999999999999988 99999999999999999999999998876532221
Q ss_pred cCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 222356899999999974 345778999999999999999999998644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=277.77 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=170.0
Q ss_pred CCcccceeeeecCceeEEEEEecC---------------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLG 503 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 503 (670)
++|++.+.||+|+||.||+++..+ ...||+|.++.. .......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987642 235899998653 3344567899999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTR---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 504 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 123678889999999999999999987 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS--GKKNRGFYR 648 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~p~~~~~ 648 (670)
++.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999886543322222222345678999999998899999999999999999998 556765433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=270.04 Aligned_cols=202 Identities=28% Similarity=0.441 Sum_probs=169.8
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc-----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
.+|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578899999999999999998754 889999987532 122346788899999999999999999998764 457
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++... ..+++...+.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999998643 23678888999999999999999988 99999999999999999999999999886
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 5322111 1122345888999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=272.48 Aligned_cols=202 Identities=29% Similarity=0.508 Sum_probs=165.5
Q ss_pred cccceeeeecCceeEEEEEecCCc---EEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------Ce
Q 005907 442 FSINNKLGEGGFGPVYKGTLVDGQ---EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 510 (670)
|.+.++||+|+||.||+|...... .+|+|.++.. .....+.+.+|+.++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346689999999999999875532 5899987642 344467888999999999999999999987542 24
Q ss_pred eEEEEEccCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 511 KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
.+++|||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345789999999999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9987643322211222345778999999999999999999999999999999 7888754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=276.05 Aligned_cols=205 Identities=30% Similarity=0.447 Sum_probs=172.9
Q ss_pred cCCcccceeeeecCceeEEEEEecC-----------------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 500 (670)
.++|++.++||+|+||.||++...+ +..||+|.+... .....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999998643 245899998753 2345678899999999999999999
Q ss_pred EEEEEEeCCeeEEEEEccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 005907 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (670)
Q Consensus 501 l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~N 572 (670)
+++++..+...+++|||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965431 125789999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCC
Q 005907 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS--GKKNRGF 646 (670)
Q Consensus 573 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~p~~~ 646 (670)
|+++.++.++|+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999987644332222333456788999999988889999999999999999998 6677653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=268.76 Aligned_cols=201 Identities=29% Similarity=0.485 Sum_probs=175.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|... +++.+|+|.++. ......+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999986 689999998864 22334568899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||+++++|..++.... ....+++..++.++.++++||.|||+.+ |+||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345789999999999999999999987 99999999999999999999999999887643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 3221 223467889999999998899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=302.83 Aligned_cols=207 Identities=26% Similarity=0.387 Sum_probs=170.0
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
...++|.+.++||+|+||.||++.... ++.+|+|.+.. ........+..|+.++++++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999999754 66789998764 2334456789999999999999999999988653 568
Q ss_pred EEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeccCCCCCEEEcC---------
Q 005907 512 LLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQ--------- 577 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~----~~ivHrDlkp~NILl~~--------- 577 (670)
+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986532 23458999999999999999999998531 24999999999999964
Q ss_pred --------CCceEEEeecCceecCCCcccCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 578 --------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 578 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||||||||||+||+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23489999999987643221 223578999999999854 4588999999999999999999999853
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=270.33 Aligned_cols=200 Identities=32% Similarity=0.502 Sum_probs=169.5
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.++||+|+||.||+|...+...||+|+++... ...+.+.+|+.++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5689999999999999999998777789999987522 23467899999999999999999999874 456789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999996532 234688999999999999999999987 9999999999999999999999999998764332211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 122345678999999988899999999999999999999 7888753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.22 Aligned_cols=198 Identities=28% Similarity=0.357 Sum_probs=167.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----- 508 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 508 (670)
...++|++.+.||+|+||.||++... .++.+|||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 4789999998653 233456778899999999999999999988644
Q ss_pred -CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 509 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
...++||||+++ +|..++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 66666632 3678888899999999999999988 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998653321 12235689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=268.52 Aligned_cols=199 Identities=30% Similarity=0.504 Sum_probs=175.3
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
++|++.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999865 78999999865332 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998542 345789999999999999999999987 99999999999999999999999999887643321
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122345788999999999889999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=276.60 Aligned_cols=207 Identities=32% Similarity=0.492 Sum_probs=173.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
..++|++.+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +||||+++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578889999999999999998643 357899988653 233456788999999999 7999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
..+++|||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12345788999999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999987654332222222345678999999988999999999999999999998 99997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.47 Aligned_cols=197 Identities=29% Similarity=0.427 Sum_probs=166.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----- 508 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 508 (670)
+..++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999874 5788999998652 223345677899999999999999999987543
Q ss_pred -CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 509 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
...++++|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 7789888742 34889999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99875432 123568999999999877 5789999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=275.94 Aligned_cols=202 Identities=26% Similarity=0.396 Sum_probs=169.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|.+.+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357999999999999999999875 47889999986432 3334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 5898888553 334788899999999999999999987 9999999999999999999999999987653222
Q ss_pred ccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11224568899999998654 57889999999999999999999986443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=268.59 Aligned_cols=201 Identities=25% Similarity=0.444 Sum_probs=175.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999875 47789999987655556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999998653 234789999999999999999999987 99999999999999999999999999876543211
Q ss_pred CCccccccccCcccccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDG---QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 11234678899999999776 8899999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.72 Aligned_cols=203 Identities=30% Similarity=0.494 Sum_probs=170.2
Q ss_pred CCcccceeeeecCceeEEEEEecC-C---cEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..|++.+.||+|+||.||+|.... + ..||+|.+... ......+|..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998753 2 36999998753 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 235788999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccCCccc-cc--cccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 595 DETEGNTNR-VV--GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
......... .. .+..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 222111111 11 2457999999999999999999999999999987 99997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.66 Aligned_cols=205 Identities=33% Similarity=0.488 Sum_probs=170.7
Q ss_pred CCcccceeeeecCceeEEEEEec--------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
++|.+.++||+|+||.||++... ....+|+|.++.. ......++.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999752 2456899988753 234456788999999999 6999999999999988
Q ss_pred eeEEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 1235788899999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999987643222221222234567999999998999999999999999999999 88887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=269.12 Aligned_cols=200 Identities=33% Similarity=0.509 Sum_probs=170.1
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57888999999999999999988888999999865322 3467899999999999999999999875 456789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999986532 234789999999999999999999987 9999999999999999999999999998764332211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 112335668999999988889999999999999999999 8889754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=275.71 Aligned_cols=202 Identities=32% Similarity=0.489 Sum_probs=167.6
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc--EEEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|...+ +. .+++|.++. ......+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 32 478888764 2334456789999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1134788999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999986432111 1111223457999999998899999999999999999998 99997543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.13 Aligned_cols=204 Identities=33% Similarity=0.484 Sum_probs=172.3
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEecccc-hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (670)
.++|.+.+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999742 24579999887532 33456789999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|.+++.... ...+++..+..++.+++.||+|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 234789999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.+.............+++.|+|||.+.+..++.++||||+||++|||++ |+.||..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 7643322111222345778999999999999999999999999999998 9999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=272.20 Aligned_cols=205 Identities=29% Similarity=0.487 Sum_probs=171.6
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc----EEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.+|++.+.||+|+||.||+|..+. +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 468888999999999999998643 32 58999876543 3345678899999999999999999999887 78899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998653 234889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
............++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 3322222222234568999999988899999999999999999999 99998655443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=281.89 Aligned_cols=192 Identities=22% Similarity=0.320 Sum_probs=163.5
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
...+|++.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++||||+++++++..+...++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34679999999999999999999754 678999975332 23568999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 6888887542 345889999999999999999999987 999999999999999999999999998753221
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122356899999999999999999999999999999999866553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=247.23 Aligned_cols=216 Identities=27% Similarity=0.385 Sum_probs=173.4
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
..+.+.-...||+|++|.|-+.++ .+|+..|+|++.. ...+..+++.+|+.+..+. .+|.+|.|+|........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 345566668999999999998887 4689999999875 4556667888899886654 799999999999999999999
Q ss_pred EEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||.| ..+|+.|-.+ ..+...+++..+-+|+..+.+||.|||++ ..+||||+||.||||+.+|++||+|||++..+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 4577776543 22445688888999999999999999995 479999999999999999999999999998774
Q ss_pred CCcccCCccccccccCcccccccC----CCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
..-... --.|-..|||||.+. ...|+.++||||||+.+.||.+++.||+.+.. ..+++.++.+
T Consensus 201 dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQVVE 267 (282)
T ss_pred hhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHHhc
Confidence 332211 124667899999984 34789999999999999999999999875544 3555555543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=266.94 Aligned_cols=200 Identities=25% Similarity=0.385 Sum_probs=173.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
+|++.+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999875 478999998854 23345567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ....++....+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988543 2344788899999999999999999987 999999999999999999999999998876432221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 2235688999999999988999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=270.37 Aligned_cols=200 Identities=28% Similarity=0.465 Sum_probs=175.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 47899999986532 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998542 5789999999999999999999987 99999999999999999999999999988753321
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......+++.|+|||.+.+..++.++||||||+++|||+||+.||...+
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 2223567889999999998889999999999999999999999986443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=270.26 Aligned_cols=204 Identities=29% Similarity=0.474 Sum_probs=171.3
Q ss_pred CCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.+|++.+.||+|+||.||+|.... ...+|+|.++.. .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 468888999999999999998642 337999988652 233456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999996532 34788999999999999999999987 99999999999999999999999999987643
Q ss_pred CcccCC-ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 595 DETEGN-TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 322111 111223568999999998899999999999999999887 999986443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=268.13 Aligned_cols=201 Identities=33% Similarity=0.505 Sum_probs=171.8
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.++||+|+||.||+|..++++.+|+|.+.... .....+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46789999999999999999998889999999986533 33567899999999999999999998864 56789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999986533 345788999999999999999999987 999999999999999999999999999876432221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1 112345678999999988889999999999999999999 9999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=267.39 Aligned_cols=195 Identities=30% Similarity=0.492 Sum_probs=162.0
Q ss_pred eeeecCceeEEEEEec---CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005907 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~ 522 (670)
.||+|+||.||+|.+. .+..||+|.+.... ....+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 34579999886532 334567899999999999999999999875 457889999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC-c
Q 005907 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-T 601 (670)
Q Consensus 523 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 601 (670)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.+........ .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998542 345889999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred cccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 602 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
....+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11223578999999988889999999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=271.00 Aligned_cols=202 Identities=32% Similarity=0.501 Sum_probs=169.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC------C
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------E 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~ 509 (670)
+.+.|++.+.||+|+||.||+|... .++.+|+|++... .....++..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999875 4788999998643 23456788999999998 699999999998753 4
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 5789999999999999986532 345788999999999999999999987 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+.+.... .......|++.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8753322 1223356899999999986 34678899999999999999999999854
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=287.49 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=174.9
Q ss_pred cCCcccceeeeecCceeEEEEEecCCc-EEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+.|+++..||.|+||.||+|..++.. ..|.|++....+...+.++-|++||....||+||+|++.|...+.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 356778889999999999999876544 4567888777778889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
|.||-.+.++.+.. ..+.+.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999886644 35889999999999999999999997 99999999999999999999999998765422 2
Q ss_pred cCCccccccccCccccccc-----CCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYA-----SDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......+.|||.|||||+. .+.+|+.++||||||+.|.||..+.+|...
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 2223447899999999986 567899999999999999999999999543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=315.58 Aligned_cols=191 Identities=27% Similarity=0.513 Sum_probs=162.0
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
....+...+.||+|+||.||+|+. .++..||||++...... ...|+.++++++||||++++++|.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677778999999999999987 46889999998653221 2346888999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++.. +++..+.+++.|+++||+|||.....+|+||||||+||+++.++.+++. |+.......
T Consensus 764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 9999999999942 7899999999999999999996644569999999999999999888876 665543211
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 112357899999999999999999999999999999999999974
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=272.54 Aligned_cols=200 Identities=23% Similarity=0.312 Sum_probs=169.8
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999998754 6889999886532 233457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999543 34788888999999999999999987 999999999999999999999999998742110
Q ss_pred cc-------------cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 596 ET-------------EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 596 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 00 001112457889999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=270.84 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=171.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 48899999886432 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++++.|..++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887643 234789999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 1222457889999999876 5678999999999999999999999864443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=274.41 Aligned_cols=205 Identities=28% Similarity=0.456 Sum_probs=170.3
Q ss_pred CCcccceeeeecCceeEEEEEec-----------------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 501 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 501 (670)
++|++.+.||+|+||.||++... +...+|+|.+... .......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998542 2346899998653 33445688999999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 005907 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (670)
Q Consensus 502 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NI 573 (670)
++++..++..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124677889999999999999999987 99999999999
Q ss_pred EEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCCC
Q 005907 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS--GKKNRGFY 647 (670)
Q Consensus 574 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~p~~~~ 647 (670)
|++.++.++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999887643322222222344678999999888889999999999999999998 67787543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.58 Aligned_cols=199 Identities=28% Similarity=0.451 Sum_probs=176.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
....|.+.+.||+|.|+.|.+|++. .+..||||.+.+.. ......+.+|+++|..++|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567899999999999999999974 48999999997732 33334588999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+.+|.+.+||..+.+ +.+.....++.|+..|++|+|+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999976554 455777889999999999999998 9999999999999999999999999998874
Q ss_pred CcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~ 645 (670)
........+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 3334455899999999999998877 589999999999999999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=267.89 Aligned_cols=199 Identities=37% Similarity=0.569 Sum_probs=172.3
Q ss_pred eeeeecCceeEEEEEecC----CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|+.+++.++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999854 778999998764332 367899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 521 KSLDSFIFDQTR------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 521 g~L~~~l~~~~~------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++|+||+|+||+++.++.+||+|||.++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999966421 356899999999999999999999987 99999999999999999999999999988754
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
...........+++.|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 432222333567889999999988899999999999999999999 69998654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=279.93 Aligned_cols=205 Identities=27% Similarity=0.480 Sum_probs=175.7
Q ss_pred CCcccceeeeecCceeEEEEEecC---Cc--EEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD---GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
......+.||+|-||.||+|...+ |+ .||||..+. ...+..+.|+.|..+|++++||||++++|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 345566899999999999998633 33 589999876 455667889999999999999999999999975 57899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||.++.|.|..||.. ++..++......++.||..||+|||+.. +|||||..+|||+....-+||+|||++|.+.
T Consensus 468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999965 3445888888899999999999999987 9999999999999999999999999999987
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 651 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~ 651 (670)
.+.+...+ ...-+..|||||.+.-..++.+||||.|||.|||+++ |.+||......+
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 66655444 3344678999999999999999999999999999987 999986554443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=275.43 Aligned_cols=195 Identities=25% Similarity=0.416 Sum_probs=158.8
Q ss_pred eeeeecCceeEEEEEecC---CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|+..+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998753 4689999886532 23467889999999999999999999854 4567899999865
Q ss_pred CCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCceEEEeecCce
Q 005907 521 KSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (670)
Q Consensus 521 g~L~~~l~~~------~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~ 590 (670)
+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 12234788889999999999999999987 9999999999999 566789999999998
Q ss_pred ecCCCccc-CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETE-GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+...... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76533221 12233568999999999876 4589999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=277.72 Aligned_cols=202 Identities=28% Similarity=0.381 Sum_probs=172.3
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (670)
...|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+|+ |.+||+|++|-..++.++|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356899999999999999999988888999998653 55667788999999999995 999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|| ...+|..+|..... .++.-.+..+-.|++.++.++|+++ |||.||||.|+|+ -.|.+||+|||+|..+..+
T Consensus 440 E~-Gd~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 EC-GDIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ec-ccccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 96 46799999965332 2332256678899999999999998 9999999999998 4578999999999998777
Q ss_pred cccCCccccccccCcccccccCCC-----------CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDG-----------QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.........+||+.||+||.+... ..++++||||+|||||+|+.|++||+.+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 666666667999999999998543 2568999999999999999999998754
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=280.79 Aligned_cols=206 Identities=31% Similarity=0.470 Sum_probs=168.5
Q ss_pred cCCcccceeeeecCceeEEEEEe------cCCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 509 (670)
.++|++.+.||+|+||.||+|.. ..++.||||+++.. .......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999974 34678999998653 233456788999999999 689999999988654 4
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------------------------------------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 532 (670)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccc
Q 005907 533 -------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605 (670)
Q Consensus 533 -------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 605 (670)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123677888899999999999999987 9999999999999999999999999988753332222222234
Q ss_pred cccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 606 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999988999999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.36 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=174.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|+..+.||+|+||.||.++.. +++.+++|.+.. ......+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999864 478899998754 2345567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986542 345788999999999999999999987 99999999999999999999999999987644332
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 22235689999999999888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=264.97 Aligned_cols=196 Identities=33% Similarity=0.473 Sum_probs=166.8
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~ 524 (670)
++||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3799999999999998888999999986543 233457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcccc
Q 005907 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (670)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 604 (670)
+++... ...+++..+..++.+++++|.|||+.+ ++||||||+||+++.++.+||+|||+++......... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 998543 234788999999999999999999987 9999999999999999999999999987653322211 1112
Q ss_pred ccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 605 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34668999999988889999999999999999999 99997543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=266.70 Aligned_cols=201 Identities=35% Similarity=0.546 Sum_probs=173.6
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|.+.+.||+|+||.||+|...+++.+|||.+... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4689999999999999999999888889999998653 234568899999999999999999999999888999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999996533 234788999999999999999999987 999999999999999999999999998876532211
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRG 645 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~ 645 (670)
. .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 1 112234568999999998899999999999999999999 999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.47 Aligned_cols=204 Identities=29% Similarity=0.497 Sum_probs=171.7
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|... .+..+|+|.+... ......++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357889999999999999999864 3678999998653 234456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR-------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~N 572 (670)
++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999964311 124678889999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCC
Q 005907 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRG 645 (670)
Q Consensus 573 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~ 645 (670)
|+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999886543322222222334678999999998999999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.22 Aligned_cols=202 Identities=32% Similarity=0.501 Sum_probs=167.9
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc--EEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|.... +. .+|+|.+... ......++.+|+.++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578889999999999999998743 43 4677777542 334456788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 515 YEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999965321 235788999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99999998643111 11111234668999999988889999999999999999998 99997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=268.48 Aligned_cols=204 Identities=29% Similarity=0.498 Sum_probs=171.0
Q ss_pred CCcccceeeeecCceeEEEEEecC-C---cEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+.+|+.++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999998753 3 36899988653 334456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999986532 45788999999999999999999987 99999999999999999999999999887643
Q ss_pred CcccCC-ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 595 DETEGN-TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
...... ......++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 222111 111223457999999988899999999999999999998 999975433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=267.10 Aligned_cols=195 Identities=32% Similarity=0.475 Sum_probs=163.1
Q ss_pred eeeecCceeEEEEEe---cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 447 KLGEGGFGPVYKGTL---VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+||+|+||.||+|.+ .+++.+|+|+++.. .....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 34788999998643 2334568899999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC-C
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-N 600 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 600 (670)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||.||+++.++.+||+|||+++.+....... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 34788999999999999999999987 9999999999999999999999999998764333211 1
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
.....++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112234578999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=278.39 Aligned_cols=204 Identities=31% Similarity=0.484 Sum_probs=170.5
Q ss_pred CCcccceeeeecCceeEEEEEecC--------CcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
.+|++.+.||+|+||.||+++... ...+|+|.++.. .....+++.+|+.+++++ +||||+++++++..+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999997522 236899988642 334457889999999999 7999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
..+++|||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234778889999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999987643322222222334567999999999999999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=267.32 Aligned_cols=200 Identities=30% Similarity=0.518 Sum_probs=170.5
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch---------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677789999999999999874 478999998864221 123568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 34788888999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCcccC----CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETEG----NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+....... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 775322111 11224578899999999988999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=269.62 Aligned_cols=201 Identities=28% Similarity=0.472 Sum_probs=173.8
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||++.. .+++.+|||.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 46889999987642 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||+++++|.+++... .....+++..+..++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 22345789999999999999999999987 99999999999999999999999999877643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 3221 123468889999999998899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.32 Aligned_cols=202 Identities=27% Similarity=0.339 Sum_probs=173.1
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccch---hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|+.+++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999999865 88999999865322 24567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 2345788999999999999999999987 999999999999999999999999998754321
Q ss_pred ccc---------------------------CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 596 ETE---------------------------GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 596 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 110 01123467889999999999899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.20 Aligned_cols=202 Identities=30% Similarity=0.448 Sum_probs=169.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
.+|+..+.||+|+||.||+|... .+..+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 48899999885421 23345688999999999999999999988753 567
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998643 23788888999999999999999887 99999999999999999999999999886
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+...... .......++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 5322111 1122345788999999999989999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=264.34 Aligned_cols=198 Identities=32% Similarity=0.500 Sum_probs=168.4
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~ 524 (670)
++||+|+||.||++...+++.||+|.++.... ...+.+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999875333 35678999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcccc
Q 005907 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (670)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 604 (670)
+++.... ..+++..++.++.+++.+++|||+++ ++||||+|+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986532 34788889999999999999999987 999999999999999999999999998865422222211222
Q ss_pred ccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 605 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
..+..|+|||.+.+..++.++|+||||+++|||+| |+.||....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 34567999999988899999999999999999999 888876544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=285.36 Aligned_cols=212 Identities=29% Similarity=0.459 Sum_probs=177.3
Q ss_pred CcccceeeeecCceeEEEEEecC--Cc--EEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
...+.++||+|.||.|++|.+.. |+ .||||.++..... ....|++|+.+|.+|+|||+++|+|+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34556799999999999998753 43 6899999764443 67899999999999999999999999887 7788999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|.++.|+|.+.|++ ..+..+....+..++.|||.||.||.++. +|||||..+|+||-....|||+||||.|-++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 45566778888899999999999999987 999999999999999999999999999988654
Q ss_pred cccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhh
Q 005907 596 ETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIG 657 (670)
Q Consensus 596 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~ 657 (670)
.... ......-...|.|||.+....|+.++|||+|||++|||+| |+.||-........+.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 4332 2222233567999999999999999999999999999999 788975544444444444
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=268.68 Aligned_cols=200 Identities=28% Similarity=0.410 Sum_probs=175.3
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
+|++.+.||.|+||.||++... .++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999985 48899999986532 2456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998553 35788999999999999999999987 9999999999999999999999999988764332
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 12234578899999999888899999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=267.04 Aligned_cols=190 Identities=25% Similarity=0.401 Sum_probs=159.8
Q ss_pred eeeeecCceeEEEEEecC-------------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 446 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258889876655555668889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc-------eEEEe
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 585 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~D 585 (670)
+||||+++++|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988542 234788999999999999999999987 999999999999987664 89999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHH-cCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIV-SGKKNRGF 646 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tG~~p~~~ 646 (670)
||++..+... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998765321 1245788999999886 467899999999999999998 58888653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.91 Aligned_cols=196 Identities=31% Similarity=0.480 Sum_probs=169.9
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333458999999999999874 5889999998654445566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|..++.. ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++.+..... .
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 999998743 34788999999999999999999987 99999999999999999999999999876543222 1
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2235688999999999988999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=270.60 Aligned_cols=198 Identities=33% Similarity=0.472 Sum_probs=165.8
Q ss_pred cccceeeeecCceeEEEEEe-----cCCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEE
Q 005907 442 FSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (670)
|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 347789999986532 23456788999999999999999999988654 35789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999998542 3899999999999999999999987 9999999999999999999999999988764
Q ss_pred CCcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 322211 11122356679999999888999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=266.66 Aligned_cols=197 Identities=30% Similarity=0.460 Sum_probs=168.2
Q ss_pred eeeeecCceeEEEEEecC--C--cEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 2 3689999876544 566789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC-
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG- 599 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 599 (670)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999966432 45789999999999999999999987 9999999999999999999999999998775422211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1122456788999999998899999999999999999999 99997533
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.33 Aligned_cols=200 Identities=34% Similarity=0.504 Sum_probs=169.2
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|.+.+.||+|++|.||+|....+..+|+|.+... ....+.+.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 468888999999999999999877778999987643 234467889999999999999999998875 456789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999996532 234788999999999999999999987 9999999999999999999999999998764332211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112345678999999988899999999999999999999 8999754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=268.97 Aligned_cols=191 Identities=25% Similarity=0.360 Sum_probs=158.6
Q ss_pred eeeecCceeEEEEEecC-------------------------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeE
Q 005907 447 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 501 (670)
+||+|+||.||+|.+.. ...|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998866544555678899999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC--
Q 005907 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 579 (670)
Q Consensus 502 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-- 579 (670)
++++..+...++||||+++++|..++... ...+++..++.++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998643 335788899999999999999999987 99999999999997654
Q ss_pred -----ceEEEeecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHH-HcCCCCCCCCC
Q 005907 580 -----NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEI-VSGKKNRGFYR 648 (670)
Q Consensus 580 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~el-ltG~~p~~~~~ 648 (670)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3799999987653221 12346788999998865 5689999999999999999 47999986443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=263.98 Aligned_cols=199 Identities=30% Similarity=0.481 Sum_probs=172.6
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++||||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999986 68899999886532 23456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
+||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998643 34788899999999999999999987 99999999999999999999999999887643
Q ss_pred CcccCCccccccccCcccccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.. ......+++.|+|||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 32 223356889999999987776 8999999999999999999999986543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=269.53 Aligned_cols=200 Identities=29% Similarity=0.524 Sum_probs=168.2
Q ss_pred CCcccceeeeecCceeEEEEEec-----CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (670)
++|++.+.||+|+||.||++... .+..||+|++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888899999999999999742 4778999998776666677899999999999999999999987543 4678
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 234789999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccCC-ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 593 GGDETEGN-TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 593 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
........ .....++..|+|||.+.+..++.++|||||||++|||++|..|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 43222111 11122345699999999889999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.27 Aligned_cols=205 Identities=30% Similarity=0.495 Sum_probs=176.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||.|+||.||+|... ++..+|+|++... .....+.+.+|+.+++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999864 5788999998642 223567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999966433345889999999999999999999987 99999999999999999999999999887654332
Q ss_pred cC--CccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EG--NTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ......|+..|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 21 22334688999999998776 7899999999999999999999998643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=275.27 Aligned_cols=199 Identities=21% Similarity=0.275 Sum_probs=164.5
Q ss_pred cceeeeec--CceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 444 INNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 444 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
++++||+| +|++||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999874 5889999998653 2334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..+......
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865332 34788999999999999999999987 999999999999999999999999865443211110
Q ss_pred -----CCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 -----GNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01112346778999999976 4689999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=270.19 Aligned_cols=208 Identities=28% Similarity=0.429 Sum_probs=171.9
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEE-----
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI----- 506 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----- 506 (670)
.+....++|++.+.||+|+||.||++... .++.+|+|++.... ....++.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456789999999999999999999874 47889999876432 2345788899999999 6999999999884
Q ss_pred eCCeeEEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 507 QGEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 507 ~~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999988542 22345788889999999999999999987 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
||+++.+...... .....|++.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 168 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 168 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9998876432221 223468999999999853 45788999999999999999999997644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=262.38 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=170.9
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 516 (670)
+|++.+.||+|++|.||++.... ++.+|+|++... .....+.+.+|+.++++++|||++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47889999999999999998754 688999998642 23445678899999999999999999988764 346789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.... ...+++..+..++.+++.|+++||+.+ ++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999986532 345789999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ......+++.|+|||++.+..++.++||||+|++++||++|+.||..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 2 22335688999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=274.24 Aligned_cols=196 Identities=30% Similarity=0.482 Sum_probs=170.0
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999874 5789999998665555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++..+..... .
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 999998843 23788899999999999999999987 99999999999999999999999999876543222 1
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2235688999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=268.20 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=167.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++|+||+++.+++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999874 58899999986532 2334467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 67777764432 34677888889999999999999987 9999999999999999999999999987643222
Q ss_pred ccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||+..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 11 1224568899999998754 5788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=262.91 Aligned_cols=200 Identities=29% Similarity=0.493 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
.+|++.+.||+|+||.||++...++..+|+|.+... .....++.+|+.++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999999877889999988643 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ..+++..+..++.+++.+++|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999986432 34788889999999999999999987 9999999999999999999999999988764332211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 112234678999999998899999999999999999998 8999753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=263.78 Aligned_cols=201 Identities=29% Similarity=0.384 Sum_probs=177.0
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|++|.||+|.... ++.+++|++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999865 88999999876433 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999653 458899999999999999999999 87 9999999999999999999999999988764333
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 222 23467889999999999999999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.45 Aligned_cols=199 Identities=27% Similarity=0.408 Sum_probs=168.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 57899999986532 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++ +|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8999886532 35788999999999999999999987 99999999999999999999999999876432211
Q ss_pred cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 112346789999999865 4588999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=273.39 Aligned_cols=202 Identities=31% Similarity=0.557 Sum_probs=167.5
Q ss_pred CCcccceeeeecCceeEEEEEec-CCc----EEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|+..+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778889999999999999864 343 47888876532 23345788999999999999999999998654 5679
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998653 234788899999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3333222223445778999999998999999999999999999997 99997543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-33 Score=309.10 Aligned_cols=224 Identities=26% Similarity=0.398 Sum_probs=184.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.+-++....+||.|.||.||-+... +|...|+|.++- ......+.+.+|+.++..++|||+|+.+|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3445666789999999999999864 478889998754 3345567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||||++|+|.+.+.. ....++.....+..|++.|+.|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999843 334667777778899999999999998 99999999999999999999999999998865
Q ss_pred Cccc--CCccccccccCcccccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 595 DETE--GNTNRVVGTYGYMAPEYASDG---QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 595 ~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
.... ...+...||+.|||||+|.+. ....+.||||+||+..||+||++||..++.+ ...++.-.+=+.+.+|+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhccCCCCCch
Confidence 5322 223456899999999999654 4567899999999999999999999866654 44555555555566665
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=266.56 Aligned_cols=198 Identities=28% Similarity=0.478 Sum_probs=172.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.|+..+.||+|+||.||+|... .++.||+|.+... .......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777789999999999999875 4789999988643 2345678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999853 34788888999999999999999987 99999999999999999999999999987643322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122345788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=265.45 Aligned_cols=202 Identities=27% Similarity=0.482 Sum_probs=171.9
Q ss_pred CcccceeeeecCceeEEEEEe-cCCcEEEEEEecccc------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 458899999986422 2235688999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceec
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~ 592 (670)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 34788999999999999999999987 99999999999998776 5999999998876
Q ss_pred CCCcccC--CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDETEG--NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
....... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 4332111 1223467889999999988899999999999999999999999986443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.25 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=172.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|+||.||++... +++.+|+|++... .+...+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999875 4788999987643 234457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+++.....++.+++.+|.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999988542 34789999999999999999999742 3999999999999999999999999998754221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1223568999999999988899999999999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.26 Aligned_cols=198 Identities=34% Similarity=0.558 Sum_probs=172.4
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35788899999999999999987 488999999975433 5678999999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999865332 35889999999999999999999988 99999999999999999999999999887632211
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1234568999999988889999999999999999997 99997644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=266.96 Aligned_cols=198 Identities=22% Similarity=0.400 Sum_probs=158.5
Q ss_pred eeeeecCceeEEEEEecCCc---EEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 446 NKLGEGGFGPVYKGTLVDGQ---EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.||+|+||.||++...++. .+++|.+... .....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999864443 4566666542 2344578999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 522 SLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 522 ~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
+|.+++..... ....+...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999965322 234566777889999999999999987 99999999999999999999999998764322222222
Q ss_pred ccccccccCcccccccCC-------CCCCccchHHHHHHHHHHHHcC-CCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASD-------GQFSIKSDVFSFGILLLEIVSG-KKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltG-~~p~~~ 646 (670)
.....++..|+|||++.. ..++.++||||||+++|||+++ +.||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 233567889999998743 2457899999999999999974 667653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=266.05 Aligned_cols=193 Identities=28% Similarity=0.403 Sum_probs=158.4
Q ss_pred eeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHH---hcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..++ ...+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 47899999886421 11223334444433 34479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999998643 34899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.....|++.|+|||.+. +..++.++||||+||++|||++|+.||.....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 12246899999999986 45689999999999999999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.55 Aligned_cols=190 Identities=28% Similarity=0.466 Sum_probs=160.7
Q ss_pred eeeeecCceeEEEEEecCCc-----------EEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 446 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999986533 4778877543333 6788999999999999999999999988 778999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-------ceEEEeec
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 587 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DFG 587 (670)
|||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999965432 5788999999999999999999987 99999999999999887 79999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
++..+.. .....++..|+|||.+.+. .++.++||||||+++|||++ |..|+....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9887543 1123467789999999776 78999999999999999999 577775543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=269.48 Aligned_cols=200 Identities=29% Similarity=0.503 Sum_probs=174.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999864 5788999998654445567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999854 23678889999999999999999987 99999999999999999999999999876543322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22346888999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=263.82 Aligned_cols=202 Identities=33% Similarity=0.496 Sum_probs=171.7
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++.+.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34688999999999999999999877888999988643 3345678899999999999999999999877 778999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999996532 334788889999999999999999987 99999999999999999999999999887643222
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
. ......++..|+|||.+....++.++|+|||||++|||+| |+.||..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 1 1122345678999999998889999999999999999999 8999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.63 Aligned_cols=195 Identities=31% Similarity=0.504 Sum_probs=166.8
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEE-eCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~ 518 (670)
++|++.+.||+|+||.||++.. .+..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. .+...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788899999999999999986 4788999988643 23467899999999999999999999765 445789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986532 234788999999999999999999987 9999999999999999999999999988653221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234568999999998899999999999999999998 9999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.41 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=170.5
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999864 4778999988643 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998843 34788899999999999999999987 99999999999999999999999999877643221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 12224578899999999998999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.21 Aligned_cols=196 Identities=25% Similarity=0.410 Sum_probs=165.8
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||+|+.. +|+.+|+|++... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 5889999998642 222345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5788777542 244889999999999999999999987 99999999999999999999999999886643221
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
. .....+++.|+|||.+.+. .++.++|||||||++|||+||+.|+
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 1 1224568899999998764 4789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.04 Aligned_cols=199 Identities=31% Similarity=0.499 Sum_probs=168.0
Q ss_pred CcccceeeeecCceeEEEEEe-----cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeE
Q 005907 441 NFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (670)
-|++.+.||+|+||.||+++. ..+..||+|.++.. .......+.+|+.++++++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999974 24778999998753 234456899999999999999999999998775 5678
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999985432 34789999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
...... .......++..|+|||.+.+..++.++||||||+++|||+|++.|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 433221 1112345677899999999889999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=276.46 Aligned_cols=206 Identities=24% Similarity=0.376 Sum_probs=173.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
...|..++.||-|+||+|.+++..+ ...+|+|.+++. .+.+....++|-.||.....+-||+|+..|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3468888999999999999998765 457899999763 455667889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec--
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-- 592 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~-- 592 (670)
|+|++||++-.+|- +...+++..+..++.++.-|+++.|..| +|||||||+|||||.+|++||.|||||.-+
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999998884 3455778888888899999999999776 999999999999999999999999998432
Q ss_pred -------CCCcccC-------------------------------CccccccccCcccccccCCCCCCccchHHHHHHHH
Q 005907 593 -------GGDETEG-------------------------------NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634 (670)
Q Consensus 593 -------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil 634 (670)
...+... ..-..+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1100000 00013699999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCc
Q 005907 635 LEIVSGKKNRGFYRSD 650 (670)
Q Consensus 635 ~elltG~~p~~~~~~~ 650 (670)
|||+.|+.||-...+.
T Consensus 862 ~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPG 877 (1034)
T ss_pred HHHhhCCCCccCCCCC
Confidence 9999999998654443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=289.61 Aligned_cols=201 Identities=23% Similarity=0.377 Sum_probs=159.6
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC--CcEEEEE------------------EecccchhchHHHHHHHHHHhcCCCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHR 496 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~ 496 (670)
...++|++.++||+|+||.||++..+. +...++| .+. ........+.+|+.++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987533 1112222 111 1222345688999999999999
Q ss_pred ceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 497 niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
||+++++++...+..++|+|++. ++|..++..... ...........++.||+.||+|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 577777643221 122335667789999999999999987 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 643 (670)
++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999877533222 22235789999999999999999999999999999999998864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=261.72 Aligned_cols=196 Identities=36% Similarity=0.539 Sum_probs=163.8
Q ss_pred eeeeecCceeEEEEEecC----CcEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997533 26899999875332 34567899999999999999999999875 5568999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996533 4789999999999999999999987 99999999999999999999999999987643332211
Q ss_pred -ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 601 -TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 601 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 111224568999999998899999999999999999998 999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=255.96 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=174.0
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
..++|.++++||+|+|..|..++++. .+.+|+|++++. ..+..+=...|-.+..+. +||.+|.+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34689999999999999999999855 678999998762 233344456677777766 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+|.||+++|+|--++..+ ..++++.+..+..+|..||.|||+.+ ||+||||.+||||+.+|++||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998777543 33788888888999999999999998 999999999999999999999999999863
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
- .....+++.+|||.|+|||++++..|+..+|+|++||+|+||+.|+.||...
T Consensus 402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 2 2334466799999999999999999999999999999999999999999643
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=264.69 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=168.4
Q ss_pred CCcccceeeeecCceeEEEEEecCC----cEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|.+.++||+|+||.||+|...+. ..+|+|...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688889999999999999986442 468999886543 4456789999999999999999999998865 557899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999996532 34789999999999999999999987 99999999999999999999999999887644
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
..... .....+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 32211 112334568999999988889999999999999999986 99997543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=265.03 Aligned_cols=203 Identities=29% Similarity=0.440 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEecC------CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
++|++.+.||+|+||.||+|+.+. .+.+++|.+...... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 478889999999999999998642 457899988653333 4578999999999999999999999999888999
Q ss_pred EEEEccCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 513 LIYEFMPNKSLDSFIFDQTRR------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654321 25889999999999999999999987 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99875432221 12223456778999999988888999999999999999999 7888753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.71 Aligned_cols=209 Identities=31% Similarity=0.439 Sum_probs=172.4
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC--
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-- 508 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-- 508 (670)
..+....++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 444556789999999999999999999874 57889999986532 2345678899999998 799999999998754
Q ss_pred ---CeeEEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 509 ---EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 509 ---~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3579999999999999988542 22345788999999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCC-----CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|||+++.+...... .....|+..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99998875432221 1224678899999998543 3688999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=264.69 Aligned_cols=195 Identities=33% Similarity=0.511 Sum_probs=161.7
Q ss_pred eeeeecCceeEEEEEecC-Cc--EEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 4688888643 334556788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 521 KSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 521 g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1124788999999999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 98632111 11111233567999999988899999999999999999997 9999743
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=267.24 Aligned_cols=198 Identities=39% Similarity=0.584 Sum_probs=166.1
Q ss_pred eeeeecCceeEEEEEecC-------CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999876532 34466889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-----ceEEEeecC
Q 005907 518 MPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 588 (670)
Q Consensus 518 ~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl 588 (670)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999987 99999999999999887 899999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 886643322222222345788999999999999999999999999999998 9999753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=258.56 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=169.4
Q ss_pred cCCcccceeeeecCceeEEEEEecC-----CcEEEEEEecccch--hchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 510 (670)
...|+....||+|.||.||+|.-.+ .+.+|+|+++.... ......-+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4578888999999999999996433 34789999865321 223456789999999999999999999877 778
Q ss_pred eEEEEEccCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CceEEE
Q 005907 511 KLLIYEFMPNKSLDSFIFDQ--TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKIS 584 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~ 584 (670)
.++++||.+. +|..+|+-+ .....++...+..|+.||+.|+.|||+.- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 777777532 23356888899999999999999999987 9999999999999877 899999
Q ss_pred eecCceecCCCccc-CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 585 DFGLVRTFGGDETE-GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 585 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
|||++|.+...-.. .....++-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++.|.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999988654333 244556779999999999875 68999999999999999999999874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=262.42 Aligned_cols=201 Identities=28% Similarity=0.430 Sum_probs=169.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
.+|.+.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999874 4889999987431 223456788999999999999999999998764 457
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998543 33788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+...... .......++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 5322111 111234688999999999988899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=264.77 Aligned_cols=194 Identities=30% Similarity=0.439 Sum_probs=165.7
Q ss_pred eeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 58899999986422 22344667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+.... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999865432 35789999999999999999999987 9999999999999999999999999987654311 1222
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..++..|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 457889999999988889999999999999999999999986443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=264.76 Aligned_cols=201 Identities=28% Similarity=0.461 Sum_probs=170.5
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
+|++.+.||+|++|.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999985 48899999986532 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888866554456899999999999999999999987 99999999999999999999999999876532211
Q ss_pred CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......+++.|++||.+.+ ..++.++||||||+++|||++|+.||..-
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1122456889999998865 45788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=261.79 Aligned_cols=192 Identities=28% Similarity=0.398 Sum_probs=167.5
Q ss_pred eeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||.|++|.||+++... ++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999854 8899999986522 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
.+++... ..++...+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9999543 33788899999999999999999987 9999999999999999999999999988764332 1223
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..+++.|+|||.+.+..++.++|+||+|+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999986544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=263.42 Aligned_cols=193 Identities=29% Similarity=0.409 Sum_probs=158.6
Q ss_pred eeeecCceeEEEEEec-CCcEEEEEEecccch---hchHHHHHHHH---HHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---QGLKELKNEVI---LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
.||+|+||.||++... .++.||+|.+.+... .....+..|.. +++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 478999999865221 11222334433 4445679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999998854 235899999999999999999999987 9999999999999999999999999987653221
Q ss_pred CccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 1234689999999998754 689999999999999999999999865533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=264.82 Aligned_cols=198 Identities=28% Similarity=0.432 Sum_probs=170.6
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999974 58899999986533 33456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986533 45889999999999999999999987 99999999999999999999999999887654322
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.......++..|+|||.+.+. .++.++||||+|+++|||++|++||.
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 122235688999999998654 46899999999999999999987764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.04 Aligned_cols=200 Identities=29% Similarity=0.431 Sum_probs=164.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|+.+ ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 48999999986532 2233455566665 666789999999999999999999999
Q ss_pred ccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 517 FMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|++ ++|.+++... .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887542 2335688999999999999999999986 5 99999999999999999999999999887532
Q ss_pred CcccCCccccccccCcccccccCC----CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASD----GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 21 1122457889999998865 4568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=263.81 Aligned_cols=199 Identities=30% Similarity=0.454 Sum_probs=168.5
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch----------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE----------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677789999999999999864 588999998753111 12346788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998653 35788888999999999999999987 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCCCC--CCccchHHHHHHHHHHHHcCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
+...............++..|+|||.+.... ++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 7654322222223356788999999987654 7899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=260.85 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=173.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch--hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 578999999865433 3677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998543 34778888999999999999999988 99999999999999999999999999887644332
Q ss_pred cCC--ccccccccCcccccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGN--TNRVVGTYGYMAPEYASDGQ---FSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... .....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 211 12346788999999998766 889999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=265.90 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=172.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 4789999988642 33345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++++.+..++.. ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777766532 234788999999999999999999987 9999999999999999999999999988765433
Q ss_pred ccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 12235678899999999888 8899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=262.70 Aligned_cols=198 Identities=29% Similarity=0.477 Sum_probs=171.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
-|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 5789999987642 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|..++.. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999843 34789999999999999999999987 99999999999999999999999999887643221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 122245788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.07 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=169.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.++||+|+||.||+|... .++.+|+|++.... ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999985 47899999876522 2234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|..+... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 223789999999999999999999987 9999999999999999999999999988764332
Q ss_pred ccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 21 222457889999999865 4578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=264.42 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=168.1
Q ss_pred CcccceeeeecCceeEEEEEec----CCcEEEEEEecccc----hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCee
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (670)
+|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 57899999986522 22346778899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34778888889999999999999987 99999999999999999999999999887
Q ss_pred cCCCcccCCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+...... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6432221 12235688999999998753 467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=260.11 Aligned_cols=200 Identities=25% Similarity=0.404 Sum_probs=172.6
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||++... +++.+|+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999874 5789999998642 334456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886532 234688899999999999999999987 99999999999999999999999999887643222
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. .....|++.|+|||++.+..++.++|+|||||+++||++|+.||..
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 1 1224578899999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=261.45 Aligned_cols=195 Identities=32% Similarity=0.518 Sum_probs=159.0
Q ss_pred eeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeeEEEEEccC
Q 005907 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMP 519 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 519 (670)
+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999988543 33446788899999999999999999998764 456789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc-
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE- 598 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 598 (670)
+++|.+++.... ...++..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999996532 23567788899999999999999987 999999999999999999999999998865332111
Q ss_pred -CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcC-CCCCC
Q 005907 599 -GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG-KKNRG 645 (670)
Q Consensus 599 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~p~~ 645 (670)
.......++..|+|||.+.+..++.++||||||+++|||++| ..||.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 111123456789999999888999999999999999999995 55554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=269.89 Aligned_cols=205 Identities=25% Similarity=0.389 Sum_probs=169.8
Q ss_pred CcccceeeeecCceeEEEEEecC---CcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (670)
+|++.++||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999754 7899999987632 34456778899999999999999999999988 7899
Q ss_pred EEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC----CCceEEEee
Q 005907 513 LIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 586 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF 586 (670)
+||||+++ +|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666643222 235788999999999999999999987 999999999999999 899999999
Q ss_pred cCceecCCCcc-cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 587 GLVRTFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 587 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
|+++.+..... ........+++.|+|||.+.+ ..++.++||||||++||||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99887643322 122233567889999998866 4578999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=267.39 Aligned_cols=198 Identities=30% Similarity=0.440 Sum_probs=168.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch-----hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+|++.+.||+|+||.||+|... +++.||+|++..... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 588999999865322 2345677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986432 35889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 3221 122346788999998854 4678999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=266.82 Aligned_cols=205 Identities=29% Similarity=0.494 Sum_probs=177.4
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
...+.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++|+||+++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999986 588999999875433 5677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996643 35889999999999999999999987 999999999999999999999999988765432
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.. ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.....
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 11234578899999999988899999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=260.11 Aligned_cols=200 Identities=39% Similarity=0.607 Sum_probs=170.5
Q ss_pred cccceeeeecCceeEEEEEecC-----CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
|++.+.||+|+||.||++...+ +..+|+|++...... ..+.+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999998654332 5678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999865322 11789999999999999999999987 999999999999999999999999999877544
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
...... ...+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 222211 2336789999999988889999999999999999999 7888654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=259.07 Aligned_cols=229 Identities=24% Similarity=0.352 Sum_probs=193.1
Q ss_pred HHhcCCcccceeeeecCceeEEEEEecC------CcEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
.....+++...++-+|.||.||+|.+.+ .+.|.+|.++. .++-+...+..|..++..+.|||+..+.+++.+.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3345678888899999999999996643 45677887765 3445567888999999999999999999998764
Q ss_pred -CeeEEEEEccCCCCHHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceE
Q 005907 509 -EEKLLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (670)
Q Consensus 509 -~~~~lV~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 582 (670)
...++++.++.-|+|+.||. +......+...+...++.|++.||+|||.++ |||.||.++|++|++..++|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEE
Confidence 56788999999999999997 3334456778888999999999999999988 99999999999999999999
Q ss_pred EEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhc
Q 005907 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~ 661 (670)
|+|=.++|.+-..++..-......+..||+||.+.+..|+.++|||||||+||||+| |+.||..-++.+....+..-.|
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 999999999877776655444455789999999999999999999999999999999 8999887777777777777777
Q ss_pred eeeecC
Q 005907 662 MHTTFS 667 (670)
Q Consensus 662 ~~~~~~ 667 (670)
+.++|+
T Consensus 517 laQP~N 522 (563)
T KOG1024|consen 517 LAQPFN 522 (563)
T ss_pred ecCCCC
Confidence 777765
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=263.18 Aligned_cols=201 Identities=29% Similarity=0.369 Sum_probs=170.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (670)
++|+..+.||.|++|.||++... .++.+|+|.+... ......++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999985 4788999988653 224456789999999999999999999998654 4689999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||+++++|.+++... .....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987542 22345788899999999999999999987 99999999999999999999999999876532
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1245788999999999999999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=263.06 Aligned_cols=196 Identities=30% Similarity=0.474 Sum_probs=169.8
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5788999988654445556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999999854 34788899999999999999999988 999999999999999999999999988765432221
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 1224588999999999988899999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=264.23 Aligned_cols=199 Identities=29% Similarity=0.424 Sum_probs=173.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|++|.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999986 4888999988653 234556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986532 457889999999999999999999 76 9999999999999999999999999987653221
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 156788999999999999999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=262.60 Aligned_cols=198 Identities=27% Similarity=0.475 Sum_probs=170.6
Q ss_pred CcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 515 (670)
.|++.+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999997 45889999998653 3445567889999999997 999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.. ..+++..++.++.++++||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 25789999999999999999999987 999999999999999999999999999877543
Q ss_pred cccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... .....|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 223468889999998865 45789999999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=257.97 Aligned_cols=200 Identities=27% Similarity=0.448 Sum_probs=172.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|+..+.||+|+||.||++... .++.+|+|.+... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 5788999998642 334467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 596 (670)
+++++|.+++.... ...+++..+..++.+++++|+|||+++ ++|+||+|+||+++.+ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 344788999999999999999999987 9999999999999865 468999999998764332
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 1 22346788999999999888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=265.48 Aligned_cols=190 Identities=27% Similarity=0.450 Sum_probs=159.3
Q ss_pred eeeeecCceeEEEEEecC--------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+.||+|+||.||+|.... ...+|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998643 234888887655455567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc--------eEEEeecCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLV 589 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFGla 589 (670)
+++++|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996532 35788899999999999999999987 999999999999987765 699999987
Q ss_pred eecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCC-CCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGK-KNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~-~p~~~ 646 (670)
..... .....+++.|+|||.+.+. .++.++||||||+++|||++|. .|+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 65432 1224578899999999764 5789999999999999999995 56543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=263.68 Aligned_cols=204 Identities=18% Similarity=0.232 Sum_probs=154.4
Q ss_pred cCCcccceeeeecCceeEEEEEecCC----cEEEEEEecccchhch-----------HHHHHHHHHHhcCCCCceeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVKLLG 503 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 503 (670)
.++|.+.++||+|+||.||+|...++ ..+|+|......+... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999997554 3456664322111110 11223344566778999999999
Q ss_pred EEEeCC----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 504 CCIQGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 504 ~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
++.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 3467888774 3666665332 22467788899999999999999987 99999999999999999
Q ss_pred ceEEEeecCceecCCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 580 NPKISDFGLVRTFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999876432211 112234699999999999999999999999999999999999999976633
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=262.14 Aligned_cols=202 Identities=27% Similarity=0.462 Sum_probs=165.5
Q ss_pred cccceeeeecCceeEEEEEec----CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
|.+.+.||+|+||.||+|... .++.+|||++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999863 3678999988652 3344667889999999999999999999886542
Q ss_pred eeEEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
..++++||+++++|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 1234788889999999999999999987 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
|+++.+.............+++.|++||.+....++.++||||||+++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99987643332222222345678999999998899999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=260.53 Aligned_cols=200 Identities=24% Similarity=0.461 Sum_probs=168.9
Q ss_pred CcccceeeeecCceeEEEEEecC--CcEEEEEEeccc----------chhchHHHHHHHHHHhc-CCCCceeeEEEEEEe
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI----------SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 507 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 507 (670)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 678999987532 22234567788888765 799999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999987542 233458889999999999999999996 44 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998764332 22335688999999999988899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=254.73 Aligned_cols=199 Identities=35% Similarity=0.555 Sum_probs=175.8
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999985 588999999976554566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999986532 45889999999999999999999987 99999999999999999999999999887654322
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23356888999999998888999999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=263.56 Aligned_cols=200 Identities=28% Similarity=0.395 Sum_probs=168.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (670)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999985 47889999986432 22334567899999999999999999998877 789999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 8988885432 35889999999999999999999987 99999999999999999999999999987654
Q ss_pred CcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... ......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 12224578899999998654 4689999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.64 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=166.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCe-----
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 510 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 510 (670)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 58899999876432 223467888999999995 6999999999887665
Q ss_pred eEEEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeec
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 587 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG 587 (670)
.++||||+++ +|.+++..... ...+++..+..++.||++||+|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888754322 245789999999999999999999987 999999999999998 8899999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 98865332111 122356788999998865 4678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=259.12 Aligned_cols=203 Identities=27% Similarity=0.458 Sum_probs=171.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 515 (670)
+|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 578899998864 233445678899999999999999999998764 44678999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLH-----QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH-----~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
||+++++|.+++.... ....+++..++.++.+|++||+||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999986532 2345889999999999999999999 555 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 876543321 223468899999999998889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=258.90 Aligned_cols=195 Identities=33% Similarity=0.536 Sum_probs=165.8
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.+.||+|+||.||++.. .++.+|+|.++.. .....+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 6788999998643 2346788999999999999999999998654 5789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++.... ...+++..++.++.|+++|+.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999996543 234788899999999999999999987 9999999999999999999999999987643211
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11234567999999998899999999999999999998 99997543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=263.04 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=167.8
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|+..+.||+|++|.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 5889999988642 222345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+. ++|..++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988885533 345789999999999999999999987 99999999999999999999999999876543221
Q ss_pred cCCccccccccCcccccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. .....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12234688999999886644 68899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=265.30 Aligned_cols=206 Identities=25% Similarity=0.394 Sum_probs=167.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (670)
..++|++.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999875 48899999886432 223345678999999999999999999987654
Q ss_pred ---eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 510 ---EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 510 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
..++||||+.+ +|..++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 34999999964 788777442 235789999999999999999999987 999999999999999999999999
Q ss_pred cCceecCCCccc--CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 587 GLVRTFGGDETE--GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 587 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
|++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999876432221 111234578899999988664 478899999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=255.09 Aligned_cols=202 Identities=31% Similarity=0.468 Sum_probs=176.3
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (670)
+|...+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999986 58899999986543 24567899999999999999999999999988 8899999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986533 5889999999999999999999987 999999999999999999999999999887544
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..........++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 33211233567889999999988889999999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=258.15 Aligned_cols=214 Identities=30% Similarity=0.413 Sum_probs=169.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+++-+..||.|+||+|++-.++ .|+..|||+++.. .+...++++.|.+...+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 4455578999999999999875 4899999999764 346678888898876555 689999999999999999999999
Q ss_pred cCCCCHHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 518 MPNKSLDSFI---FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 518 ~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
| ..+|+.+- ... .+..+++..+-+|......||.||.+.- .|||||+||+||||+..|.+||+|||++..+..
T Consensus 145 M-d~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred H-hhhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9 45665443 222 2344788888888888999999998754 699999999999999999999999999877643
Q ss_pred CcccCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
... ...-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.||..+++ ..+.+..+....
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gd 286 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGD 286 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCC
Confidence 221 222457788999999953 3589999999999999999999999877655 444555444433
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=263.35 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=170.0
Q ss_pred CCcccceeeeecCceeEEEEEec-----CCcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEe--CCee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 511 (670)
+.|++.+.||+|+||.||+|... .++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999863 3678999998754332 56789999999999999999999999877 5578
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996533 24889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
+...... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 7532221 11112234567999999988899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=261.80 Aligned_cols=207 Identities=30% Similarity=0.483 Sum_probs=170.8
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEe----
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ---- 507 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---- 507 (670)
......+.|++.+.||+|+||.||+|... .++.+|+|.+... .....++..|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 33445678999999999999999999974 4788999987543 23446788899999998 69999999999853
Q ss_pred --CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 508 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
....+++|||+++++|.+++.... ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence 457799999999999999986533 234778888899999999999999987 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 165 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 165 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred Ccchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999876532211 222356889999999985 356788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=261.24 Aligned_cols=203 Identities=31% Similarity=0.485 Sum_probs=170.6
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 509 (670)
..++|++.+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999985 47789999886533 2446789999999999 6999999999997644
Q ss_pred eeEEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999886422 2345789999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+........ ......|+..|+|||.+.. ..++.++||||||++||||++|+.||..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 876543221 1223568899999998753 3567899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=231.42 Aligned_cols=111 Identities=50% Similarity=0.764 Sum_probs=82.2
Q ss_pred CCceEEeccCCCCCCCC--cceEEEecCCcEEEECCCCcEEEee-cCccCccCceEEEEecCCCEEEeeCCCCCCcceEE
Q 005907 14 PHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSA-YLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFW 90 (670)
Q Consensus 14 ~~t~vW~ANr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~Wst-~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~W 90 (670)
++||||+|||++|+..+ ..+|.+..||+|+|.|+.++++|++ ++.........|+|+|+|||||++. .+.+||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~----~~~~lW 76 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS----SGNVLW 76 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET----TSEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee----cceEEE
Confidence 46999999999999553 4899999999999999999999999 4443322578999999999999996 678999
Q ss_pred eecCCCCCcccCCCccccccccccceeEEEeccCCCCC
Q 005907 91 QSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128 (670)
Q Consensus 91 qSFd~PtdtlLpg~~l~~~~~tg~~~~l~S~~s~~dps 128 (670)
|||||||||+||||+|+.+..++....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988888777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=263.05 Aligned_cols=192 Identities=30% Similarity=0.481 Sum_probs=167.8
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~ 524 (670)
.+||+|+||.||++... +++.+|+|++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986544455667889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcccc
Q 005907 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (670)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 604 (670)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+...... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 98743 23788899999999999999999987 999999999999999999999999998766432211 2234
Q ss_pred ccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 605 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.|++.|+|||.+.+..++.++|+||+|+++|||++|+.||..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 678999999999888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=256.15 Aligned_cols=189 Identities=28% Similarity=0.346 Sum_probs=159.5
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.||+|+||.||+|... .++.||+|.+.+.. ......+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 47899999986532 1222334455444 4456899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 34788999999999999999999987 99999999999999999999999999876432
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 1234578899999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=269.18 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=166.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----ee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 511 (670)
.++|++.++||+|+||.||+|... +++.||+|+++.. .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 5889999998642 2334566888999999999999999999876543 57
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++|+||+++ +|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 78777732 34888999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCcccC-CccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEG-NTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
........ ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 64322211 1123468899999998754 5689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=269.69 Aligned_cols=198 Identities=29% Similarity=0.382 Sum_probs=167.9
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (670)
..++|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999874 5889999998642 233445778899999999999999999988643
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
...++||||+. ++|.+++... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35689999996 4888877431 788888999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++....... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 987643221 22345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.95 Aligned_cols=201 Identities=31% Similarity=0.438 Sum_probs=167.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (670)
..++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999975 48899999986432 22234567899999999999999999998765 4679
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999974 888887543 245889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...... .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 533211 122345788999999865 5678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=258.65 Aligned_cols=194 Identities=29% Similarity=0.391 Sum_probs=167.2
Q ss_pred eeecCceeEEEEEecC-CcEEEEEEecccch---hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999865322 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc------
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET------ 597 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------ 597 (670)
.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986532 5789999999999999999999987 99999999999999999999999999876533211
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 11223356788999999998888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=262.13 Aligned_cols=196 Identities=31% Similarity=0.470 Sum_probs=166.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.+.|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+.+++.++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999875 58899999886432 23345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 5777766432 234889999999999999999999987 99999999999999999999999999876532
Q ss_pred CcccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ....+++.|+|||.+. ...++.++||||||+++|||+||+.||..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2 1245788999999874 45688999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=255.33 Aligned_cols=194 Identities=24% Similarity=0.346 Sum_probs=161.1
Q ss_pred HHHhcCCcccceee--eecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 005907 435 IANATDNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 435 ~~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (670)
.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+...... +. |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677776666 99999999999874 4778899987643211 11 22222222 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCc
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLV 589 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla 589 (670)
.++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999986532 5899999999999999999999987 99999999999999998 9999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
+...... ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 8764221 2357889999999998899999999999999999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=262.42 Aligned_cols=207 Identities=30% Similarity=0.427 Sum_probs=171.2
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEec--c-----cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--K-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~-----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 509 (670)
.++|-++.+||+|+|+.||+|.+- ..+-||+|+-. + ..+...+...+|..|.+.|.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356888899999999999999864 46678888742 2 122334567789999999999999999999864 56
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEee
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDF 586 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DF 586 (670)
.++-|+|||+|.+|+.||.. ...++++++..|+.||+.||.||.+. +++|||-||||.|||+-+ -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 77899999999999999954 34589999999999999999999987 478999999999999954 378999999
Q ss_pred cCceecCCCcccC-----CccccccccCcccccccC----CCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 587 GLVRTFGGDETEG-----NTNRVVGTYGYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 587 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
|+++.+..+.... .+....||..|++||.+. ...++.|+||||+|||+|+.+.|++||+...+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 9999986554431 244567999999999873 23678999999999999999999999986443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-29 Score=252.20 Aligned_cols=199 Identities=32% Similarity=0.494 Sum_probs=174.1
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccch--hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|++|.||++... .++.+++|.+..... .....+.+|++++++++|||++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999875 478999999876433 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 45889999999999999999999987 99999999999999999999999999987754332
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. .....++..|+|||...+..++.++||||+|+++|||++|+.||...
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 2 22346788999999998888899999999999999999999997643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=260.21 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=165.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999886432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 595 (670)
|++ ++|.+++.... ....++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57877774432 223577888889999999999999987 999999999999985 457999999999765432
Q ss_pred cccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||..
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1122456889999998866 4578999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=259.40 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=169.2
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEEEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 516 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 516 (670)
|++.++||+|++|.||+|...+ ++.+|+|++... .......+.+|+.++++++|||++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999998764 789999999764 233456788999999999999999999999888 78999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++ +|..++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887543 245889999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 21 1222356788999998765 4678999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=229.80 Aligned_cols=211 Identities=25% Similarity=0.398 Sum_probs=170.6
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|...++||+|.||+||+|+..+ .+.||+|+++- .++.......+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666899999999999999765 67899999864 2333445678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
| ..+|..|.... .+.++.+....++.|+++||.+.|++. +.||||||+|.||+.+|+.||+|||+++.++-...
T Consensus 83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9 45788876442 345888899999999999999999998 99999999999999999999999999998764332
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCC-CCCCCCcccchHhhhhhce
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKN-RGFYRSDTKVNLIGHVSKM 662 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p-~~~~~~~~~~~l~~~i~~~ 662 (670)
- .+..+-|..|.+|.++.+. .|+...|+||.|||+.|+....+| |. ..+..+.+..|.+.
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp---g~dvddqlkrif~~ 218 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRL 218 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC---CCcHHHHHHHHHHH
Confidence 2 2224558999999998775 588999999999999999885555 43 33344444444443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=245.06 Aligned_cols=212 Identities=25% Similarity=0.423 Sum_probs=170.8
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecc-cchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 516 (670)
++.+.+..||+|..|.|++.+.+. |..+|||.+.+ .+....++++..+.++.+-+ .|+||+-+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445566789999999999999855 78999999976 34556678888888877765 8999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
.|. .-++.+|.. ...++++..+-++...+.+||.||.++. +|+|||+||.|||+|+.|++||+|||++..+-...
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 884 345555543 2345888888889999999999998865 69999999999999999999999999998774333
Q ss_pred ccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
.. ....|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||..-+.+ .+++..|..
T Consensus 247 Ah---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln 309 (391)
T KOG0983|consen 247 AH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN 309 (391)
T ss_pred cc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh
Confidence 22 23467899999999853 47889999999999999999999998754333 455555544
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=258.83 Aligned_cols=198 Identities=30% Similarity=0.452 Sum_probs=167.0
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999874 58999999986432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
+ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.+......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689998865332 35789999999999999999999987 999999999999999999999999998765322211
Q ss_pred CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1223468899999988654 578999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-31 Score=269.91 Aligned_cols=202 Identities=24% Similarity=0.325 Sum_probs=176.6
Q ss_pred CCcccceeeeecCceeEEEEEecCCc-EEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.+++.+..||-|+||.|-++...... .+|+|++++ ...++.+.+..|-.+|...+.|.||+++-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667789999999999999875433 378888865 45566778889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|-|-||.|-..|++. +.++......++..+++|++|||+++ ||+|||||+|.|++.+|-+||.|||.|+.++..
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999653 34677777778888999999999998 999999999999999999999999999998643
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
..+.+++|||.|.|||++.++..+.++|.||||+++||||+|++||...++.
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 3456689999999999999999999999999999999999999997655443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=259.61 Aligned_cols=202 Identities=30% Similarity=0.456 Sum_probs=174.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (670)
++|.+.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999875 5889999998652 2334567889999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999653 25899999999999999999999987 99999999999999999999999999887654
Q ss_pred Cccc------------------CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETE------------------GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3321 1222345788999999998888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=266.82 Aligned_cols=202 Identities=29% Similarity=0.454 Sum_probs=167.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC--Cee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 511 (670)
..++|++.+.||+|+||.||+|... +++.+|+|++.. ........+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568999999999999999999875 478899998854 2233445677899999999 999999999998653 367
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5998888542 5788888999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc---CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 592 FGGDETE---GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+...... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6433221 12223568899999998755 46788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.96 Aligned_cols=202 Identities=28% Similarity=0.417 Sum_probs=167.2
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (670)
..++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568999999999999999999985 47899999986532 233456788999999999999999999987654
Q ss_pred -----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 510 -----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 510 -----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
..++|+||+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 677776442 335789999999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|||++..+...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999876433221 1122345778999998864 4578999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.50 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=170.9
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||+|.... +..+|+|.+... .....+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999999854 788999998642 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 596 (670)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++ .+||+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986532 234788999999999999999999987 99999999999999885 46999999988764322
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 1224578899999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=255.48 Aligned_cols=197 Identities=25% Similarity=0.345 Sum_probs=162.5
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CeeEEEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 516 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e 516 (670)
|++.++||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. ||||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999874 57899999986532 222234457888888885 99999999999987 88999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5888877542 245889999999999999999999987 999999999999999 999999999998764332
Q ss_pred ccCCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.. ....+++.|+|||.+. +..++.++||||+||++|||++|+.||...+
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 21 2245788999999764 4567889999999999999999999986443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=263.78 Aligned_cols=201 Identities=29% Similarity=0.429 Sum_probs=167.9
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG- 508 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 508 (670)
.++....++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556778999999999999999999986 45889999998653 223346788899999999999999999988643
Q ss_pred -----CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 509 -----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 509 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2357788876 7899888743 23788999999999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+|||+++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998764321 223467889999999866 5688999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=258.94 Aligned_cols=194 Identities=31% Similarity=0.490 Sum_probs=164.8
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.|...+.||+|+||.||+|... ++..+|+|++... .......+.+|+.++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999874 5789999998643 22334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 777776432 344889999999999999999999987 99999999999999999999999998875432
Q ss_pred ccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 12245788999999973 45688999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=257.22 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=168.0
Q ss_pred CcccceeeeecCceeEEEEEec----CCcEEEEEEecccc----hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCee
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (670)
+|++.+.||+|++|.||++... +++.+|||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999753 46789999986421 23345788999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++... ..+++..+..++.|++++|+|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998542 34788889999999999999999987 99999999999999999999999999887
Q ss_pred cCCCcccCCccccccccCcccccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 6433221 122346789999999987665 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=284.13 Aligned_cols=207 Identities=34% Similarity=0.468 Sum_probs=173.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC--------CcEEEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEEEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 506 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 506 (670)
...+++.+.+.||+|+||.|++|.... ...||||.++. ......+.+..|+++|+.+ +||||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344455666799999999999998531 35799999876 3335678899999999998 5999999999999
Q ss_pred eCCeeEEEEEccCCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 005907 507 QGEEKLLIYEFMPNKSLDSFIFDQT-----RR--------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (670)
Q Consensus 507 ~~~~~~lV~e~~~~g~L~~~l~~~~-----~~--------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NI 573 (670)
.....++|+||++.|+|..||+... .. ..+...+.+.++.|||.||+||++.. +|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997654 00 24888999999999999999999987 99999999999
Q ss_pred EEcCCCceEEEeecCceecCCCcccCCc-cccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 574 LLDQDMNPKISDFGLVRTFGGDETEGNT-NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 574 Ll~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
|+.++..+||+|||+++........... ....-...|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999976544433211 11112456999999999999999999999999999999 8889875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=258.98 Aligned_cols=200 Identities=31% Similarity=0.466 Sum_probs=164.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|...++||+|+||.||++... .++.+|+|++.... ......+.+|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5666789999999999999875 47899999986532 344567889999999996 99999999999998899999999
Q ss_pred cCCCCHHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 518 MPNKSLDSFI---FDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 518 ~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
+.. +|.++. ... ....+++..+..++.++++||+|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 554433 221 224588899999999999999999975 5 9999999999999999999999999987654
Q ss_pred CCcccCCccccccccCcccccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDG---QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..... ....|++.|+|||.+.+. .++.++||||+||++|||++|+.||..+.
T Consensus 160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 32211 223578899999999776 68999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=262.53 Aligned_cols=199 Identities=28% Similarity=0.428 Sum_probs=167.5
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-- 509 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 509 (670)
+....++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446778999999999999999999864 5889999998542 2333457889999999999999999999987553
Q ss_pred ----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 510 ----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 510 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 7799888742 34789999999999999999999987 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
||+++..... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9998865322 122456889999999876 4588999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=249.09 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=175.6
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|.+.+.||+|+||.||++... +++.+++|++.... ....+++.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 48899999986532 24567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 1356889999999999999999999987 9999999999999999999999999988764433
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
. ......|++.|+|||.+.+..++.++|+||+|+++++|++|+.||...
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1 122346888999999998888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=264.38 Aligned_cols=200 Identities=24% Similarity=0.400 Sum_probs=167.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (670)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68999999999999999999875 4889999998653 22345677889999999999999999988753 34679
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 589888843 234889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccC--CccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 593 GGDETEG--NTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 593 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 4332211 1123468899999999865 4688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=264.07 Aligned_cols=200 Identities=26% Similarity=0.407 Sum_probs=167.1
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (670)
.++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999874 5889999998652 233455678899999999999999999987654 34
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6888887542 34889999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 7643221 1223457889999998865 46889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=260.64 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=167.0
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeeE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 512 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 512 (670)
...++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999865 6889999987542 22345678899999999999999999999876 55788
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+|+||+ +++|..++.. ..++......++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 5689888742 23677888889999999999999987 999999999999999999999999998754
Q ss_pred CCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 122456889999998765 578999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=245.22 Aligned_cols=219 Identities=23% Similarity=0.296 Sum_probs=176.5
Q ss_pred hcCCcccc-eeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEe----CCe
Q 005907 438 ATDNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ----GEE 510 (670)
Q Consensus 438 ~~~~~~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 510 (670)
.+++|++. ++||-|-.|.|.....+. ++.+|+|++.. ....++|+++.-.. .|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34556553 689999999999888754 78899998853 23446788776555 69999999999753 356
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeec
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG 587 (670)
+++|||.|+||.|.+.+.++. ...+.+.++-+|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999987654 345889999999999999999999987 999999999999975 4568999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC-cccchHhhhhhceeeec
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS-DTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~-~~~~~l~~~i~~~~~~~ 666 (670)
+|+.-.. .......+-||.|.|||++...+|+...|+||+|||||-||.|.+||.--+. .-.--+-..|...+-+|
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9987432 3334457889999999999999999999999999999999999999743332 22345667777788777
Q ss_pred CC
Q 005907 667 SS 668 (670)
Q Consensus 667 ~~ 668 (670)
|+
T Consensus 287 P~ 288 (400)
T KOG0604|consen 287 PE 288 (400)
T ss_pred CC
Confidence 75
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=251.77 Aligned_cols=201 Identities=30% Similarity=0.477 Sum_probs=173.4
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+|++.+.||+|+||.||++... +++.+|+|.+... ......++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999764 5788999998652 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
+++++|..++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|.||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986522 2345788999999999999999999987 999999999999999999999999998876443
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222457889999999999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=259.71 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=165.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
.++|++.++||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999875 47899999885422 222346788999999999999999999875433
Q ss_pred --eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 510 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999965 67666643 2335889999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCcccC---------CccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 588 LVRTFGGDETEG---------NTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 588 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 998654322111 11223568889999987654 578999999999999999999999764333
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=260.84 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=166.0
Q ss_pred CCcc-cceeeeecCceeEEEEEec-CCcEEEEEEecccchhc--------------hHHHHHHHHHHhcCCCCceeeEEE
Q 005907 440 DNFS-INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLLG 503 (670)
Q Consensus 440 ~~~~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 503 (670)
++|. +.+.||+|+||.||+|... .++.||+|+++...... ...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 3467999999999999875 58899999986432111 125778999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 504 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
++..++..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 689888853 334788999999999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcc------------cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 584 SDFGLVRTFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 584 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
+|||+++.+..... ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987652111 1111123467889999998764 468999999999999999999999865443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=256.48 Aligned_cols=199 Identities=27% Similarity=0.441 Sum_probs=164.3
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc-hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|.... ++.||||.++... .....++..|+.++.+.. ||||+++++++..+...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3578889999999999999999865 8899999986532 233456667777776665 999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||++ ++|..++.... ..+++..+..++.++++||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 47777664422 3588899999999999999999974 5 99999999999999999999999999876533
Q ss_pred CcccCCccccccccCcccccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQ----FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.... ....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2211 2235778999999987554 78899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.98 Aligned_cols=199 Identities=28% Similarity=0.429 Sum_probs=165.1
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecccc--hhchHHHHHHHHHHhcC---CCCceeeEEEEEEeCCe-----
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 510 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 510 (670)
|++.+.||+|+||.||+|+... ++.+|+|+++... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999865 8899999986422 22234566777776655 69999999999988776
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 79888855322 34789999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.+...... ....++..|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 76433221 22347889999999999999999999999999999999999976433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=282.71 Aligned_cols=221 Identities=30% Similarity=0.493 Sum_probs=174.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-------
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------- 507 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 507 (670)
.-..+|+.++.||+||||.||+++.+ ||+.||||++.-. .......+.+|+.++++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44568999999999999999999964 7999999998542 44556678899999999999999998743110
Q ss_pred -----------------------------------------------------------------------C--------
Q 005907 508 -----------------------------------------------------------------------G-------- 508 (670)
Q Consensus 508 -----------------------------------------------------------------------~-------- 508 (670)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005907 509 ---------------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555 (670)
Q Consensus 509 ---------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yL 555 (670)
..+|+-||||+...|++++.++.... .....++++.+|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 12467899999999999986543211 4677889999999999999
Q ss_pred HhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC----------------CCcccCCccccccccCcccccccCCC
Q 005907 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG----------------GDETEGNTNRVVGTYGYMAPEYASDG 619 (670)
Q Consensus 556 H~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 619 (670)
|+++ ||||||||.||+++++..|||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 00111123446899999999999765
Q ss_pred ---CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 620 ---QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 620 ---~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.|+.|+|+||+|||++||+. | +....++...+..+.+...+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---P--F~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---P--FGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---c--CCchHHHHHHHHhcccCCCCCC
Confidence 49999999999999999985 3 3455677788888776655554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=248.17 Aligned_cols=191 Identities=31% Similarity=0.424 Sum_probs=166.3
Q ss_pred eeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
||+|+||.||++... +++.+|+|.+.... ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 48899999986532 22456889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (670)
.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 9998643 24789999999999999999999987 99999999999999999999999999887643321 2233
Q ss_pred cccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 604 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 5678899999999888889999999999999999999999753
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.06 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=163.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
.++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999864 5889999998642 2233456889999999999999999999987543
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 7766651 24788899999999999999999987 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 764321 123457889999999876 46889999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=278.95 Aligned_cols=146 Identities=27% Similarity=0.410 Sum_probs=130.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|.+.++||+|+||.||+|... .++.||||+++.. .......+..|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999985 5889999998653 233346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
|||+.+++|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998543 34788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=260.93 Aligned_cols=201 Identities=29% Similarity=0.443 Sum_probs=170.8
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eeE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (670)
+|++.+.||+|++|.||+|.... ++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999999754 8899999987533 345568899999999999999999999988775 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||++ ++|.+++... ..+++..+..++.+++.||+|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 4888888542 35889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc-CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
...... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 543210 112234578899999999887 88999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.70 Aligned_cols=198 Identities=23% Similarity=0.265 Sum_probs=162.1
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.+.+|.|+++.|+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++...+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334555556666666554 6899999998653 3445678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc----
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---- 597 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 597 (670)
+|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986542 234788888999999999999999987 99999999999999999999999998876532211
Q ss_pred -cCCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 -EGNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
........++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1111224567889999998763 588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.43 Aligned_cols=198 Identities=31% Similarity=0.436 Sum_probs=168.6
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEecccch--hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
|++.+.||+|++|.||++... +++.+++|++..... .....+..|+.++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999875 588899999865322 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||.+..+.....
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 8888875532 45889999999999999999999987 99999999999999999999999999987754331
Q ss_pred CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||...
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 11224577889999998776 7899999999999999999999997543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.06 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=161.4
Q ss_pred eeeeec--CceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
..||+| +||+||++.+. .++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999874 5899999998642 233457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC-
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG- 599 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 599 (670)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999865432 34788888999999999999999987 9999999999999999999999998654332111110
Q ss_pred ----CccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 600 ----NTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 600 ----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 01112345679999999764 4789999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=257.90 Aligned_cols=200 Identities=29% Similarity=0.412 Sum_probs=163.4
Q ss_pred CcccceeeeecCceeEEEEEecC---CcEEEEEEeccc--chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC----Ce
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 510 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 510 (670)
+|++.+.||+|+||.||+++... +..+|+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999999743 678999998642 222345778899999999 599999999876433 35
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 689888843 345789999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCccc--CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 591 TFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.+...... .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 76432221 11223568999999998765 56899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.59 Aligned_cols=199 Identities=28% Similarity=0.383 Sum_probs=166.3
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecccch-hchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
|++.+.||+|++|.||+|...+ ++.+++|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999854 78899999865321 22234557899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998886533 245789999999999999999999987 99999999999999999999999999887643221
Q ss_pred CCccccccccCcccccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYAS-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 12245788999999874 4567899999999999999999999985443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=261.65 Aligned_cols=201 Identities=24% Similarity=0.359 Sum_probs=165.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC---------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------- 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------- 508 (670)
..+|.+.+.||+|+||.||+|... .++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999874 4889999998765556667889999999999999999999776543
Q ss_pred -----CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceE
Q 005907 509 -----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPK 582 (670)
Q Consensus 509 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~k 582 (670)
...++||||++ ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588888743 24788999999999999999999987 999999999999974 56789
Q ss_pred EEeecCceecCCCcccC-CccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 583 ISDFGLVRTFGGDETEG-NTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|+|||+++.+....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998764321111 1122357889999998754 56888999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=251.88 Aligned_cols=193 Identities=32% Similarity=0.491 Sum_probs=162.9
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
|...+.||+|+||.||+|... .++.+++|++... .......+.+|+.++++++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 5789999998642 223345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+. ++|.+++... ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5777776432 335789999999999999999999987 99999999999999999999999998764321
Q ss_pred cCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....|+..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12356888999999984 45688999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=253.92 Aligned_cols=196 Identities=32% Similarity=0.487 Sum_probs=165.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999975 4778999988642 2234457888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 5787776432 234788999999999999999999987 999999999999999999999999998765321
Q ss_pred cccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2245788999999974 356788999999999999999999997544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=265.24 Aligned_cols=213 Identities=30% Similarity=0.488 Sum_probs=180.7
Q ss_pred HHHHHHhcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEe--
Q 005907 432 LATIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-- 507 (670)
Q Consensus 432 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 507 (670)
+......++-|++.++||.|.+|.||+++. ++++..|+|++.. ..+..+++..|..+++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334445667899999999999999999986 4588889998755 345567888899999988 59999999999864
Q ss_pred ---CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 508 ---GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 508 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
++.++||||||.+|+..+++.... ...+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 568999999999999999997644 556889999999999999999999887 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
|||++..+. ..........|||.|||||++.- ..|+..+|+||||++..||--|.+|+..-++..
T Consensus 166 DFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 166 DFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred eeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 999998873 34445556789999999999953 457889999999999999999999976555443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=251.66 Aligned_cols=197 Identities=31% Similarity=0.460 Sum_probs=168.5
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
|+..+.||+|++|.||+|.... ++.+|+|.+... .....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566889999999999999864 889999998764 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
+ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999986532 35889999999999999999999987 999999999999999999999999998876433221
Q ss_pred CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 1223457789999998776 889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=259.59 Aligned_cols=198 Identities=28% Similarity=0.440 Sum_probs=167.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe---
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 510 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 510 (670)
...++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999985 4788999998642 23344667889999999999999999988766554
Q ss_pred ---eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 511 ---KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 511 ---~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699998853 34889999999999999999999987 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98875332 122457889999999865 36789999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=246.48 Aligned_cols=199 Identities=29% Similarity=0.418 Sum_probs=164.9
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEeccc-----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 344556655431 222334567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||+++++|..++... .....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23346889999999999999999999987 999999999999975 569999999988764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3322 1223457889999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=247.04 Aligned_cols=211 Identities=21% Similarity=0.290 Sum_probs=173.7
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCC--C----ceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH--R----NLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~ 510 (670)
..++|.+..++|+|.||.|-+..+.. +..||||+++... ...+..+-|+++++++.+ | -+|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 46789999999999999999998744 6789999986543 345566789999999942 3 27889999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--------------
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-------------- 576 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-------------- 576 (670)
.++|+|.+ |-++.+||.++ +-.+++...+..|+.|+++++++||+.+ ++|.||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 66999999654 3456888999999999999999999987 99999999999983
Q ss_pred ------CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 577 ------QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 577 ------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
++..+||+|||.|..-.... ...+.|..|.|||++.+-.++.++||||+||||+|+.||...|..-+.-
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13458999999988743222 3467899999999999999999999999999999999999998765544
Q ss_pred ccchHhhhh
Q 005907 651 TKVNLIGHV 659 (670)
Q Consensus 651 ~~~~l~~~i 659 (670)
+...+++.|
T Consensus 316 EHLaMMerI 324 (415)
T KOG0671|consen 316 EHLAMMERI 324 (415)
T ss_pred HHHHHHHHh
Confidence 444444444
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=211.55 Aligned_cols=109 Identities=50% Similarity=1.141 Sum_probs=105.1
Q ss_pred EeeCCCCCccccC-CCCCCCCceeEEEeecCceEEEEEeecCCceEEEEEEeeeeeEEEEEEEecCCCcEEEEEecCCCC
Q 005907 154 YRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQ 232 (670)
Q Consensus 154 ~~sg~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~~~~~~~~W~~~~~~~~~~ 232 (670)
||+|||||..|++ |++....++.+.|+.+++|++++|.+.+.++++|++|+.+| +++++.|++.+++|.++|++|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999 99998889999999999999999999999999999999999 899999999999999999999999
Q ss_pred CCcCCCCCCCcccccCCCCccccccccccCC
Q 005907 233 CDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263 (670)
Q Consensus 233 C~~~~~CG~~giC~~~~~~~C~C~~Gf~~~~ 263 (670)
||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=240.67 Aligned_cols=179 Identities=22% Similarity=0.195 Sum_probs=152.5
Q ss_pred cCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhh
Q 005907 451 GGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (670)
Q Consensus 451 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~ 529 (670)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++...+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999874 57899999986532 233455555666799999999999999999999999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccC
Q 005907 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609 (670)
Q Consensus 530 ~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 609 (670)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||.+..+.... ....++..
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 32 3789999999999999999999987 9999999999999999999999999876653321 12345678
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 610 y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
|+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 999999988889999999999999999999998864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=255.56 Aligned_cols=197 Identities=27% Similarity=0.384 Sum_probs=167.9
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc--------hhchHHHHHHHHHHhcCC---CCceeeEEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCI 506 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~ 506 (670)
..+|...+.+|+|+||.|+++.++. ..+|+||.+.+.. ....-.+-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468889999999999999999865 5688999886521 111224557999999997 999999999999
Q ss_pred eCCeeEEEEEccC-CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 507 QGEEKLLIYEFMP-NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 507 ~~~~~~lV~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
+++.++|+||-.. +.+|.+||..+ +.+++.+...|+.|++-|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999774 45888998543 44889999999999999999999998 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~ 645 (670)
||.+...... .....+||..|.|||++.+.+| +..-|||++|++||.++..+.||.
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998876433 2345789999999999999887 466899999999999999999963
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=232.85 Aligned_cols=216 Identities=31% Similarity=0.412 Sum_probs=181.3
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999865 789999998765443 56789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+..+..... .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999865322 1788899999999999999999987 99999999999999999999999999887754321 1
Q ss_pred CccccccccCccccccc-CCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceee
Q 005907 600 NTNRVVGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~ 664 (670)
......++..|++||.+ ....++.++|+|+||++++||++|+.||. -..+....+.+.+....+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS-GEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc-ccchhHHHHHHHHhcCCc
Confidence 22335678889999998 67778889999999999999999999972 214555667777766653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=237.25 Aligned_cols=213 Identities=25% Similarity=0.447 Sum_probs=166.9
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------G 508 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 508 (670)
..|+...+||+|.||+||+|+.++ ++.||+|++-.. .+.......+|+.+|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 346666799999999999999755 677899876432 22233456789999999999999999988753 2
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
..+++||.+|+. +|.-+|.+. ...++..++.+++.++..||.|+|+.. |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999965 777777442 234788899999999999999999876 99999999999999999999999999
Q ss_pred ceecCCCccc--CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 589 VRTFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 589 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
++.+...... ......+-|+.|.+||.+.+ ..|+++.|||..||||.||.||.+.+. .+.....+..|..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq---gnteqqql~~Is~ 243 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ---GNTEQQQLHLISQ 243 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc---CChHHHHHHHHHH
Confidence 9877533222 22333456999999999876 579999999999999999999999854 3334444444433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=257.52 Aligned_cols=204 Identities=22% Similarity=0.314 Sum_probs=153.0
Q ss_pred hcCCcccceeeeecCceeEEEEEe-----------------cCCcEEEEEEecccchhchH--------------HHHHH
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLK--------------ELKNE 486 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~--------------~~~~E 486 (670)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23467999998643222222 23457
Q ss_pred HHHHhcCCCCce-----eeEEEEEEe--------CCeeEEEEEccCCCCHHHHHhhcCC---------------------
Q 005907 487 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDSFIFDQTR--------------------- 532 (670)
Q Consensus 487 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~--------------------- 532 (670)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677777753 3567999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCccc
Q 005907 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612 (670)
Q Consensus 533 ~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 612 (670)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 122456778889999999999999987 999999999999999999999999999765432211 1112234789999
Q ss_pred ccccCCCC--------------------CC--ccchHHHHHHHHHHHHcCCC-CCC
Q 005907 613 PEYASDGQ--------------------FS--IKSDVFSFGILLLEIVSGKK-NRG 645 (670)
Q Consensus 613 PE~~~~~~--------------------~~--~~sDvwSlGvil~elltG~~-p~~ 645 (670)
||.+.... ++ .+.||||+|||++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99885432 11 34799999999999999975 654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=254.55 Aligned_cols=193 Identities=26% Similarity=0.377 Sum_probs=162.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+++.|.+...+|.|+|+.|-++... .++..++|++.+.. .+..+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678888889999999999988864 57889999997642 2234566555544 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE-cCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~ 594 (670)
|.+.++-|.+.++... .....+..|+.+|+.++.|||+++ ||||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877775432 222667789999999999999998 9999999999999 6889999999999887643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ....+-|..|.|||++....|+.++||||||++|||||+|+.||..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 3 2234568899999999999999999999999999999999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=238.74 Aligned_cols=206 Identities=27% Similarity=0.419 Sum_probs=166.8
Q ss_pred ceeeeecCceeEEEEEe-cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eeEEEEE
Q 005907 445 NNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLIYE 516 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 516 (670)
.+.||-|+||.||.+.+ ++|+.||+|++-.. .-...+.+.+|+.+|.-++|.|++..++.-.-.. +++++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46899999999999987 45899999988542 2334567889999999999999999888754332 3567788
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
.| ..+|..+|-. ...++...+.-+..||++||.|||+.+ |.||||||.|.|++.+..+||+|||+++.-..++
T Consensus 138 Lm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 77 4577776633 334677777778999999999999988 9999999999999999999999999999876555
Q ss_pred ccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhh
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 658 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 658 (670)
....+.. +-|..|.|||++++. .|+.+.||||.|||+.||+-.+..|.--.+.+..++|..
T Consensus 211 ~~hMTqE-VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 211 RLNMTHE-VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhhHHH-HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 5555543 458899999999875 689999999999999999999999876666655555543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=257.86 Aligned_cols=199 Identities=21% Similarity=0.294 Sum_probs=140.8
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-----CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEE------EE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 506 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 506 (670)
..++|++.++||+|+||.||+|.+.+ +..||+|++...... +....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999854 588999988643221 111111 1122222222222211 24
Q ss_pred eCCeeEEEEEccCCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 005907 507 QGEEKLLIYEFMPNKSLDSFIFDQTRR-----------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (670)
Q Consensus 507 ~~~~~~lV~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk 569 (670)
.+...++||||+++++|.+++...... .......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998643210 01122345578999999999999987 9999999
Q ss_pred CCCEEEcC-CCceEEEeecCceecCCCcccCCccccccccCcccccccCCC----------------------CCCccch
Q 005907 570 ASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG----------------------QFSIKSD 626 (670)
Q Consensus 570 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 626 (670)
|+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999876432221 22346789999999976322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCC
Q 005907 627 VFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 627 vwSlGvil~elltG~~p~ 644 (670)
||||||+||||+++..|+
T Consensus 362 VwSlGviL~el~~~~~~~ 379 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS 379 (566)
T ss_pred cHHHHHHHHHHHhCcCCC
Confidence 999999999999977663
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=218.49 Aligned_cols=207 Identities=24% Similarity=0.425 Sum_probs=168.6
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC--eeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 513 (670)
..++|++.+++|+|.+++||.|.. .+.+.++||+++.. ..+.+.+|+.||+.|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 346899999999999999999985 46788999999754 3467899999999997 999999999987764 4579
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCceec
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~ 592 (670)
|+||+.+.++..+- ..+....+..++.++++||.|.|+.| |+|||+||.|++||.. ..++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998887764 22667788889999999999999998 9999999999999865 57999999999887
Q ss_pred CCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
..... .+..+.+..|--||.+.+ ..|+..-|+|||||+|.+|+..+.|| |...+.-+.+..|++
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAK 248 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHH
Confidence 54332 223445667889999865 46888999999999999999999996 445444444444444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=226.79 Aligned_cols=186 Identities=31% Similarity=0.470 Sum_probs=163.7
Q ss_pred CceeEEEEEecC-CcEEEEEEecccchhc-hHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhh
Q 005907 452 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (670)
Q Consensus 452 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~ 529 (670)
+||.||+|...+ ++.+|+|++....... .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999987654444 68899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccC
Q 005907 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609 (670)
Q Consensus 530 ~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 609 (670)
... +++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 788999999999999999999987 9999999999999999999999999998765432 2223567889
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 610 y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|++||.+.+..++.++||||+|++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=243.21 Aligned_cols=228 Identities=20% Similarity=0.244 Sum_probs=190.0
Q ss_pred ccHHHHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC------CCceeeEE
Q 005907 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ------HRNLVKLL 502 (670)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~ 502 (670)
+.+.-.+....+|.+....|+|-|++|.+|... .|+.||||++.. ++-..+.=+.|+++|++|+ .-|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333334455678999999999999999999874 488999999965 3444566678999999996 34899999
Q ss_pred EEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ce
Q 005907 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NP 581 (670)
Q Consensus 503 g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~ 581 (670)
-.|...+++|||+|-+ ..+|.+.|........+....+..++.|++-||..|...+ |+|.||||+|||+++.. .+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999987 5699999988777777888999999999999999999887 99999999999999765 57
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
||||||.|...+.+.... ..-+.-|.|||+|.+.+|+...|+||.||.||||.||+..|. ......++..+..
T Consensus 577 KLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp---G~TNN~MLrl~me 649 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP---GRTNNQMLRLFME 649 (752)
T ss_pred eeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC---CCCcHHHHHHHHH
Confidence 999999988765433221 223557999999999999999999999999999999999965 3445678888888
Q ss_pred eeeecCCC
Q 005907 662 MHTTFSSI 669 (670)
Q Consensus 662 ~~~~~~~~ 669 (670)
++..||..
T Consensus 650 ~KGk~p~K 657 (752)
T KOG0670|consen 650 LKGKFPNK 657 (752)
T ss_pred hcCCCcHH
Confidence 88888864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=253.96 Aligned_cols=197 Identities=29% Similarity=0.460 Sum_probs=160.7
Q ss_pred cccceeeeecCcee-EEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 442 FSINNKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 442 ~~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
|.-.+.+|.|+-|+ ||+|.. ++++||||++-. ....-..+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44457889999885 689988 789999998853 3445667899999988 5999999999988899999999999
Q ss_pred CCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---C--CceEEEeecCceecC
Q 005907 520 NKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLVRTFG 593 (670)
Q Consensus 520 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~ 593 (670)
..+|.+++... ...........+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999653 11111111344668899999999999987 999999999999976 3 468999999999987
Q ss_pred CCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcC-CCCCCC
Q 005907 594 GDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG-KKNRGF 646 (670)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~p~~~ 646 (670)
.+... .......||.+|+|||++....-+.++||||+||++|+.++| +.||+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 65443 234557799999999999988888899999999999999997 899973
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=220.80 Aligned_cols=131 Identities=27% Similarity=0.384 Sum_probs=109.6
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCC-----C---CceeeEEEEEEe---
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIQ--- 507 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 507 (670)
.+|.+.++||-|.|++||++.+.. .+-||+|+.+. .....+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 589999999999999999998754 66789998864 3445567789999999984 3 369999999975
Q ss_pred -CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 508 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
+.+.+||+|++ |.+|..+|....- ..++...+.+|+.||+.||.|||.++ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 5677777755433 34788999999999999999999987 79999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=220.95 Aligned_cols=214 Identities=24% Similarity=0.470 Sum_probs=172.6
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEecC----CcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (670)
+....+.|..+++||+|.|++||++.+.. ...||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34455678899999999999999998643 5689999986543 3457899999999995 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGl 588 (670)
...+|+||+++....++... ++..++..++..++.||+++|.+| ||||||||.|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999999854 667888999999999999999998 9999999999999865 5679999999
Q ss_pred ceecCCCc-------------cc-----------------------------CCccccccccCcccccccCC-CCCCccc
Q 005907 589 VRTFGGDE-------------TE-----------------------------GNTNRVVGTYGYMAPEYASD-GQFSIKS 625 (670)
Q Consensus 589 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~s 625 (670)
|....... .. .......||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87221000 00 00012359999999999855 4568899
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 626 DVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 626 DvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
||||.|||+.-+++++.|| |...+....+.++..
T Consensus 260 Diws~GVI~Lslls~~~PF--f~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPF--FKAKDDADALAEIAT 293 (418)
T ss_pred ceeeccceeehhhcccccc--ccCccccchHHHHHH
Confidence 9999999999999999996 555555555554443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=213.34 Aligned_cols=193 Identities=30% Similarity=0.379 Sum_probs=159.4
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------e
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------E 510 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 510 (670)
.+|.-++.+|.|+- .|..+.+ ..+++||+|++.. ......+...+|+.++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788899888 5554443 3588999998754 23445567789999999999999999999986543 4
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++|||+| ..+|...+.. .++-..+..+..|++.|++|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 68999999 5688888752 2566777889999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.-... ...+..+.|..|.|||++.+..+...+||||+|||+.||++|+-.|.
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 75333 23334567889999999999889999999999999999999999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-26 Score=236.84 Aligned_cols=200 Identities=27% Similarity=0.440 Sum_probs=175.6
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+..++|+....+|+|.+|.|||++.+ .++..|+|.++-...+...-+..|+.+++..+||||+.++|-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 44578999999999999999999975 47889999998777777888889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|||.+|+|.+.-+ .-.++++.++..++++.++|++|||+++ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999988753 2356888999999999999999999998 79999999999999999999999999877642
Q ss_pred cccCCccccccccCccccccc---CCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYA---SDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.........||+.|||||+. +...|..++|||++|+...|+---++|.
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 22334457899999999986 4567999999999999999998888773
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-23 Score=200.53 Aligned_cols=183 Identities=38% Similarity=0.613 Sum_probs=157.8
Q ss_pred eeecCceeEEEEEecC-CcEEEEEEecccchh-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005907 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~ 525 (670)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999855 889999998754332 35678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCCCcccCCcccc
Q 005907 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRV 604 (670)
Q Consensus 526 ~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 604 (670)
++.... ..++...+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986532 34788999999999999999999987 999999999999999 89999999999887643321 12224
Q ss_pred ccccCcccccccCCC-CCCccchHHHHHHHHHHH
Q 005907 605 VGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEI 637 (670)
Q Consensus 605 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~el 637 (670)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 567899999999877 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-25 Score=207.30 Aligned_cols=194 Identities=23% Similarity=0.386 Sum_probs=155.0
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEE-EEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 515 (670)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+.+. ....++|.+|...--.| .|.||+.-+++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578999999999999999999865 568899988542 23457888888765555 58999987765 55667788999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCceEEEeecCceecC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFG 593 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~ 593 (670)
||++.|+|.+-+.. ..+-+....+++.|++.|+.|+|++. +||||||.+||||-. ...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887733 33667777889999999999999998 999999999999943 3479999999987654
Q ss_pred CCcccCCccccccccCcccccccCCC-----CCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDG-----QFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.-... ..-+..|.+||..... ...+.+|||.||+|+|.+|||+.|+.
T Consensus 175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 22211 2235679999976432 34678999999999999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=213.50 Aligned_cols=167 Identities=19% Similarity=0.180 Sum_probs=129.6
Q ss_pred HHhcCCcccceeeeecCceeEEEEEec--CCcEEEEEEeccc-----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
....++|.+.+.||+|+||.||+|... +++.+|||++... .....+.|.+|++++++++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 4677899986532 12235578999999999999999853322 2
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEcCCCceEEEeec
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFG 587 (670)
...++||||+++++|.... . .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 1 11 1457889999999999988 999999 9999999999999999999
Q ss_pred CceecCCCcccCC------ccccccccCcccccccCC
Q 005907 588 LVRTFGGDETEGN------TNRVVGTYGYMAPEYASD 618 (670)
Q Consensus 588 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 618 (670)
+++.+........ .....+++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9998754332211 124568889999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=206.05 Aligned_cols=204 Identities=25% Similarity=0.321 Sum_probs=166.5
Q ss_pred CcccceeeeecCceeEEEEEecCC--cEEEEEEecccchhchHHHHHHHHHHhcCCC----CceeeEEEEE-EeCCeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 513 (670)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997554 4788887655433333378889999888873 5889999888 47778899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-----CceEEEeecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 588 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGl 588 (670)
||+.+ |.+|.++..... ...++....++++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 789999875544 456889999999999999999999998 9999999999999865 4689999999
Q ss_pred ce--ecCCCcc----cC-C-ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 589 VR--TFGGDET----EG-N-TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 589 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
++ .+..... .. . .....||.+|.++....+.+.+.+.|+||++.++.|++.|..|+.....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99 4322211 11 1 2335699999999999999999999999999999999999999865544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=184.66 Aligned_cols=219 Identities=21% Similarity=0.310 Sum_probs=180.2
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 516 (670)
..+|.++++||+|+||.+|.|.. .+|.+||||.-+.... .-++..|..+...|+| ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999986 5699999998654322 3467789999999975 678888888888889999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 593 (670)
.+ |-+|.++..-..+ .++.+.++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 7788887643333 2778889999999999999999988 9999999999998654 468999999999875
Q ss_pred CCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeee
Q 005907 594 GDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665 (670)
Q Consensus 594 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~ 665 (670)
..... .......||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|..||.........+..+.|.+.+-+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 43322 1223467999999998888888899999999999999999999999988888888887777766544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-20 Score=192.89 Aligned_cols=202 Identities=34% Similarity=0.493 Sum_probs=169.9
Q ss_pred cccceeeeecCceeEEEEEecCCcEEEEEEecccchh---chHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCeeEEEEEc
Q 005907 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~ 517 (670)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999876 88899998763322 467899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 596 (670)
+.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977744321125788899999999999999999988 99999999999999998 79999999998664433
Q ss_pred ccC----CccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEG----NTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..|+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 2345689999999999987 578899999999999999999999965443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=183.58 Aligned_cols=216 Identities=19% Similarity=0.327 Sum_probs=177.4
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
-.|.+.++||+|.||.++.|.. -+++.||||.-...+ ..-++..|....+.|. .++|..++.+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3799999999999999999974 579999999643221 2235677888888875 68999999998889899999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-----CceEEEeecCceec
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLVRTF 592 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~~~ 592 (670)
+ |-+|.++..-..+ .++.+.+..+|.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7788887644333 3889999999999999999999998 9999999999999643 45899999999987
Q ss_pred CCCcccC-----CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 593 GGDETEG-----NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 593 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
....... ......||.+||+-....+.+.+.+.|+-|+|-|+.++|-|..||.....+...+..+.|-.-+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 5443321 2233579999999999999999999999999999999999999999888877777666665443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=230.72 Aligned_cols=148 Identities=19% Similarity=0.236 Sum_probs=112.5
Q ss_pred cCCC-CceeeEEEEE-------EeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005907 492 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (670)
Q Consensus 492 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 563 (670)
.++| +||+++++.+ .+....++++||+ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4456 5788888877 2334567788987 56999999542 345889999999999999999999988 9
Q ss_pred EeccCCCCCEEEcCCC-------------------ceEEEeecCceecCCCcc--------------cCCccccccccCc
Q 005907 564 IHRDLKASNVLLDQDM-------------------NPKISDFGLVRTFGGDET--------------EGNTNRVVGTYGY 610 (670)
Q Consensus 564 vHrDlkp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 610 (670)
+||||||+||||+..+ .+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455566665543211000 0001113578899
Q ss_pred ccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 611 ~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
||||++.+..++.++|||||||+||||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999998864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=182.97 Aligned_cols=170 Identities=14% Similarity=0.168 Sum_probs=131.9
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhch---HH------HHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KE------LKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
..++|...++||.|+||.||++.. ++..+|+|.+........ .. +.+|+..+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999766 677899999975322222 22 67899999999999999998886543
Q ss_pred --------CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 509 --------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 509 --------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
...++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++||||+|.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 24558999999999988 99999999999999988
Q ss_pred eEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHH
Q 005907 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEI 637 (670)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el 637 (670)
++|+|||........... ...+....|..++|+||||+.+.-+
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 999999987654211110 1134455677799999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=177.18 Aligned_cols=139 Identities=18% Similarity=0.159 Sum_probs=107.2
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchh--c-------hH-----------------HHHHHHHHHhcCCCCce
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--G-------LK-----------------ELKNEVILFSKLQHRNL 498 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~ni 498 (670)
...||+|+||.||+|...+|+.||||+++..... . .. ....|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998653211 1 11 22349999999988776
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCEEEcC
Q 005907 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 577 (670)
Q Consensus 499 v~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~ivHrDlkp~NILl~~ 577 (670)
.....+.. ...++||||++++++...+.. ...++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44332222 233899999999877654322 23478889999999999999999 6777 99999999999998
Q ss_pred CCceEEEeecCceec
Q 005907 578 DMNPKISDFGLVRTF 592 (670)
Q Consensus 578 ~~~~kl~DFGla~~~ 592 (670)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=171.72 Aligned_cols=140 Identities=19% Similarity=0.214 Sum_probs=109.8
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhc--------------------------hHHHHHHHHHHhcCCCCce
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--------------------------LKELKNEVILFSKLQHRNL 498 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 498 (670)
...||+|+||.||+|...+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987532110 1123578899999999987
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcC
Q 005907 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (670)
Q Consensus 499 v~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~ 577 (670)
.....+... ..++||||++++++...... ...++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 24899999998865433211 2346778889999999999999999 77 99999999999998
Q ss_pred CCceEEEeecCceecC
Q 005907 578 DMNPKISDFGLVRTFG 593 (670)
Q Consensus 578 ~~~~kl~DFGla~~~~ 593 (670)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=168.50 Aligned_cols=184 Identities=17% Similarity=0.167 Sum_probs=138.4
Q ss_pred ccceeeeecCceeEEEEEecCCcEEEEEEecccchh----chHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEc
Q 005907 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457999999999998776 6778887777543221 1225789999999995 5889999886 456899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
+.|.+|...+.. ....++.|++++|+++|+++ |+|||| ||.|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654311 11347788999999999998 999999 7999999999999999999998654322
Q ss_pred cc----CC-------ccccccccCcccccccCCC-CCC-ccchHHHHHHHHHHHHcCCCCC
Q 005907 597 TE----GN-------TNRVVGTYGYMAPEYASDG-QFS-IKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 597 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvil~elltG~~p~ 644 (670)
.. .. .-....++.|++|+...-. ..+ ...++++.|..+|.++|+..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 0012357888888864322 333 5679999999999999999985
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=159.07 Aligned_cols=83 Identities=48% Similarity=0.773 Sum_probs=71.5
Q ss_pred CccCCCCCCCCCCCceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCC
Q 005907 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEH 81 (670)
Q Consensus 2 ~~~~~~~~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~ 81 (670)
+||++.+ .++||.|||+.|. ...+.|.|+.||+|+|.|.+|.++|+|+++. .....+|+|+|+|||||++.
T Consensus 34 v~~~~~~------~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~-~~~~~~~~L~ddGnlvl~~~- 104 (116)
T cd00028 34 ILYKGSS------RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR-VNGNYVLVLLDDGNLVLYDS- 104 (116)
T ss_pred EEEeCCC------CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEecccC-CCCceEEEEeCCCCEEEECC-
Confidence 4666655 3799999999994 4558899999999999999999999999775 34678899999999999997
Q ss_pred CCCCcceEEeecCCC
Q 005907 82 DGDSETYFWQSFDYP 96 (670)
Q Consensus 82 ~~~~~~~~WqSFd~P 96 (670)
.+.+||||||||
T Consensus 105 ---~~~~~W~Sf~~P 116 (116)
T cd00028 105 ---DGNFLWQSFDYP 116 (116)
T ss_pred ---CCCEEEcCCCCC
Confidence 568999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=169.53 Aligned_cols=106 Identities=25% Similarity=0.244 Sum_probs=92.8
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
|+|.+++... ...+++..++.++.|+++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899998642 345899999999999999999999864 999999999999999 99988754321
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2578999999999999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-20 Score=173.45 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=158.1
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.+.+..+|.+...|+.|+|++ .|..+++|++.. ......+.|..|.-.|+-+.||||+.++|.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345556899999999999999 455666777643 44455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
+.|+|+..|++... ...+..+..+++.++|+|++|||+..+ -|.--.|.+..|+||++.+.+|+- +-++. .
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------s 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------S 340 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------e
Confidence 99999999977543 446778889999999999999999863 244456899999999999888752 11111 1
Q ss_pred CCccccccccCcccccccCCCCCC---ccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFS---IKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
.........|.||+||.+..++.+ .++|+|||+++||||.|.+.||....+-
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 111123347899999999776544 5799999999999999999999866654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-20 Score=196.05 Aligned_cols=200 Identities=28% Similarity=0.347 Sum_probs=159.5
Q ss_pred eeeecCceeEEEEEe----cCCcEEEEEEecccchh--chHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEccC
Q 005907 447 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKISEQ--GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
.+|+|.||.|++++. ..++.+|+|.+++.... .......|..++...+ ||.++++...++.....+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 33677899988653211 1114556788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+|.|...+.. .....+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9998776633 233556666667788999999999988 99999999999999999999999999887532222
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.+||..|||||++. .....+|.||||++++||+||..||.. ++...|.+....+|
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p 207 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMP 207 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCc
Confidence 28999999999997 567789999999999999999999864 45555555444444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-18 Score=164.05 Aligned_cols=135 Identities=19% Similarity=0.254 Sum_probs=104.7
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcC-----CCCceeeEEEEEEeCC---e-eEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---E-KLLI 514 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV 514 (670)
-.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 444344479988654444567899999999999 5799999999998864 3 3378
Q ss_pred EEc--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCEEEcCC----CceEEEeec
Q 005907 515 YEF--MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFG 587 (670)
Q Consensus 515 ~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l-~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFG 587 (670)
+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5579999999542 24444 35677888777 9999998 9999999999999743 479999944
Q ss_pred Cc
Q 005907 588 LV 589 (670)
Q Consensus 588 la 589 (670)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=150.04 Aligned_cols=75 Identities=49% Similarity=0.815 Sum_probs=66.4
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||+|||+.|+... +.|.+..||+|+|.|.+|.++|+|++. ......+|+|+|+|||||++. .+.+||||||
T Consensus 40 ~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S~t~-~~~~~~~~~L~ddGnlvl~~~----~~~~~W~Sf~ 113 (114)
T smart00108 40 RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSSNTT-GANGNYVLVLLDDGNLVIYDS----DGNFLWQSFD 113 (114)
T ss_pred CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEeccc-CCCCceEEEEeCCCCEEEECC----CCCEEeCCCC
Confidence 4799999999999775 889999999999999999999999876 224677899999999999987 5679999999
Q ss_pred C
Q 005907 95 Y 95 (670)
Q Consensus 95 ~ 95 (670)
|
T Consensus 114 ~ 114 (114)
T smart00108 114 Y 114 (114)
T ss_pred C
Confidence 7
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-19 Score=195.99 Aligned_cols=196 Identities=26% Similarity=0.341 Sum_probs=154.7
Q ss_pred cceeeeecCceeEEEEEecC-CcEEEEEEec----c-cch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS----K-ISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..+.+|.|++|.|+...... ....+.|... . ..+ +....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45799999999777766432 3333444322 1 111 112226678888888999999888777777666666699
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++ +|..++... ..+...++-.++.|++.|++|||+.+ |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999988543 34777888889999999999999998 9999999999999999999999999988765444
Q ss_pred cc--CCccccccccCcccccccCCCCCCc-cchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TE--GNTNRVVGTYGYMAPEYASDGQFSI-KSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......+|+..|+|||++.+.+|.+ ..||||.|+++..|.+|+.||..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 33 4455678999999999999999975 58999999999999999999853
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-18 Score=193.04 Aligned_cols=198 Identities=21% Similarity=0.286 Sum_probs=158.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (670)
..+.|.+.+.||+|+||.||+|...+|+.||+|+=+....- +|.--.+++.+|+ -+-|..+..+....+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 44678999999999999999999988999999986543221 2222233444444 23344555555667778899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------CCceEEEeec
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKISDFG 587 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFG 587 (670)
+||.+.|+|.+++. ....+++.....++.|++..+++||..+ |||+||||+|+||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999985 4456899999999999999999999988 999999999999953 3458999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.+-.+.--.........++|-.+--+|...+.+++.+.|.|.++-+++-||.|+..-
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 987764333333445567899999999999999999999999999999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=156.70 Aligned_cols=134 Identities=19% Similarity=0.275 Sum_probs=112.7
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccch--------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997643211 1124577899999999999988877777777888999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 12 77789999999999999988 99999999999999 78999999998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=159.21 Aligned_cols=147 Identities=18% Similarity=0.172 Sum_probs=112.1
Q ss_pred HhcCCcccceeeeecCceeEEEEE--ecCCcEEEEEEecccchh------------------------chHHHHHHHHHH
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISEQ------------------------GLKELKNEVILF 490 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l 490 (670)
.....|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333458888999999999999998 567999999998643210 012356899999
Q ss_pred hcCCCC--ceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 005907 491 SKLQHR--NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (670)
Q Consensus 491 ~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl 568 (670)
.++.+. .+.++++. ...++||||+++.+|..++.. ...........++.|++.++++||+.+ .|+||||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 999753 34444443 235799999999888765422 223455667789999999999999875 3999999
Q ss_pred CCCCEEEcCCCceEEEeecCceecC
Q 005907 569 KASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 569 kp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.4e-18 Score=187.94 Aligned_cols=197 Identities=18% Similarity=0.254 Sum_probs=149.5
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecccc-hhchHHHHHHHHH--HhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++...+.||++.|=+|.++++++|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-+-......+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998787 8899876533 3334444443333 5556899999988776666666788888
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC-CCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG-GDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~-~~~ 596 (670)
.. .+|++.| ..++.+...+...|+.|++.||...|..+ |+|+|||.+||||+.-.-+.|+||..-+... ..+
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 4788877 34567788888999999999999999988 9999999999999999999999998765432 112
Q ss_pred ccCCcccccc----ccCcccccccCCC----------C-CCccchHHHHHHHHHHHHc-CCCCCC
Q 005907 597 TEGNTNRVVG----TYGYMAPEYASDG----------Q-FSIKSDVFSFGILLLEIVS-GKKNRG 645 (670)
Q Consensus 597 ~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~sDvwSlGvil~ellt-G~~p~~ 645 (670)
.......+.- -..|+|||.+-.. . .+++.||||+||++.||++ |++||+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2222222222 2359999987431 2 5688999999999999988 688875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=158.26 Aligned_cols=200 Identities=23% Similarity=0.357 Sum_probs=131.8
Q ss_pred CcccceeeeecCceeEEEEEecC-CcEEEEEEecc---cchhchHHHHHHHHHHhcCCC----------CceeeEEEEE-
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGCC- 505 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~- 505 (670)
.+...+.||.|+++.||.+.+.+ ++++|||++.. ......+++++|......+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45567899999999999999865 89999998753 233456677777766665433 1122212221
Q ss_pred --------EeCC--------eeEEEEEccCCCCHHHHHh---hcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005907 506 --------IQGE--------EKLLIYEFMPNKSLDSFIF---DQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565 (670)
Q Consensus 506 --------~~~~--------~~~lV~e~~~~g~L~~~l~---~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 565 (670)
.... ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+++ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1111 235677777 568877753 2221 122334556677789999999999998 999
Q ss_pred ccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCC--------CCCCccchHHHHHHHHHHH
Q 005907 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSIKSDVFSFGILLLEI 637 (670)
Q Consensus 566 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~el 637 (670)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999987765432211 123577999997643 2578899999999999999
Q ss_pred HcCCCCCCCCCC
Q 005907 638 VSGKKNRGFYRS 649 (670)
Q Consensus 638 ltG~~p~~~~~~ 649 (670)
.+|+.||+...+
T Consensus 244 WC~~lPf~~~~~ 255 (288)
T PF14531_consen 244 WCGRLPFGLSSP 255 (288)
T ss_dssp HHSS-STCCCGG
T ss_pred HHccCCCCCCCc
Confidence 999999975443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=153.57 Aligned_cols=131 Identities=22% Similarity=0.324 Sum_probs=106.7
Q ss_pred eeeecCceeEEEEEecCCcEEEEEEecccch--------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.||+|+||.||+|.. ++..+++|....... ....++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998643211 12356778999999999887665555566677789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998874311 0 68899999999999988 99999999999999 889999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=151.94 Aligned_cols=137 Identities=19% Similarity=0.199 Sum_probs=107.7
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecccch----------------------hchHHHHHHHHHHhcCCCCc-
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFSKLQHRN- 497 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~n- 497 (670)
.|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4777889999999999999988899999998653210 01123567888999988874
Q ss_pred -eeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 498 -LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 498 -iv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
+...++ ....++||||+++++|..... ......++.++++++.++|+.+ |+||||+|.||+++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 444443 245589999999999876541 0234568889999999999987 99999999999999
Q ss_pred CCCceEEEeecCceecC
Q 005907 577 QDMNPKISDFGLVRTFG 593 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~ 593 (670)
+++.++|+|||++..+.
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-17 Score=180.88 Aligned_cols=184 Identities=25% Similarity=0.346 Sum_probs=131.3
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..+|+.+++|..|++|.||.++++. .+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4689999999999999999999865 5678874 32211 11110 33344455544
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc-
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE- 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 596 (670)
|+=...+.. -+.++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 ---gDc~tllk~---~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 222222211 12233222 67899999988 9999999999999999999999999987542111
Q ss_pred ------------ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceee
Q 005907 597 ------------TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664 (670)
Q Consensus 597 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~ 664 (670)
.+......+|||.|.|||++....|+..+|+|++|+|+||.+-|+.|| ..+..++++.++.+--.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpf---fGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---FGDTPEELFGQVISDDI 275 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeec---cCCCHHHHHhhhhhhhc
Confidence 112233468999999999999999999999999999999999999994 45555667776666665
Q ss_pred ecCC
Q 005907 665 TFSS 668 (670)
Q Consensus 665 ~~~~ 668 (670)
+|++
T Consensus 276 ~wpE 279 (1205)
T KOG0606|consen 276 EWPE 279 (1205)
T ss_pred cccc
Confidence 5554
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-17 Score=126.15 Aligned_cols=66 Identities=44% Similarity=1.024 Sum_probs=58.7
Q ss_pred CCCCcceeEeccccCCCCccceeecccChHHHHHHhccCCceEEEeeccccCCCccccccccccccc
Q 005907 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347 (670)
Q Consensus 281 c~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~~l~~~ 347 (670)
|..+|+|+++++|++|++....+..+.++++|++.||+||||+||+|.+.+ ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 444689999999999999877776779999999999999999999998765 678999999999985
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-16 Score=175.07 Aligned_cols=137 Identities=20% Similarity=0.292 Sum_probs=111.4
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEE-eccc-c------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-S------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
..|...+.||+|+||.||+|...+. .+++|+ +.+. . ....+.+.+|+.++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456678999999999999987544 344443 2221 1 11235688999999999999999888888777788
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999873 34668999999999999988 9999999999999 678999999999876
Q ss_pred c
Q 005907 592 F 592 (670)
Q Consensus 592 ~ 592 (670)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.6e-16 Score=163.67 Aligned_cols=168 Identities=27% Similarity=0.422 Sum_probs=133.3
Q ss_pred HhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 005907 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (670)
Q Consensus 490 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk 569 (670)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ...+++.....++.+|++||+|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 46789999999999999999999999999999999999763 345889999999999999999999865 23999999
Q ss_pred CCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCC-------CCccchHHHHHHHHHHHHcCCC
Q 005907 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ-------FSIKSDVFSFGILLLEIVSGKK 642 (670)
Q Consensus 570 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvil~elltG~~ 642 (670)
+.|++++....+||+|||+.................-..-|.|||.++... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987763211111111112345699999997641 4677999999999999999999
Q ss_pred CCCCCCCc-ccchHhhhhhc
Q 005907 643 NRGFYRSD-TKVNLIGHVSK 661 (670)
Q Consensus 643 p~~~~~~~-~~~~l~~~i~~ 661 (670)
||...... +..+++..+++
T Consensus 157 ~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccccccccCChHHHHHHHHh
Confidence 99754332 22456666665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=151.82 Aligned_cols=144 Identities=24% Similarity=0.350 Sum_probs=107.0
Q ss_pred CCCceeeEEEEEEe---------------------------CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 005907 494 QHRNLVKLLGCCIQ---------------------------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546 (670)
Q Consensus 494 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~ 546 (670)
+|||||+++++|.+ +..+++||.-. ..+|..|+.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988753 23468888866 458999996543 45566667889
Q ss_pred HHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCC--ceEEEeecCceecCCC----cccCCccccccccCcccccccCC
Q 005907 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGLVRTFGGD----ETEGNTNRVVGTYGYMAPEYASD 618 (670)
Q Consensus 547 ~ia~~l~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 618 (670)
|+++|+.|||.++ |.|||+|++||||. +++ .+.|+|||++---... .+........|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999984 333 4689999987543221 11111222346677899998743
Q ss_pred CC------CCccchHHHHHHHHHHHHcCCCCCC
Q 005907 619 GQ------FSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 619 ~~------~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.+ --.|+|.|+.|-+.||++....||.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 21 1258999999999999999999974
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=133.99 Aligned_cols=135 Identities=22% Similarity=0.193 Sum_probs=113.0
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeeEEEEEccCCC
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 521 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 521 (670)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++...++..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999844 7899998865332 4678899999999976 58999998888778899999999988
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 522 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
.+..+ +......++.++++++++||......++|+||+|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999986444599999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.6e-15 Score=141.13 Aligned_cols=136 Identities=21% Similarity=0.231 Sum_probs=96.6
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchh--chHH----------------------HHHHHHHHhcCCCCc--e
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHRN--L 498 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 498 (670)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987642211 1111 134555666654432 4
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcC
Q 005907 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (670)
Q Consensus 499 v~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~ 577 (670)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 345899999999543221111000 11 5567789999999999998 76 99999999999999
Q ss_pred CCceEEEeecCceec
Q 005907 578 DMNPKISDFGLVRTF 592 (670)
Q Consensus 578 ~~~~kl~DFGla~~~ 592 (670)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=141.16 Aligned_cols=134 Identities=17% Similarity=0.198 Sum_probs=104.1
Q ss_pred eeee-ecCceeEEEEEecCCcEEEEEEecccc-------------hhchHHHHHHHHHHhcCCCCce--eeEEEEEEeCC
Q 005907 446 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 509 (670)
Q Consensus 446 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 509 (670)
..|| .|+.|+||++.. .+..++||.+.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999987 47789999875311 1223467889999999998875 67777654332
Q ss_pred e----eEEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 510 E----KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 510 ~----~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
. .++|||++++ .+|.+++.. ..++.. .+.+|+.++.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 699888743 224433 3567899999999998 9999999999999999999999
Q ss_pred eecCcee
Q 005907 585 DFGLVRT 591 (670)
Q Consensus 585 DFGla~~ 591 (670)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.8e-16 Score=159.59 Aligned_cols=124 Identities=30% Similarity=0.482 Sum_probs=106.8
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++.|++|...+|.++|.........++...+.++.|++.|++| ++ .+|||+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999755555556788889999999999999 55 999999999999999999999999998
Q ss_pred eecCCCc----ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc
Q 005907 590 RTFGGDE----TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639 (670)
Q Consensus 590 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt 639 (670)
....... .........||..||+||.|.+..|+.|+||||||+||+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765443 1223344679999999999999999999999999999999998
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=114.18 Aligned_cols=71 Identities=18% Similarity=0.251 Sum_probs=62.1
Q ss_pred CCCCcceeEeccccCCCCccceeecccChHHHHHHhcc---CCceEEEeeccccCCCcccccccccc-cccccCCCCCcc
Q 005907 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE---NSSCMAYTNSDIRGGGSGCAMWFGEL-IDMRDFPGGGQD 356 (670)
Q Consensus 281 c~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~c~~~~~~l-~~~~~~~~~~~~ 356 (670)
|...++|+++.+|++|++.. .+++||+++|++ ||||.||+|.+. +.||.+|++++ +|++.+...+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 33457899999999998864 689999999999 999999999763 35899999999 999988888999
Q ss_pred eEEE
Q 005907 357 FYIR 360 (670)
Q Consensus 357 lylr 360 (670)
||+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.9e-15 Score=164.40 Aligned_cols=206 Identities=27% Similarity=0.355 Sum_probs=164.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC--CcEEEEEEecccc--hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 513 (670)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3467777889999999998887644 3456666665432 334445556787877886 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCcee
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRT 591 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~ 591 (670)
+.||..++++...+.. ......+......+..|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999877731 11113455566678999999999999 766 99999999999999999 999999999998
Q ss_pred cCC-CcccCCcccccc-ccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 592 FGG-DETEGNTNRVVG-TYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 592 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+..-.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 866 555555556788 9999999999885 44678999999999999999999976433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.1e-13 Score=143.90 Aligned_cols=140 Identities=26% Similarity=0.303 Sum_probs=98.8
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhch----------------------------------------HHHHH
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL----------------------------------------KELKN 485 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 485 (670)
+.||.|++|+||+|++++|+.||||+.+....... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865311100 02344
Q ss_pred HHHHHhcCC----CCceeeEEEEE-EeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005907 486 EVILFSKLQ----HRNLVKLLGCC-IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR-GLLYLHQDS 559 (670)
Q Consensus 486 E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~-~l~yLH~~~ 559 (670)
|+..+.+++ |.+-+.+-.++ ......++||||++|++|.++...... ..+ +..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 555555542 32223322222 224457899999999999887643211 122 3346666655 478889887
Q ss_pred CCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 560 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++|+|++|.||+++.++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998875
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.9e-13 Score=109.80 Aligned_cols=80 Identities=44% Similarity=0.982 Sum_probs=65.5
Q ss_pred CCCCCCC---cceeEeccccCCCCccceeecccChHHHHHHhccCCceEEEeeccccCCCcccccccccccccccCCCCC
Q 005907 278 PLNYSRQ---DGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354 (670)
Q Consensus 278 ~l~c~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~~l~~~~~~~~~~ 354 (670)
+++|... ++|+.+.++++|+..... .++++++|++.|++||+|.||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3456543 689999999999886543 6789999999999999999999975 3578999999999877655456
Q ss_pred cceEEEec
Q 005907 355 QDFYIRMS 362 (670)
Q Consensus 355 ~~lylrls 362 (670)
..+|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-12 Score=138.01 Aligned_cols=148 Identities=20% Similarity=0.211 Sum_probs=94.1
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchh----------------------------------chH--
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLK-- 481 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~-- 481 (670)
...|+. +.||+|++|+||+|++++ |+.||||+.++...+ ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 799999999999999987 999999998753111 011
Q ss_pred ----HHHHHHHHHhcCC----CCceeeEEEEEEe-CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 005907 482 ----ELKNEVILFSKLQ----HRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552 (670)
Q Consensus 482 ----~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l 552 (670)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-.. ...+........ +..-+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--~g~d~~~la~~~--v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--AGTDMKLLAERG--VEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh--cCCCHHHHHHHH--HHHHH
Confidence 1333444444432 3333333333322 456789999999999987532111 112222211111 11112
Q ss_pred HHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEeecCceecCC
Q 005907 553 LYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLVRTFGG 594 (670)
Q Consensus 553 ~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 594 (670)
..++..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344455 99999999999999988 999999999988743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=114.63 Aligned_cols=130 Identities=23% Similarity=0.154 Sum_probs=95.9
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCcee-eEEEEEEeCCeeEEEEEccCCCCHH
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLD 524 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g~L~ 524 (670)
+.|+.|.++.||+++. .++.+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 5789999999999987 477899998754321 233567899999988665544 455443 33457999999998875
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
... . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 1 11235678999999999876 22359999999999999 66899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=124.51 Aligned_cols=165 Identities=17% Similarity=0.253 Sum_probs=126.4
Q ss_pred cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHH
Q 005907 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541 (670)
Q Consensus 462 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~ 541 (670)
.++.+|.|...+..........++-++.|+.++||||++++.........|+|.|-+ ..|..++.+. .....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHHH
Confidence 467888888886654444556778889999999999999999999999999999987 3677777542 24455
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCC
Q 005907 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621 (670)
Q Consensus 542 ~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 621 (670)
..-+.||+.||.+||+.+ +++|++|....|+++..|+.||++|.++......... .....---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc-
Confidence 567889999999999766 6999999999999999999999999987654322211 11111123467777654333
Q ss_pred CccchHHHHHHHHHHHHcC
Q 005907 622 SIKSDVFSFGILLLEIVSG 640 (670)
Q Consensus 622 ~~~sDvwSlGvil~elltG 640 (670)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 345999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.8e-10 Score=104.96 Aligned_cols=135 Identities=15% Similarity=0.131 Sum_probs=97.3
Q ss_pred eeeeecCceeEEEEEecC-------CcEEEEEEeccc-------------c---------hhchHHHH----HHHHHHhc
Q 005907 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------S---------EQGLKELK----NEVILFSK 492 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~-------------~---------~~~~~~~~----~E~~~l~~ 492 (670)
..||.|--+.||.|...+ +..+|||+.+.. . ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998643 478999987431 0 01122333 79999998
Q ss_pred CCC--CceeeEEEEEEeCCeeEEEEEccCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccC
Q 005907 493 LQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDL 568 (670)
Q Consensus 493 l~H--~niv~l~g~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~ivHrDl 568 (670)
+.. -++.+++++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 864 456666654 56789999998754422 2211 1244455667788999999999 7776 999999
Q ss_pred CCCCEEEcCCCceEEEeecCceec
Q 005907 569 KASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 569 kp~NILl~~~~~~kl~DFGla~~~ 592 (670)
++.|||++ ++.+.|+|||.+-..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-11 Score=125.33 Aligned_cols=198 Identities=26% Similarity=0.348 Sum_probs=154.8
Q ss_pred CCcccceeeee--cCceeEEEEEe---cCCcEEEEEEecc--cchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCee
Q 005907 440 DNFSINNKLGE--GGFGPVYKGTL---VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 511 (670)
..|.+.+.+|+ |.+|.||.+.. .++..+|+|+-+. ..+.....=.+|+...++++ |+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667789999 99999999986 3477889987433 22233344456777777774 99999998888999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDF 586 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~----~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DF 586 (670)
++-.|++. .+|..+... ....++....+....+... |+.++|+.. ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 788777643 3344667777888888888 999999987 9999999999999999 88999999
Q ss_pred cCceecCCCcccCCc---cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 587 GLVRTFGGDETEGNT---NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 587 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
|+...++........ ....|...|++||.+. ..++...|+||+|.+..|..++-.+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 999988765432221 1235778899999864 56688999999999999998886653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=100.72 Aligned_cols=131 Identities=20% Similarity=0.309 Sum_probs=99.2
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEE-eccc-------chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..+++|+-+.+|.+.+. |..+++|. +.+. ..-......+|+.++.+++--.|.-.+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999774 43455664 3221 011234567899999998766665555566778888999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++|..|.+++... ...++..+-.-+.-||..+ |+|+||.++||++.... +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998543 2346666777788899988 99999999999997765 99999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.7e-10 Score=108.47 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=107.5
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccch-hchHHHHHHHHHHhcCCC--CceeeEEEEEEeCC---eeEEEEEccC
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMP 519 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~ 519 (670)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+.+++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999986678999998754322 245678899999999976 34577777765532 5689999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS---------------------------------------- 559 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 559 (670)
+.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 23566677777888888888887521
Q ss_pred -------------CCCeEeccCCCCCEEEcC--CCceEEEeecCcee
Q 005907 560 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRT 591 (670)
Q Consensus 560 -------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 591 (670)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-09 Score=97.33 Aligned_cols=143 Identities=24% Similarity=0.298 Sum_probs=106.6
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEE-eccc-------chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
....|-+|+-+.|+++.. .|+...||. +.+. ..-..++.++|+.++.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 577666664 3321 1123456788999999987656555455666777788999
Q ss_pred EccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEEeecCcee
Q 005907 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRT 591 (670)
Q Consensus 516 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 591 (670)
||+++ .++.+|+........ .......++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 488889876543322 23333678888999999999987 99999999999997665 358999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.3e-11 Score=133.16 Aligned_cols=223 Identities=20% Similarity=0.291 Sum_probs=161.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEec---ccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
...+.+.+.+-+-+|.++.++.+.-.. |...++|... +......+....+-.++-..+||.+++...-+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 456778888899999999999876432 3333333322 222333344444444444456788887766666677889
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
|+++|+.+++|..-|+... ..+..-....+..+..+++|||... +.|||++|.|+|+..++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999998886533 2444444456667888999999876 899999999999999999999999843322
Q ss_pred CCC---------------------cc----c----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 005907 593 GGD---------------------ET----E----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 593 ~~~---------------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 643 (670)
+.- .. . ...-...||+.|.+||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 011224689999999999999999999999999999999999999
Q ss_pred CCCCCCcccchHhhhhhceeeecCC
Q 005907 644 RGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 644 ~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
++.+....+.+++.++..+++.
T Consensus 1035 ---~na~tpq~~f~ni~~~~~~~p~ 1056 (1205)
T KOG0606|consen 1035 ---FNAETPQQIFENILNRDIPWPE 1056 (1205)
T ss_pred ---CCCcchhhhhhccccCCCCCCC
Confidence 5566666777888887777664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.8e-10 Score=110.38 Aligned_cols=156 Identities=22% Similarity=0.253 Sum_probs=116.5
Q ss_pred HHHHhcCCCCceeeEEEEEEeC-----CeeEEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005907 487 VILFSKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSR 560 (670)
Q Consensus 487 ~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 560 (670)
..-|-++.|.|||+++.++.+. ....++.|||.-|+|.+||++.. ....+......+++.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3455667899999999887543 35688999999999999997632 3345677788889999999999999975
Q ss_pred CCeEeccCCCCCEEEcCCCceEEEeecCc--eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHH
Q 005907 561 LRIIHRDLKASNVLLDQDMNPKISDFGLV--RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~~~~~kl~DFGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 638 (670)
++|+|+++..+-|++..++-+||.--.-. ...-.......+....+-++|.|||.=.....+..+|||+||+...||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 77999999999999999998888531110 0000000111122234678999999866666778999999999999998
Q ss_pred cCCCC
Q 005907 639 SGKKN 643 (670)
Q Consensus 639 tG~~p 643 (670)
-+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 88764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.6e-09 Score=115.78 Aligned_cols=196 Identities=23% Similarity=0.241 Sum_probs=145.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec--CCcEEEEEEecccchhchHH--HHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKISEQGLKE--LKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
...+|..+..||.|.|+.|+..... ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-.+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4467888999999999999987643 47789999876532222221 23455555555 4888888877777777778
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCcee
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRT 591 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 591 (670)
+--||++++++...+. ....+++..++++..|++.++.++|+.. ++|+|+||.||++..+ +.-++.|||+...
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 9999999998876652 2234677788889999999999999876 9999999999999886 7789999998764
Q ss_pred cCCCcccCCccccccccCcc--cccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYM--APEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
+.-... .....-+++ +++......+..+.|++|||.-+.|.+++...-
T Consensus 417 ~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 417 LAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred cceecc-----cccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 311110 011233444 555556678889999999999999999887753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=8e-08 Score=96.83 Aligned_cols=140 Identities=16% Similarity=0.098 Sum_probs=98.3
Q ss_pred eeeecCceeEEEEEecCCcEEEEEEecccchh-ch----------HHHHHHHHHHhcCCCCce--eeEEEEEEe-----C
Q 005907 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GL----------KELKNEVILFSKLQHRNL--VKLLGCCIQ-----G 508 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~ 508 (670)
.+-+-.-..|.++.+ +|+.+.||+....... .. ..+.+|...+.++...+| ++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667665 6788999976432211 11 147788888888854333 344555543 2
Q ss_pred CeeEEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------CCc
Q 005907 509 EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMN 580 (670)
Q Consensus 509 ~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-------~~~ 580 (670)
..-++|+|++++. +|.+++.... ....+......++.+++..+.-||+.+ |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3467999999986 8999885321 123456677789999999999999998 999999999999975 468
Q ss_pred eEEEeecCcee
Q 005907 581 PKISDFGLVRT 591 (670)
Q Consensus 581 ~kl~DFGla~~ 591 (670)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.6e-08 Score=93.59 Aligned_cols=125 Identities=22% Similarity=0.265 Sum_probs=81.3
Q ss_pred eEEEEEecCCcEEEEEEecccc--------------h------------hchHHHHHHHHHHhcCCCC--ceeeEEEEEE
Q 005907 455 PVYKGTLVDGQEIAVKRLSKIS--------------E------------QGLKELKNEVILFSKLQHR--NLVKLLGCCI 506 (670)
Q Consensus 455 ~Vy~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 506 (670)
.||.|...++..+|||..+... + .......+|...|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998899999999874310 0 0123456899999999865 45666644
Q ss_pred eCCeeEEEEEccC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 507 QGEEKLLIYEFMP--NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 507 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~y-LH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
....+||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 65665543211 1122334566777775555 56766 9999999999999888 9999
Q ss_pred EeecCceec
Q 005907 584 SDFGLVRTF 592 (670)
Q Consensus 584 ~DFGla~~~ 592 (670)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.8e-07 Score=96.71 Aligned_cols=169 Identities=23% Similarity=0.351 Sum_probs=126.3
Q ss_pred ceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEE----eCCeeEEEEEccCC-CCHHHH
Q 005907 453 FGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----QGEEKLLIYEFMPN-KSLDSF 526 (670)
Q Consensus 453 fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~-g~L~~~ 526 (670)
-.+.|++.. .+|..|++|++.....+.......-+++++++.|+|+|+|..++. .+..+++||+|.++ .+|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 456788875 579999999994432232223344577899999999999998886 24567899999986 477776
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 527 IFDQT------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 527 l~~~~------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
-+... .....++..++.++.|+..||.++|+.| +.-+-|.+.+||++.+..++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 1234678899999999999999999998 88899999999999999999998887665533
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 643 (670)
+. . |-+. -..+-|.=.||.++..|.||...
T Consensus 446 d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 22 0 1111 12466889999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.8e-07 Score=89.88 Aligned_cols=134 Identities=18% Similarity=0.206 Sum_probs=94.5
Q ss_pred ccceeeeecCceeEEEEEecCCcEEEEEEecccc----------------------hhchHHHHHHHHHHhcCCCC--ce
Q 005907 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------------EQGLKELKNEVILFSKLQHR--NL 498 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--ni 498 (670)
.+..+||-|--+.||.|..+.|.++|||.=+... .-......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457999999999999999999999999642110 00123456888999998654 56
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC
Q 005907 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (670)
Q Consensus 499 v~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~ 578 (670)
.+.+++ +...+||||+++..|...-. ...+... ++..|++-+.-+-..| |||+|+++-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666654 56789999999977754320 1122333 3444444444444555 9999999999999999
Q ss_pred CceEEEeecCcee
Q 005907 579 MNPKISDFGLVRT 591 (670)
Q Consensus 579 ~~~kl~DFGla~~ 591 (670)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999975543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=7.3e-07 Score=85.19 Aligned_cols=139 Identities=16% Similarity=0.156 Sum_probs=102.6
Q ss_pred eeecCceeEEEEEecCCcEEEEEEecc-c-----chhchHHHHHHHHHHhcCCCCc--eeeEEEEEEeC----CeeEEEE
Q 005907 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK-I-----SEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQG----EEKLLIY 515 (670)
Q Consensus 448 lG~G~fg~Vy~~~~~~~~~vavK~l~~-~-----~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~----~~~~lV~ 515 (670)
-|+||.+.|++..+ +|+.+-+|+-.. . -+.....|.+|...+.++..-+ +.+.+.+.... ..-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46689999999877 455788998652 1 1345678999999999986432 44444222111 2357999
Q ss_pred EccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc--eEEEeecCcee
Q 005907 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (670)
Q Consensus 516 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 591 (670)
|-+++ .+|.+++.+.. ....+...+..+..++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 48988885432 223567777889999999999999998 999999999999986666 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.4e-07 Score=99.93 Aligned_cols=147 Identities=17% Similarity=0.235 Sum_probs=95.2
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhc----------------------------------hH----
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG----------------------------------LK---- 481 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------~~---- 481 (670)
..|+. +-|+.++-|+||+|++++|+.||||+.+..-++. .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34543 6899999999999999999999999986521110 01
Q ss_pred --HHHHHHHHHhcCC-----CCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 005907 482 --ELKNEVILFSKLQ-----HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554 (670)
Q Consensus 482 --~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~y 554 (670)
.+.+|...+.+++ .|++.--.-+........|+|||++|..+.++..... ...+.+.+.....++. +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHH
Confidence 1234444444432 2333222222233567889999999999988853222 2345444333322222 222
Q ss_pred HHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 555 LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
+-..+ ++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 32344 99999999999999999999999999887643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=89.77 Aligned_cols=191 Identities=13% Similarity=0.157 Sum_probs=125.5
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc-CCCCceeeEEEEE-------EeCCeeEEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCC-------IQGEEKLLIY 515 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~-------~~~~~~~lV~ 515 (670)
..+.||+|+.+.+|-.- .-...+.|+..........+.. ..|.. -.||-+..-+.+= ..+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 44689999999999543 2222355776553332222222 22333 2466443311110 1112245677
Q ss_pred EccCCC-CHHHHHhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 516 EFMPNK-SLDSFIFD---QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 516 e~~~~g-~L~~~l~~---~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
..+.+. ....++.- ...-....|...++.+..++.+.+-||..| -+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 777654 33333321 122345779999999999999999999998 89999999999999999999998554333
Q ss_pred cCCCcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcC-CCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSG-KKNRG 645 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG-~~p~~ 645 (670)
. .........+|.+.|.+||... +-.-+...|.|.|||++++++.| ++||.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 2 1122223357899999999754 33456789999999999999987 99985
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=85.27 Aligned_cols=106 Identities=26% Similarity=0.296 Sum_probs=82.5
Q ss_pred HHHHHHHHHHhcCCCC--ceeeEEEEEEeCC----eeEEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 005907 481 KELKNEVILFSKLQHR--NLVKLLGCCIQGE----EKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553 (670)
Q Consensus 481 ~~~~~E~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~ 553 (670)
....+|...+..+... ...+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 4567888887777543 3455666655432 347999999885 89999865322 456667789999999999
Q ss_pred HHHhCCCCCeEeccCCCCCEEEcCCC---ceEEEeecCceec
Q 005907 554 YLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTF 592 (670)
Q Consensus 554 yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 592 (670)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999998 99999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.4e-07 Score=73.22 Aligned_cols=72 Identities=38% Similarity=0.780 Sum_probs=56.1
Q ss_pred cceeEeccccCCCCccceeecccChHHHHHHhcc-CCceEEEeeccccCCCccccccc-ccccccccCCCCCcceEEE
Q 005907 285 DGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMWF-GELIDMRDFPGGGQDFYIR 360 (670)
Q Consensus 285 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~c~~~~-~~l~~~~~~~~~~~~lylr 360 (670)
..|..+.++.+++..... ....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+....+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 568999999999665432 356799999999999 99999999964 456899999 7777766445556666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=76.71 Aligned_cols=88 Identities=25% Similarity=0.402 Sum_probs=61.3
Q ss_pred EEEecCCcEEEECCC-CcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCcccccccc
Q 005907 34 LMINKTGNLVLTSQS-NIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (670)
Q Consensus 34 l~~~~~g~l~l~~~~-~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~t 112 (670)
+....||+||+.+.. +.++|++++.........+.|.++|||||++. .+.++|+|= |.
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~S~---t~-------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG----DGRVVWSSN---TT-------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC----CCCEEEEec---cc--------------
Confidence 344578999999765 58999998754433447889999999999986 457899971 11
Q ss_pred ccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeC
Q 005907 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (670)
Q Consensus 113 g~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg 157 (670)
...|.+.+.|+.+|+..++- ..+++.|.|.
T Consensus 83 --------------~~~~~~~~~L~ddGnlvl~~-~~~~~~W~Sf 112 (114)
T smart00108 83 --------------GANGNYVLVLLDDGNLVIYD-SDGNFLWQSF 112 (114)
T ss_pred --------------CCCCceEEEEeCCCCEEEEC-CCCCEEeCCC
Confidence 12345788888888765432 2345677653
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.8e-06 Score=75.68 Aligned_cols=87 Identities=24% Similarity=0.332 Sum_probs=61.6
Q ss_pred Eec-CCcEEEECCC-CcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCccccccccc
Q 005907 36 INK-TGNLVLTSQS-NIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG 113 (670)
Q Consensus 36 ~~~-~g~l~l~~~~-~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~tg 113 (670)
... ||+||+.+.. ++++|++|+.........+.|.++|||||.+. .+.++|+|=-.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~S~~~------------------ 83 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG----SGTVVWSSNTT------------------ 83 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC----CCcEEEEeccc------------------
Confidence 344 8999998765 58999999764334567899999999999986 45789986421
Q ss_pred cceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 114 LERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 114 ~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
.+.+.+.+.|+.+|+..++-- .+.+.|.|..
T Consensus 84 -------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 84 -------------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred -------------CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 024567888888887654322 2466787643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.1e-06 Score=78.01 Aligned_cols=138 Identities=14% Similarity=0.141 Sum_probs=92.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHH---------HHHHHHHhcCC---CCceeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL---------KNEVILFSKLQ---HRNLVKLLGCC 505 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~g~~ 505 (670)
...+|...+++-......|.+... +++.+++|..+.......+.| .+.+..+.+++ -...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446788888898888888888776 678999998865332222222 23333333332 22233322222
Q ss_pred E-----eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 506 I-----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 506 ~-----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
. .....+++|||++|..|.++.. ++. .++..+++++.-||+.| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2234578999999988866531 222 24456778899999998 99999999999998654
Q ss_pred eEEEeecCcee
Q 005907 581 PKISDFGLVRT 591 (670)
Q Consensus 581 ~kl~DFGla~~ 591 (670)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999986554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.4e-05 Score=78.93 Aligned_cols=140 Identities=16% Similarity=0.158 Sum_probs=84.9
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCeeEEEEEccCCCC-
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 522 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~g~- 522 (670)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 35567788875422 3355788999998886443 4667777777777889999999863
Q ss_pred HHHHH------------------hh-cCC-CCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEeccCC
Q 005907 523 LDSFI------------------FD-QTR-RTLLDWSQRF-HIIC----------GTAR-GLLYLHQD-SRLRIIHRDLK 569 (670)
Q Consensus 523 L~~~l------------------~~-~~~-~~~~~~~~~~-~i~~----------~ia~-~l~yLH~~-~~~~ivHrDlk 569 (670)
+...+ .. +.- .......... .+-. .+.+ ..++|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 000 0001111100 0100 0011 12222211 23357899999
Q ss_pred CCCEEEcCCCceEEEeecCcee
Q 005907 570 ASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 570 p~NILl~~~~~~kl~DFGla~~ 591 (670)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-05 Score=87.39 Aligned_cols=141 Identities=15% Similarity=0.208 Sum_probs=88.6
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhc-------------------------------hH------HHHHHHH
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-------------------------------LK------ELKNEVI 488 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~~------~~~~E~~ 488 (670)
+.|+..+.|.||+|++++|+.||||+-+..-++. .+ .|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865421111 01 2334444
Q ss_pred HHhc----CCCCce---eeEEEEEE-eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005907 489 LFSK----LQHRNL---VKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560 (670)
Q Consensus 489 ~l~~----l~H~ni---v~l~g~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 560 (670)
...+ ++|-++ |.+=.++. ......|+||||+|..+.+.-.- .+..++...+..-+.++..-+-+- .|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~--~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFK--TG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHh--cC-
Confidence 3333 334441 11222222 23567899999999877654321 122255555444433332222222 23
Q ss_pred CCeEeccCCCCCEEEcC----CCceEEEeecCceecC
Q 005907 561 LRIIHRDLKASNVLLDQ----DMNPKISDFGLVRTFG 593 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~ 593 (670)
++|+|-+|.||++.. +..+.+.|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999987664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.5e-07 Score=99.30 Aligned_cols=187 Identities=17% Similarity=0.145 Sum_probs=131.9
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~ 518 (670)
..+.....+++++++.++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++...++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 344455678899999999987644444456655432 44566889999999999 666666666667788999999
Q ss_pred CCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 519 PNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 519 ~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
..+ +-..-. ......+...+...+...-++++++||+.. -+|+| ||+..+ +..|..||+....+....
T Consensus 317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 876 221111 001111222333345556678899999864 58998 777755 678999999887764433
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
......+|+.++|||++....+..+.|+|++++--.+|--|-+|.
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 233467899999999999999999999999999877887777764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.5e-05 Score=77.39 Aligned_cols=144 Identities=20% Similarity=0.180 Sum_probs=84.6
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCC--ceeeEEEEEEe---CCeeEEEEEccC
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ---GEEKLLIYEFMP 519 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~e~~~ 519 (670)
++.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 68999987543 4456777888888887533 35666665433 334689999999
Q ss_pred CCCHHH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005907 520 NKSLDS----------------FIF---DQ-TRRTLLDWSQ---------RFHI------------ICGTAR-GLLYLHQ 557 (670)
Q Consensus 520 ~g~L~~----------------~l~---~~-~~~~~~~~~~---------~~~i------------~~~ia~-~l~yLH~ 557 (670)
+..+.. ++. .. .......... .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 0111111100 0000 011122 2333332
Q ss_pred ----CCCCCeEeccCCCCCEEEc-CCCceEEEeecCcee
Q 005907 558 ----DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (670)
Q Consensus 558 ----~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 591 (670)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334599999999999999 566668999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.9e-05 Score=75.64 Aligned_cols=141 Identities=15% Similarity=0.142 Sum_probs=84.8
Q ss_pred eeeecCc-eeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005907 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (670)
Q Consensus 447 ~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g~L~ 524 (670)
.|..|.. ..||+.... +..+++|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788998764 4678888775432 345677888888874 344667787777666788999999998776
Q ss_pred HHH-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 005907 525 SFI-------------------FDQTR-RTLLDW--SQRFHIIC--------------------GTARGLLYLHQ----D 558 (670)
Q Consensus 525 ~~l-------------------~~~~~-~~~~~~--~~~~~i~~--------------------~ia~~l~yLH~----~ 558 (670)
... +.... ...... ...+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 00000 001110 00000000 01111222211 1
Q ss_pred CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 559 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124489999999999999987789999997653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.1e-05 Score=75.08 Aligned_cols=105 Identities=24% Similarity=0.234 Sum_probs=81.3
Q ss_pred HHHHHHHhcCCC-CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005907 484 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (670)
Q Consensus 484 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ 562 (670)
.+|..+++.+++ +++++++|.| ..++|.||.+.+++...-.....-...+|..+.+||.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999998 34679999987755321000001122689999999999999999999865445
Q ss_pred eEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 563 ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+...|++++|+-+++++++|+.|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.3e-06 Score=95.21 Aligned_cols=100 Identities=23% Similarity=0.415 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc-cCC------ccccccccCcccccccCC
Q 005907 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET-EGN------TNRVVGTYGYMAPEYASD 618 (670)
Q Consensus 546 ~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~------~~~~~gt~~y~aPE~~~~ 618 (670)
.+++.|+.|+|..- .+||++|.|++|.++.++..||+.|+.+........ ... .........|.|||.+.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 699999999999999999999999998765433111 000 011123567999999999
Q ss_pred CCCCccchHHHHHHHHHHHH-cCCCCCCCC
Q 005907 619 GQFSIKSDVFSFGILLLEIV-SGKKNRGFY 647 (670)
Q Consensus 619 ~~~~~~sDvwSlGvil~ell-tG~~p~~~~ 647 (670)
...+.++|+||+||++|.+. .|+.-+...
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc
Confidence 88899999999999999999 455555433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.6e-05 Score=72.50 Aligned_cols=150 Identities=19% Similarity=0.255 Sum_probs=95.2
Q ss_pred HHHHHHhcCCcccce---eeeecCceeEEEEEecCCcEEEEEEecccchh-------------------chHH-----HH
Q 005907 432 LATIANATDNFSINN---KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-------------------GLKE-----LK 484 (670)
Q Consensus 432 ~~~~~~~~~~~~~~~---~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~-----~~ 484 (670)
...+.....+..+.. .|..|--+.||+|...++..+|||+.+..... ..++ ..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444444444443 56677788999998878999999998542110 0011 23
Q ss_pred HHHHHHhcCC--CCceeeEEEEEEeCCeeEEEEEccCCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005907 485 NEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561 (670)
Q Consensus 485 ~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 561 (670)
.|...|.++. +-.+.+-+++ .+-.|||||+....+ .--|.+ ..+...+...+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 5666666663 3334444444 245799999975421 111211 11223355667777888888887632
Q ss_pred CeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 562 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
++||+||+.=|||+. ++.+.|+|||-|-..
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 499999999999999 889999999977654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=69.68 Aligned_cols=130 Identities=16% Similarity=0.283 Sum_probs=92.2
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccc----------------hhchHHHHHHHHHHhcCC------CCceeeEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 502 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 502 (670)
...||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35899999999995 5667778889886544 223456667776666555 78899999
Q ss_pred EEEEeCCeeEEEEEccCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 503 GCCIQGEEKLLIYEFMPN------KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 503 g~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
|+.......-+|+|.+.+ -+|.+++.+ ..++. ...+. +-+-.+||-+.. |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888899988743 267888843 22444 33333 334456666665 99999999999996
Q ss_pred CCC----ceEEEe-ec
Q 005907 577 QDM----NPKISD-FG 587 (670)
Q Consensus 577 ~~~----~~kl~D-FG 587 (670)
... .+.|+| ||
T Consensus 153 ~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLG 168 (199)
T ss_pred ecCCCceEEEEEeCCC
Confidence 432 577777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=66.53 Aligned_cols=130 Identities=19% Similarity=0.262 Sum_probs=88.8
Q ss_pred cccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCcee-eEEEEEEeCCeeEEEEEccCC
Q 005907 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~ 520 (670)
....+.|++|.+|.||++.+ .+..+|+|+-+.. .....+..|+++|..+.-.++. +++.+ +..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence 34557899999999999998 4568888876543 3446888999999999866654 34444 233455999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCCEEEcCCCceEEEeecCcee
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~ 591 (670)
-+|...-.. .+.+. ...+++.---|...+ |-|..|. |..++|-.++.+.|+||..|..
T Consensus 97 ~~L~~~~~~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888765421 12222 334455544455545 9999987 4445555555999999998774
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00041 Score=81.90 Aligned_cols=79 Identities=15% Similarity=0.330 Sum_probs=57.2
Q ss_pred ceeeeecCceeEEEEEecCC---cEEEEEEecccc-hhchHHHHHHHHHHhcCC-CCce--eeEEEEEEeC---CeeEEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 514 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 514 (670)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999877553 467777753321 123356889999999995 6665 7888887664 357899
Q ss_pred EEccCCCCH
Q 005907 515 YEFMPNKSL 523 (670)
Q Consensus 515 ~e~~~~g~L 523 (670)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00025 Score=70.69 Aligned_cols=73 Identities=15% Similarity=0.266 Sum_probs=45.4
Q ss_pred eeeeecCcee-EEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCC---ceeeEEEEEEeC---CeeEEEEEcc
Q 005907 446 NKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQG---EEKLLIYEFM 518 (670)
Q Consensus 446 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~ 518 (670)
+.|+.|+... ||+. +..+++|..... .....+.+|.+++..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4677777764 8875 335777765432 2345788899998877532 234444433222 2347899999
Q ss_pred CCCCHH
Q 005907 519 PNKSLD 524 (670)
Q Consensus 519 ~~g~L~ 524 (670)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00053 Score=70.73 Aligned_cols=79 Identities=13% Similarity=0.097 Sum_probs=57.1
Q ss_pred cccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCC---CceeeEEEEEEeC---CeeEEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIY 515 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~ 515 (670)
..-.+.||.|..+.||+....++ .+++|..+.. .....+.+|...++.+.. ..+.++++++..+ +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33456899999999999876555 4666764321 123578899999988853 3678888887543 5689999
Q ss_pred EccCCCCH
Q 005907 516 EFMPNKSL 523 (670)
Q Consensus 516 e~~~~g~L 523 (670)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00055 Score=65.15 Aligned_cols=125 Identities=27% Similarity=0.379 Sum_probs=89.1
Q ss_pred CCcccceeeeecCc-eeEEEEEecCCcEEEEEEecc---cc---------h---------hchHHHHHHHHHHhcCC---
Q 005907 440 DNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK---IS---------E---------QGLKELKNEVILFSKLQ--- 494 (670)
Q Consensus 440 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 494 (670)
.+++.++.||.|.- |.||+++. +|+.+|+|.++. .. . .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68899999999999 99999998 788999999322 00 0 11235778888877775
Q ss_pred CCce--eeEEEEEEeC------------------CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 005907 495 HRNL--VKLLGCCIQG------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554 (670)
Q Consensus 495 H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~y 554 (670)
+.++ |+.+|+..-. ....||.||++... .+.. +-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 8888887422 12346777765432 1222 234567777888
Q ss_pred HHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 555 LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 3489999853
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00061 Score=67.81 Aligned_cols=73 Identities=22% Similarity=0.319 Sum_probs=47.8
Q ss_pred eeeeecCceeEEEEEecC--CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEccCCCC
Q 005907 446 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKS 522 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g~ 522 (670)
+.|..|-...+|+....+ ++.+++|+...... ......+|+.++..+...++ .++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999998654 57888887654222 12233568888888854333 44444332 237999999876
Q ss_pred H
Q 005907 523 L 523 (670)
Q Consensus 523 L 523 (670)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00052 Score=69.33 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=78.4
Q ss_pred eeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005907 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g~L~~ 525 (670)
.+..|-...+|+... +++.+++|..............+|..+++.+....+ .+++... . ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 455677889998874 577888887644322211235778888888864333 3344332 1 368999999876532
Q ss_pred --------------HHhh---cCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeccCCCCC
Q 005907 526 --------------FIFD---QTR-RTLLDWSQR-FHIICG---------TARGLLYLHQD-----SRLRIIHRDLKASN 572 (670)
Q Consensus 526 --------------~l~~---~~~-~~~~~~~~~-~~i~~~---------ia~~l~yLH~~-----~~~~ivHrDlkp~N 572 (670)
.+.+ ... ...++.... ..+..+ +...++.+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1111 110 111222211 111111 11112222211 12348999999999
Q ss_pred EEEcCCCceEEEeecCcee
Q 005907 573 VLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 573 ILl~~~~~~kl~DFGla~~ 591 (670)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0013 Score=69.97 Aligned_cols=74 Identities=15% Similarity=0.224 Sum_probs=53.9
Q ss_pred eeeeecCceeEEEEEecCC-cEEEEEEeccc----c---hhchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEE
Q 005907 446 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (670)
+.||.|.+..||++...+| +.++||.-... . +...+.+..|.+.|+.+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5899999999999998776 58999985321 1 124556777888888763 2456777766 44567899
Q ss_pred EEccCCC
Q 005907 515 YEFMPNK 521 (670)
Q Consensus 515 ~e~~~~g 521 (670)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00085 Score=58.35 Aligned_cols=74 Identities=30% Similarity=0.451 Sum_probs=49.0
Q ss_pred CceEEec-cCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEec--CCCEEEeeCCCCCCcceEEe
Q 005907 15 HEVVWVA-NRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD--SGNLVLRDEHDGDSETYFWQ 91 (670)
Q Consensus 15 ~t~vW~A-Nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld--~GNlvl~~~~~~~~~~~~Wq 91 (670)
.++||.+ +...+.. ..+.+.|.++|||||.|..+.++|++... .....+...+ .||++ ... ...+.|.
T Consensus 38 ~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~---ptdt~L~~q~l~~~~~~-~~~----~~~~sw~ 108 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY---PTDTLLPGQKLGDGNVT-GKN----DSLTSWS 108 (114)
T ss_dssp TEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS---SS-EEEEEET--TSEEE-EES----TSSEEEE
T ss_pred CCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC---CccEEEeccCcccCCCc-ccc----ceEEeEC
Confidence 3679999 4333333 45889999999999999999999999422 2345556666 88988 543 3467898
Q ss_pred ecCCCC
Q 005907 92 SFDYPS 97 (670)
Q Consensus 92 SFd~Pt 97 (670)
|=+.|.
T Consensus 109 s~~dps 114 (114)
T PF01453_consen 109 SNTDPS 114 (114)
T ss_dssp SS----
T ss_pred CCCCCC
Confidence 876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0015 Score=67.45 Aligned_cols=143 Identities=20% Similarity=0.188 Sum_probs=84.7
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEEE------EEeCCeeEEEEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e 516 (670)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 467888888899998764 45788888754 23345667887777775332 4444431 223456689999
Q ss_pred ccCCCCHHH----H-------H---hhcCC---C-----CCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005907 517 FMPNKSLDS----F-------I---FDQTR---R-----TLLDWSQRF----------HIICGTARGLLYLHQ----DSR 560 (670)
Q Consensus 517 ~~~~g~L~~----~-------l---~~~~~---~-----~~~~~~~~~----------~i~~~ia~~l~yLH~----~~~ 560 (670)
|++|..+.. . | +.... . ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 1 11000 0 011111110 011123334445443 112
Q ss_pred CCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
..++|+|+.|.|||+++++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.003 Score=65.51 Aligned_cols=141 Identities=26% Similarity=0.368 Sum_probs=82.1
Q ss_pred eeeeecCceeEEEEEecC-------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 517 (670)
+.|..|-.-.+|+....+ ++.+++|...... .......+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899988654 4788889875432 223455778888887753333 345555432 358999
Q ss_pred cCCCCHHHH--------------H---hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 005907 518 MPNKSLDSF--------------I---FDQTRRT------LLD--WSQRFH--------------------------IIC 546 (670)
Q Consensus 518 ~~~g~L~~~--------------l---~~~~~~~------~~~--~~~~~~--------------------------i~~ 546 (670)
++|..+... | +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 1 1111100 011 101100 011
Q ss_pred HHHHHHHHHHh------CCCCCeEeccCCCCCEEEcCC----CceEEEeecCcee
Q 005907 547 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (670)
Q Consensus 547 ~ia~~l~yLH~------~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 591 (670)
.+...++.|.. .....++|+|+.+.|||++++ +.+.++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 134568999999999999985 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00056 Score=68.74 Aligned_cols=134 Identities=16% Similarity=0.171 Sum_probs=91.6
Q ss_pred CcccceeeeecCceeEEEEEecCCcEEEEEEecc---------cchh-------------chHHHHHHHHHHhcCC-CCc
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---------ISEQ-------------GLKELKNEVILFSKLQ-HRN 497 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~---------~~~~-------------~~~~~~~E~~~l~~l~-H~n 497 (670)
-+.+.++||-|--+.||.+...+|++.++|.-+- ..++ ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4677899999999999999998899999884211 0010 0113346777777774 322
Q ss_pred -eeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 498 -LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 498 -iv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
+.+.++ .+..++|||++.+-.|...- ...+...+ ...+..-+--|..+| +||+|..--||+|+
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 334443 35678999999998886542 11233333 333344455666677 99999999999999
Q ss_pred CCCceEEEeecCce
Q 005907 577 QDMNPKISDFGLVR 590 (670)
Q Consensus 577 ~~~~~kl~DFGla~ 590 (670)
+++.++++||--+-
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997543
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0008 Score=53.37 Aligned_cols=49 Identities=18% Similarity=0.436 Sum_probs=35.1
Q ss_pred ccccCCCCccceeecccChHHHHHHhccCCceEEEeeccccCCCccccccccc
Q 005907 291 TELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGE 343 (670)
Q Consensus 291 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~~ 343 (670)
.++.++....... ...+.++|+..|+.+|+|.||.|.. +...|.++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 4566665544333 3568999999999999999999964 34568776553
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.02 Score=59.80 Aligned_cols=142 Identities=20% Similarity=0.200 Sum_probs=76.3
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEE------EEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLG------CCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~e~ 517 (670)
+.|..|....+|+....+| .+++|+.... ..+.+..|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5677788889999886544 6888987521 2233444555555543211 333332 12235567899999
Q ss_pred cCCCCHH-----------HHHh---hcCCC------C--CC-CHHHHHH------------HH-HHHHHHHHHHHhC---
Q 005907 518 MPNKSLD-----------SFIF---DQTRR------T--LL-DWSQRFH------------II-CGTARGLLYLHQD--- 558 (670)
Q Consensus 518 ~~~g~L~-----------~~l~---~~~~~------~--~~-~~~~~~~------------i~-~~ia~~l~yLH~~--- 558 (670)
++|..+. ..|. ..... . .+ .+..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987431 1111 10000 0 01 1111111 11 1111122333211
Q ss_pred -CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 559 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 559 -~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
-...+||+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 133599999999999999776668999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.02 Score=59.51 Aligned_cols=143 Identities=23% Similarity=0.227 Sum_probs=81.0
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEEE------EEeCCeeEEEEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e 516 (670)
.+.++.|....+|+....++ .+++|+..... ...++..|+.++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876444 67788765421 2344556667776664222 3444432 122456789999
Q ss_pred ccCCCCHH-----------HHH---hhcCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005907 517 FMPNKSLD-----------SFI---FDQTRR------T---LLDWSQRF------------HIICGTARGLLYLHQ---- 557 (670)
Q Consensus 517 ~~~~g~L~-----------~~l---~~~~~~------~---~~~~~~~~------------~i~~~ia~~l~yLH~---- 557 (670)
|++|..+. ..+ +..... . ...|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 111 110000 0 01111100 011123344555542
Q ss_pred CCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 558 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.-...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.021 Score=58.30 Aligned_cols=75 Identities=20% Similarity=0.256 Sum_probs=49.1
Q ss_pred ccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEEEEccC
Q 005907 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+.+++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345689999999999987 578889999865 334457788888888773 3467888988887778899999998
Q ss_pred CC
Q 005907 520 NK 521 (670)
Q Consensus 520 ~g 521 (670)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.012 Score=59.98 Aligned_cols=31 Identities=23% Similarity=0.502 Sum_probs=25.6
Q ss_pred CCeEeccCCCCCEEEcCCCc-eEEEeecCcee
Q 005907 561 LRIIHRDLKASNVLLDQDMN-PKISDFGLVRT 591 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 591 (670)
..++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.018 Score=60.79 Aligned_cols=141 Identities=18% Similarity=0.265 Sum_probs=79.9
Q ss_pred eeeeecCceeEEEEEecC-----CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEccC
Q 005907 446 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~ 519 (670)
+.|-.|-.-.+|++...+ ++.+++|+.....+.... -.+|..+++.+...++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355557777888887532 357888887654333222 3678888888864444 3455655332 5799998
Q ss_pred CCCHHHH--------------Hhh-cCCC----C-CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 005907 520 NKSLDSF--------------IFD-QTRR----T-LLDWSQRFHIICG-----------------TARGLLYL----HQ- 557 (670)
Q Consensus 520 ~g~L~~~--------------l~~-~~~~----~-~~~~~~~~~i~~~-----------------ia~~l~yL----H~- 557 (670)
+.+|..- |.+ +... . ...+..+..+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7766421 000 0000 0 1112222222211 11112222 11
Q ss_pred CCCCCeEeccCCCCCEEEcC-CCceEEEeecCcee
Q 005907 558 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (670)
Q Consensus 558 ~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 591 (670)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12335899999999999986 46899999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0081 Score=70.02 Aligned_cols=155 Identities=21% Similarity=0.188 Sum_probs=112.3
Q ss_pred HHHHHHHHHhcCCCCceeeEEEEEEeCCeeE----EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005907 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557 (670)
Q Consensus 482 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~ 557 (670)
....|+..+.++.|+|++.++.+-.+....- +.-|++..-++...+.. ...++....+.+..++.+|++|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 4456778888999999999999876654332 34577777788777743 3447778888889999999999999
Q ss_pred CCCCCeEeccCCCC---CEEEcCCCceEEE--eecCceecCCCcccCCccccccccCcccccccCCCCCCc--cchHHHH
Q 005907 558 DSRLRIIHRDLKAS---NVLLDQDMNPKIS--DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSI--KSDVFSF 630 (670)
Q Consensus 558 ~~~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwSl 630 (670)
.. ..|.-|... +-.++.++.+.++ ||+.++.+........ ..-+..+.+||......+.. ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 85 666655555 4555666777777 9988877643333221 22355688888877665554 4799999
Q ss_pred HHHHHHHHcCCCCCC
Q 005907 631 GILLLEIVSGKKNRG 645 (670)
Q Consensus 631 Gvil~elltG~~p~~ 645 (670)
|..+..+..|..+-.
T Consensus 379 gll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISE 393 (1351)
T ss_pred HHHHhhhhhcCcccc
Confidence 999999999988754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.025 Score=58.28 Aligned_cols=138 Identities=22% Similarity=0.251 Sum_probs=92.1
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEeccc-----ch-----------------hchHH----HHHHHHHHhcCCCCc
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-----SE-----------------QGLKE----LKNEVILFSKLQHRN 497 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-----~~-----------------~~~~~----~~~E~~~l~~l~H~n 497 (670)
+...|..|--+.||.|.-.+|..+|||+++.. .+ ...+. ...|+..|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34578889999999999989999999987531 00 00111 235677777776544
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDS-FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 498 iv~l~g~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
|.-.-.... ....|||+|+....... .| ....++...+..+-.+++.-|.-|.+.+ .+||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 322111111 23468999996432211 12 2234666677778888888899998877 599999999999995
Q ss_pred CCCceEEEeecCce
Q 005907 577 QDMNPKISDFGLVR 590 (670)
Q Consensus 577 ~~~~~kl~DFGla~ 590 (670)
+|.+.|+|.+-+-
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 5689999977553
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.036 Score=57.94 Aligned_cols=79 Identities=13% Similarity=0.159 Sum_probs=50.9
Q ss_pred eeeecCceeEEEEEecCC-cEEEEEEecc----cc---hhchHHHHHHHHHHhcCC--CC-ceeeEEEEEEeCCeeEEEE
Q 005907 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSK----IS---EQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~----~~---~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 515 (670)
.||.|...-||++...++ +.++||.-.. .. +-..++...|...|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 5899997532 11 233445566777776653 24 34555544 455667999
Q ss_pred EccCCC-CHHHHH
Q 005907 516 EFMPNK-SLDSFI 527 (670)
Q Consensus 516 e~~~~g-~L~~~l 527 (670)
|+++.. .|+..|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.034 Score=57.23 Aligned_cols=146 Identities=15% Similarity=0.276 Sum_probs=78.9
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEec-ccchhchHHHHHHHHHHhcCCC--CceeeEEEEEEeCC--eeEEEEEccC
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIYEFMP 519 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~ 519 (670)
.+.+..|.--.+|.... .++++++.+-. ...........+|+.+++.+.- .-+.+.++.|.++. ..+.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34443333334444433 27777777221 1222334556678888887753 23445567776666 5689999998
Q ss_pred CCCHHHHH----------h--------hcC-----------------CCCCCCHHHHHHHH--------HHHHHHHHHHH
Q 005907 520 NKSLDSFI----------F--------DQT-----------------RRTLLDWSQRFHII--------CGTARGLLYLH 556 (670)
Q Consensus 520 ~g~L~~~l----------~--------~~~-----------------~~~~~~~~~~~~i~--------~~ia~~l~yLH 556 (670)
|..+...+ . ... .+....+....+.+ -....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84332111 1 000 00000011111000 01112233443
Q ss_pred hC-----CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 557 QD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 557 ~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
.. ++..++|+|+++.||+++.++-+-+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 235699999999999999998899999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.071 Score=56.76 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=50.0
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecc----cch---hchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~----~~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (670)
.+.||.|..-.||+... +++.++||+-.. ... ....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 456799998542 111 23344445566666553 247788888875 456788
Q ss_pred EEccCC
Q 005907 515 YEFMPN 520 (670)
Q Consensus 515 ~e~~~~ 520 (670)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.00063 Score=80.43 Aligned_cols=163 Identities=13% Similarity=-0.021 Sum_probs=109.8
Q ss_pred HHHHHHHHHHhcCCCCceeeEEEEEE--eCCeeEEEEEccCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 005907 481 KELKNEVILFSKLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQ 557 (670)
Q Consensus 481 ~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~ 557 (670)
+....|...+++..|+++.....-.. .....+.+++|+..|.+...|-+...+ ..++..-......+......-.|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33445555666678998876544332 233457889999999999988553322 223332222222232344444443
Q ss_pred CC--CCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHH
Q 005907 558 DS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLL 635 (670)
Q Consensus 558 ~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ 635 (670)
+. ..-.+|++||+.|.+|..+..+|+.++|+.+....... ......+++-|++|++...-.++.++|+|+.|+-+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 32 12368999999999999999999999999883321111 122246788899999988888898899999999999
Q ss_pred HHHcCCCCCC
Q 005907 636 EIVSGKKNRG 645 (670)
Q Consensus 636 elltG~~p~~ 645 (670)
+..-|..+|-
T Consensus 1432 ~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1432 LRSDGNAYFI 1441 (2724)
T ss_pred HHhcccHHHH
Confidence 9988888863
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.12 Score=54.33 Aligned_cols=141 Identities=15% Similarity=0.227 Sum_probs=77.8
Q ss_pred eeeeecCceeEEEEEecC----CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~ 520 (670)
+.|..|=.-.+|+....+ +..+++|+.....+. .-.-.+|..+++.+..-++ .++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557777888886543 237888887553332 2233578888888865555 35565552 22 48899977
Q ss_pred CCHHH-------HH-------hh-cCCC-----CCCCHHHHHHHHHHH----------------------HHHHHH---H
Q 005907 521 KSLDS-------FI-------FD-QTRR-----TLLDWSQRFHIICGT----------------------ARGLLY---L 555 (670)
Q Consensus 521 g~L~~-------~l-------~~-~~~~-----~~~~~~~~~~i~~~i----------------------a~~l~y---L 555 (670)
..|.. .+ .. +... .+..+..+.++..++ .+-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 11 11 1100 011122222222111 111111 1
Q ss_pred H-hC-CCCCeEeccCCCCCEEEcC-CCceEEEeecCcee
Q 005907 556 H-QD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (670)
Q Consensus 556 H-~~-~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 591 (670)
. .. ...-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 1223799999999999975 47899999997754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.026 Score=55.09 Aligned_cols=30 Identities=30% Similarity=0.494 Sum_probs=21.3
Q ss_pred CeEeccCCCCCEEE-cCCCceEEEeecCcee
Q 005907 562 RIIHRDLKASNVLL-DQDMNPKISDFGLVRT 591 (670)
Q Consensus 562 ~ivHrDlkp~NILl-~~~~~~kl~DFGla~~ 591 (670)
-++|+||.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 670 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-125
Identities = 93/259 (35%), Positives = 140/259 (54%), Gaps = 18/259 (6%)
Query: 417 ENEDQNI-DLELPLFELATIANATDNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 469
EN+ + D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 470 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645
FGL R T+R+VGT YMAPE G+ + KSD++SFG++LLEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 646 FYRSDTKVNLIGHVSKMHT 664
+R L+ ++
Sbjct: 236 EHREP--QLLLDIKEEIED 252
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-118
Identities = 101/238 (42%), Positives = 145/238 (60%), Gaps = 5/238 (2%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 488
F L + A+DNFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICG 547
+ S HRNL++L G C+ E+LL+Y +M N S+ S + ++ + LDW +R I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ARGL YLH +IIHRD+KA+N+LLD++ + DFGL + +T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS--DTKVNLIGHVSKMH 663
G++APEY S G+ S K+DVF +G++LLE+++G++ R D V L+ V +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-109
Identities = 98/271 (36%), Positives = 149/271 (54%), Gaps = 12/271 (4%)
Query: 408 TENSRETDQENEDQNIDLELPL----FELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
++ S+ T+ N+ + +P L + AT+NF +G G FG VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G ++A+KR + S QG++E + E+ S +H +LV L+G C + E +LIY++M N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 524 DSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
++ T+ + W QR I G ARGL YLH + IIHRD+K+ N+LLD++ PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 583 ISDFGLVRTF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
I+DFG+ + D+T +T V GT GY+ PEY G+ + KSDV+SFG++L E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 642 KNRGFYRSDTKVNLIGHVSKMHT--TFSSIV 670
VNL + H IV
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 5e-85
Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 25/260 (9%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI 475
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ 58
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDSFIFDQT 531
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---- 113
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKIS 584
+ ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSIKSDVFSFGILLLEIVS 639
DFGL F ++ G+T+ VGT YMAPE ++ D+++ G++L E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 640 GKKNRGFYRSDTKVNLIGHV 659
+ + +
Sbjct: 234 RCTAADGPVDEYMLPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-70
Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
DN + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 498 LVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ + + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 553 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG------DETEGN 600
YLH + + I HRDL + NVL+ D ISDFGL G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 601 TNRVVGTYGYMAPEYASD-------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
VGT YMAPE + D+++ G++ EI + S +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 654 NL 655
+
Sbjct: 245 QM 246
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 7e-65
Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 20/243 (8%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+I + + +D +I +L +I K+G G FG V++
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWC----DL----------NIKEKIGAGSFGTVHRAE 57
Query: 461 LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
G ++AVK L + + E EV + +L+H N+V +G Q ++ E++
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
SL + R LD +R + A+G+ YLH I+HR+LK+ N+L+D+
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638
K+ DFGL R T ++ GT +MAPE D + KSDV+SFG++L E+
Sbjct: 176 YTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 639 SGK 641
+ +
Sbjct: 234 TLQ 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG+G FG K T G+ + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+K +G + + I E++ +L I + WSQR A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR------------VVG 606
+ IIHRDL + N L+ ++ N ++DFGL R ++T+ R VVG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
+MAPE + + K DVFSFGI+L EI+
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-61
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL G C+ L+ E+ SL + + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 560 RLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
+IHRDLK N+LL KI DFG + + + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 619 GQFSIKSDVFSFGILLLEIVSGKK 642
+S K DVFS+GI+L E+++ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-60
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 499
+ +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L G C++ L+ EF L+ + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 560 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
+ IIHRDLK+SN+L+ Q + KI+DFGL R + G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGK 641
APE FS SDV+S+G+LL E+++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-59
Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 491
+ ++G+GGFG V+KG LV D +A+K L +G +E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ Y+ I+HRDL++ N+ L + K++DFGL + ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 607 TYGYMAPE--YASDGQFSIKSDVFSFGILLLEIVSGKK 642
+ +MAPE A + ++ K+D +SF ++L I++G+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-59
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 498 LVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ +LG C I +MP SL + + + T + D SQ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE- 614
H L I L + +V++D+DM +IS + +F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 615 --YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ +D++SF +LL E+V+ +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG VYKG ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ +G + ++ ++ SL + T + + I TARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE--- 614
IIHRDLK++N+ L +D KI DFGL ++ G+ +MAPE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
+S +SDV++FGI+L E+++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 36/246 (14%)
Query: 410 NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV 469
+ +T ++ +I E +L I +G+G FG VY G E+A+
Sbjct: 17 KASQTSIFLQEWDIPFE----QL----------EIGELIGKGRFGQVYHGRW--HGEVAI 60
Query: 470 KRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
+ + + +E LK K EV+ + + +H N+V +G C+ +I ++L S +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ + +LD ++ I +G+ YLH I+H+DLK+ NV D + I+DFG
Sbjct: 121 --RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 588 LVRTFGGDETEGNTNR---VVGTYGYMAPE---------YASDGQFSIKSDVFSFGILLL 635
L G + ++ G ++APE FS SDVF+ G +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 636 EIVSGK 641
E+ + +
Sbjct: 235 ELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-53
Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 26/256 (10%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
E+ R+ ++++ LPL TIA + ++G+G +G V+ G G++
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEK 62
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKS 522
+AVK E + E+ ++H N++ + I+G LI ++ N S
Sbjct: 63 VAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQ 577
L ++ + T LD + + GL +LH + I HRDLK+ N+L+ +
Sbjct: 122 LYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 578 DMNPKISDFGLVRTF--GGDETEGNTNRVVGTYGYMAPE------YASDGQFSIKSDVFS 629
+ I+D GL F +E + N VGT YM PE + Q I +D++S
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 630 FGILLLEIVSGKKNRG 645
FG++L E+ + G
Sbjct: 238 FGLILWEVARRCVSGG 253
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-53
Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--S 491
T+A + ++ +G+G +G V++G+ G+ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 492 KLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L+H N++ + + LI + SL ++ + T LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 548 TARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGN 600
A GL +LH + I HRDLK+ N+L+ ++ I+D GL + ++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 601 TNRVVGTYGYMAPE------YASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645
N VGT YMAPE + D+++FG++L E+ + G
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 61/260 (23%), Positives = 107/260 (41%), Gaps = 28/260 (10%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ ++ + LPL TIA + +G+G FG V++G G+
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGE 66
Query: 466 EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPN 520
E+AVK S E+ +E E+ L+H N++ + + L+ ++ +
Sbjct: 67 EVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLL 575
SL ++ R + + TA GL +LH + + I HRDLK+ N+L+
Sbjct: 125 GSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 576 DQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYGYMAPE------YASDGQFSIKSDV 627
++ I+D GL D + N VGT YMAPE + ++D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 628 FSFGILLLEIVSGKKNRGFY 647
++ G++ EI G +
Sbjct: 241 YAMGLVFWEIARRCSIGGIH 260
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-48
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 497
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+V+L+G C Q + ++ E + +F+ +T L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY----MAP 613
IHRDL A N L+ + KISDFG+ R +E +G G AP
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAP 284
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E + G++S +SDV+SFGILL E S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------Y 610
+ + +HRDL A N +LD+ K++DFGL R D + V G +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-46
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYA 616
+IHRDL A N L+ ++ K+SDFG+ R D+ GT + +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPEVF 177
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
S ++S KSDV+SFG+L+ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------------IFDQTRRTLLDWSQR 541
QH+++V+ G C +G L+++E+M + L+ F + L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+ A G++YL + L +HRDL N L+ Q + KI DFG+ R D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213
Query: 602 NRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R VG +M PE +F+ +SDV+SFG++L EI +
Sbjct: 214 YR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-46
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G C + ++ E++ N L +++ ++ L+ SQ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYA 616
+ IHRDL A N L+D+D+ K+SDFG+ R D+ VGT + APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVF 177
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
++S KSDV++FGIL+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-46
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQ 540
QH ++VK G C G+ ++++E+M + L+ F + + L SQ
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
HI A G++YL + +HRDL N L+ ++ KI DFG+ R D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187
Query: 601 TNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R VG + +M PE +F+ +SDV+SFG++L EI +
Sbjct: 188 YYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-46
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYA 616
+ +HRDL A N L++ K+SDFGL R DE VG+ + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 193
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
+FS KSD+++FG+L+ EI S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG--- 609
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEPGESP 211
Query: 610 --YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE ++ +FS+ SDV+SFG++L E+ +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG--- 609
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESP 180
Query: 610 --YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE ++ +FS+ SDV+SFG++L E+ +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 498
+ +G+G FG VY G +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 499 VKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L+G + E ++ +M + L FI ++ + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------YM 611
+ + +HRDL A N +LD+ K++DFGL R D + V +
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPVKWT 195
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
A E +F+ KSDV+SFG+LL E+++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 500 KLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L I E+M SL ++ + R++L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------YMA 612
+HRDL A NVL+ +D K+SDFGL + + + + A
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVS 639
PE + +FS KSDV+SFGILL EI S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------Y 610
+ + +HRDL A N +LD+ K++DFGL R D + + V G +
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKW 262
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+VK G + L+ E++P+ L F+ Q R LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG--- 609
YL R +HRDL A N+L++ + + KI+DFGL + D+ VV G
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSP 193
Query: 610 --YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE SD FS +SDV+SFG++L E+ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------IFDQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S+ + + S+ +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL + + +HRDL A N ++ +D KI DFG+ R D E + R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-K 196
Query: 606 GTYGY-----MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G G M+PE DG F+ SDV+SFG++L EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY--MAPEYAS 617
IHRDL+A+N+L+ ++ KI+DFGL R +E T R + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
G F+IKSDV+SFGILL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
I +G G G V G L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G +G +++ E+M N SLD+F+ +T Q ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY---- 610
L S L +HRDL A NVL+D ++ K+SDFGL R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 611 --------MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
APE + FS SDV+SFG+++ E+++
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 31/219 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTA 549
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 610 -----YMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKK 642
+MA E ++ +SDV+S+G+ + E+++ G K
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-----RVVGTYGYMAP 613
+ IHRDL A N L+ ++ K++DFGL R GD + + + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVS 639
E + +FSIKSDV++FG+LL EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 65/213 (30%), Positives = 88/213 (41%), Gaps = 24/213 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H +++K GCC L+ E++P SL ++ R + +Q G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG-- 609
+ YLH IHRDL A NVLLD D KI DFGL + V G
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDS 199
Query: 610 ---YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE + +F SDV+SFG+ L E+++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+VK G C + LI EF+P+ SL ++ + ++ Q+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG-- 609
+ YL + +HRDL A NVL++ + KI DFGL + D+ V
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDDRDS 191
Query: 610 ---YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ APE +F I SDV+SFG+ L E+++
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-43
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY--MAPEYA 616
+HRDL A NVL+ +D K+SDFGL + E ++ + G APE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 358
Query: 617 SDGQFSIKSDVFSFGILLLEIVS 639
+ +FS KSDV+SFGILL EI S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 493
+ + LGEG FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 494 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHII 545
H N+++LLG CI+ + ++I FM L +++ +T + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL S +HRDL A N +L DM ++DFGL + G+ R
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQ- 205
Query: 606 GTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ + + Q ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY--M 611
YL + + +HRDL A N+L++ ++ K+SDFGL R D+ E G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
APE S +F+ SDV+SFGI++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWS 539
LQH N+V LLG + + +I+ + + L F D+T ++ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAA 181
Query: 600 NTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ + + +MAPE G+FSI SD++S+G++L E+ S
Sbjct: 182 DYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F + + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 602 N-----RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R +MA E + ++ SDV+S+G+LL EIVS
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 494 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTL-----LDWSQRF 542
H ++ KL+G ++ K ++I FM + L +F+ R L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLV 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ A G+ YL S IHRDL A N +L +DM ++DFGL R G+
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYY 193
Query: 603 RVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R G ++A E +D +++ SDV++FG+ + EI++
Sbjct: 194 RQ-GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G YL IHRD+ A N LL KI DFG+ R D + R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201
Query: 606 GTYGY-----MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-43
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + E +I EFM SL F+ + + A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY--MAPEYAS 617
+ IHRDL+A+N+L+ + KI+DFGL R +E T R + APE +
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 358
Query: 618 DGQFSIKSDVFSFGILLLEIVS 639
G F+IKSDV+SFGILL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
N SI+ +G G FG V G L +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + + +++ E+M N SLDSF+ + Q ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG----- 609
L S + +HRDL A N+L++ ++ K+SDFGL R D T G
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA-----AYTTRGGKIPI 214
Query: 610 -YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ +PE + +F+ SDV+S+GI+L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-43
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 7/201 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
+ IHR+L A N L+ ++ K++DFGL R GD + + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 619 GQFSIKSDVFSFGILLLEIVS 639
+FSIKSDV++FG+LL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 597 TEGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ + T G +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 208 NNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++V+LLG C L+ +++P SL + + R L + A+G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG---- 609
YL ++HR+L A NVLL +++DFG+ D+ + ++ +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEAKTPI 181
Query: 610 -YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MA E G+++ +SDV+S+G+ + E+++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G YL IHRD+ A N LL KI DFG+ R D R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242
Query: 606 GTYGY-----MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 45/235 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT---- 548
+ H +++KL G C Q LLI E+ SL F+ + R + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLD 140
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
++G+ YL + ++++HRDL A N+L+ + KISDFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 590 RTFGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R D E ++ + G +MA E D ++ +SDV+SFG+LL EIV+
Sbjct: 198 R----DVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 491
++ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL H++LV G C+ G+E +L+ EF+ SLD+++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNTNR 603
+ +L +IH ++ A N+LL ++ + K+SD G+ T +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 604 VVGTYGY-----MAPEYASDG-QFSIKSDVFSFGILLLEIVS 639
+ PE + ++ +D +SFG L EI S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---------------------IFDQT 531
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 592 FGGDETEGNTNRVVGTYGY-----MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ + + M PE +++ +SDV+++G++L EI S
Sbjct: 223 ---NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 597 TEGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ + T G +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 254 NNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ ++ +LLG C+ LI + MP L ++ + + + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG---- 609
YL R++HRDL A NVL+ + KI+DFGL + G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 610 -YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MA E ++ +SDV+S+G+ + E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L+G C Q E +L+ E L F+ +R + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY--------- 610
+HRDL A NVLL KISDFGL + G D++ Y
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSAGKWP 176
Query: 611 ---MAPEYASDGQFSIKSDVFSFGILLLEIVS 639
APE + +FS +SDV+S+G+ + E +S
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG----- 609
L R +HRD+ A NVL+ + K+ DFGL R + G
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIK 182
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+MAPE + +F+ SDV+ FG+ + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 42/231 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C G L+I E+ L +F+ + +R S+ I
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDEL 140
Query: 549 --------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFG 593
A+G+ +L + IHRDL A N+LL KI DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 594 GDETEGNTN-----RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
N + +MAPE + ++ +SDV+S+GI L E+ S
Sbjct: 198 DSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 72/226 (31%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L QH N+V LLG C G L+I E+ L +F+ + + +L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 549 ----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
A+G+ +L + IHRD+ A NVLL KI DFGL R D
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMN 216
Query: 599 GNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ V +MAPE D ++++SDV+S+GILL EI S
Sbjct: 217 DSNYIV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+F +G GGFG V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 499 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF 542
V GC + L I EF +L+ +I ++ R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +G+ Y+H ++I+RDLK SN+ L KI DFGLV + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
R GT YM+PE S + + D+++ G++L E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 494
++ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + E +I E P L ++ + + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYM 611
L + +HRD+ N+L+ K+ DFGL R ++ + T +M
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWM 181
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVS 639
+PE + +F+ SDV+ F + + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+ + K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+ + ++ ++ L I Q + L Q L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
+I+HRD+K+ N+ L +D ++ DFG+ R +GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
+ ++ KSD+++ G +L E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-41
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
R+ +HRDL+A+N+L+ +++ K++DFGL R +E + APE A G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 620 QFSIKSDVFSFGILLLEIVS 639
+F+IKSDV+SFGILL E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 65/228 (28%), Positives = 93/228 (40%), Gaps = 27/228 (11%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQ 478
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----T 534
+ + EV L HRNL++L G + ++ E P SL + T
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L ++ A G+ YL R IHRDL A N+LL KI DFGL+R
Sbjct: 123 LSRYAV------QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 595 DETEGNTNRVVGT---YGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
++ + + APE FS SD + FG+ L E+ +
Sbjct: 174 NDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 493 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF-------------IFDQTRRTLLD 537
+ H N+V LLG C + L +I EF +L ++ + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
A+G+ +L + + IHRDL A N+LL + KI DFGL R D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199
Query: 598 EGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ +MAPE D ++I+SDV+SFG+LL EI S
Sbjct: 200 KDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 241
Query: 597 TEGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
+ + T G +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 242 HHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-41
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
R+ +HRDL+A+N+L+ +++ K++DFGL R +E + APE A G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 620 QFSIKSDVFSFGILLLEIVS 639
+F+IKSDV+SFGILL E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F LG GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 498 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+V+ + K+ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV- 604
A + +LH ++HRDLK SN+ D K+ DFGLV DE E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 605 ---------VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEI 637
VGT YM+PE +S K D+FS G++L E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 66/235 (28%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C LI+E+ L +++ +++R + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEE 162
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
A+G+ +L +HRDL A NVL+ KI DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 590 RTFGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
R D + V +MAPE +G ++IKSDV+S+GILL EI S
Sbjct: 220 R----DIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ KLGEGGF V L DG A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 500 KLLGCCIQ----GEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLY 554
+L+ C++ E L+ F +L + I + + L Q ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-------GT 607
+H HRDLK +N+LL + P + D G + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 608 YGYMAPE------YASDGQFSIKSDVFSFGILLLEIVSGK 641
Y APE + + ++DV+S G +L ++ G+
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGE 243
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ ++ Q R + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHV-KDKNIIELVHQVSMGMKYL---EES 136
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG------YMAPEY 615
+HRDL A NVLL KISDFGL + DE + APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 616 ASDGQFSIKSDVFSFGILLLEIVS 639
+ +FS KSDV+SFG+L+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 24/249 (9%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K R + + E ++ L L L + +LG G FG V
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA---------DIELGCGNFGSVR 353
Query: 458 KGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513
+G + ++I A+K L + +E+ E + +L + +V+L+G C Q E +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 412
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E L F+ +R + S ++ + G+ YL +HR+L A NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---YGYMAPEYASDGQFSIKSDVFSF 630
LL KISDFGL + G D++ + APE + +FS +SDV+S+
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 631 GILLLEIVS 639
G+ + E +S
Sbjct: 526 GVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-39
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
L R +HRD+ A NVL+ + K+ DFGL R + + +MAPE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 615 YASDGQFSIKSDVFSFGILLLEIVS 639
+ +F+ SDV+ FG+ + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H+ D ++HRDLK +NV LD N K+ DFGL R D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+PE + ++ KSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 56/243 (23%), Positives = 107/243 (44%), Gaps = 25/243 (10%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+ E +++ D E + + ++N + ++G G F VYKG
Sbjct: 1 QEERNQQQDDIEELETKAVG--------MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTV 52
Query: 466 EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI---QGEEKLLIY-EFMP 519
E+A + K+++ + K E + LQH N+V+ +G++ +++ E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QD 578
+ +L +++ R ++ +GL +LH + IIHRDLK N+ +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638
+ KI D GL + V+GT +MAPE + + DV++FG+ +LE+
Sbjct: 169 GSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMA 223
Query: 639 SGK 641
+ +
Sbjct: 224 TSE 226
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+F LG+G FG V K +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 498 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+V+ ++K ++ E+ N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF------------ 592
L Y+H IIHRDLK N+ +D+ N KI DFGL +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 593 GGDETEGNTNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSG 640
+ N +GT Y+A E G ++ K D++S GI+ E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 495
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLL 553
N++K I+ + +L I E L I ++ L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
++H R++HRD+K +NV + K+ D GL R F T ++ +VGT YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSGK 641
E + ++ KSD++S G LL E+ + +
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 16/242 (6%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-L 461
+ TEN + L + + K+GEG G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALR--MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
G+++AVK + +Q + L NEV++ QH N+V++ + GEE ++ EF+
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
+L D + L+ Q + + L YLH +IHRD+K+ ++LL D
Sbjct: 128 ALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 582 KISDFGLVRTFGGDETEGNTNR--VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS 639
K+SDFG F ++ R +VGT +MAPE S ++ + D++S GI+++E+V
Sbjct: 181 KLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 640 GK 641
G+
Sbjct: 237 GE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 56/216 (25%), Positives = 113/216 (52%), Gaps = 14/216 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
+ L +LH + ++IHRD+K+ N+LL D + K++DFG F + + +V
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMV 177
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 507 QGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ I+ E +P SL + + + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 566 RDLKASNVLLDQDM-NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE--YASDGQFS 622
RD+K NVL++ KISDFG + G T GT YMAPE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203
Query: 623 IKSDVFSFGILLLEIVSGK 641
+D++S G ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 16/208 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QH 495
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+L + L + E SL + L +Q + + T L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH ++H D+K +N+ L K+ DFGL+ G T G G YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE 226
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKK 642
G + +DVFS G+ +LE+ +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L E + + F + KLGEG +G VYK GQ +A+K++ E L+E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+ + ++VK G + + ++ E+ S+ I + R L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
T +GL YLH R IHRD+KA N+LL+ + + K++DFG G +T N V+
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVI 186
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT +MAPE + ++ +D++S GI +E+ GK
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE- 614
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT YM PE
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 615 ----------YASDGQFSIKSDVFSFGILLLEIVSGK 641
S + S KSDV+S G +L + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
V G + + + E M + SLD F + ++D Q I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVG 606
L +LH S+L +IHRD+K SNVL++ K+ DFG LV + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-------DIDAG 171
Query: 607 TYGYMAPE----YASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE + +S+KSD++S GI ++E+ +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 70 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE- 614
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT YM PE
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 615 ----------YASDGQFSIKSDVFSFGILLLEIVSGK 641
S + S KSDV+S G +L + GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 499 --VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++L ++ + + N L+S++ ++ +D +R + +H
Sbjct: 117 KIIRLYDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-- 614
Q I+H DLK +N L+ D K+ DFG+ D T + VG YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 615 ---------YASDGQFSIKSDVFSFGILLLEIVSGK 641
S + S KSDV+S G +L + GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 59/252 (23%), Positives = 104/252 (41%), Gaps = 23/252 (9%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K + + K + ++NE + +L + + ++G G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVH 75
Query: 458 KGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
+ G + AVK RL + E++ + L +V L G +G + I
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNI 127
Query: 515 Y-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E + SL I + L + + + GL YLH RI+H D+KA NV
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNV 181
Query: 574 LLDQDMNP-KISDFGL---VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFS 629
LL D + + DFG ++ G ++ + + GT +MAPE K D++S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 630 FGILLLEIVSGK 641
++L +++G
Sbjct: 242 SCCMMLHMLNGC 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ + + + I +LG+G FG VYK G A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ H +VKLLG + ++ EF P ++D+ + L Q +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVVGT 607
L +LH RIIHRDLKA NVL+ + + +++DFG +T + +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
Query: 608 YGYMAPE-----YASDGQFSIKSDVFSFGILLLEIVSGK 641
+MAPE D + K+D++S GI L+E+ +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+V+ G + + + E M + S D F + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVG 606
L +L L+IIHRD+K SN+LLD+ N K+ DFG LV + R G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA-------KTRDAG 187
Query: 607 TYGYMAPE----YASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE AS + ++SDV+S GI L E+ +G+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 493
A+ + F+ K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ K G ++ + +I E++ S D LD +Q I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
YLH + + IHRD+KA+NVLL + K++DFG+ +T+ N VGT +MAP
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 188
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSGK 641
E + K+D++S GI +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 19/220 (8%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELK 484
+ EL + FS ++G G FG VY + + + +A+K++S K S + +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
EV KL+H N ++ GC ++ L+ E+ + D + + L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G +GL YLH +IHRD+KA N+LL + K+ DFG N+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--F 210
Query: 605 VGTYGYMAPE---YASDGQFSIKSDVFSFGILLLEIVSGK 641
VGT +MAPE +GQ+ K DV+S GI +E+ K
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 23/223 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 498
+ L EGGF VY+ + G+E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 499 VKLLGCCIQGEEK-------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-------- 603
+ ++H+ + IIHRDLK N+LL K+ DFG T + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 604 --VVGTYGYMAPE---YASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y PE S+ K D+++ G +L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 12/234 (5%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLV-DGQEIA 468
E + +E Q LE L + + D+F ++LG G G V+K + G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 469 VKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
K + +I ++ E+ + + +V G E + E M SLD +
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
R + + +GL YL + +I+HRD+K SN+L++ K+ DFG
Sbjct: 123 KKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
G + N VGT YM+PE +S++SD++S G+ L+E+ G+
Sbjct: 178 ----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 24/222 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +L + I+HR++K N++ D K++DFG R DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 608 YGYMAPE--------YASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 494
T F K+G G FG V+K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 495 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGL 552
H ++V+ + + +LI E+ SL I + R + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLVRTFG 593
Y+H ++H D+K SN+ + + P KI D G V
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 594 GDETEGNTNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ E G ++A E + K+D+F+ + ++ +
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
YLH+ R+IHRDLK N+ L++D+ KI DFGL D + GT Y+A
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE S S + DV+S G ++ ++ GK
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 59/266 (22%), Positives = 93/266 (34%), Gaps = 72/266 (27%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F +G GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 498 LVKLLGCCIQG----------------------------------EEKLL-------IYE 516
+V+ ++ + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 517 FMPNKSLDSFIFDQT----RRTLLDWSQR------------FHIICGTARGLLYLHQDSR 560
+ S +++ Q + L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR----------TFGGDETEGNTNRVVGTYGY 610
++HRDLK SN+ D K+ DFGLV VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLE 636
M+PE +S K D+FS G++L E
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
YLH R R+IHRDLK N+ L++D+ KI DFGL D + GT Y+A
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 183
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE S S + DV+S G ++ ++ GK
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 20/225 (8%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVI 488
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 489 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
+ K HRN+ G I+ +++L L+ EF S+ + T+ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+I RGL +LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
Query: 602 NRVVGTYGYMAPE-----YASDGQFSIKSDVFSFGILLLEIVSGK 641
N +GT +MAPE D + KSD++S GI +E+ G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G G V+K G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V+ G I + + E M + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYGYMA 612
+ +IHRD+K SN+LLD+ K+ DFG LV +R G YMA
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-------DRSAGCAAYMA 192
Query: 613 PE-----YASDGQFSIKSDVFSFGILLLEIVSGK 641
PE + + I++DV+S GI L+E+ +G+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 24/222 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +L + I+HR++K N++ D K++DFG R DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 608 YGYMAPE--------YASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 61/209 (29%), Positives = 114/209 (54%), Gaps = 17/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGL 552
++++L + + L+ E N ++ ++ ++ + + ++ F II G +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG----M 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
LYLH I+HRDL SN+LL ++MN KI+DFGL + T + GT Y++
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE A+ ++SDV+S G + ++ G+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 499
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ C + + + E +L ++ + + + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 559 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETE-GNTNRVVGTYGYMA 612
L I+HRDLK N+L+ + ISDFGL + + V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 613 PEY---ASDGQFSIKSDVFSFGILLLEIVSG 640
PE + D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 42/222 (18%), Positives = 84/222 (37%), Gaps = 16/222 (7%)
Query: 432 LATIANATDNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNE 486
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ + H N+V I E ++ FM S + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDET-EGNT 601
G + L Y+H +HR +KAS++L+ D +S ++
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 602 NRVVGTYGYMAPE--YASDGQFSIKSDVFSFGILLLEIVSGK 641
V +++PE + + KSD++S GI E+ +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 496
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 497 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH+ RIIHRDLK N++L Q + KI D G + E VG
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y+APE ++++ D +SFG L E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N+++L G ++ LI E+ P ++ + + ++ +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITEL 118
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-GT 607
A L Y H R+IHRD+K N+LL KI+DFG + + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTDLCGT 170
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+ PE K D++S G+L E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQ 494
D++ + +G G V +++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL---VRTFGGDETEGNTNRVVG 606
GL YLH++ IHRD+KA N+LL +D + +I+DFG+ + T G VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 607 TYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE + K+D++SFGI +E+ +G
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 499
I +KLG GG VY + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
+RI+HRD+K N+L+D + KI DFG+ + + + TN V+GT Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
+D++S GI+L E++ G+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 35/222 (15%), Positives = 66/222 (29%), Gaps = 22/222 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 492
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTAR 550
+K + +L+ E +L + I + T ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLVRTFGGDETEG 599
+ +H IIH D+K N +L D + D G
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T G+ E S+ ++ + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-29
Identities = 30/283 (10%), Positives = 68/283 (24%), Gaps = 48/283 (16%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLEL-----PLFELATIANATDNFSINNKLGEGGF 453
KR + + + + + + ++ + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 454 GPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC---- 505
V+ V+ ++ A+K + S L+ L ++L + +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 506 ------IQGEEK----------------LLIYEFMP---NKSLDSFIFDQTRRTLLDWSQ 540
+Q + LL+ + F R
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+ R L ++H N+ + D + D + G
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-- 250
Query: 601 TNRVVGTYGYMAPEY--ASDGQFSIKSDVFSFGILLLEIVSGK 641
Y E+ AS F+ + + G+ + +
Sbjct: 251 ---SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 39/209 (18%), Positives = 83/209 (39%), Gaps = 30/209 (14%)
Query: 444 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 501 LLGCCIQGEE-----KLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ E + Y E++ +SL +++ L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
YLH + +++ DLK N++L ++ K+ D G V + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQA 245
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE ++ +D+++ G L +
Sbjct: 246 PEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 480
+++ I L +G F + L D + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRT 534
+ KNE+ + + +++ + G I +++ +IYE+M N S+ F D+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ II Y+H + I HRD+K SN+L+D++ K+SDFG
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-- 202
Query: 595 DETEGNTNRVVGTYGYMAPE-YASDGQFS-IKSDVFSFGILLLEIVSGK 641
+ GTY +M PE ++++ ++ K D++S GI L +
Sbjct: 203 --VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N++++ +++ L+ EF P L + + ++ RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEEL 123
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGT 607
A L Y H ++IHRD+K N+L+ KI+DFG V + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGT 175
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+ PE K D++ G+L E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 498
+ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
++ C + L + E N +L + L ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLVRTFGGDET--E 598
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 599 GNTNRVVGTYGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSG 640
N N GT G+ APE + + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 499
+ +G GG G VY+ V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+ GE +Y + L + + R+ L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
HRD+K N+L+ D + DFG+ DE VGT YMAPE
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
S+ + ++D+++ +L E ++G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 16/241 (6%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+S + ++ +F + + ++ + KLG G +G V V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 466 EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
E A+K + K +S +L EV + L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMN 580
I + + +D + + G+ YLH+ I+HRDLK N+LL ++D
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDAL 177
Query: 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
KI DFGL F + +GT Y+APE ++ K DV+S G++L +++G
Sbjct: 178 IKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233
Query: 641 K 641
Sbjct: 234 Y 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 34/233 (14%), Positives = 62/233 (26%), Gaps = 43/233 (18%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-------- 495
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 496 --------RNLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIF------DQTRR 533
+LVK + L + P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
L R + R L LH ++H L+ +++LDQ ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 594 GDETEGNTNRVVGTYGYMAPE-----YASDGQFSIKSDVFSFGILLLEIVSGK 641
G R A + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 38/298 (12%), Positives = 82/298 (27%), Gaps = 55/298 (18%)
Query: 390 VLIAGYLIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKL 448
V+I R + N+ +E + D + P + + L
Sbjct: 22 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 81
Query: 449 GEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ---------- 494
G+ + T G+ V +K++K EV+ L+
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 495 ---------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSF--IFDQTR-RT 534
+ ++++ +Y M + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L R + R L LH ++H L+ +++LDQ ++ F + G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 595 DETEGNTNRVVGTYGYMAPEYASD-----------GQFSIKSDVFSFGILLLEIVSGK 641
+ G+ PE + + D ++ G+++ I
Sbjct: 259 RVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR---- 550
VKL Q +EKL + N L R+ F C R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETC--TRFYTA 137
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH IIHRDLK N+LL++DM+ +I+DFG + + + N VG
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y++PE ++ SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 33/216 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ +A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V L+ I E L L++EFM K L + +T L SQ + RG+
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGV 132
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
+ HQ RI+HRDLK N+L++ D K++DFGL R F G T+ VV T Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRA 187
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
P+ Y++ S+ D++S G + E+++GK
Sbjct: 188 PDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 32/221 (14%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILF 490
+++ F KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLDSFIFDQTRRTLLDWSQRFHIICG 547
+L+H N+V+L I E KL L++EFM N K L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+GL + H++ +I+HRDLK N+L+++ K+ DFGL R F G ++ VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 608 YGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
Y AP+ Y++ SI D++S G +L E+++GK
Sbjct: 172 LWYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-27
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + LG+G FG V + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N++KL + + L+ E L I + R + +D ++ + G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GIT 140
Query: 554 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
Y+H+ +I+HRDLK N+LL +D N +I DFGL F + +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYY 194
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
+APE G + K DV+S G++L ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG GG V+ L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 499 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V + GE + ++ E++ +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-TEGNTNRVVGTYGY 610
L + H + IIHRD+K +N+++ K+ DFG+ R + T V+GT Y
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
++PE A +SDV+S G +L E+++G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 16/182 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + LGEG F VYK Q +A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N++ LL + + L+++FM L+ I + +L S + T +GL
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
YLHQ I+HRDLK +N+LLD++ K++DFGL ++F G T++VV T Y A
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRA 180
Query: 613 PE 614
PE
Sbjct: 181 PE 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 493
+ + +KLGEG + VYKG + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+V L I E+ L L++E++ +K L ++ +++ + RGL
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
Y H+ +++HRDLK N+L+++ K++DFGL R T+ N VV T Y
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRP 168
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
P+ Y++ I D++ G + E+ +G+
Sbjct: 169 PDILLGSTDYST----QI--DMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 21/183 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L+H+N+V+L + ++KL L++EF + L + + LD + +G
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKG 113
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
L + H ++HRDLK N+L++++ K+++FGL R F G + VV T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYR 168
Query: 612 APE 614
P+
Sbjct: 169 PPD 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 4e-26
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+VKL I +++L L++E + + L + L+ + G+
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
Y H R++HRDLK N+L++++ KI+DFGL R F G T+ +V T Y A
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRA 168
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
P+ Y++ +I D++S G + E+V+G
Sbjct: 169 PDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
Y+APE G + K DV+S G++L ++SG
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMP---------NKSLDSFIFDQTRRTLLDWSQRF--- 542
R +V L + + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-------AIFYTA 296
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
I+ G L +LHQ II+RDLK NVLLD D N +ISD GL +T+ T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT G+MAPE ++ D F+ G+ L E+++ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 21/222 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGTARG 551
R +V L + ++ L L+ M L I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
L LH R RI++RDLK N+LLD + +ISD GL +T VGT GYM
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 352
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
APE + +++ D ++ G LL E+++G+ F + K+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKI 392
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 29/253 (11%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + Q I + ++ +++ KLG G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 465 QEIAVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
E A+K + K E+ +E+ NE+ L L H N++KL + ++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKY 120
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ EF L I ++ + D + I G+ YLH+ I+HRD+K
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---GICYLHK---HNIVHRDIKP 174
Query: 571 SNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDV 627
N+LL + +N KI DFGL F D +GT Y+APE +++ K DV
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDV 230
Query: 628 FSFGILLLEIVSG 640
+S G+++ ++ G
Sbjct: 231 WSCGVIMYILLCG 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + K+GEG +G V+K GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + + +L L++E+ + ++ + + + I T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAV 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
+ H+ IHRD+K N+L+ + K+ DFG R ++ + V T Y +
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRS 170
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
PE Y + DV++ G + E++SG
Sbjct: 171 PELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 610 YMAPEYASDGQFSIKSDVFSFG----ILL 634
Y+APE G + K DV+S G ILL
Sbjct: 189 YIAPEVL-RGTYDEKCDVWSAGVILYILL 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 48/226 (21%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 499 VKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHI----- 544
V L +K L+ E++P ++ + + +L I
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML------LIKLYMY 148
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H + I HRD+K N+LLD K+ DFG + E N +
Sbjct: 149 QLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 603 RVVGTYGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ Y Y APE Y + +I D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPELIFGATNYTT----NI--DIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LGEG +G V + AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 503 GCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLLYLHQ 557
+ EEK +Y E+ + +R + + + +I G YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
I+H+D+K N+LL KIS G+ + G+ + PE A+
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 618 -----DGQFSIKSDVFSFGILLLEIVSGK 641
G K D++S G+ L I +G
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 23/240 (9%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+++L E+ IY E L + + D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---A 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ Y H+ L + HRDLK N L D K+ DFGL F + VGT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTP 172
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
Y++P+ +G + + D +S G+++ ++ G F + T ++ + + TF
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY--PPFS-APTDSEVMLKIREGTFTFPE 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 20/279 (7%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFS----INNKLGEGGF 453
R + K + T N D + + + D+ I+ +LG G F
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 454 GPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512
G V++ T G A K + E + ++ E+ S L+H LV L E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 513 LIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
+IYEFM L + + + + + + +C GL ++H+ +H DLK
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPE 284
Query: 572 NVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFS 629
N++ + K+ DFGL + + GT + APE A +D++S
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 630 FGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
G+L ++SG F + + +V
Sbjct: 342 VGVLSYILLSGL--SPFG-GENDDETLRNVKSCDWNMDD 377
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 14/238 (5%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLEL-PLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+ K + + D + ++I + P + D + I +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 461 -LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
G+ K ++ +KNE+ + ++L H L+ L E +LI EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 520 NKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
L D + + + + C GL ++H+ I+H D+K N++ +
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 579 MNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
KI DFGL DE T + APE +D+++ G+L
Sbjct: 186 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYL 555
+VKL I+ E+ L LI E+ + ++ R + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H + RI+HRDLKA N+LLD DMN KI+DFG F + G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPEL 184
Query: 616 ASDGQFS-IKSDVFSFGILLLEIVSGK 641
++ + DV+S G++L +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 70/253 (27%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
R ++ +K S + + + +N++L + L ++FS++ +G GGFG VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCR 209
Query: 461 LVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKL- 512
D ++ A+K L K +QG NE I+ S + +V + +KL
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLK 569
I + M L + + RF+ II G L ++H +++RDLK
Sbjct: 269 FILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN---RFVVYRDLK 319
Query: 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKS-DVF 628
+N+LLD+ + +ISD GL F + VGT+GYMAPE G S D F
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 629 SFGILLLEIVSGK 641
S G +L +++ G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D + KLGEG +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGT 548
LQHRN+++L I +L LI+E+ + + +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 549 A---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN 600
G+ + H R +HRDLK N+LL KI DFGL R F G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 601 TNRVVGTYGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
T+ ++ T Y PE Y++ S+ D++S + E++
Sbjct: 195 THEII-TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKELKN 485
+ ++GEG +G V+K G+ +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 486 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+H N+V+L E KL L++E + ++ L +++ D+ +
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
++ RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T+ VV T Y APE ++ D++S G + E+ K
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
F LG G F V+ + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
+V L E Y + + L I ++ T D S + + Y
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---AVKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
LH+ I+HRDLK N+L +++ I+DFGL + G + GT GY+
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYV 174
Query: 612 APEYASDGQFSIKSDVFSFG----ILL 634
APE + +S D +S G ILL
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS-- 617
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 618 --DGQFSIKSDVFSFGILLLEIVSG 640
+ DV+S GI+L +++G
Sbjct: 183 EFHAE---PVDVWSCGIVLTAMLAG 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + +GEG +G V K G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + +++ L++EF+ + ++ + + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
+ H IIHRD+K N+L+ Q K+ DFG RT E + V T Y A
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRA 192
Query: 613 PE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
PE Y ++ DV++ G L+ E+ G+
Sbjct: 193 PELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 36/198 (18%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------LK 481
AT + ++G G +G VYK G +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL 536
L+ +H N+V+L+ E K+ L++E + ++ L +++ D+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++ RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 597 TEGNTNRVVGTYGYMAPE 614
T VV T Y APE
Sbjct: 175 A--LTPVVV-TLWYRAPE 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKL 493
D F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRR----TLLDWSQRFHIIC 546
H N++K+ E+ +Y E L I R + ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNR 603
L Y H ++H+DLK N+L KI DFGL F DE +
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STN 185
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT YMAPE + K D++S G+++
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 50/252 (19%), Positives = 94/252 (37%), Gaps = 35/252 (13%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + + + Q++ E L + A + + +G G V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 465 QEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
E AVK + E+ + + E IL H +++ L+ E ++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMF 176
Query: 516 ---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572
+ M L ++ ++ + + + + +LH I+HRDLK N
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE---AVSFLHA---NNIVHRDLKPEN 230
Query: 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE------YASDGQFSIKSD 626
+LLD +M ++SDFG E + GT GY+APE + + + D
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 627 VFSFG----ILL 634
+++ G LL
Sbjct: 288 LWACGVILFTLL 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 491
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFH-IICGT 548
+++H N++K+L + + L+ E + L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
YL IIHRD+K N+++ +D K+ DFG E GT
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTI 193
Query: 609 GYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSG--------KKNRGFYR-----SDT 651
Y APE G + +++S G+ L +V + S
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250
Query: 652 KVNLIGHVSKM 662
++L+ S +
Sbjct: 251 LMSLV---SGL 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS-- 617
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 618 --DGQFSIKSDVFSFGILLLEIVSG 640
+ DV+S GI+L +++G
Sbjct: 183 EFHAE---PVDVWSCGIVLTAMLAG 204
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/253 (19%), Positives = 89/253 (35%), Gaps = 54/253 (21%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
+ + +G+G +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--------- 542
L H N+ +L + E+ + L+ E L + + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 543 ----------------------------HIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
+I+ L YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 575 L--DQDMNPKISDFGLVRTFGGDETEGNT--NRVVGTYGYMAPE--YASDGQFSIKSDVF 628
++ K+ DFGL + F GT ++APE ++ + K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 629 SFGILLLEIVSGK 641
S G+LL ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L +E+ Y + + L I + + D S I +
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SI 118
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
Y H I+HR+LK N+LL + K++DFGL E + GT G
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 172
Query: 610 YMAPEYASDGQFSIKSDVFSFG----ILL 634
Y++PE +S D+++ G ILL
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 47/226 (20%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 498 LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHI----- 544
+V+L EK L+ +++P +++ + + ++TL ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV----IYVKLYMY 163
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H I HRD+K N+LLD D K+ DFG + E N +
Sbjct: 164 QLF---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 603 RVVGTYGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ Y Y APE Y S SI DV+S G +L E++ G+
Sbjct: 216 YICSRY-YRAPELIFGATDYTS----SI--DVWSAGCVLAELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH+ IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 607 TYGYMAPE---YASDGQFSIKSDVFSFGILL 634
T Y+APE ++ D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 56/251 (22%)
Query: 433 ATIANATDNFSINN-----KLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------ 474
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 475 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 517
++++ E+ + KL H N+VKL+ + + +Y E
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFEL 119
Query: 518 MPNKSLDSFIFDQTRRTLL--DWSQRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ + + L D ++ + +I G + YLH +IIHRD+K SN+
Sbjct: 120 VNQGPV----MEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNL 168
Query: 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSI---KSDVFSF 630
L+ +D + KI+DFG+ F G + + VGT +MAPE S+ + DV++
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAM 226
Query: 631 GILLLEIVSGK 641
G+ L V G+
Sbjct: 227 GVTLYCFVFGQ 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 25/246 (10%)
Query: 405 AEKTENSRETDQENEDQNIDLELP--LFELATI----ANATDNFSINNK--LGEGGFGPV 456
A+ TE + +D+ P F+ + ++++ LG G FG V
Sbjct: 46 ADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQV 105
Query: 457 YKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
+K G ++A K + + +E+KNE+ + ++L H NL++L + +L+
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165
Query: 516 EFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
E++ L D I + T LD IC G+ ++HQ + I+H DLK N+L
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ---MYILHLDLKPENIL 219
Query: 575 L-DQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFG- 631
++D KI DFGL R + E GT ++APE + S +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 632 ---ILL 634
+LL
Sbjct: 277 IAYMLL 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 21/209 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
D + + +G+G F V + GQ+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL----DWSQRFHIICGT 548
L+H ++V+LL +++EFM L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H IIHRD+K VLL + K+ FG+ G V
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT +MAPE + DV+ G++L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
+ D++ + +LG G F V K G+E A K + K +E++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++H N++ L + +LI E + L F+ ++ T + +Q I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH RI H DLK N++L + K+ DFG+ +
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT ++APE + +++D++S G++
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 26/213 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 487
+N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
IL H N+++L L+++ M L ++ ++ + + + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ LH+ L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 136 ---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 186
Query: 608 YGYMAPE------YASDGQFSIKSDVFSFGILL 634
Y+APE + + + D++S G+++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178
Query: 607 TYGYMAPE---YASDGQFSIKSDVFSFGILL 634
T Y+APE ++ D +S G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ T + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L KI DFGL +
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT ++APE + +++D++S G++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+G+G FG V+K GQ++A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 493 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN---KSLDSFIFDQTRRTLLDWSQR 541
L+H N+V L+ C L+++F + L + S+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEI 126
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN- 600
++ GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGL R F +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 601 --TNRVVGTYGYMAPE 614
TNRVV T Y PE
Sbjct: 184 RYTNRVV-TLWYRPPE 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 42/202 (20%), Positives = 76/202 (37%), Gaps = 14/202 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
RN++ L EE ++I+EF+ + + + H +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
LH I H D++ N++ + KI +FG R + + Y A
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171
Query: 613 PEYASDGQFSIKSDVFSFGILL 634
PE S +D++S G L+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 20/210 (9%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L P K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT ++APE + +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V+L IQ E L+++ + L I + + D S I + Y
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAY 143
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H I+HR+LK N+LL + K++DFGL E + GT GY+
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL 197
Query: 612 APEYASDGQFSIKSDVFSFG----ILL 634
+PE +S D+++ G ILL
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 20/210 (9%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L + K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
GT ++APE + +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 495
D + + LGEG V L+ QE AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
RN+++L+ + + L++E M S+ S I + L+ S + L +L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---ALDFL 127
Query: 556 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF--GGDETEGNTNR---VVGT 607
H I HRDLK N+L +Q KI DF L GD + +T G+
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 608 YGYMAPE-----YASDGQFSIKSDVFSFGILL 634
YMAPE + + D++S G++L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 53/234 (22%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFS 491
D F + G+G FG V G G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 492 KLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQR 541
L H N+V+L GE ++ E++P ++ ++ Q +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI----- 129
Query: 542 FHI------ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGG 594
I + R + LH S + + HRD+K NVL+++ K+ DFG +
Sbjct: 130 -LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 595 DETEGNTNRVVGTYGYMAPE-------YASDGQFSIKSDVFSFGILLLEIVSGK 641
E N + Y Y APE Y + ++ D++S G + E++ G+
Sbjct: 185 SEP--NVAYICSRY-YRAPELIFGNQHYTT----AV--DIWSVGCIFAEMMLGE 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 16/201 (7%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
TD + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ L G+ ++ E M L I Q + + S I + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK---TVEYLHA 134
Query: 558 DSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
++HRDLK SN+L D+ NP +I DFG + + T T ++AP
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAP 189
Query: 614 EYASDGQFSIKSDVFSFGILL 634
E + D++S G+LL
Sbjct: 190 EVLERQGYDAACDIWSLGVLL 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 30/218 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSK 492
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 493 LQHR--NLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++LL + + LI E P + L FI T R L
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQV 158
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 211
Query: 608 YGYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSGK 641
Y PE+ G+ + V+S GILL ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-22
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 433 ATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVIL 489
T T+ + + +LG+G F V + ++ GQE A ++ +S + ++L+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
L+H N+V+L E+ Y + + L I + + D S I
Sbjct: 64 CRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNR 603
+L+ HQ + ++HR+LK N+LL + K++DFGL G++
Sbjct: 121 E---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFG----ILL 634
GT GY++PE + D+++ G ILL
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 444 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 499 VKLLGCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+ L + + K+ L++++ L I + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGG-DETEGNTNRVV 605
G+ YLH + ++HRDLK +N+L+ + KI+D G R F + + + VV
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 606 GTYGYMAPE 614
T+ Y APE
Sbjct: 197 VTFWYRAPE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+D F + ++LG G VY+ + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
++KL E I E + L I ++ + D + I + Y
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAY 163
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
LH+ I+HRDLK N+L D KI+DFGL + V GT GY
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYC 217
Query: 612 APEYASDGQFSIKSDVFSFG----ILL 634
APE + + D++S G ILL
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILL 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 19/229 (8%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLS 473
+ +DL ++ N + + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 474 K--ISEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
K + E+ +E+ + + ++ L E +LI E+ + S +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 531 TRRTL--LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISD 585
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
FG+ R G ++GT Y+APE + + +D+++ GI+
Sbjct: 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I ++ E++ L +I R ++ + F I+ Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYMAPEYAS- 617
++HRDLK NVLLD MN KI+DFGL E T G+ Y APE S
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEVISG 184
Query: 618 ---DGQFSIKSDVFSFGILLLEIVSGK 641
G + D++S G++L ++ G
Sbjct: 185 RLYAGP---EVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----I 488
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF--HI 544
+ + H +++LL + +E L+ E P + D F + + L S+ F +
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNR 603
+ + + H ++HRD+K N+L+D K+ DFG G +
Sbjct: 149 VAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS----GALLHDEPYTD 197
Query: 604 VVGTYGYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSG 640
GT Y PE+ S + V+S GILL ++V G
Sbjct: 198 FDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCG 235
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTAR 550
N++ L + L++E + N +TL D+ RF++ I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---K 141
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
L Y H S I+HRD+K NV++D + ++ D+GL + RV Y
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY- 195
Query: 610 YMAPEYASDGQFSIKS-DVFSFGILLLEIVSGKK 642
+ PE D Q S D++S G +L ++ K+
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI------ICGT 548
LV L Q EE + ++ + + L R L + F IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL---------RYHLQQNVHFKEETVKLFICEL 124
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
L YL RIIHRD+K N+LLD+ + I+DF + + + GT
Sbjct: 125 VMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTK 178
Query: 609 GYMAPE--YASDGQFSIKS-DVFSFGILLLEIVSGKKNRGFYRSDTK 652
YMAPE + G + D +S G+ E++ G+ R ++ +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRSST 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
TD++ ++ + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V +L G+ L +I E M L F + R +++R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDI 137
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +LH I HRD+K N+L ++D K++DFG + T+
Sbjct: 138 GT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQ 187
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
T Y+APE ++ D++S G+++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 55/219 (25%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LGEG FG V T Q++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFI---------FD---QTRRTLLDWSQRF--HIICGTA 549
Y+ + + D + FD + +R D +RF IIC
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVG 606
Y H R +I+HRDLK N+LLD ++N KI+DFGL T G
Sbjct: 123 ----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SCG 169
Query: 607 TYGYMAPEYAS----DGQFSIKSDVFSFGILLLEIVSGK 641
+ Y APE + G + DV+S GI+L ++ G+
Sbjct: 170 SPNYAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 48/193 (24%), Positives = 76/193 (39%), Gaps = 16/193 (8%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 504
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E + L I + + + S + + ++H + ++
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSHMHD---VGVV 128
Query: 565 HRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF 621
HRDLK N+L + ++ KI DFG R D T T Y APE + +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGY 186
Query: 622 SIKSDVFSFGILL 634
D++S G++L
Sbjct: 187 DESCDLWSLGVIL 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I + ++ E++ L +I R + + F I+ G Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYMAPEYAS- 617
++HRDLK NVLLD MN KI+DFGL E T G+ Y APE S
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEVISG 189
Query: 618 ---DGQFSIKSDVFSFGILLLEIVSGK 641
G + D++S G++L ++ G
Sbjct: 190 RLYAGP---EVDIWSSGVILYALLCGT 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 405 AEKTENSRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLVD 463
A K + +E+ +E + + L +E + A D F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 464 GQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFM 518
A+K L K LK++ NE + + LVKL + L ++ E++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYV 123
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR--------GLLYLHQDSRLRIIHRDLKA 570
+ F RR RF AR YLH L +I+RDLK
Sbjct: 124 AGGEM----FSHLRR-----IGRFSE--PHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSF 630
N+L+DQ +++DFG + +G T + GT +APE ++ D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 631 GILLLEIVSG 640
G+L+ E+ +G
Sbjct: 225 GVLIYEMAAG 234
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 54/255 (21%), Positives = 107/255 (41%), Gaps = 37/255 (14%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
+R +NI E E ++ + + + ++F I +G G FG V
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHR--------------EDFEILKVIGRGAFGEVAV 92
Query: 459 GTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
L + ++ A+K L+K E + E + + + L Q + L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ ++ L + + R + + RF+ ++ + +HQ L +HRD+K
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA----IDSVHQ---LHYVHRDIKP 203
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-----YASDGQFSIKS 625
N+L+D + + +++DFG D T ++ VGT Y++PE G++ +
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 626 DVFSFGILLLEIVSG 640
D +S G+ + E++ G
Sbjct: 263 DWWSLGVCMYEMLYG 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 34/212 (16%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V+++ G + L ++ E + L F + R +++R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSI 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ YLH + I HRD+K N+L + K++DFG + +
Sbjct: 171 GEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LT 221
Query: 603 RVVGTYGYMAPEYASDGQFSIKSDVFSFGILL 634
T Y+APE ++ D++S G+++
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 45/260 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY- 457
+ + +A+ + + ++ + D+F I +G G F V
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQR--------------DDFEILKVIGRGAFSEVAV 79
Query: 458 ---KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
K T GQ A+K ++K + + + E + R + +L Q E
Sbjct: 80 VKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENY 135
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRD 567
L L+ E+ L + + R + + RF+ I+ + +H+ L +HRD
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA----IDSVHR---LGYVHRD 187
Query: 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-------YASDGQ 620
+K N+LLD+ + +++DFG D T + VGT Y++PE G
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 621 FSIKSDVFSFGILLLEIVSG 640
+ + D ++ G+ E+ G
Sbjct: 247 YGPECDWWALGVFAYEMFYG 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 493
F + LG+G FG V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTA 549
H +VKL Q E KL LI +F+ L F + +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
L +LH L II+RDLK N+LLD++ + K++DFGL + E + + GT
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE + + +D +SFG+L+ E+++G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 19/251 (7%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANAT------DNFSINNKLGEGGFGP 455
+ +A+ + + + + E+ + F LG+G FG
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 456 VYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
V A+K L K +++ + E + +H L L Q ++
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L + E+ L F R + RF+ L YLH S +++RDLK
Sbjct: 223 LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVYRDLKL 277
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSF 630
N++LD+D + KI+DFGL + D T GT Y+APE D + D +
Sbjct: 278 ENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 631 GILLLEIVSGK 641
G+++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 50/250 (20%), Positives = 101/250 (40%), Gaps = 59/250 (23%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 496 RNLVKLLGCCIQGEEKL--------------------------------------LIYEF 517
N++KL+ ++ +I E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 518 MPNKSLDSFI--FDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+P +L + F ++ R++ +I + R + ++H L I HRD+K N+
Sbjct: 120 VP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNL 172
Query: 574 LLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSIKSDVFSFG 631
L++ N K+ DFG + +E + + + Y APE +++ D++S G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIG 229
Query: 632 ILLLEIVSGK 641
+ E++ GK
Sbjct: 230 CVFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 40/210 (19%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
I L +I E+ L ++ R D ++ F ++ G + Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH--- 133
Query: 560 RLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGDE---TEGNTNRVVGTYGYMAPE 614
++I HRDLK N LLD KI DFG ++ + VGT Y+APE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAYIAPE 187
Query: 615 YAS----DGQFSIKSDVFSFGILLLEIVSG 640
DG+ +DV+S G+ L ++ G
Sbjct: 188 VLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+QH N++ LL + L+ FM L + + ++ ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LV 132
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+GL Y+H ++HRDLK N+ +++D KI DFGL R + T V
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 184
Query: 606 GTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE S ++ D++S G ++ E+++GK
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 9/136 (6%)
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
EEK L D + T L+ +S + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSI 623
IHRDL A N+LL + KI DFGL R D +MAPE D ++I
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 624 KSDVFSFGILLLEIVS 639
+SDV+SFG+LL EI S
Sbjct: 275 QSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 19/162 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 493 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ H N+V LLG C + G ++I EF +L +++ S+R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ L+ E M L I + L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LL 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE + D++S G ++ E+V K
Sbjct: 226 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 495
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH----------I 544
++++ G Q +++ +I +++ L F R+ SQRF +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----FSLLRK-----SQRFPNPVAKFYAAEV 115
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
L YLH II+RDLK N+LLD++ + KI+DFG + T +
Sbjct: 116 CLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163
Query: 605 VGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG 640
GT Y+APE S ++ D +SFGIL+ E+++G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 14/207 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
L L Q ++L + E+ L F R + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH +++RD+K N++LD+D + KI+DFGL + D T GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
D + D + G+++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 56/254 (22%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
++ +NI ++T + D + +++ + +G G FG V
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--------------EDYEVVKVIGRGAFGEVQL 87
Query: 459 GTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
+++ A+K LSK I E + + +V+L Q + L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ E+MP L W+ RF+ ++ L +H + IHRD+K
Sbjct: 147 VMEYMPGGDL--VNLMSNYDVPEKWA-RFYTAEVVLA----LDAIHS---MGFIHRDVKP 196
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE----YASDGQFSIKSD 626
N+LLD+ + K++DFG + + VGT Y++PE DG + + D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 627 VFSFGILLLEIVSG 640
+S G+ L E++ G
Sbjct: 256 WWSVGVFLYEMLVG 269
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 6e-18
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
L +L C Q ++L + E++ L + Q R + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAE-IAIGLF 456
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYGYMA 612
+L II+RDLK NV+LD + + KI+DFG+ + T T GT Y+A
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIA 510
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGK 641
PE + + D ++FG+LL E+++G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 31/252 (12%)
Query: 404 IAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
I++ E ++ L + +F +G+G FG V
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 464 GQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQHRNLVKLLGCCIQGEEKL-LIYEF 517
+ AVK L K + ++ K + +E +L ++H LV L Q +KL + ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDY 120
Query: 518 MPNKSL-----DSFIFDQTRRTLLDWSQRF---HIICGTARGLLYLHQDSRLRIIHRDLK 569
+ L F + R RF I L YLH L I++RDLK
Sbjct: 121 INGGELFYHLQRERCFLEPR-------ARFYAAEIASA----LGYLHS---LNIVYRDLK 166
Query: 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFS 629
N+LLD + ++DFGL + E T+ GT Y+APE + D +
Sbjct: 167 PENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 630 FGILLLEIVSGK 641
G +L E++ G
Sbjct: 225 LGAVLYEMLYGL 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ ++ E M +L I + L + ++
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LL 133
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 188
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE + D++S G ++ E++ G
Sbjct: 189 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 491
+ F + LG+GG+G V+ K T + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICG 547
+++H +V L+ Q KL LI E++ L F+ + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L +LHQ II+RDLK N++L+ + K++DFGL + D T +T GT
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
YMAPE + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
H LV L C Q E +L + E++ L Q +R L + RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYG 609
L YLH+ II+RDLK NVLLD + + K++D+G+ + +T T+ GT
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 175
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE + D ++ G+L+ E+++G+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
+F+ LG+G FG V E+ AVK L K + + ++V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRV 73
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---I 544
L + L +L C Q ++L + E++ L + Q R + F+ I
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAEI 130
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNR 603
G L +L II+RDLK NV+LD + + KI+DFG+ + T T
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKT 180
Query: 604 VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
GT Y+APE + + D ++FG+LL E+++G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E++ ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVV 605
RGL Y+H S ++HRDLK SN+LL+ + KI DFGL R D T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 606 GTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE + ++ D++S G +L E++S +
Sbjct: 194 -TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
DNF LG+G FG V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L H L +L CC Q ++L + EF+ L F ++RR + RF+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARA-RFYAAE- 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L++LH II+RDLK NVLLD + + K++DFG+ + + T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE + + D ++ G+LL E++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 462
N+ + ++E E N + +F + +G G + V L
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVIGRGSYAKVLLVRLK 74
Query: 463 DGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQHRNLVKLLGCCIQGEEKL-LIYE 516
I A++ + K ++ + ++ E + H LV L C Q E +L + E
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIE 133
Query: 517 FMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
++ L Q +R L + RF+ I L YLH+ II+RDLK NV
Sbjct: 134 YVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE---RGIIYRDLKLDNV 184
Query: 574 LLDQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGI 632
LLD + + K++D+G+ + +T T+ GT Y+APE + D ++ G+
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 633 LLLEIVSGK 641
L+ E+++G+
Sbjct: 242 LMFEMMAGR 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
++F ++ LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H L + C Q +E L + E++ L Q+ F+ GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYGYMA 612
+LH I++RDLK N+LLD+D + KI+DFG+ + GD TN GT Y+A
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIA 186
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSG 640
PE +++ D +SFG+LL E++ G
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 38/226 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 483
+++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 484 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDW 538
+ L + H N++ L + E + L+ E M L I +R ++
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISP 133
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-- 596
+ + GL LH+ ++HRDL N+LL + + I DF L R D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 597 TEGNTNRVVGTYGYMAPEY-ASDGQFSIKSDVFSFGILLLEIVSGK 641
T V Y APE F+ D++S G ++ E+ + K
Sbjct: 191 TH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 43/194 (22%), Positives = 85/194 (43%), Gaps = 23/194 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
D + I + +G G +G V + ++ + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 492 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L H ++VK+L I + + ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G+ Y+H S I+HRDLK +N L++QD + K+ DFGL RT E + +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 607 TYGYMAPEYASDGQ 620
M +
Sbjct: 221 REDDMNLVTFPHTK 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + L+ FM L + + L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLV 134
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+GL Y+H IIHRDLK N+ +++D KI DFGL R + T V
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YV 186
Query: 606 GTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE + +++ D++S G ++ E+++GK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + + +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + + L+ M L++ + Q L D +F +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK---LTDDHVQF-LI 138
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YV 190
Query: 606 GTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
T Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 490
+NF + LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IIC 546
Q LV L Q E KL LI +++ L F R + + + I+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L +LH+ L II+RD+K N+LLD + + ++DFGL + F DETE G
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCG 222
Query: 607 TYGYMAPE--YASDGQFSIKSDVFSFGILLLEIVSGK 641
T YMAP+ D D +S G+L+ E+++G
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 494
+ LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 495 HRNLVKLL----------GCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
H N+VK+ + +L ++ E+M L + + LL+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP---LLEEHA 122
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEG 599
R + RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGL R +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 600 N--TNRVVGTYGYMAPE-YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ +V T Y +P S ++ D+++ G + E+++GK
Sbjct: 179 GHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 23/194 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
DN+ I + +G G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 492 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L+ +++L I K ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ++H IIHRDLK +N LL+QD + K+ DFGL RT ++ N +
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 607 TYGYMAPEYASDGQ 620
Q
Sbjct: 194 NEEPGPHNKNLKKQ 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
+ +F + + LGEG +G V T G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E +I E M L I Q L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM---LSDDHIQY-FIYQ 120
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV--- 604
T R + LH + +IHRDLK SN+L++ + + K+ DFGL R + +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 605 -----VGTYGYMAPEY-ASDGQFSIKSDVFSFGILLLEIVSGK 641
V T Y APE + ++S DV+S G +L E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-14
Identities = 36/222 (16%), Positives = 65/222 (29%), Gaps = 63/222 (28%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 489
T+ K+GEG FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 490 FSKLQ---------HRNLVKLLGCCI-----------------------------QGEEK 511
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
L I +D +Q R L + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 572 NVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
NVLL + K+ ++ + + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 428 PLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 486
++ A D + LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 487 V-ILFSKLQHRNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQ 540
V + + Q ++V+++ G + L ++ E + L F + R +++
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTE 116
Query: 541 R-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGL 588
R I + YLH + I HRD+K N+L + K++DFG
Sbjct: 117 REASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + KLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 492 KLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V LL + L++++M L + I L +++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI---LEPVHKQY-VVYQLI 119
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV----- 604
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL R+F N +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 605 --------------VGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGK 641
V T Y APE +++ D++S G +L EI+ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 24/199 (12%), Positives = 55/199 (27%), Gaps = 41/199 (20%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
G ++ +++A+ + + + L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
L++ E++ SL T + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 622
+ S V + D G V V+ M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA-------N 180
Query: 623 IKSDVFSFGILLLEIVSGK 641
+ D+ G L ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 492
+ KLG G F V+ +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 493 LQHRNLVKLLGC-CIQGEEKL---LIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICG 547
+ +++KLL +G + +++E + ++L + I R + L + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI----- 136
Query: 548 TAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFGLVRTFGGDET 597
++ GL Y+H R IIH D+K NVL++ +P KI+D G + +
Sbjct: 137 -SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEH- 191
Query: 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+ T Y +PE + +D++S L+ E+++G
Sbjct: 192 ---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + C +G+ +++ E + SL+ +F+ R + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKF-----SLKTVLLLADQMISRIE 119
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
Y+H + IHRD+K N L+ I DFGL + +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 52/229 (22%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 494
D + I++ +G+G FG V K V+ + +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 495 HR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDW 538
+V L C+ E +L +Y+ + N + + TR+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFA--- 163
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDE 596
Q LL+L L IIH DLK N+LL KI DFG G
Sbjct: 164 QQMC-------TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR 214
Query: 597 TEGNTNRVVGTY----GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+ Y Y +PE + + D++S G +L+E+ +G+
Sbjct: 215 --------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 496
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 497 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEG 599
+ L LH + RIIH DLK N+LL Q K+ DFG +
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY------- 251
Query: 600 NTNRVVGTY----GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
++ V TY Y APE ++ + D++S G +L E+++G
Sbjct: 252 -EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ F + K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 499 V-KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + ++G+ +L+ + + SL+ +F+ R L + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKL-----SLKTVLMLADQMINRVE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
++H S +HRD+K N L+ I DFGL + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 35/166 (21%), Positives = 80/166 (48%), Gaps = 27/166 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL-- 553
+ + +G +L+ + + SL+ + D R +F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGR-------KFSVKTVAMAAKQMLAR 118
Query: 554 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
+H+ S +++RD+K N L+ + + + DFG+V+ +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-08
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ W + Y
Sbjct: 92 DGNVVIYGSD-------IWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 25 NPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGD 84
++ ++ + NLVL + VW++ + L GN V+ D
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-- 70
Query: 85 SETYFWQS 92
W S
Sbjct: 71 --RSLWAS 76
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNL 498
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL--- 553
++ G+ ++ E + SL+ +FD R F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDR-------TFSLKTVLMIAIQLISRM 118
Query: 554 -YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
Y+H + +I+RD+K N L+ + N I DF L + +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 39/209 (18%), Positives = 73/209 (34%), Gaps = 50/209 (23%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 500 ---------KLLG-----CCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWSQR 541
LG E K Y FM L + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK---------ISGQNGT 147
Query: 542 FHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTFG 593
F + +L Y+H++ +H D+KA+N+LL ++ +D+GL +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 594 GDET-----EGNTNRVVGTYGYMAPEYAS 617
+ E GT E+ S
Sbjct: 205 PNGNHKQYQENPRKGHNGT-----IEFTS 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/211 (17%), Positives = 69/211 (32%), Gaps = 51/211 (24%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 498
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 499 V---------------KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWS 539
+ K G + + Y FM L I++ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAK------ 147
Query: 540 QRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRT 591
RF + + +L Y+H+ +H D+KASN+LL+ ++ D+GL
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 592 FGGDET-----EGNTNRVVGTYGYMAPEYAS 617
+ + GT E+ S
Sbjct: 204 YCPEGVHKAYAADPKRCHDGT-----IEFTS 229
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 55/239 (23%), Positives = 87/239 (36%), Gaps = 62/239 (25%)
Query: 442 FSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR 496
+ I + LGEG FG V + G+ +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 497 ------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLD 537
V++L CI E LL Y+F+ F D R +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC- 128
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT------ 591
+ + +LH ++ H DLK N+L Q + + + R
Sbjct: 129 ------------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 592 -------FGG--DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
FG + E + + +V T Y APE +S DV+S G +L+E G
Sbjct: 174 PDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 54/239 (22%), Positives = 87/239 (36%), Gaps = 58/239 (24%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR- 496
F + K+G+G FG V + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 497 ----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
N+VK G C+ E L +YE + + + F + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIK---------- 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ L YL ++ + H DLK N+LLD K T G T
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 603 R--------------------VVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
++ T Y APE + + + SD++SFG +L E+ +G
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW +N + L + GNLV+ QSN V+W + + + VL L
Sbjct: 35 YDSGKPVWASNTGGLGSGCRLTL--HNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQ 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ W +
Sbjct: 92 DRNVVIYG-------PVVWAT 105
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 48/238 (20%), Positives = 79/238 (33%), Gaps = 54/238 (22%)
Query: 439 TDNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 493
+ + I LGEG FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 494 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLD 537
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT------ 591
H+ L +LH ++ H DLK N+L + +
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 592 -------FGGDETEGNT-NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
FG + +V T Y PE + ++ DV+S G +L E G
Sbjct: 179 TSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 32/208 (15%), Positives = 71/208 (34%), Gaps = 45/208 (21%)
Query: 441 NFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELK------- 484
+ + + G +Y+ Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 485 -NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLL 536
+V + KL L+ +G + ++ Y F+ +SL S D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTFGG 594
+ C L +LH++ +H ++ A N+ +D + ++ + +G +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 595 DET-----EGNTNRVVGTYGYMAPEYAS 617
EG+ + G E+ S
Sbjct: 214 SGKHVAYVEGSRSPHEGD-----LEFIS 236
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + VL L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQP 101
Query: 72 SGNLVL 77
N+V+
Sbjct: 102 DRNVVI 107
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKT-GNLVLTSQSNIVVWSAYLSKE 60
++ K+P+ ++P +++ L + + + I +T NLVL +N +W+ +
Sbjct: 3 IIFSKQPDDNHP--QILHATESLEILFGTHVYRFIMQTDCNLVLY-DNNNPIWATN-TGG 58
Query: 61 VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92
+ L G LV+ + WQS
Sbjct: 59 LGNGCRAVLQPDGVLVVITNEN----VTVWQS 86
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 17/81 (20%), Positives = 25/81 (30%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y +W +N S L + GNLV+ +N VW + + L L
Sbjct: 35 YQNGRQIWASNTDR--RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQK 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
G V+ W
Sbjct: 92 DGRFVIYG-------PVLWSL 105
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 51/266 (19%), Positives = 93/266 (34%), Gaps = 74/266 (27%)
Query: 439 TDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 494
+ + KLG G F V+ + + +A+K + K +E + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 495 -----HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHI 544
+V+LL I G +++E + L +I + L L ++ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL----------------------------- 575
I +GL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 576 --------------------DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
+ + KI+D G TE + T Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEV 264
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
++ +D++S + E+ +G
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-06
Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S +W++ + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ D + W +
Sbjct: 90 DRNVVIYDNSN----NAIWAT 106
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 41/246 (16%), Positives = 79/246 (32%), Gaps = 60/246 (24%)
Query: 379 IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANA 438
I++S A+ + + L+ K+ + + E + + F ++ I
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------------FLMSPIKTE 101
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIA---VKRLSKISE--QGLKELK--------- 484
S+ ++ +Y D Q A V RL + Q L EL+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 485 ----------NEVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYEFMPNKSLDS 525
+V L K+Q + K+ L C E L L+Y+ PN + S
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ + R LL ++ +++ + +++ KI
Sbjct: 218 DHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI-- 268
Query: 586 FGLVRT 591
L+ T
Sbjct: 269 --LLTT 272
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N D L + GNLV+ S N +W++ E V L
Sbjct: 34 YDVDKPIWATNTGG--LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQK 90
Query: 72 SGNLVLRDE 80
N+V+
Sbjct: 91 DRNVVIYGT 99
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-05
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
+ W +N N FL +N G L++ +WS+ S + Q VL L D G
Sbjct: 40 GGKYGWQSNTHG--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDG 96
Query: 74 NLVL 77
V+
Sbjct: 97 FGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNL 75
W +N N N L + G LV+ + VW + ++ V+ + G L
Sbjct: 37 NGNWQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRL 93
Query: 76 VLRDEHDGDSETY 88
V+ + +
Sbjct: 94 VVFGPSVFKIDPW 106
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ + V L
Sbjct: 165 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSG-NSRSAGRYVFVLQP 221
Query: 72 SGNLVL 77
NL +
Sbjct: 222 DRNLAI 227
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 19/149 (12%), Positives = 42/149 (28%), Gaps = 11/149 (7%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ VW +N + ++ G LV+ + N + WS+ VL L
Sbjct: 41 FDSDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQP 96
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+ + DS T S ++ + S
Sbjct: 97 DRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHP-------QTLHATQSLQL 149
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWN 160
+ + + + +V++ + + T
Sbjct: 150 SPYRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 38.7 bits (90), Expect = 8e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
+VW + F+ + +G L +T V+ + + + VL L +G V
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAV 102
Query: 77 L 77
+
Sbjct: 103 V 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.6 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.57 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.52 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.47 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.42 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.38 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.28 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.26 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.24 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.17 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.02 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.0 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.98 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.79 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.77 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.63 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.72 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 82.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.35 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=398.37 Aligned_cols=221 Identities=27% Similarity=0.413 Sum_probs=196.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 5889999999752 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 34899999999999999999999998 999999999999999999999999999988655
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.........+||+.|||||++.+..|+.++||||+||+||||+||+.||. .++...++..|.+...+||+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~---~~~~~~~~~~i~~~~~~~p~~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEGLIFAKIIKLEYDFPEK 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCCCCCTT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHcCCCCCCcc
Confidence 44445556799999999999999999999999999999999999999964 445667778888877777764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=396.94 Aligned_cols=216 Identities=31% Similarity=0.532 Sum_probs=185.8
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999864 367899999987777777899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 514 IYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
|||||++|+|.++|.... ....+++..++.++.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2356899999999999999999999987 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhc
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~ 661 (670)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..+++..+.+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQ 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc
Confidence 99999987754443333444679999999999999999999999999999999999 899976443 3344555544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=397.17 Aligned_cols=216 Identities=30% Similarity=0.508 Sum_probs=178.3
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46788899999999999999864 367899999987777778899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 514 IYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
|||||++|+|.++|..... ...+++.+++.++.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 246899999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhh
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVS 660 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~ 660 (670)
||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+++..+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 9999999998755444444445679999999999999999999999999999999999 8999764433 34444444
Q ss_pred c
Q 005907 661 K 661 (670)
Q Consensus 661 ~ 661 (670)
+
T Consensus 275 ~ 275 (329)
T 4aoj_A 275 Q 275 (329)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=393.26 Aligned_cols=209 Identities=28% Similarity=0.435 Sum_probs=184.4
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999985 58999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999864 23899999999999999999999998 99999999999999999999999999998754322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhh
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVS 660 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~ 660 (670)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||... ....++..+.
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~ 283 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR 283 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH
Confidence 233478999999999999999999999999999999999999997543 3334444443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=392.48 Aligned_cols=216 Identities=30% Similarity=0.506 Sum_probs=183.3
Q ss_pred CCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
.++++.++||+|+||.||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35677889999999999999863 4678999999753 3345678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
+|||||++|+|.++|..... ...+++..+++++.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 245899999999999999999999988 99999999999999999
Q ss_pred ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhh
Q 005907 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGH 658 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 658 (670)
.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+++..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999998755444444455689999999999999999999999999999999999 8999865443 344444
Q ss_pred hhc
Q 005907 659 VSK 661 (670)
Q Consensus 659 i~~ 661 (670)
+.+
T Consensus 260 i~~ 262 (308)
T 4gt4_A 260 IRN 262 (308)
T ss_dssp HHT
T ss_pred HHc
Confidence 443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=386.98 Aligned_cols=202 Identities=30% Similarity=0.521 Sum_probs=169.3
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.+++.+.++||+|+||+||+|++.+ .||||+++. ...+..++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4678889999999999999998743 599999864 334556789999999999999999999998864 56899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
||++|+|.++|... ...+++..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999653 345899999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||....
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 3334445789999999999864 468999999999999999999999986443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=393.26 Aligned_cols=214 Identities=23% Similarity=0.386 Sum_probs=178.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|+++++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999974 5899999998652 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|||++|+|.++|.... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999996532 345788999999999999999999998 999999999999999999999999999876422
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.. ....+++..+.+
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~ 239 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIIS 239 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHH
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHc
Confidence 1 122346899999999999999999999999999999999999999753 334445554444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=387.45 Aligned_cols=219 Identities=26% Similarity=0.353 Sum_probs=182.7
Q ss_pred CCcccceeeeecCceeEEEEEec----CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.+.||+|+||.||+|+.. .++.||||++++. .......+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 3678999999753 23344578899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.... .....+||+.|||||++.+..|+.++||||+||+||||+||+.||. ..+..+++..+.+...++|+.
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~---~~~~~~~~~~i~~~~~~~p~~ 248 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAKLGMPQF 248 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCCCCCTT
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC---CcCHHHHHHHHHcCCCCCCCc
Confidence 3322 2334789999999999999999999999999999999999999964 445566777777777777654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=395.10 Aligned_cols=199 Identities=29% Similarity=0.450 Sum_probs=180.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.++|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999985 4899999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
|++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999998542 3899999999999999999999998 99999999999999999999999999998754322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....+||+.|||||++.+..|+.++||||||||||||++|+.||..
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23347899999999999999999999999999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.29 Aligned_cols=218 Identities=26% Similarity=0.420 Sum_probs=174.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999974 5899999998652 234456799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+ +|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 67999998653 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.. .....+||+.|||||++.+..| +.++||||+||+||||+||+.||. .+....++..+.+...++|+.
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~---~~~~~~~~~~i~~~~~~~p~~ 234 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNISNGVYTLPKF 234 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCCCCCTT
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC---CCCHHHHHHHHHcCCCCCCCC
Confidence 22 2234689999999999998886 579999999999999999999975 344556777777776666653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=381.79 Aligned_cols=199 Identities=26% Similarity=0.327 Sum_probs=171.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+.|++.++||+|+||.||+|+.+ .|+.||||+++... ...+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999975 48999999996522 224699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecCCCc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 596 (670)
|++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999653 34899999999999999999999988 99999999999999987 69999999999875432
Q ss_pred cc---CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TE---GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 22 12234689999999999999999999999999999999999999986433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=371.50 Aligned_cols=196 Identities=26% Similarity=0.435 Sum_probs=168.4
Q ss_pred cccceeeeecCceeEEEEEecC-CcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 514 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 514 (670)
|++.++||+|+||.||+|.... +..||+|++.. ......+.|.+|+.++++++|||||++++++.. +...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3667789999999999999754 78999999864 234456789999999999999999999999865 3457899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 593 (670)
||||++|+|.++|... ..+++..+..++.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999653 34899999999999999999999875 35999999999999984 7899999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||..
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 22344789999999999865 699999999999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=383.22 Aligned_cols=217 Identities=29% Similarity=0.447 Sum_probs=185.3
Q ss_pred ccHHHHHHhcCCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCC-CceeeE
Q 005907 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKL 501 (670)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H-~niv~l 501 (670)
++..+++...++|++.++||+|+||.||+|.+.. ++.||||++... .....++|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445555667899999999999999999998643 357999999763 33446789999999999965 999999
Q ss_pred EEEEEeC-CeeEEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 005907 502 LGCCIQG-EEKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567 (670)
Q Consensus 502 ~g~~~~~-~~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrD 567 (670)
+|+|.+. +..++|||||++|+|.++|+... .+..+++..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 56899999999999999997532 1345889999999999999999999988 99999
Q ss_pred CCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 568 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
|||+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765544444455789999999999999999999999999999999998 9999865
Q ss_pred CCC
Q 005907 647 YRS 649 (670)
Q Consensus 647 ~~~ 649 (670)
...
T Consensus 291 ~~~ 293 (353)
T 4ase_A 291 VKI 293 (353)
T ss_dssp CCC
T ss_pred CCH
Confidence 443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.85 Aligned_cols=200 Identities=29% Similarity=0.472 Sum_probs=161.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--------
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 509 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 509 (670)
++|++.+.||+|+||.||+|+.+ +++.||||+++.. .+...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999974 5889999998653 3344567899999999999999999999987644
Q ss_pred ----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 510 ----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 510 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
..++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544344567778899999999999999998 99999999999999999999999
Q ss_pred ecCceecCCCcccC----------CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 586 FGLVRTFGGDETEG----------NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 586 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99999875432211 1233579999999999999999999999999999999997 653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.38 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=163.8
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 515 (670)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3578889999999999999998 689999999965322 2223345666777899999999999998754 579999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
|||++|+|.++|... .+++..+++++.|++.||+|||++. .++||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999653 3889999999999999999999861 2359999999999999999999999999999
Q ss_pred ecCCCccc--CCccccccccCcccccccCCC------CCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 591 TFGGDETE--GNTNRVVGTYGYMAPEYASDG------QFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||++|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 87543322 223346799999999999764 46789999999999999999988764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=383.23 Aligned_cols=221 Identities=25% Similarity=0.354 Sum_probs=186.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHH---HHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.++||+|+||.||+|+.+ +|+.||||++.+. .......+. .++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999985 4889999999652 122223333 446677788999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||++||+|..+|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999654 34899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
+.... ....+||+.|||||++.+ ..|+.++||||+|||||||++|+.||......+...+...+......+|+.
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~ 416 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc
Confidence 75332 234689999999999964 579999999999999999999999987555555556666777666666653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=364.35 Aligned_cols=201 Identities=24% Similarity=0.394 Sum_probs=171.1
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe------CC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 509 (670)
.++|++.++||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999974 5899999999653 23445678899999999999999999999764 35
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..+||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 679998854 345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcc--cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDET--EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+.+..... .......+||+.|||||++.+. .++.++||||+|||+|||++|+.||..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 87643322 2223457899999999998875 569999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.31 Aligned_cols=210 Identities=22% Similarity=0.378 Sum_probs=174.8
Q ss_pred HhcCCcccceeeeecCceeEEEEEec----CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (670)
...++|++.++||+|+||.||+|+.+ .++.||+|++.+. .....+.+|+.+++.+ +||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999863 3678999998653 2345788999999998 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCce
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVR 590 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 590 (670)
++||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999983 2789999999999999999999998 9999999999999877 799999999998
Q ss_pred ecCCCccc--------------------------CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCC
Q 005907 591 TFGGDETE--------------------------GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 591 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p 643 (670)
........ ......+||+.|||||++.+. .|+.++||||+|||+|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 76432211 112235799999999999875 589999999999999999999999
Q ss_pred CCCCCCcccchHhhhh
Q 005907 644 RGFYRSDTKVNLIGHV 659 (670)
Q Consensus 644 ~~~~~~~~~~~l~~~i 659 (670)
|. ...+..+.+..|
T Consensus 247 f~--~~~~~~~~l~~I 260 (361)
T 4f9c_A 247 FY--KASDDLTALAQI 260 (361)
T ss_dssp SS--CCSSHHHHHHHH
T ss_pred CC--CCCCHHHHHHHH
Confidence 73 333334444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=374.12 Aligned_cols=217 Identities=25% Similarity=0.401 Sum_probs=187.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999985 4899999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--CceEEEeecCceecCCC
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~ 595 (670)
|++|+|.++|.+ ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999854 2345889999999999999999999998 9999999999999854 89999999999987533
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
. .....+||+.|||||++.+..|+.++||||+||+||||++|+.||.. .....++..|.+....+
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~---~~~~~~~~~i~~~~~~~ 375 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSCDWNM 375 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHTTCCCC
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHhCCCCC
Confidence 2 23346899999999999999999999999999999999999999753 33445555665554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.02 Aligned_cols=218 Identities=22% Similarity=0.313 Sum_probs=185.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++++. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999975 4889999999753 344567789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998653 34789999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+...+...+......+|
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~p 225 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCC
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC---CCHHHHHHHHHcCCCCCC
Confidence 22 223346899999999999999999999999999999999999999753 333444555544444444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.77 Aligned_cols=220 Identities=26% Similarity=0.391 Sum_probs=183.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
..++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999975 4889999999753 334556788999999988 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999654 34889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....++..+.+....||.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~~~~~~p~ 245 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAILNDEVVYPT 245 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCCT
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCCC
Confidence 3222 223346899999999999999999999999999999999999999753 3445666666666666654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=322.15 Aligned_cols=202 Identities=26% Similarity=0.480 Sum_probs=180.6
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999986 4588999999976655667788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999653 3889999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2234679999999999999999999999999999999999999986443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=333.84 Aligned_cols=222 Identities=23% Similarity=0.360 Sum_probs=183.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.++||+|+||.||+|+.+. ++.||+|++++. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4679999999999999999999854 788999999753 233445688899999887 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998653 34899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc------ccchHhhhhhceeeecC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD------TKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~------~~~~l~~~i~~~~~~~~ 667 (670)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+.+....+|
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 222 2234478999999999999999999999999999999999999998643221 12234455555555554
Q ss_pred C
Q 005907 668 S 668 (670)
Q Consensus 668 ~ 668 (670)
.
T Consensus 283 ~ 283 (396)
T 4dc2_A 283 R 283 (396)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.33 Aligned_cols=220 Identities=26% Similarity=0.388 Sum_probs=185.7
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCee
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (670)
...++|.+.+.||+|+||.||+|+.+ +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35678999999999999999999985 4889999999753 234556788899999877 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999996532 4889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+...+...+......+|
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~p 238 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYP 238 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCC
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHhCCCCCC
Confidence 43222 223446899999999999999999999999999999999999999753 334455555555555554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.01 Aligned_cols=208 Identities=21% Similarity=0.304 Sum_probs=179.7
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
.++....++|++.++||+|+||.||+|+... ++.||+|++.+. .......+.+|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444556899999999999999999999865 788999999752 223344588999999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 9999999999999999999652 345899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
++.+...... .....+||+.|+|||++. ...++.++|||||||+||||++|+.||..
T Consensus 222 a~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 222 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp CEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 9876543322 223367999999999986 56789999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.64 Aligned_cols=221 Identities=25% Similarity=0.404 Sum_probs=188.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999999754 788999998652 334567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+.+|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999964 334899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........++..+......+|.
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~ 241 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence 32 2334679999999999964 45899999999999999999999999766555555566655555555543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=322.71 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=184.2
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999985 5889999999753 234566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999653 34889999999999999999999987 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....++..+.+....+|
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~p 223 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 223 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHHCCCCCC
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCCCC
Confidence 2 2346799999999999999999999999999999999999999753 233444455544444444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.77 Aligned_cols=220 Identities=25% Similarity=0.343 Sum_probs=187.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
..++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999865 788999999753 234566788999999988 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999996533 4889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+...++..+.+....+|.
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~~~~~~p~ 242 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAYPK 242 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCCT
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC---CCHHHHHHHHHhCCCCCCC
Confidence 3222 223346899999999999999999999999999999999999999753 3445566666665555553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.32 Aligned_cols=218 Identities=28% Similarity=0.420 Sum_probs=184.8
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999997 56899999998653 344566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999996543 3889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||... ....+...+.+....+|
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKYRIP 234 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC
Confidence 22 23346799999999999888775 7999999999999999999997543 33444444444444333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.55 Aligned_cols=215 Identities=39% Similarity=0.674 Sum_probs=188.2
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+....++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34567899999999999999999999888999999998776666678899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||+++++|.+++..... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999865322 235889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCccc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~ 652 (670)
............||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 43333333445689999999999989999999999999999999999999865444433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.49 Aligned_cols=217 Identities=21% Similarity=0.296 Sum_probs=183.0
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
.+....++|++.++||+|+||.||+|+... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 344456789999999999999999999864 789999998652 2334456889999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999999998642 3789999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQ----FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
+.+...... .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.. ++...++..+.+
T Consensus 216 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~ 287 (410)
T 3v8s_A 216 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMN 287 (410)
T ss_dssp EECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHT
T ss_pred EeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC---CChhhHHHHHHh
Confidence 876543221 223468999999999997665 88999999999999999999999753 333444444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.46 Aligned_cols=216 Identities=24% Similarity=0.315 Sum_probs=186.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357999999999999999999985 5889999998653 234567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999996543 3889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....++..+.+....+|.
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~p~ 259 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPS 259 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCCT
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC---CCHHHHHHHHHcCCCCCCC
Confidence 2 2346799999999999999999999999999999999999999753 3344555666555555543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.35 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=175.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999985 4789999999753 234456788999999988 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999996532 4889999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 22 223346899999999999999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.73 Aligned_cols=207 Identities=31% Similarity=0.489 Sum_probs=180.1
Q ss_pred cCCcccceeeeecCceeEEEEEec--------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (670)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999863 3457999999753 344567899999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976431 234789999999999999999999998 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999998765444334444567889999999999999999999999999999999 999986543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=318.35 Aligned_cols=206 Identities=32% Similarity=0.504 Sum_probs=180.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|.+.++||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357899999999999999999985 4889999998776777788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999763 345899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cC------------CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 598 EG------------NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 598 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 11 11135799999999999999999999999999999999999999875544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.59 Aligned_cols=211 Identities=29% Similarity=0.432 Sum_probs=182.8
Q ss_pred CCcccHHHHHHhcCC----------cccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCC
Q 005907 427 LPLFELATIANATDN----------FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495 (670)
Q Consensus 427 ~~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H 495 (670)
.+.+..+++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 344555555554432 677789999999999999986 689999999977666667789999999999999
Q ss_pred CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 496 ~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999843 34899999999999999999999988 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999887543222 2346799999999999999999999999999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.95 Aligned_cols=208 Identities=21% Similarity=0.291 Sum_probs=179.8
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
.+.....++|++.+.||+|+||.||+++.+ +++.||||++++. .....+.+.+|..++.+++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334445688999999999999999999985 5899999999752 233445688999999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999996532 34889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccC-------CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYAS-------DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
++.+...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 209 a~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 209 CLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp CEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred heeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 9887543221 223368999999999987 45789999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=323.01 Aligned_cols=214 Identities=25% Similarity=0.381 Sum_probs=182.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchh------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
..+.|++.+.||+|+||.||+++.. +++.||+|++.+.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999985 4889999998753221 35689999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEee
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 586 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DF 586 (670)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999954 345899999999999999999999998 99999999999998877 7999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
|+++.+.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....++..+.+..
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcC
Confidence 9998875432 223467999999999999999999999999999999999999997533 3334444444443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.25 Aligned_cols=218 Identities=26% Similarity=0.365 Sum_probs=173.7
Q ss_pred cCCcccceeeeecCceeEEEEEe----cCCcEEEEEEecccc----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
.++|++.+.||+|+||.||+++. ..++.||+|++++.. ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 368899999987532 2345568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999653 34788999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ....++..+.+....+|
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKILKCKLNLP 241 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCC
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCCC
Confidence 6432221 223457999999999999999999999999999999999999997533 33344444444444433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=326.23 Aligned_cols=218 Identities=22% Similarity=0.292 Sum_probs=174.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.+.||+|+||.||+|+.+. ++.||||++.+.. ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999864 7889999997532 2334556677776 577899999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999653 34788899999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....+...+.+....++
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~~~~~~~ 259 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS---RNTAEMYDNILNKPLQLK 259 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC---SBHHHHHHHHHHSCCCCC
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhcccCCC
Confidence 222 223446899999999999999999999999999999999999999753 334445555554444433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.21 Aligned_cols=225 Identities=28% Similarity=0.403 Sum_probs=189.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999985 4899999999653 234456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999875432 346899999999999999999999998 9999999999999999999999999998865
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc-ccchHhhhhhceeeecCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD-TKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~-~~~~l~~~i~~~~~~~~~ 668 (670)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+......+|.
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~ 414 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence 3322 223358999999999999999999999999999999999999998654322 234455555555445543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.57 Aligned_cols=202 Identities=18% Similarity=0.195 Sum_probs=174.4
Q ss_pred hcCCcccceeeeecCceeEEEEE------ecCCcEEEEEEecccchhchHHHHHHHHHHhcCC---CCceeeEEEEEEeC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 508 (670)
..++|.+.++||+|+||.||+|. ...++.||||++... ...++..|+.++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 345889999999653 3456777888888886 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---------
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQ--TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------- 577 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--------- 577 (670)
+..++||||+++|+|.+++... .....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999642 23456899999999999999999999987 999999999999998
Q ss_pred --CCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 578 --DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 578 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 89999999999987643333333344679999999999999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=318.74 Aligned_cols=207 Identities=31% Similarity=0.517 Sum_probs=170.6
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|+. .++.||||++... .....+++.+|+.++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456899999999999999999987 6889999998653 3344568899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++........+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965433334889999999999999999999874 24999999999999999999999999999865332
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 12234678999999999999999999999999999999999999986544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.42 Aligned_cols=218 Identities=44% Similarity=0.757 Sum_probs=188.0
Q ss_pred CCcccHHHHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEE
Q 005907 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (670)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (670)
...+...++....++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34567788888999999999999999999999998889999999987532 22344789999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 506 ~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
......++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 23458999999999999999999999822239999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999876433222 2233568999999999988899999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=319.24 Aligned_cols=205 Identities=29% Similarity=0.421 Sum_probs=176.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999975 58899999986432 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999843 345899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 33333345679999999999987775 778999999999999999999986443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.80 Aligned_cols=202 Identities=28% Similarity=0.443 Sum_probs=172.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+.. .++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999874 5889999998542 334456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999654 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 222 2233457999999999999999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.01 Aligned_cols=215 Identities=26% Similarity=0.409 Sum_probs=181.4
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999875 4889999998652 334556789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 591 (670)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998854 345889999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceee
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~ 664 (670)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+.....
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~~i~~~~~ 247 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAY 247 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCC
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCC
Confidence 653221 22367999999999999999999999999999999999999997532 33344444444433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.99 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=176.4
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3468999999999999999999975 4788999998643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCceEEEeecCceecCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGG 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~ 594 (670)
|+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999998542 335899999999999999999999998 999999999999987 78999999999988743
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 32 22345789999999999998899999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.72 Aligned_cols=207 Identities=30% Similarity=0.436 Sum_probs=175.8
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.++||+|+||.||+|+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999998653 2233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 788877543 345889999999999999999999988 999999999999999999999999999886433
Q ss_pred cccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCccc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 652 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~ 652 (670)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22 2223568999999999876 5689999999999999999999999875554433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.43 Aligned_cols=215 Identities=20% Similarity=0.285 Sum_probs=183.7
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 468899999986532 235688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc-----eEEEeecCcee
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVRT 591 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~ 591 (670)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 345899999999999999999999998 999999999999998887 99999999998
Q ss_pred cCCCcccC-----CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 592 FGGDETEG-----NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 592 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....++....+..+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 65433211 12346799999999999999999999999999999999999999987666655555555443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.63 Aligned_cols=218 Identities=24% Similarity=0.377 Sum_probs=182.2
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4568999999999999999999874 5889999998653 334456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~ 591 (670)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998653 34899999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
+...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.. ++...++..+.+....+
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRLYQQIKAGAYDF 232 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHTCCCC
T ss_pred ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHhCCCCC
Confidence 6543222 2236799999999999999999999999999999999999999743 33344455555444333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.65 Aligned_cols=222 Identities=27% Similarity=0.407 Sum_probs=187.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999985 5899999999652 234456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986533 334889999999999999999999998 99999999999999999999999999988643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc-ccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD-TKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~-~~~~l~~~i~~~~~~~~ 667 (670)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+......++
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p 409 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence 321 23357999999999999999999999999999999999999998654332 22344445555444444
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.51 Aligned_cols=198 Identities=26% Similarity=0.426 Sum_probs=173.8
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.+. .......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 45889999998652 223356789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 68898888653 34889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 322 234579999999999988876 7899999999999999999999854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.22 Aligned_cols=203 Identities=27% Similarity=0.371 Sum_probs=175.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999875 58899999986421 124578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc---eEEEeecC
Q 005907 513 LIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGL 588 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGl 588 (670)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 2345789999999999999999999998 999999999999987654 99999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 988754322 12335799999999999999999999999999999999999999854
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.25 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=177.4
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.++++++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3468999999999999999999875 478999999876555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCceEEEeecCceecCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGG 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~ 594 (670)
|+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+++.+..
T Consensus 129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999998542 335889999999999999999999998 999999999999974 47799999999988753
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 32 22335789999999999999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.00 Aligned_cols=218 Identities=23% Similarity=0.305 Sum_probs=173.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999874 4889999998752 334456778999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|||+++++|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998653 348899999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||... ....+...+......+|
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMEEIRFP 369 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCCCC
Confidence 2222 223467999999999999999999999999999999999999997533 33444444444444443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=313.73 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=175.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.+.|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999985 488999999865322 1357899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEeec
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG 587 (670)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999954 345899999999999999999999988 99999999999999887 79999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 9988743322 2335799999999999999999999999999999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.43 Aligned_cols=200 Identities=31% Similarity=0.514 Sum_probs=172.5
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 514 (670)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357999999999999999999874 8899999996533 33445667999999999999999999998754 46999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~----------~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
|||+++++|.+++... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999653 388999999999999999999987 6 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9999988765544444444679999999999986 35667899999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=327.51 Aligned_cols=206 Identities=28% Similarity=0.456 Sum_probs=177.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|.+.+.||+|+||.||+|... +++.||||+++.. .....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467899999999999999999986 6889999998753 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999996532 34789999999999999999999998 9999999999999999999999999998754333
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
.........+++.|+|||.+.+..++.++|||||||+||||+| |+.||.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2222222345788999999998899999999999999999999 9999865443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.57 Aligned_cols=219 Identities=40% Similarity=0.662 Sum_probs=189.0
Q ss_pred CCcccHHHHHHhcCCcccc------eeeeecCceeEEEEEecCCcEEEEEEeccc----chhchHHHHHHHHHHhcCCCC
Q 005907 427 LPLFELATIANATDNFSIN------NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 496 (670)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~ 496 (670)
.+.+...++...+++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3457788888888888776 8999999999999987 6889999998652 233457899999999999999
Q ss_pred ceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 497 niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976544556899999999999999999999988 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999987654333333334678999999998865 5789999999999999999999998755443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.67 Aligned_cols=204 Identities=27% Similarity=0.458 Sum_probs=173.4
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
..++|++.+.||+|+||.||+|+.. +++.||||++... .+...+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3457999999999999999999986 6899999998653 3345678999999999999999999999986654
Q ss_pred ---------------------------------------------------eeEEEEEccCCCCHHHHHhhcCCCCCCCH
Q 005907 510 ---------------------------------------------------EKLLIYEFMPNKSLDSFIFDQTRRTLLDW 538 (670)
Q Consensus 510 ---------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~ 538 (670)
..++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27899999999999999977655555677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc----------CCcccccccc
Q 005907 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE----------GNTNRVVGTY 608 (670)
Q Consensus 539 ~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~ 608 (670)
..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999988 999999999999999999999999999987544221 1223357999
Q ss_pred CcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 609 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.|+|||++.+..++.++||||||+++|||++|..|+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999999998874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.34 Aligned_cols=212 Identities=24% Similarity=0.391 Sum_probs=175.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|++.++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999985 4889999998653 23344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 555555432 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCccccccccCcccccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+ +...+....+..+.+
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~--~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFR 217 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS--CCCSSHHHHHHHHHH
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC--cCCCCHHHHHHHHHH
Confidence 2 223357899999999997765 899999999999999999999985 233333444444433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=343.13 Aligned_cols=220 Identities=25% Similarity=0.348 Sum_probs=189.3
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (670)
..++|++.++||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999999754 778999999752 344566788999999988 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999997543 4889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
..... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.. .+...++..|.+....||.
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAYPK 563 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHSSCCCCCT
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC---CCHHHHHHHHHhCCCCCCc
Confidence 32222 23447899999999999999999999999999999999999999753 4456677777776666664
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.90 Aligned_cols=216 Identities=24% Similarity=0.394 Sum_probs=182.0
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 514 (670)
.++|.+.++||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3579999999999999999999864 8899999987533 344677889999999999999999999998765 77999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCceEEEeecCce
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~ 590 (670)
|||+++++|.+++........+++..++.++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 788889999999998
Q ss_pred ecCCCcccCCccccccccCcccccccC--------CCCCCccchHHHHHHHHHHHHcCCCCCCCCCC-cccchHhhhhh
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYAS--------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS-DTKVNLIGHVS 660 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvil~elltG~~p~~~~~~-~~~~~l~~~i~ 660 (670)
.+..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .....++..+.
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 8754322 22356899999999986 57889999999999999999999999865443 33334444443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.87 Aligned_cols=199 Identities=28% Similarity=0.422 Sum_probs=167.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch--------------------------hchHHHHHHHHHHh
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------------------------QGLKELKNEVILFS 491 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 491 (670)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999874 578999999865321 12357889999999
Q ss_pred cCCCCceeeEEEEEEe--CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 005907 492 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (670)
Q Consensus 492 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk 569 (670)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 2345899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQ---FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 570 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|+|||++.++.+||+|||+++.+...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999886533221 23357899999999997765 47889999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.36 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|+||.||+|+...++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999977999999998653 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++ +|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 898888543 245889999999999999999999998 99999999999999999999999999987643222
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12235689999999999764 58999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.69 Aligned_cols=205 Identities=29% Similarity=0.477 Sum_probs=174.4
Q ss_pred cCCcccceeeeecCceeEEEEEec----CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357899999999999999999974 3456999999753 44456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999653 345899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 594 GDETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 594 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 432221 1222346788999999998999999999999999999999 999975443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=311.08 Aligned_cols=209 Identities=32% Similarity=0.468 Sum_probs=180.3
Q ss_pred hcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
..++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3468999999999999999999862 3478999998753 34456788999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk 569 (670)
.++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 234789999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 570 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
|+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999988755443333334567889999999999999999999999999999999 999986544
Q ss_pred C
Q 005907 649 S 649 (670)
Q Consensus 649 ~ 649 (670)
.
T Consensus 258 ~ 258 (314)
T 2ivs_A 258 P 258 (314)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.41 Aligned_cols=204 Identities=24% Similarity=0.401 Sum_probs=168.3
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe---
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 510 (670)
..++|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356899999999999999999997 46889999999753 23345678999999999999999999999876543
Q ss_pred -eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 511 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 48999999999999999653 34889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 590 RTFGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 590 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 876433222 2233456899999999999999999999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.46 Aligned_cols=208 Identities=32% Similarity=0.469 Sum_probs=180.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec--------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (670)
..++|.+.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468999999999999999999863 2357999998753 344557889999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
++..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976431 235899999999999999999999998 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987755444344444567899999999999999999999999999999999 999976443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.23 Aligned_cols=206 Identities=29% Similarity=0.498 Sum_probs=170.1
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc----EEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.+.||+|+||.||+|++.. ++ .||+|.+.. ......+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 579999999999999999998643 43 368888754 33455678999999999999999999999998754 778
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999763 345889999999999999999999998 9999999999999999999999999998876
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 651 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~ 651 (670)
............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 5544444444567889999999999999999999999999999999 999987554433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=304.05 Aligned_cols=202 Identities=29% Similarity=0.489 Sum_probs=177.0
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35799999999999999999999889999999997532 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999653 345889999999999999999999998 999999999999999999999999999876433221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 2223456788999999998999999999999999999999 99997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=321.04 Aligned_cols=216 Identities=29% Similarity=0.458 Sum_probs=181.7
Q ss_pred ccHHHHHHhcCCcccceeeeecCceeEEEEEe------cCCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeE
Q 005907 430 FELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL 501 (670)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l 501 (670)
+.........++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455556678999999999999999999974 23578999999763 334456799999999999 79999999
Q ss_pred EEEEEeCCe-eEEEEEccCCCCHHHHHhhcCC------------------------------------------------
Q 005907 502 LGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTR------------------------------------------------ 532 (670)
Q Consensus 502 ~g~~~~~~~-~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------ 532 (670)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999975432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 533 ---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 533 ---------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
........||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 333344678999999999999999999999999999999999 999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=301.62 Aligned_cols=199 Identities=22% Similarity=0.369 Sum_probs=176.5
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999855 67899999977656667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 593 (670)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988653 34889999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.... .....||+.|+|||++.+. ++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 3322 2335689999999998754 89999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.77 Aligned_cols=203 Identities=31% Similarity=0.503 Sum_probs=164.1
Q ss_pred CCcccceeeeecCceeEEEEEec----CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|+.. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999875 4678999999753 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999653 345889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 595 DETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 595 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 32211 1222345778999999999999999999999999999998 99998544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.35 Aligned_cols=204 Identities=31% Similarity=0.463 Sum_probs=178.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||+|...++..||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999999888899999996532 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999996532 34889999999999999999999998 999999999999999999999999999876543322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 2 223456778999999998899999999999999999999 9999865443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.79 Aligned_cols=208 Identities=28% Similarity=0.468 Sum_probs=178.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC------CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
...++|++.+.||+|+||.||+|+..+ ++.||||+++.. .....+.+.+|+.++++++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345789999999999999999999753 478999999753 3344678999999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl 568 (670)
..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999976321 146889999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 569 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654333233334567899999999998999999999999999999999 99997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.61 Aligned_cols=195 Identities=28% Similarity=0.380 Sum_probs=167.6
Q ss_pred ceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
.+.||+|+||.||+|... +++.||+|+++.......+++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999874 5889999999876556677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE--cCCCceEEEeecCceecCCCcccCCc
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLVRTFGGDETEGNT 601 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (670)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..... .
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 9988653 234889999999999999999999998 9999999999999 5678999999999998753322 2
Q ss_pred cccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 602 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2356999999999999999999999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.91 Aligned_cols=209 Identities=26% Similarity=0.335 Sum_probs=179.1
Q ss_pred ccHHHHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-----CCceeeEEE
Q 005907 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKLLG 503 (670)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g 503 (670)
+.........++|.+.++||+|+||.||+|+.. +++.||||++... ....+.+..|+.++++++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 334444456789999999999999999999984 5789999998642 344567788999999986 999999999
Q ss_pred EEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC------
Q 005907 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------ 577 (670)
Q Consensus 504 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~------ 577 (670)
++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999997643 234889999999999999999999998 999999999999975
Q ss_pred -------------------CCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHH
Q 005907 578 -------------------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIV 638 (670)
Q Consensus 578 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 638 (670)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999875332 12357899999999999999999999999999999999
Q ss_pred cCCCCCCCCCC
Q 005907 639 SGKKNRGFYRS 649 (670)
Q Consensus 639 tG~~p~~~~~~ 649 (670)
+|+.||.....
T Consensus 254 ~g~~pf~~~~~ 264 (360)
T 3llt_A 254 TGSLLFRTHEH 264 (360)
T ss_dssp HSSCSCCCSSH
T ss_pred HCCCCCCCCcH
Confidence 99999865443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.59 Aligned_cols=206 Identities=32% Similarity=0.499 Sum_probs=176.1
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|... .++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357999999999999999999853 3568999998653 344556789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 584 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 584 (670)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 2245889999999999999999999998 99999999999999555 59999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986543333333334568999999999999999999999999999999998 99997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=307.93 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=162.0
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999875 48899999986532 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886432 2235889999999999999999999988 9999999999999999999999999998864
Q ss_pred CCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3322 2223578999999999976 4689999999999999999999999865443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.30 Aligned_cols=215 Identities=26% Similarity=0.412 Sum_probs=182.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999985 58999999996532 23456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999854 345899999999999999999999988 99999999999999999999999999988653
Q ss_pred CcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeee
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~ 665 (670)
... ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||... ....+...+.+....
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~ 234 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD---HVPTLFKKICDGIFY 234 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS---SSHHHHHHHHTTCCC
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCCcC
Confidence 322 233579999999999988776 68999999999999999999997533 333444444444333
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.67 Aligned_cols=192 Identities=26% Similarity=0.335 Sum_probs=150.7
Q ss_pred eeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
+.||+|+||.||++... +++.||||++.+ .....+.+|+.+++++. ||||+++++++.++...++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999985 488999999864 23467788999999997 99999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEEeecCceecCCCcccCC
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 600 (670)
.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9999653 34899999999999999999999988 99999999999998765 8999999999876433222
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 233578999999999999999999999999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.29 Aligned_cols=213 Identities=18% Similarity=0.300 Sum_probs=181.5
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||+|.. .+++.||||++... ...+.+.+|+.+++++ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 46889999998643 2345688999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc-----eEEEeecCcee
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVRT 591 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~ 591 (670)
|+ +++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996532 34899999999999999999999987 999999999999987776 99999999998
Q ss_pred cCCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhh
Q 005907 592 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHV 659 (670)
Q Consensus 592 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i 659 (670)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 7543322 1233467999999999999999999999999999999999999999876554444444433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.71 Aligned_cols=217 Identities=22% Similarity=0.373 Sum_probs=181.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||++..+ +++.||||++.+... ...+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999985 488999999965332 345688888887 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CceEEEeecCcee
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 591 (670)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999998643 35899999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....+....++..+.+....+
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 643322 2234678999999999988889999999999999999999999987654455556666665554443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.58 Aligned_cols=206 Identities=20% Similarity=0.274 Sum_probs=177.5
Q ss_pred hcCCcccceeeeec--CceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
..++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34689999999999 99999999986 5889999998653 2445567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999997642 234889999999999999999999998 999999999999999999999999988754
Q ss_pred CCCcc-----cCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 593 GGDET-----EGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 593 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 22111 111223478999999999987 67999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.14 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=165.9
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999986 58899999996532 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc--eEEEeecCceecCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRTFGG 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~ 594 (670)
|+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999986533 3889999999999999999999988 999999999999987765 99999999875422
Q ss_pred CcccCCccccccccCcccccccCCCCCCcc-chHHHHHHHHHHHHcCCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIK-SDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 2 12233579999999999988887665 899999999999999999986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.35 Aligned_cols=217 Identities=29% Similarity=0.411 Sum_probs=179.2
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+|.... ++.||+|++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34679999999999999999998754 678999998652 22345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999986543 3889999999999999999999987 9999999999999999999999999886543
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ........+.+....++
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~ 227 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFTFP 227 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHHHHHhCCCCCC
Confidence 22 122357899999999999999999999999999999999999997643 23334444444444433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=310.79 Aligned_cols=208 Identities=26% Similarity=0.461 Sum_probs=161.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCc----EEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
..++|++.+.||+|+||.||+|...... .||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999875432 7999998653 344567899999999999999999999999877655
Q ss_pred ------EEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceE
Q 005907 512 ------LLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (670)
Q Consensus 512 ------~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 582 (670)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 89999999999999986432 2225889999999999999999999998 99999999999999999999
Q ss_pred EEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
|+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 999999987654443333334557889999999999999999999999999999999 899976543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.58 Aligned_cols=206 Identities=26% Similarity=0.455 Sum_probs=172.3
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcE----EEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
++|++.+.||+|+||.||+|.... ++. ||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 579999999999999999998743 443 777877542 2344567788999999999999999999886 566889
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999653 345788899999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 651 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~ 651 (670)
............||+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 5544444445678889999999999999999999999999999999 999987554433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.69 Aligned_cols=199 Identities=27% Similarity=0.378 Sum_probs=160.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|+... ++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45689999999999999999999864 7889999987532 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 593 (670)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999854 345889999999999999999999988 999999999999975 8899999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 322 123357899999999999999999999999999999999999998543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=305.28 Aligned_cols=206 Identities=28% Similarity=0.435 Sum_probs=175.8
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..++|++.+.||+|+||.||++...++..||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346899999999999999999999888899999997532 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999996532 34889999999999999999999998 99999999999999999999999999987643222
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 176 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 176 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp H-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred c-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 1 2223456788999999998899999999999999999999 99998654443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.40 Aligned_cols=204 Identities=27% Similarity=0.461 Sum_probs=164.7
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC--e
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--E 510 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 510 (670)
...++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999874 588999999864 23445567889999999997 999999999998654 6
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 589998865 24788999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcc-------------------cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 591 TFGGDET-------------------EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 591 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.+..... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7643111 111233579999999999976 678999999999999999999999986443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.70 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=173.9
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-eeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|.. .++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 346789999999999999999988 47899999997533 4578999999999999999999999988765 7899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999997643 334788999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
....+++.|+|||++.+..++.++|||||||+||||+| |+.||......
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 12356889999999999999999999999999999999 99998754443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.75 Aligned_cols=200 Identities=29% Similarity=0.393 Sum_probs=167.8
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 457999999999999999999998899999999864 234455788999999999986 9999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999653 34889999999999999999999998 99999999999997 67899999999987754
Q ss_pred CcccCCccccccccCcccccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASD-----------GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 443333345679999999999864 6789999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.79 Aligned_cols=203 Identities=28% Similarity=0.507 Sum_probs=157.3
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 446799999999999999999997 46889999998653 22335778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999653 345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 32221 22356899999999999999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.73 Aligned_cols=203 Identities=26% Similarity=0.365 Sum_probs=173.5
Q ss_pred cCCcccceeeeecCceeEEEEEe----cCCcEEEEEEeccc----chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
.++|++.+.||+|+||.||+++. .+++.||||++++. .....+.+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999997 36889999998653 223456678899999999 6999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999996543 4889999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+.+...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 876432222 2234579999999999985 357899999999999999999999986443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.63 Aligned_cols=208 Identities=32% Similarity=0.485 Sum_probs=176.6
Q ss_pred hcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
..++|.+.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4568999999999999999999862 3568999998753 334567899999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRR--------------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlk 569 (670)
..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 33789999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 570 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
|+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333334567889999999999999999999999999999998 999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=298.19 Aligned_cols=200 Identities=27% Similarity=0.438 Sum_probs=175.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999875 4889999998652 334457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc---eEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~ 591 (670)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999888653 34889999999999999999999998 999999999999987655 99999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 643322 2235789999999999999999999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.42 Aligned_cols=199 Identities=26% Similarity=0.392 Sum_probs=175.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchh------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999975 4889999998653221 356799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEeec
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG 587 (670)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999642 34789999999999999999999998 99999999999999888 79999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++.+..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 9988754322 2335689999999999999999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=307.54 Aligned_cols=202 Identities=29% Similarity=0.518 Sum_probs=171.3
Q ss_pred cCCcccceeeeecCceeEEEEEe-----cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999984 35789999999876666778899999999999999999999998653 458
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996642 34889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
+...... .......+++.|+|||.+.+..++.++||||||+++|||+||..|+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 6443222 12223457788999999999999999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.19 Aligned_cols=210 Identities=23% Similarity=0.298 Sum_probs=172.3
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-----chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
+....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999874 4788999998653 334567899999999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQT-------------------------------------RRTLLDWSQRFHIICGTARG 551 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~ia~~ 551 (670)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984210 01123567788899999999
Q ss_pred HHHHHhCCCCCeEeccCCCCCEEEcCCC--ceEEEeecCceecCCCccc--CCccccccccCcccccccCC--CCCCccc
Q 005907 552 LLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLVRTFGGDETE--GNTNRVVGTYGYMAPEYASD--GQFSIKS 625 (670)
Q Consensus 552 l~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~s 625 (670)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999876432211 12234578999999999965 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCC
Q 005907 626 DVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 626 DvwSlGvil~elltG~~p~~~~ 647 (670)
||||||+++|||++|+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999997543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.58 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=179.3
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.++||+|+||.||+|.+.. +..||||+++.. ....++|.+|+.++++++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34578899999999999999999865 789999999753 3346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999997643 345889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
.. ......+++.|+|||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 22 2223456789999999999999999999999999999999 9999865443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.91 Aligned_cols=204 Identities=33% Similarity=0.490 Sum_probs=176.0
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..++|++.+.||+|+||.||+|...++..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456899999999999999999999888999999997533 45678999999999999999999999986 6678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 124788899999999999999999988 99999999999999999999999999987643221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
. ......+++.|+|||++....++.++|||||||+||||+| |+.||....
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 1 1222446789999999998999999999999999999999 999986443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.41 Aligned_cols=204 Identities=26% Similarity=0.343 Sum_probs=170.0
Q ss_pred cCCcccc-eeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.+.|.+. +.||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578874 78999999999999864 5889999999776556677899999999985 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc---eEEEeecCceec
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRTF 592 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~ 592 (670)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999654 34889999999999999999999998 999999999999998776 999999998765
Q ss_pred CCCcc-----cCCccccccccCcccccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDET-----EGNTNRVVGTYGYMAPEYASD-----GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 32211 111223468999999999875 568899999999999999999999986543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.25 Aligned_cols=207 Identities=31% Similarity=0.495 Sum_probs=177.9
Q ss_pred hcCCcccceeeeecCceeEEEEEec--------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (670)
..++|.+.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3468999999999999999999863 4678999999753 334567889999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
.+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 134789999999999999999999998 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999988765443333334567889999999998899999999999999999999 99998644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.50 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=177.2
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|.+.+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34679999999999999999999864 778999998653 23455678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988653 34889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3222 223356899999999999999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.54 Aligned_cols=205 Identities=26% Similarity=0.353 Sum_probs=171.2
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999854 889999998653 2333567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999987543 34889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 221 223578999999999876 678999999999999999999999986554433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=305.13 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=177.6
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|.+.+.||+|+||.||++...+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999854 778999998653 23456778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999998653 34889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 3222 223357899999999999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.26 Aligned_cols=199 Identities=29% Similarity=0.388 Sum_probs=168.1
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCC--CCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998642 3445678999999999996 599999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
| +.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999997543 4788899999999999999999987 99999999999995 589999999999877544
Q ss_pred cccCCccccccccCcccccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASD-----------GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 33333344679999999999865 4689999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.88 Aligned_cols=208 Identities=31% Similarity=0.454 Sum_probs=179.4
Q ss_pred hcCCcccceeeeecCceeEEEEEe------cCCcEEEEEEecccc-hhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
..++|++.+.||+|+||.||+|.. ..++.||+|++.... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 246789999997532 33457889999999999 9999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 124889999999999999999999998 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999988755443333334567889999999999999999999999999999999 999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.06 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=175.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999985 4778999998652 223456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999996543 4889999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 21 22357899999999999999999999999999999999999998643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=303.40 Aligned_cols=196 Identities=27% Similarity=0.475 Sum_probs=171.4
Q ss_pred cCCcccceeeeecCceeEEEEEecC-C-------cEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
.++|.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3579999999999999999998754 2 4699999977666777889999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc--------eE
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK 582 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~k 582 (670)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 234889999999999999999999998 999999999999998887 99
Q ss_pred EEeecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCC-CCC
Q 005907 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKK-NRG 645 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~-p~~ 645 (670)
|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|.. |+.
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 999999865422 223568899999999987 778999999999999999999654 444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.64 Aligned_cols=199 Identities=29% Similarity=0.467 Sum_probs=165.5
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.+.||+|+||.||+|+. .++.||+|++.. ....+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788999999999999999987 578899999864 334578899999999999999999999876 45789999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc-eEEEeecCceecCCCccc
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETE 598 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 598 (670)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976544445788999999999999999999932224999999999999998886 799999998765322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 122468999999999999999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=302.32 Aligned_cols=203 Identities=27% Similarity=0.407 Sum_probs=169.6
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccc-----hhchHHHHHHHHHHhcCC---CCceeeEEEEEEeC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 508 (670)
..++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999997 458899999986422 122346677887777764 99999999999876
Q ss_pred C-----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 509 E-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 509 ~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 59999986543 234899999999999999999999998 999999999999999999999
Q ss_pred EeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 584 SDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764322 2234678999999999999999999999999999999999999975433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=297.01 Aligned_cols=205 Identities=29% Similarity=0.423 Sum_probs=177.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999985 5889999998643 2344578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999843 345889999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 33233344678999999999987765 779999999999999999999986543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=299.41 Aligned_cols=202 Identities=29% Similarity=0.431 Sum_probs=172.0
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
+|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555569999999999999974 578999999977666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCceEEEeecCceecCCCccc
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 598 (670)
+++|.+++........+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999977544455778889999999999999999988 999999999999987 89999999999987643222
Q ss_pred CCccccccccCcccccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQ--FSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 123356899999999987653 889999999999999999999998643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.54 Aligned_cols=203 Identities=32% Similarity=0.538 Sum_probs=161.8
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.++||+|+||.||+|+.. ..+|+|+++.. .....+.+.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3468999999999999999999863 35999998643 344567899999999999999999999965 556789999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999998543 345889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..........||+.|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 3333334467899999999986 6678899999999999999999999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.62 Aligned_cols=207 Identities=29% Similarity=0.498 Sum_probs=167.5
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcE----EEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQE----IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
.++|++.++||+|+||.||+|.... ++. ||+|.+.. ......+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3689999999999999999998643 443 57777654 33456678999999999999999999999998754 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+|+||+.+++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 899999999999999763 345889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 651 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~ 651 (670)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 54444333344567889999999999999999999999999999999 999987554433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=301.38 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=172.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457999999999999999999975 588999999976544455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 593 (670)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999986532 4789999999999999999999988 9999999999999 788999999999987643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 21 22335689999999999999999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.56 Aligned_cols=203 Identities=18% Similarity=0.252 Sum_probs=168.5
Q ss_pred hcCCcccceeeeecCceeEEEEEecC------CcEEEEEEecccchh-----------chHHHHHHHHHHhcCCCCceee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVK 500 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~ 500 (670)
..++|++.++||+|+||.||+|.+.. ++.||||++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998755 378999998653321 1123445666778889999999
Q ss_pred EEEEEEeC----CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 501 LLGCCIQG----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 501 l~g~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4579999999 99999999653 345899999999999999999999998 99999999999999
Q ss_pred --CCCceEEEeecCceecCCCcccC-----CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 577 --QDMNPKISDFGLVRTFGGDETEG-----NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 577 --~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||+||+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 88999999999998764332211 11234599999999999999999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.77 Aligned_cols=204 Identities=26% Similarity=0.404 Sum_probs=163.4
Q ss_pred cCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4579999999999999999998743 456999998653 334456789999999999999999999997 4567889
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999653 335889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 33221 1223456789999999998999999999999999999997 9999865443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.05 Aligned_cols=195 Identities=28% Similarity=0.363 Sum_probs=163.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.++||+|+||+||+|+.. +++.||||++... .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 6899999998642 223334455566555555 8999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 678988886542 45899999999999999999999987 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 22 233568999999999876 7899999999999999999997764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=317.69 Aligned_cols=216 Identities=24% Similarity=0.393 Sum_probs=180.7
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 514 (670)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3579999999999999999999864 8899999997532 344577889999999999999999999998765 67999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCceEEEeecCce
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~ 590 (670)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976544445899999999999999999999998 9999999999999 778889999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCC--------CCCCccchHHHHHHHHHHHHcCCCCCCCCCC-cccchHhhhhh
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS-DTKVNLIGHVS 660 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~elltG~~p~~~~~~-~~~~~l~~~i~ 660 (670)
.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..+.. .....++..+.
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 8643322 223568999999999865 5678899999999999999999999865443 33334444443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.00 Aligned_cols=199 Identities=28% Similarity=0.350 Sum_probs=165.9
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (670)
..++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999875 4889999999753 344567788999999999999999999999654
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
...++||||++++ |.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3569999999764 6666522 2789999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
++...... .....+||+.|+|||++.+..|+.++||||+||+||||++|+.||...+
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98764322 2334679999999999999999999999999999999999999986433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.61 Aligned_cols=208 Identities=29% Similarity=0.484 Sum_probs=177.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
...++|++.+.||+|+||.||+|... .++.||+|++... .......+.+|+.++++++||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999864 3678999998753 2344567899999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceE
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT-------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 582 (670)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999986422 1245689999999999999999999998 99999999999999999999
Q ss_pred EEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999987643332222333467889999999999999999999999999999999 88997644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.13 Aligned_cols=210 Identities=33% Similarity=0.479 Sum_probs=178.5
Q ss_pred HHhcCCcccceeeeecCceeEEEEEecC-C-----cEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (670)
....++|.+.+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999998743 2 47999998753 334557789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~ 576 (670)
++..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 999999999999999999986532 1245789999999999999999999998 99999999999999
Q ss_pred CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999987644333222333567889999999999999999999999999999999 999986543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=296.60 Aligned_cols=200 Identities=34% Similarity=0.553 Sum_probs=164.4
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccc----hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 48899999986532 23456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--------CCceEEEee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISDF 586 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--------~~~~kl~DF 586 (670)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999984 335889999999999999999999987555899999999999986 678999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|+++.+..... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99987643222 2356899999999999999999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.01 Aligned_cols=201 Identities=25% Similarity=0.351 Sum_probs=175.1
Q ss_pred HhcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccc--------hhchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (670)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3456899999999999999999986 458899999987532 1234567889999999999999999999999
Q ss_pred CCeeEEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 508 GEEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 508 ~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
.+..++||||+..| +|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 999998643 34899999999999999999999998 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|+++.+..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99988653322 233679999999999988877 7899999999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.67 Aligned_cols=198 Identities=22% Similarity=0.299 Sum_probs=162.3
Q ss_pred cCCcccc-eeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHh-cCCCCceeeEEEEEEe----CCee
Q 005907 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQ----GEEK 511 (670)
Q Consensus 439 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~ 511 (670)
.++|.+. +.||+|+||.||++... +++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999975 478999999853 245677888874 4589999999999876 5678
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeecC
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl 588 (670)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 245899999999999999999999988 999999999999998 78999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
++...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 98764322 2234678999999999999999999999999999999999999986443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.26 Aligned_cols=199 Identities=25% Similarity=0.397 Sum_probs=172.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch------hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999986 588999999865321 23578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEeecC
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 588 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 588 (670)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999653 34889999999999999999999988 99999999999998877 899999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+..+..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 987643322 22356899999999999999999999999999999999999997643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.79 Aligned_cols=202 Identities=26% Similarity=0.411 Sum_probs=166.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch-hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999985 588999999865322 2223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 5898888653 345889999999999999999999998 99999999999999999999999999986542222
Q ss_pred cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2223568999999999876 5789999999999999999999999865443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=300.55 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=165.6
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc--CCCCceeeEEEEEEeC----Cee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEK 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~ 511 (670)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346899999999999999999987 7899999998653 33455566666665 8999999999997653 457
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEEEcCCCceEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
++||||+++++|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 899999999999999943 35899999999999999999999 666 999999999999999999999
Q ss_pred EeecCceecCCCccc--CCccccccccCcccccccCCC------CCCccchHHHHHHHHHHHHcC----------CCCCC
Q 005907 584 SDFGLVRTFGGDETE--GNTNRVVGTYGYMAPEYASDG------QFSIKSDVFSFGILLLEIVSG----------KKNRG 645 (670)
Q Consensus 584 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltG----------~~p~~ 645 (670)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999876433222 112334799999999999876 455799999999999999999 88875
Q ss_pred CC
Q 005907 646 FY 647 (670)
Q Consensus 646 ~~ 647 (670)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.80 Aligned_cols=203 Identities=21% Similarity=0.293 Sum_probs=165.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999975 58899999987532 233477899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999653 34889999999999999999999998 999999999999999999999999998876
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 433221 22235689999999999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.50 Aligned_cols=206 Identities=23% Similarity=0.412 Sum_probs=177.6
Q ss_pred HHHHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch--------hchHHHHHHHHHHhcC-CCCceeeE
Q 005907 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------QGLKELKNEVILFSKL-QHRNLVKL 501 (670)
Q Consensus 432 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l 501 (670)
........++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999985 689999999865321 2245678999999999 79999999
Q ss_pred EEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 502 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999653 34889999999999999999999988 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCC------CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999988753322 234679999999999853 3688999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.34 Aligned_cols=203 Identities=32% Similarity=0.502 Sum_probs=170.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..++|++.++||+|+||.||+|...++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346789999999999999999999888889999997533 345789999999999999999999999866 678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999996422 234789999999999999999999988 99999999999999999999999999987643322
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
. ......+++.|+|||.+.+..++.++||||||++||||++ |+.||...
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 1223456789999999999999999999999999999999 99998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=295.78 Aligned_cols=202 Identities=29% Similarity=0.476 Sum_probs=176.5
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35789999999999999999999888999999997533 23468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999999653 345789999999999999999999998 99999999999999999999999999887643221
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 11223456789999999998899999999999999999999 89997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=303.42 Aligned_cols=210 Identities=27% Similarity=0.451 Sum_probs=165.8
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
...++|.+.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345689999999999999999998643 457999998643 34445778999999999999999999999987553
Q ss_pred -----eEEEEEccCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceE
Q 005907 511 -----KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (670)
Q Consensus 511 -----~~lV~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 582 (670)
.++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 48999999999999998542 23356899999999999999999999987 99999999999999999999
Q ss_pred EEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
|+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 999999987654433333334567889999999999999999999999999999999 8889765433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.86 Aligned_cols=215 Identities=29% Similarity=0.453 Sum_probs=180.8
Q ss_pred cHHHHHHhcCCcccceeeeecCceeEEEEEe------cCCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEE
Q 005907 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 502 (670)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~ 502 (670)
.........++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344445567899999999999999999984 24678999998753 334456789999999999 799999999
Q ss_pred EEEEeCC-eeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 005907 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (670)
Q Consensus 503 g~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl 568 (670)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987754 48999999999999999975432 223788999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 569 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433333334567899999999999999999999999999999998 99998654
Q ss_pred C
Q 005907 648 R 648 (670)
Q Consensus 648 ~ 648 (670)
.
T Consensus 255 ~ 255 (316)
T 2xir_A 255 K 255 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.58 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=177.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.+.|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357999999999999999999874 5889999998653 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999843 35889999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 2 2233578999999999999999999999999999999999999986443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.15 Aligned_cols=195 Identities=31% Similarity=0.481 Sum_probs=170.2
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
+.|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999997 46889999998642 2334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+. |+|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6788877542 245889999999999999999999998 999999999999999999999999999865321
Q ss_pred cccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2357899999999984 56789999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.96 Aligned_cols=203 Identities=26% Similarity=0.392 Sum_probs=170.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3457999999999999999999874 47899999986533 335678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCcee
Q 005907 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRT 591 (670)
Q Consensus 516 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~ 591 (670)
||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988543 12345899999999999999999999998 9999999999999 4567899999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+..... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 177 FKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 643222 23356899999999986 56899999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=304.82 Aligned_cols=202 Identities=27% Similarity=0.377 Sum_probs=164.5
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
...++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45578999999999999999999864 58899999986532 2334567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-----CCCceEEEeecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-----QDMNPKISDFGL 588 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DFGl 588 (670)
||||++ ++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 49999986543 3889999999999999999999998 99999999999994 455699999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 987643322 22335689999999999874 5899999999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=319.09 Aligned_cols=197 Identities=26% Similarity=0.440 Sum_probs=155.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (670)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 5889999998652 334557889999999999999999999998543 56
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+ +++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5789988854 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-------------------------CCccccccccCccccccc-CCCCCCccchHHHHHHHHHHHHcCCC
Q 005907 591 TFGGDETE-------------------------GNTNRVVGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGKK 642 (670)
Q Consensus 591 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltG~~ 642 (670)
.+...... ......+||+.|+|||++ .+..++.++||||||||||||++|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 76432211 112335789999999986 56679999999999999999999433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.04 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=171.7
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe--------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 507 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 507 (670)
.++|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 45889999998653 23335678899999999999999999999987
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
.+..++||||+++ +|...+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999975 777776543 234899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCccc--CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 588 LVRTFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 588 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99876532221 22234578999999999876 4689999999999999999999999765433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.34 Aligned_cols=204 Identities=31% Similarity=0.518 Sum_probs=174.1
Q ss_pred CCcccce-eeeecCceeEEEEEec---CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|.+.+ .||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999863 5778999999763 344567899999999999999999999999 56678999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999954 3345899999999999999999999998 99999999999999999999999999988754
Q ss_pred Cccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 595 DETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 595 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 3322 12223456889999999988899999999999999999999 9999865443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.04 Aligned_cols=200 Identities=26% Similarity=0.447 Sum_probs=167.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----C
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 509 (670)
..++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35689999999999999999999754 788999999752 334456889999999999999999999998766 5
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999986 599999854 344899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccc--------------------CCccccccccCccccccc-CCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 590 RTFGGDETE--------------------GNTNRVVGTYGYMAPEYA-SDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 590 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
+.+...... ......+||+.|+|||++ ....++.++||||+||+||||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 987533221 112446789999999986 5667999999999999999999865554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.13 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=163.2
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc--------hhchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (670)
...++|.+.+.||+|+||.||+|.... ++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 356789999999999999999998754 7899999986521 122346889999999999999999999975
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---ceEEE
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 584 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 584 (670)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5568999999999999998853 345899999999999999999999988 99999999999997554 59999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999998764322 2234679999999999853 67889999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.36 Aligned_cols=196 Identities=28% Similarity=0.426 Sum_probs=165.2
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999974 5889999998542 3344567889999999999999999999997653
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999865 24789999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 223578999999999877 68999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=292.88 Aligned_cols=199 Identities=27% Similarity=0.445 Sum_probs=167.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999985 5889999998653 233456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999996543 3789999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 321 223568999999999988765 6899999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.37 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=175.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999985 5889999998753 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|+++++|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||+++.+...
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999996543 478999999999999999999985 6 999999999999999999999999998765221
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12235789999999999999999999999999999999999999865443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=318.49 Aligned_cols=213 Identities=30% Similarity=0.430 Sum_probs=177.6
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccch-------------hchHHHHHHHHHHhcCCCCceeeEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLL 502 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~ 502 (670)
...++|.+.++||+|+||.||+|.... ++.||+|++.+... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 356789999999999999999999854 78999999865321 3356789999999999999999999
Q ss_pred EEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---
Q 005907 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM--- 579 (670)
Q Consensus 503 g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~--- 579 (670)
+++.+....++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999988653 34899999999999999999999998 99999999999998776
Q ss_pred ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhh
Q 005907 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHV 659 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i 659 (670)
.+||+|||+++.+.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||... ....++..+
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i 259 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKKV 259 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Confidence 69999999998875432 223357999999999987 46899999999999999999999997543 333444444
Q ss_pred hce
Q 005907 660 SKM 662 (670)
Q Consensus 660 ~~~ 662 (670)
.+.
T Consensus 260 ~~~ 262 (504)
T 3q5i_A 260 EKG 262 (504)
T ss_dssp HHC
T ss_pred HcC
Confidence 443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.85 Aligned_cols=213 Identities=29% Similarity=0.407 Sum_probs=175.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.++||+|+||.||+|+.. .+..||+|++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999985 5789999998753 234467889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~ 591 (670)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999988653 34889999999999999999999998 9999999999999764 4599999999988
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
+..... .....||+.|+|||++. ..++.++||||+||++|||++|+.||... ....++..+.+..
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKVEKGK 253 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTC
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC
Confidence 754322 23357999999999986 56899999999999999999999997543 2334444444443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.62 Aligned_cols=199 Identities=31% Similarity=0.447 Sum_probs=172.4
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
..++|++.++||+|+||.||++... +++.||||++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999999999999975 5889999998652 234567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~ 591 (670)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988654 34889999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+..... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||..
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 643322 233579999999999875 589999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.16 Aligned_cols=207 Identities=25% Similarity=0.375 Sum_probs=174.9
Q ss_pred HHHHhcCCcccc-eeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCC-CCceeeEEEEEEeC
Q 005907 434 TIANATDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 508 (670)
Q Consensus 434 ~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 508 (670)
......++|.+. +.||+|+||.||+|... +++.||+|++.... .....++.+|+.++.+++ ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556678877 89999999999999875 48899999987532 334678899999999995 69999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEe
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISD 585 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 585 (670)
...++||||+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999998543 2345899999999999999999999998 999999999999998 78999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
||+++.+..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999987643322 23357899999999999999999999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=295.02 Aligned_cols=213 Identities=22% Similarity=0.340 Sum_probs=173.8
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEE-EeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.++++++|++++..+..+ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 468899999875432 234688899999999988776666555 6677889999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCceec
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~ 592 (670)
||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 234899999999999999999999998 9999999999999 78899999999999987
Q ss_pred CCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhh
Q 005907 593 GGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 658 (670)
Q Consensus 593 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 658 (670)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence 543321 122346789999999999999999999999999999999999999976655544444443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.08 Aligned_cols=214 Identities=21% Similarity=0.343 Sum_probs=177.5
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEE-EeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+.++++++|++++..+..+ ..+...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 356899999999999999999997 568999999986532 335688999999999988866655554 6677889999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCceec
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~ 592 (670)
||+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999999643 235899999999999999999999998 9999999999999 48889999999999887
Q ss_pred CCCcccC-----CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhh
Q 005907 593 GGDETEG-----NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHV 659 (670)
Q Consensus 593 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i 659 (670)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 5443211 123457999999999999999999999999999999999999999866554444444443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=309.03 Aligned_cols=203 Identities=31% Similarity=0.503 Sum_probs=161.1
Q ss_pred CcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeeEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 514 (670)
.|.+.+.||+|+||.||+|...+ ...||+|.++.. .....+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 47778999999999999998743 236899998653 33456789999999999999999999998765 4577999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999643 345788999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc--CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 595 DETE--GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 595 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
.... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 3221 11223457889999999999999999999999999999999 677765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.44 Aligned_cols=202 Identities=28% Similarity=0.423 Sum_probs=170.0
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|+... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4579999999999999999999854 889999998643 2333556889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999888643 234889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 22235689999999999775 78999999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.66 Aligned_cols=200 Identities=31% Similarity=0.488 Sum_probs=171.5
Q ss_pred CCcccceeeeecCceeEEEEEe-----cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--Cee
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (670)
+.|++.+.||+|+||.||+|++ ..++.||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999983 35889999998753 334557899999999999999999999999876 668
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996533 34889999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 7544321 2223356788899999999999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.23 Aligned_cols=213 Identities=31% Similarity=0.426 Sum_probs=180.3
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||++... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457999999999999999999985 5889999998652 23456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCce
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVR 590 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~ 590 (670)
||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999988643 34889999999999999999999998 9999999999999 567899999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhcee
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~ 663 (670)
.+.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||... ....++..+.+..
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKGK 243 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCC
Confidence 764332 2234579999999999876 6899999999999999999999997543 3334444444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.77 Aligned_cols=205 Identities=30% Similarity=0.495 Sum_probs=169.2
Q ss_pred CCcccce-eeeecCceeEEEEEec---CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....+++.+|+.++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3455555 8999999999999874 4567999999764 33456789999999999999999999999876 568999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999999543 445899999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 595 DETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 595 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 32211 1122345789999999999999999999999999999998 99998755443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.75 Aligned_cols=207 Identities=30% Similarity=0.481 Sum_probs=179.7
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|.... +..||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45679999999999999999999865 788999998653 3446788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999997643 345889999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 22 2223457889999999999999999999999999999999 99998654443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=294.86 Aligned_cols=204 Identities=24% Similarity=0.373 Sum_probs=170.2
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc----hhchHHHHHHHHHHhcCCCCceeeEEEEEE--eCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~ 510 (670)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999974 47899999986532 234578999999999999999999999984 4457
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||++++ |.+++.... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999877 777775533 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 875433333333456899999999997644 47899999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.14 Aligned_cols=199 Identities=18% Similarity=0.226 Sum_probs=163.5
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc---cchhchHHHHHHH---HHHhcCCCCceeeEE-------EE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL-------GC 504 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 504 (670)
.++|.+.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999997 4589999999874 2334567889999 556666899999998 66
Q ss_pred EEeCC-----------------eeEEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005907 505 CIQGE-----------------EKLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (670)
Q Consensus 505 ~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 563 (670)
+...+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 6899999965321 112335788889999999999999998 9
Q ss_pred EeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCC-----------CCCccchHHHHHH
Q 005907 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-----------QFSIKSDVFSFGI 632 (670)
Q Consensus 564 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGv 632 (670)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2223567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 005907 633 LLLEIVSGKKNRGFY 647 (670)
Q Consensus 633 il~elltG~~p~~~~ 647 (670)
+||||++|+.||...
T Consensus 302 il~elltg~~Pf~~~ 316 (377)
T 3byv_A 302 VIYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHHSSCCC---
T ss_pred HHHHHHHCCCCCccc
Confidence 999999999998643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.00 Aligned_cols=202 Identities=33% Similarity=0.510 Sum_probs=174.0
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46799999999999999999998888899999986532 34578999999999999999999999976 45688999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999985421 124789999999999999999999998 999999999999999999999999999887543222
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 1223456889999999988899999999999999999999 89997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.89 Aligned_cols=204 Identities=30% Similarity=0.471 Sum_probs=168.2
Q ss_pred cCCcccceeeeecCceeEEEEEecC-----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
..+|.+.+.||+|+||.||+|.... +..||||++... .......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578888999999999999998753 235999998753 3344567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999653 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 543221 11222346788999999999999999999999999999999 99998543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=292.91 Aligned_cols=202 Identities=30% Similarity=0.567 Sum_probs=169.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchh-------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999974 5889999998643221 1267899999999999999999999986544
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc-----eEEEe
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISD 585 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~D 585 (670)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999988653 345899999999999999999999874 23999999999999988776 99999
Q ss_pred ecCceecCCCcccCCccccccccCccccccc--CCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYA--SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||......
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 999875432 22335789999999998 4556789999999999999999999998755443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.05 Aligned_cols=202 Identities=29% Similarity=0.485 Sum_probs=172.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
...++|++.+.||+|+||.||+|.... ++.||+|++... ...+++.+|+.++++++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345789999999999999999999854 889999998653 34578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998642 345889999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223356899999999999999999999999999999999999998644
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=304.20 Aligned_cols=203 Identities=30% Similarity=0.410 Sum_probs=166.7
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch-----hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (670)
...++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999985 488999999864221 123578899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++ +|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 888888542 345788889999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 7643322 22335789999999999764 5899999999999999999999997543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.96 Aligned_cols=201 Identities=19% Similarity=0.266 Sum_probs=165.7
Q ss_pred cCCcccceeeeecCceeEEEEEec----CCcEEEEEEecccchh-----------chHHHHHHHHHHhcCCCCceeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 503 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 503 (670)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999985 5678999998653221 2234668888999999999999999
Q ss_pred EEEe----CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 005907 504 CCIQ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 504 ~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77889999999 999999986533 5899999999999999999999998 99999999999999887
Q ss_pred --ceEEEeecCceecCCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 580 --NPKISDFGLVRTFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 580 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999877432211 111345789999999999999999999999999999999999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.41 Aligned_cols=201 Identities=28% Similarity=0.429 Sum_probs=175.8
Q ss_pred CCcccceeeeecCceeEEEEEe-----cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEE--eCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 512 (670)
++|++.+.||+|+||.||++++ ..++.||||++........+.+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999984 357899999998766666778999999999999999999999987 445688
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996532 34889999999999999999999988 999999999999999999999999999887
Q ss_pred CCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 533321 12233467888999999999999999999999999999999999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.72 Aligned_cols=206 Identities=26% Similarity=0.426 Sum_probs=171.5
Q ss_pred hcCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
..++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999998643 336999998753 34456789999999999999999999999764 4568
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999653 234789999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 433221 1223456889999999998999999999999999999998 99998644433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=326.29 Aligned_cols=203 Identities=32% Similarity=0.502 Sum_probs=174.8
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
..++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 446789999999999999999999888889999997533 345789999999999999999999999866 678999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.++|.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999996422 234789999999999999999999988 99999999999999999999999999987643221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
. ......++..|+|||++.+..++.++|||||||+||||++ |+.||...
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1222456789999999999999999999999999999999 99998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.20 Aligned_cols=206 Identities=32% Similarity=0.499 Sum_probs=171.5
Q ss_pred cCCcccceeeeecCceeEEEEEe------cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|+. ..++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 24678999998643 344566889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKIS 584 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 584 (670)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245889999999999999999999998 999999999999984 4469999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999986644333333334567899999999998999999999999999999999 99997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.82 Aligned_cols=200 Identities=23% Similarity=0.339 Sum_probs=165.5
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe------eE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 512 (670)
..+|.+.+.||+|+||.||+|+...+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998877899998864322 22369999999999999999999865433 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCceEEEeecCcee
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 591 (670)
+||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655444332223456889999999999999999999998 99999999999999 789999999999988
Q ss_pred cCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6433222 235689999999998765 58999999999999999999999976543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.01 Aligned_cols=207 Identities=25% Similarity=0.367 Sum_probs=169.1
Q ss_pred HHHHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccch-----------hchHHHHHHHHHHhcCCCCceee
Q 005907 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-----------QGLKELKNEVILFSKLQHRNLVK 500 (670)
Q Consensus 432 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~ 500 (670)
..++....++|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4456677899999999999999999999988899999999864221 12368899999999999999999
Q ss_pred EEEEEEeC-----CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 501 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 501 l~g~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
+++++... ...++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998653 35799999997 688888754 3345899999999999999999999998 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999997643222 2233578999999999877 67899999999999999999999997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.30 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=169.1
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (670)
+.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999875 4778999998642 34456788999999999999999999999875 35679
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCceEEEeecCcee
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 591 (670)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 34789999999999999999999874 3499999999999998 789999999999875
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||..
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 4322 223356899999999886 4589999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.51 Aligned_cols=204 Identities=29% Similarity=0.455 Sum_probs=171.7
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 44689999999999999999999864 88999999977666677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999986532 34889999999999999999999988 9999999999999999999999999875432111
Q ss_pred ccCCccccccccCccccccc-----CCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYA-----SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 112235689999999998 46778999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.13 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=175.0
Q ss_pred HHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---------hhchHHHHHHHHHHhcCC-CCceeeEEEE
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGC 504 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~ 504 (670)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345678999999999999999999985 47899999986432 123457889999999996 9999999999
Q ss_pred EEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 505 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
+......++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999999653 34889999999999999999999998 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccC------CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS------DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
|||++..+..... .....|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 167 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999987653322 23356899999999984 457889999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=290.80 Aligned_cols=199 Identities=26% Similarity=0.385 Sum_probs=170.7
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35799999999999999999998 5889999998753 344556899999999999999999999999877 778999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.... ...+++..++.++.|+++||+|||+++ ..|+||||||+|||++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999999999996532 235899999999999999999999864 349999999999999999999999998765421
Q ss_pred CcccCCccccccccCcccccccCCCCCCc---cchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSI---KSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 12346899999999998765544 799999999999999999998644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=292.61 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=170.5
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999985 6899999998752 334456788999999999 99999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--------------
Q 005907 514 IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------- 578 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-------------- 578 (670)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965321 245889999999999999999999998 9999999999999844
Q ss_pred -----CceEEEeecCceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 579 -----MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 579 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|++|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998764322 23589999999999776 56689999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=308.07 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=172.4
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcC------CCCceeeEEEEEEeCCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 510 (670)
...+|++.++||+|+||.||+|.... ++.||||++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999998754 789999999653 33446677888888876 57799999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc--eEEEeecC
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGL 588 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGl 588 (670)
.++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 68999886643 234889999999999999999999988 999999999999999887 99999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9765322 2235789999999999999999999999999999999999999765443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.87 Aligned_cols=203 Identities=32% Similarity=0.496 Sum_probs=168.4
Q ss_pred cCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 512 (670)
..+|++.+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468889999999999999998643 235899998753 33455788999999999999999999998654 55779
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999653 345789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 593 GGDETE--GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 593 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 443221 12233457889999999999999999999999999999999 4555543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.48 Aligned_cols=199 Identities=30% Similarity=0.442 Sum_probs=168.7
Q ss_pred CcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee-EEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 514 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 514 (670)
.|...++||+|+||.||+|...+ +..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998643 236999998753 334567889999999999999999999999876655 899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999652 345789999999999999999999998 99999999999999999999999999986643
Q ss_pred Ccc--cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 595 DET--EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 595 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 321 12223356789999999999999999999999999999999966653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=302.52 Aligned_cols=197 Identities=27% Similarity=0.355 Sum_probs=162.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (670)
.++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999874 5889999998652 3344567889999999999999999999997665
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 78887742 3788999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 8764321 122357899999999999999999999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=300.99 Aligned_cols=219 Identities=25% Similarity=0.393 Sum_probs=183.1
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhc-----------------hHHHHHHHHHHhcCCCCceee
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-----------------LKELKNEVILFSKLQHRNLVK 500 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~ 500 (670)
..++|.+.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999998 89999999986532211 178999999999999999999
Q ss_pred EEEEEEeCCeeEEEEEccCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCE
Q 005907 501 LLGCCIQGEEKLLIYEFMPNKSLDSF------IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNV 573 (670)
Q Consensus 501 l~g~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NI 573 (670)
+++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||+|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999998 5321 24568999999999999999999998 77 99999999999
Q ss_pred EEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCC-CCCc-cchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSI-KSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 574 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-- 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC--
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc--
Confidence 9999999999999999876433 22335689999999999877 6666 99999999999999999999864433
Q ss_pred cchHhhhhhceeeecC
Q 005907 652 KVNLIGHVSKMHTTFS 667 (670)
Q Consensus 652 ~~~l~~~i~~~~~~~~ 667 (670)
...+...+.+....++
T Consensus 258 ~~~~~~~i~~~~~~~~ 273 (348)
T 2pml_X 258 LVELFNNIRTKNIEYP 273 (348)
T ss_dssp SHHHHHHHTSCCCCCC
T ss_pred HHHHHHHHhccCcCCc
Confidence 1344445544444443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.89 Aligned_cols=202 Identities=32% Similarity=0.501 Sum_probs=169.2
Q ss_pred CCcccceeeeecCceeEEEEEecC-CcE--EEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE--IAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||.||+|+... +.. +|+|.+.. ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 579999999999999999998754 554 49998865 2344556789999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999988 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 9999999875321 112223456889999999998899999999999999999998 99997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=303.89 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=165.6
Q ss_pred HhcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-------
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 508 (670)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999987 458999999986432 2234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005907 509 -------------------------------EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLH 556 (670)
Q Consensus 509 -------------------------------~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH 556 (670)
...++||||++ ++|.+.+... .....+++..+..++.||+.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5887777531 23355899999999999999999999
Q ss_pred hCCCCCeEeccCCCCCEEEc-CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHH
Q 005907 557 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILL 634 (670)
Q Consensus 557 ~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil 634 (670)
+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999998 688999999999997643332 2235689999999998775 589999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 005907 635 LEIVSGKKNRGFYR 648 (670)
Q Consensus 635 ~elltG~~p~~~~~ 648 (670)
|||++|+.||....
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.84 Aligned_cols=198 Identities=28% Similarity=0.430 Sum_probs=155.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (670)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999864 5889999998652 334456788999999999999999999998754
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 6899988843 34899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875422 223578999999999977 688999999999999999999999986543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.81 Aligned_cols=204 Identities=27% Similarity=0.454 Sum_probs=165.9
Q ss_pred hcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecc---cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||+|.. .+++.||+|++.. ........+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345799999999999999999987 4688999999864 234456678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 514 IYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
||||+++++|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998642 12345889999999999999999999998 999999999999999999999999998876
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 43222 12235689999999999999999999999999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=293.96 Aligned_cols=204 Identities=30% Similarity=0.452 Sum_probs=171.0
Q ss_pred cCCcccce-eeeecCceeEEEEEec---CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 439 TDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 439 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
.++|.+.+ .||+|+||.||+|... .++.||||++.... ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788887 9999999999999652 36789999987532 33357899999999999999999999998 667789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 34889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 593 GGDETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 593 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 5433221 1222346788999999988889999999999999999999 9999865443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=291.46 Aligned_cols=196 Identities=30% Similarity=0.503 Sum_probs=171.3
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe---------
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------- 507 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 507 (670)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999985 68999999986532 456789999999999999999998864
Q ss_pred -------CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc
Q 005907 508 -------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (670)
Q Consensus 508 -------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~ 580 (670)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345789999999999999996532 245889999999999999999999988 999999999999999999
Q ss_pred eEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 581 PKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
+||+|||+++.+..... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 99999999988754322 22356899999999999999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=297.51 Aligned_cols=204 Identities=27% Similarity=0.383 Sum_probs=171.7
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 513 (670)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999997 4688999999876666667889999999999999999999999873 346789
Q ss_pred EEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 514 IYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
||||+++++|.+++... .....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998652 22356899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccC-------CccccccccCcccccccCCCC---CCccchHHHHHHHHHHHHcCCCCCC
Q 005907 593 GGDETEG-------NTNRVVGTYGYMAPEYASDGQ---FSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 593 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 3211110 011245799999999987554 6899999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=296.24 Aligned_cols=197 Identities=31% Similarity=0.453 Sum_probs=170.4
Q ss_pred cccceeeeecCceeEEEEEec-----CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeeEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (670)
|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998642 5788999999753 334567799999999999999999999999884 67899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999543 3889999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 594 GDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
..... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 43221 12233457888999999999899999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=300.88 Aligned_cols=203 Identities=24% Similarity=0.369 Sum_probs=171.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Cee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 511 (670)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999875 5788999998753 233457789999999999999999999998765 367
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 5899988542 3889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccC-CccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 592 FGGDETEG-NTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 64332221 1234579999999998754 4589999999999999999999999764433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=308.19 Aligned_cols=197 Identities=25% Similarity=0.372 Sum_probs=162.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC----C--eeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----E--EKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 512 (670)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+|+.++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999985 48999999986432 2334799999999999999999998542 1 357
Q ss_pred EEEEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeecCce
Q 005907 513 LIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVR 590 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 590 (670)
+||||+++ +|.+++.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 56555532 123456899999999999999999999987 9999999999999965 578999999999
Q ss_pred ecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 2235789999999999765 7999999999999999999999997643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=295.02 Aligned_cols=198 Identities=27% Similarity=0.469 Sum_probs=161.4
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc--CCCCceeeEEEEEEeC----
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG---- 508 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~---- 508 (670)
.....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3345578999999999999999999874 8999999985432 2344455555554 4899999999999887
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCEEEcCCCceEE
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKI 583 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kl 583 (670)
...++||||+++++|.+++... .+++..++.++.|++.||+|||++. +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6889999999999999999553 3889999999999999999999870 113999999999999999999999
Q ss_pred EeecCceecCCCcccC--CccccccccCcccccccCCCCCCcc------chHHHHHHHHHHHHcC
Q 005907 584 SDFGLVRTFGGDETEG--NTNRVVGTYGYMAPEYASDGQFSIK------SDVFSFGILLLEIVSG 640 (670)
Q Consensus 584 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvil~elltG 640 (670)
+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999998764433221 1223579999999999988776655 9999999999999999
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.80 Aligned_cols=208 Identities=29% Similarity=0.424 Sum_probs=173.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 513 (670)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999985 5889999998642 34456789999999999999999999998865 567899
Q ss_pred EEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 514 IYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996532 2345899999999999999999999875 1239999999999999999999999999988
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 7643221 1223568999999999999999999999999999999999999986543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.00 Aligned_cols=206 Identities=28% Similarity=0.359 Sum_probs=160.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEe--------C
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--------G 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~ 508 (670)
..+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999974 58899999987666666778999999999996 9999999999953 3
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
...++||||+. |+|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 34789999996 799998866444556899999999999999999999864 3499999999999999999999999999
Q ss_pred ceecCCCcccC----------CccccccccCccccccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 589 VRTFGGDETEG----------NTNRVVGTYGYMAPEYA---SDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 589 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
++.+....... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 98765332211 11134689999999998 567789999999999999999999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=295.21 Aligned_cols=202 Identities=24% Similarity=0.391 Sum_probs=165.8
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEE-----------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------- 506 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 506 (670)
.++|.+.+.||+|+||.||+|.... ++.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8899999997766667788999999999999999999999873
Q ss_pred ---eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCceE
Q 005907 507 ---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 582 (670)
Q Consensus 507 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~k 582 (670)
+....++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 699999843 34889999999999999999999998 99999999999997 567999
Q ss_pred EEeecCceecCCCcc-cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 583 ISDFGLVRTFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 583 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
|+|||+++.+..... ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999987643221 112233567999999998865 678999999999999999999999986443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.71 Aligned_cols=192 Identities=22% Similarity=0.391 Sum_probs=169.1
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEe--CCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|.. .+++.||||++.. ...+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999986 4588999999864 33467899999999997 9999999999988 6678999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 593 (670)
|||+++++|.+++.. +++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998842 788999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 3322 233578999999999977 678999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.92 Aligned_cols=209 Identities=27% Similarity=0.441 Sum_probs=159.3
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 58899999986432 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 515 YEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
|||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998641 12345889999999999999999999988 999999999999999999999999998
Q ss_pred eecCCCcc---cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 590 RTFGGDET---EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 590 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..+..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 76643221 111233568999999999876 568999999999999999999999987544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.39 Aligned_cols=200 Identities=17% Similarity=0.273 Sum_probs=171.1
Q ss_pred cCCcccceeeeecCceeEEEEEecC---------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceee---------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 500 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 500 (670)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999864 789999998643 46889999999999999987
Q ss_pred ------EEEEEEe-CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 005907 501 ------LLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (670)
Q Consensus 501 ------l~g~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NI 573 (670)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 67889999999 999999997542 245899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEEeecCceecCCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 574 LLDQDM--NPKISDFGLVRTFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 574 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 112335789999999999999999999999999999999999999875
Q ss_pred CC
Q 005907 647 YR 648 (670)
Q Consensus 647 ~~ 648 (670)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 43
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=323.96 Aligned_cols=198 Identities=31% Similarity=0.454 Sum_probs=164.9
Q ss_pred eeeeecCceeEEEEEec---CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 48999999999999653 3578999999753 2334678999999999999999999999986 4568899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc-C
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-G 599 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 599 (670)
++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999653 34889999999999999999999998 999999999999999999999999999877543321 1
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 2223456789999999999999999999999999999998 99998654443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.13 Aligned_cols=197 Identities=32% Similarity=0.517 Sum_probs=160.3
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHH--HHHhcCCCCceeeEEEEEEe-----CCe
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV--ILFSKLQHRNLVKLLGCCIQ-----GEE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~--~~l~~l~H~niv~l~g~~~~-----~~~ 510 (670)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|. ..+..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346899999999999999999987 78999999986432 23344444 44556899999999986643 235
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeccCCCCCEEEcCCCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD---------SRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~---------~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
.++||||+++++|.+++.... .++..+..++.||++||+|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 689999999999999996532 47889999999999999999998 6 9999999999999999999
Q ss_pred EEEeecCceecCCCcc------cCCccccccccCcccccccCC-------CCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 582 KISDFGLVRTFGGDET------EGNTNRVVGTYGYMAPEYASD-------GQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 582 kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 9999999987653321 111223569999999999987 456789999999999999999988753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=297.89 Aligned_cols=205 Identities=31% Similarity=0.485 Sum_probs=168.8
Q ss_pred HHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEe------
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ------ 507 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------ 507 (670)
....++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 345678999999999999999999974 5889999998653 23457889999999999 79999999999987
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
....++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 467899999999999999997542 245789999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++..+..... ......||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 175 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9887643221 223357899999999987 567899999999999999999999998543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.77 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=167.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (670)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457999999999999999999875 47899999986421 12334688999999999999999999998765
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc---eEEEe
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISD 585 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~D 585 (670)
. .++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998854 345889999999999999999999988 999999999999987664 99999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
||+++.+.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99998764322 122356899999999973 5678999999999999999999999986443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.28 Aligned_cols=204 Identities=24% Similarity=0.351 Sum_probs=175.0
Q ss_pred cCCcccceeeeecCceeEEEEEe--cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc------eeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 510 (670)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35789999998653 344567889999999887664 9999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------------
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 577 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~------------- 577 (670)
.++||||+ +++|.+++.... ...+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999986643 235789999999999999999999998 999999999999987
Q ss_pred ------CCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 578 ------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 578 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999875322 223578999999999999999999999999999999999999987655444
Q ss_pred cc
Q 005907 652 KV 653 (670)
Q Consensus 652 ~~ 653 (670)
..
T Consensus 242 ~~ 243 (339)
T 1z57_A 242 HL 243 (339)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=298.12 Aligned_cols=202 Identities=29% Similarity=0.518 Sum_probs=174.2
Q ss_pred cCCcccceeeeecCceeEEEEEe-----cCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--ee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 511 (670)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999984 358899999998766666788999999999999999999999986644 67
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999997642 34889999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
+...... .......+++.|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 7543221 11222456788999999998889999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.90 Aligned_cols=211 Identities=22% Similarity=0.339 Sum_probs=176.7
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||+|+. .+++.||||++.... ...++.+|+.+++.++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999997 458899999876432 23468899999999987 566677777788889999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCceEEEeecCceecC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 593 (670)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999643 234899999999999999999999998 9999999999999 688999999999999875
Q ss_pred CCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhh
Q 005907 594 GDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 657 (670)
Q Consensus 594 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~ 657 (670)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 43322 11224679999999999999999999999999999999999999997665544443333
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.26 Aligned_cols=202 Identities=22% Similarity=0.302 Sum_probs=170.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC--------CCceeeEEEEEE---
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 506 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 506 (670)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999874 4789999999643 344567889999999985 788999999987
Q ss_pred -eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCC-----
Q 005907 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM----- 579 (670)
Q Consensus 507 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~----- 579 (670)
.+...++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 55666665443 224589999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------ceEEEeecCceecCCCcccCCccccccccCcccccc
Q 005907 580 --------------------------------------------NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615 (670)
Q Consensus 580 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 615 (670)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 223578999999999
Q ss_pred cCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 616 ~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
+.+..++.++|||||||+||||++|+.||......+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 999999999999999999999999999997655443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.85 Aligned_cols=202 Identities=29% Similarity=0.386 Sum_probs=159.0
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999974 6889999998653 2223334555566688899999999999999999999999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 516 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||++ ++|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4888777542 2345689999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCcccCCccccccccCccccccc----CCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYA----SDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 3322 2234689999999996 5667899999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.79 Aligned_cols=206 Identities=22% Similarity=0.307 Sum_probs=159.3
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe--
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 510 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 510 (670)
......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999985 5889999998653 3334566778888999999999999999976433
Q ss_pred -----eEEEEEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeccCCCCCEEEcC-CCce
Q 005907 511 -----KLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDQ-DMNP 581 (670)
Q Consensus 511 -----~~lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~ia~~l~yLH--~~~~~~ivHrDlkp~NILl~~-~~~~ 581 (670)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999986 44444332 234456889999999999999999999 777 999999999999997 8999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 9999999987653322 2235689999999998665 4899999999999999999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=302.93 Aligned_cols=198 Identities=12% Similarity=0.141 Sum_probs=152.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---hhchHHHHHHHHHHhcC--CCCceeeEE-------EEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL--QHRNLVKLL-------GCC 505 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 505 (670)
...|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345899999999999999999975 68899999997632 34456677885444444 699988755 455
Q ss_pred EeC-----------------CeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 005907 506 IQG-----------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR------FHIICGTARGLLYLHQDSRLR 562 (670)
Q Consensus 506 ~~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~ia~~l~yLH~~~~~~ 562 (670)
... ...++||||++ ++|.+++..... .+++..+ +.++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999998 899999975322 2344445 678899999999999998
Q ss_pred eEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcC
Q 005907 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSG 640 (670)
Q Consensus 563 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG 640 (670)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764221 13456799999999987 7899999999999999999999
Q ss_pred CCCCCCC
Q 005907 641 KKNRGFY 647 (670)
Q Consensus 641 ~~p~~~~ 647 (670)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.31 Aligned_cols=202 Identities=26% Similarity=0.424 Sum_probs=170.6
Q ss_pred hcCCcccceeeeecCceeEEEEEec--CCcEEEEEEecccc--hhchHHHHHHHHHHhcC---CCCceeeEEEEEE----
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI---- 506 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 506 (670)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 57899999986432 22334667787777766 8999999999987
Q ss_pred -eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEe
Q 005907 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (670)
Q Consensus 507 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 585 (670)
.....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999987643 234789999999999999999999998 99999999999999999999999
Q ss_pred ecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 586 FGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99998754221 223357899999999999999999999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.00 Aligned_cols=203 Identities=27% Similarity=0.404 Sum_probs=170.7
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (670)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468999999999999999999975 5889999999653 334456788999999999999999999998654 67
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 689998865 24889999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccC--------CccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 591 TFGGDETEG--------NTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 591 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 765322211 1223468999999998754 778999999999999999999999986544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=290.32 Aligned_cols=198 Identities=31% Similarity=0.492 Sum_probs=164.8
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-CeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~ 517 (670)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 5889999998653 3457889999999999999999999997654 468999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999996532 223688899999999999999999988 9999999999999999999999999987653221
Q ss_pred cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12357889999999999999999999999999999998 999986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.32 Aligned_cols=202 Identities=28% Similarity=0.379 Sum_probs=167.5
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCC--CCceeeEEEEEEeCCeeEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 513 (670)
..++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4467999999999999999999988899999999864 23445678899999999997 5999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||| +.+++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||+++ +.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6688999999653 34789999999999999999999998 999999999999964 899999999998765
Q ss_pred CCcccCCccccccccCcccccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASD-----------GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 4433333334578999999999875 47888999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=286.39 Aligned_cols=201 Identities=30% Similarity=0.433 Sum_probs=173.6
Q ss_pred HHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344568999999999999999999985 5889999998653 2345678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CceEEEeecCc
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLV 589 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla 589 (670)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999886533 4889999999999999999999998 9999999999999764 46999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
........ .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 87643322 2234689999999998764 89999999999999999999999754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.79 Aligned_cols=193 Identities=17% Similarity=0.151 Sum_probs=146.3
Q ss_pred CCCceEEeccCCCCCCCC----cceEEEecCCcEEE--ECCCCcEEEeecCccCc----cCceEEEEecCCCEEEeeCCC
Q 005907 13 PPHEVVWVANRLNPINDS----FGFLMINKTGNLVL--TSQSNIVVWSAYLSKEV----QTPVVLQLLDSGNLVLRDEHD 82 (670)
Q Consensus 13 ~~~t~vW~ANr~~p~~~~----~~~l~~~~~g~l~l--~~~~~~~~Wst~~~~~~----~~~~~~~lld~GNlvl~~~~~ 82 (670)
|++ |||+||||+|++++ +++|+|+.||+|+| .|++|.+||||+++... ..+++|+|+|+|||||++
T Consensus 51 ~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--- 126 (276)
T 3m7h_A 51 NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--- 126 (276)
T ss_dssp TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---
T ss_pred CCC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---
Confidence 566 99999999999875 68999999999999 88889999999875421 346789999999999997
Q ss_pred CCCcceEEeecCCCCCcccCCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEe-CCeeEEeeCCCCC
Q 005907 83 GDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNG 161 (670)
Q Consensus 83 ~~~~~~~WqSFd~PtdtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~~~~sg~~~g 161 (670)
+.+|||| |||||||||||||.++++|.. | ++.+||++|.|++.++++|. +++++ ++.+||++|+|++
T Consensus 127 ---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~ 194 (276)
T 3m7h_A 127 ---SLALWNG--TPAIPLVPGAIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGK 194 (276)
T ss_dssp ---EEEEEES--CTTSCCCCSCTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTT
T ss_pred ---CceeeCc--ccccccccccccccccccCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCC
Confidence 3689999 999999999999999988864 6 67899999999999999995 44554 4689999999975
Q ss_pred ccccCCCCCCCCceeEEEeecCc-eEEEEEeecCCceEEEEEEeeeeeEEEEEEEecCCCcEEEEEecCC
Q 005907 162 LRFSAPSLRPNPIFSFSFVSNDV-ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPR 230 (670)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~~~~~~~~W~~~~~~~~ 230 (670)
.. ....++..+.+ .+.++.. .+..+++. .....|++|+.|| ++++|.| ...|..++.+|.
T Consensus 195 ~~-~~l~l~~dGnL--vl~d~~~~~vWsS~t~--~~~~~rl~Ld~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 195 GA-VRAVFQGDGNL--VVYGAGNAVLWHSHTG--GHASAVLRLQANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp TC-CEEEECTTSCE--EEECTTSCEEEECSCT--TCTTCEEEECTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred cc-EEEEEcCCCeE--EEEeCCCcEEEEecCC--CCCCEEEEEcCCc-cEEEEcC---CCeEEccCccCC
Confidence 32 11222333322 2333322 34333332 2234899999999 8889988 345666666554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.60 Aligned_cols=196 Identities=27% Similarity=0.430 Sum_probs=166.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee---
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK--- 511 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 511 (670)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999875 5889999998752 334457888999999999999999999999877654
Q ss_pred ---EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 512 ---LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 512 ---~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888762 23889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865322 223568999999999987 78899999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=293.44 Aligned_cols=203 Identities=25% Similarity=0.406 Sum_probs=171.1
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhc--CCCCceeeEEEEEEeCC--
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE-- 509 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~-- 509 (670)
......++|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3344567899999999999999999998 6899999998643 34567788888887 78999999999998876
Q ss_pred --eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEEEcCCC
Q 005907 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDM 579 (670)
Q Consensus 510 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivHrDlkp~NILl~~~~ 579 (670)
..++||||+++++|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 789999999999999999653 3789999999999999999999 666 99999999999999999
Q ss_pred ceEEEeecCceecCCCcccC--CccccccccCcccccccCCC------CCCccchHHHHHHHHHHHHcC----------C
Q 005907 580 NPKISDFGLVRTFGGDETEG--NTNRVVGTYGYMAPEYASDG------QFSIKSDVFSFGILLLEIVSG----------K 641 (670)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltG----------~ 641 (670)
.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765433211 22345789999999999766 334789999999999999999 7
Q ss_pred CCCCCC
Q 005907 642 KNRGFY 647 (670)
Q Consensus 642 ~p~~~~ 647 (670)
.||...
T Consensus 265 ~p~~~~ 270 (342)
T 1b6c_B 265 LPYYDL 270 (342)
T ss_dssp CTTTTT
T ss_pred cCcccc
Confidence 787543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=287.54 Aligned_cols=195 Identities=28% Similarity=0.500 Sum_probs=161.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe----------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 507 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 507 (670)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999974 688999999864 33456788999999999999999999999865
Q ss_pred ---CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 508 ---GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 508 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34678999999999999999753 234678899999999999999999998 9999999999999999999999
Q ss_pred eecCceecCCCcc------------cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHc
Q 005907 585 DFGLVRTFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVS 639 (670)
Q Consensus 585 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~ellt 639 (670)
|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999987643211 1122335689999999999765 78999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.74 Aligned_cols=203 Identities=29% Similarity=0.421 Sum_probs=163.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC--Cc--EEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|++.. ++ .||+|+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3579999999999999999998632 33 6899988653 3345678899999999999999999999987654 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999996532 34789999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 592 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
+...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 7543322 12223457889999999998889999999999999999999 99997644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=297.01 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=170.9
Q ss_pred HhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-CC-----ceeeEEEEEEeCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQGE 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~ 509 (670)
...++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 35679999999999999999999875 4788999999643 334567778888888875 44 4999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCceEEEeec
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFG 587 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFG 587 (670)
..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 59999987643 23488999999999999999999953 12499999999999995 47889999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99886432 223578999999999999999999999999999999999999976443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.60 Aligned_cols=202 Identities=24% Similarity=0.411 Sum_probs=154.1
Q ss_pred CCccc-ceeeeecCceeEEEEEec---CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEE
Q 005907 440 DNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 513 (670)
Q Consensus 440 ~~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 513 (670)
+.|++ .++||+|+||.||+|+.. +++.||||++... .....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999975 4788999999653 234578899999999999999999999965 668899
Q ss_pred EEEccCCCCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCceEE
Q 005907 514 IYEFMPNKSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKI 583 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl 583 (670)
||||++ ++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 4787777431 12234889999999999999999999998 9999999999999 67789999
Q ss_pred EeecCceecCCCccc-CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 584 SDFGLVRTFGGDETE-GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 584 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999876533221 223346789999999999874 5899999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.09 Aligned_cols=202 Identities=21% Similarity=0.322 Sum_probs=171.3
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-C-cEEEEEEecccchhchHHHHHHHHHHhcCCCCc------eeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-G-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~ 509 (670)
..++|++.+.||+|+||.||+|.... + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34689999999999999999998743 3 68999999653 344567888999999998766 999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE--------------
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 575 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl-------------- 575 (670)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 667777765432 245889999999999999999999987 9999999999999
Q ss_pred -----cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCc
Q 005907 576 -----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650 (670)
Q Consensus 576 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~ 650 (670)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999875322 22357899999999999999999999999999999999999998654433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.83 Aligned_cols=195 Identities=27% Similarity=0.432 Sum_probs=165.8
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (670)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999975 5889999998652 33345678899999999999999999999987654
Q ss_pred -eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 511 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58887762 23889999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 765322 223568999999999877 67899999999999999999999997643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.42 Aligned_cols=202 Identities=29% Similarity=0.427 Sum_probs=151.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468999999999999999999985 5889999998753 2333445556665 777889999999999999999999999
Q ss_pred EccCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 516 EFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 516 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 78777643 11245588999999999999999999997 7 999999999999999999999999999876
Q ss_pred CCCcccCCccccccccCccccccc----CCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYA----SDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 43221 2234689999999998 5667899999999999999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=315.69 Aligned_cols=204 Identities=26% Similarity=0.401 Sum_probs=170.6
Q ss_pred hcCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
..++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 44678999999999999999998743 457999998653 3344578999999999999999999999984 46689
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999653 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 433222 2223456789999999998999999999999999999997 999976443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.60 Aligned_cols=199 Identities=22% Similarity=0.321 Sum_probs=168.0
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhcCC-----------CCceeeEEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 506 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 506 (670)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999997 45889999998642 334567888999999886 899999999988
Q ss_pred eCC----eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEc-----
Q 005907 507 QGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 576 (670)
Q Consensus 507 ~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~----- 576 (670)
... ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 788999999 899999987643 23488999999999999999999997 7 99999999999994
Q ss_pred -CCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 577 -QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 577 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999876432 223578999999999999999999999999999999999999987544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.01 Aligned_cols=202 Identities=29% Similarity=0.471 Sum_probs=166.9
Q ss_pred hcCCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++|++.+.||+|+||.||+|...+ .+|+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998743 5999998642 2344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999542 345888999999999999999999998 99999999999998 679999999998765322
Q ss_pred cc---cCCccccccccCcccccccCC---------CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ET---EGNTNRVVGTYGYMAPEYASD---------GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.. ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 122233468999999999864 45789999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=300.21 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=157.1
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455667899999999998776678999999998642 345678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-------------Cce
Q 005907 519 PNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------MNP 581 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~----~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~ 581 (670)
+ ++|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996533211 1123345679999999999999988 9999999999999754 489
Q ss_pred EEEeecCceecCCCcccC--CccccccccCcccccccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEG--NTNRVVGTYGYMAPEYASD-------GQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
||+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||..
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999999999875433221 1234579999999999976 678999999999999999999 9999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=290.06 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=171.4
Q ss_pred HHhcCCcccceeeeecCceeEEEEEe-cCCcEEEEEEecccch------hchHHHHHHHHHHhcCC--CCceeeEEEEEE
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCI 506 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~ 506 (670)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999986 4588999999865322 12356778999999996 599999999999
Q ss_pred eCCeeEEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCceEEE
Q 005907 507 QGEEKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKIS 584 (670)
Q Consensus 507 ~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 584 (670)
..+..++|||++.+ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999998653 34889999999999999999999988 99999999999999 78899999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~ 645 (670)
|||+++.+.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 999998864322 223568999999999987765 688999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=288.36 Aligned_cols=201 Identities=26% Similarity=0.410 Sum_probs=162.7
Q ss_pred HHHhcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch------hchHHHHHHHHHHhcC----CCCceeeEEE
Q 005907 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLLG 503 (670)
Q Consensus 435 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g 503 (670)
.....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999874 578999999865322 1234566788999888 8999999999
Q ss_pred EEEeCCeeEEEEEc-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCce
Q 005907 504 CCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNP 581 (670)
Q Consensus 504 ~~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~ 581 (670)
++...+..++|||| +.+++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999999653 24889999999999999999999988 99999999999999 88999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCC
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFS-IKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~p~~ 645 (670)
||+|||+++.+.... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 999999998875332 2235689999999999777664 58999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=287.37 Aligned_cols=198 Identities=23% Similarity=0.295 Sum_probs=146.5
Q ss_pred hcCCcccce-eeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCee
Q 005907 438 ATDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 511 (670)
Q Consensus 438 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 511 (670)
..++|.+.+ .||+|+||.||+|... +++.||||++.... ....+....++.++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456888854 6999999999999986 58899999986421 222223334667799999999999876 4457
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeecC
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl 588 (670)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999997543 245899999999999999999999998 999999999999986 45599999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 98764322 22356899999999999889999999999999999999999998543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=298.36 Aligned_cols=198 Identities=26% Similarity=0.400 Sum_probs=157.6
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.+|.+.+.||+|+||+|+.....+++.||||++.... ...+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4688999999999999765555689999999986522 23456899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-----CCceEEEeecCceecC
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTFG 593 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 593 (670)
+ ++|.+++..... ......++.++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++.+.
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6 599999865432 2334456789999999999999998 999999999999953 3368899999998765
Q ss_pred CCccc-CCccccccccCcccccccC---CCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 005907 594 GDETE-GNTNRVVGTYGYMAPEYAS---DGQFSIKSDVFSFGILLLEIVS-GKKNRGF 646 (670)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~ellt-G~~p~~~ 646 (670)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 33221 2233467999999999997 4567889999999999999999 9999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=314.18 Aligned_cols=191 Identities=20% Similarity=0.371 Sum_probs=165.1
Q ss_pred cCCcccceeeeecCceeEEEEEec--CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (670)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999985 5889999998653 33455678999999999999999999999987655
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987732 4899999999999999999999998 9999999999999886 89999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.+... ....||+.|+|||++.+.. +.++|||||||+||||++|..|+.
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 76432 2357999999999987654 899999999999999999999865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=296.95 Aligned_cols=191 Identities=19% Similarity=0.204 Sum_probs=161.5
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccc--------hhchHHHHHHHHHHhcCC---------CCceeeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVKL 501 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 501 (670)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45789999999999999999998 78999999987532 223477889999998885 8888888
Q ss_pred EEEEE------------------------------eCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 005907 502 LGCCI------------------------------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551 (670)
Q Consensus 502 ~g~~~------------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~ 551 (670)
.+++. .....++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77653 26789999999999976666532 447899999999999999
Q ss_pred HHHHH-hCCCCCeEeccCCCCCEEEcCCC--------------------ceEEEeecCceecCCCcccCCccccccccCc
Q 005907 552 LLYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610 (670)
Q Consensus 552 l~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 610 (670)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999876422 35799999
Q ss_pred ccccccCCCCCCccchHHHHHHH-HHHHHcCCCCCC
Q 005907 611 MAPEYASDGQFSIKSDVFSFGIL-LLEIVSGKKNRG 645 (670)
Q Consensus 611 ~aPE~~~~~~~~~~sDvwSlGvi-l~elltG~~p~~ 645 (670)
+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998776 899999998777 888999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=309.70 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=172.9
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEe------CC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 509 (670)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. ++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999874 5889999998653 44456789999999999999999999998755 66
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCc---eEEEee
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 586 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DF 586 (670)
..++||||+++++|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 77999999999999999976555556888899999999999999999988 999999999999997765 899999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
|+++.+..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 99987643322 233578999999999999999999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=282.44 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=151.2
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc--hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457899999999999999999985 58899999986532 222334455556788889999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
||+ ++.+..++... ...+++..+..++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 55555554332 24488999999999999999999985 7 99999999999999999999999999977643
Q ss_pred CcccCCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
... .....||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 221 22356899999999994 557889999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.50 Aligned_cols=174 Identities=11% Similarity=0.063 Sum_probs=151.7
Q ss_pred cCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccc---hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999854 8899999997532 33457889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++++|.+++.. . ....++.+++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999843 2 355678889999999999999998 9999999999999999999997433
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 649 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~ 649 (670)
|++| ++.++|||||||++|||+||+.||.....
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 4443 68899999999999999999999875443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.91 Aligned_cols=199 Identities=19% Similarity=0.253 Sum_probs=153.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCC-Cce---------------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNL--------------- 498 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~ni--------------- 498 (670)
...|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778899999999999999964 5899999998742 23346789999999999987 221
Q ss_pred ee------EEEEEEe-----CCeeEEEEEccCCCCHHHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005907 499 VK------LLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (670)
Q Consensus 499 v~------l~g~~~~-----~~~~~lV~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 563 (670)
+. +..++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 1111111 12356777765 6899988842 122344678889999999999999999998 9
Q ss_pred EeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCccccccc----------CCCCCCccchHHHHHHH
Q 005907 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA----------SDGQFSIKSDVFSFGIL 633 (670)
Q Consensus 564 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvi 633 (670)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 233567 999999999 66678899999999999
Q ss_pred HHHHHcCCCCCCCC
Q 005907 634 LLEIVSGKKNRGFY 647 (670)
Q Consensus 634 l~elltG~~p~~~~ 647 (670)
||||++|+.||...
T Consensus 307 l~elltg~~Pf~~~ 320 (413)
T 3dzo_A 307 IYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHSSCCCCTT
T ss_pred HHHHHHCCCCCCCc
Confidence 99999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=262.06 Aligned_cols=177 Identities=22% Similarity=0.316 Sum_probs=151.4
Q ss_pred hcCCcccc-eeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHH-hcCCCCceeeEEEEEEe----CCe
Q 005907 438 ATDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEE 510 (670)
Q Consensus 438 ~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~ 510 (670)
..++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34567777 78999999999999874 588999999854 24567888887 56699999999999987 667
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeec
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG 587 (670)
.++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 899999999999999997643 235899999999999999999999998 999999999999998 7889999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+++... +..++.++|||||||++|||++|+.||...
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 987542 244678999999999999999999998543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=257.61 Aligned_cols=177 Identities=13% Similarity=0.176 Sum_probs=136.9
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
+|+||+|||+.| +.+.|+|+.||||||.|++|.+||+|++... ....+|+|+|+|||||++. ++|||||
T Consensus 44 ~~~vW~an~~~~---~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~-~~~~~~~l~d~Gnlvl~~~-------~~W~S~~ 112 (236)
T 1dlp_A 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYGP-------GLWDSGT 112 (236)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCC---CCeEEEEcCCCcEEEEcCCCcEEEeCCcccc-CCcEEEEEeCCCCEEEecC-------CEEECCC
Confidence 599999999998 4589999999999999999999999987543 2345899999999999852 7999999
Q ss_pred CCCCcc-cCCCcccccc-cccc-----ceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCCCCCccccC-
Q 005907 95 YPSDTL-LPGMKLGWDL-KTGL-----ERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA- 166 (670)
Q Consensus 95 ~Ptdtl-Lpg~~l~~~~-~tg~-----~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~~~g~~~~~- 166 (670)
|||||+ |||| |.|. .+|+ .++|+| .+||++|.|++.++++| +++++++..+||++++|++. +..
T Consensus 113 ~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~ 184 (236)
T 1dlp_A 113 SNKGSVVVANN--GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCR 184 (236)
T ss_dssp CCSSCCCCSSC--CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCE
T ss_pred CCCcccccCCc--cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceE
Confidence 999887 6665 5554 5555 567874 78999999999999998 67888888899999999753 433
Q ss_pred CCCCCCCceeEEEeecCceEEEEEeecCCceEEEEEEeeeeeEEEEE
Q 005907 167 PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRF 213 (670)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~ 213 (670)
+.+...+.+ +.+..+..+++.+|..... ...|++|+.+| ++++|
T Consensus 185 ~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~~rl~Ld~dG-~l~ly 228 (236)
T 1dlp_A 185 AVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GRYVFVLQPDR-NLAIY 228 (236)
T ss_dssp EEEETTTEE-EEEETTTEEEEECCCCCSS-SCCEEEECSSS-CEEEE
T ss_pred EEECCCCcE-EEEeCCCcEEEEeCCCCCC-CCEEEEEcCCC-cEEEe
Confidence 556555532 2233445556666654433 36899999999 77777
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=277.52 Aligned_cols=185 Identities=18% Similarity=0.178 Sum_probs=129.7
Q ss_pred eeeecCceeEEEEEe-cCCcEEEEEEeccc----------chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 447 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
..+.|++|.+..++. --|+.+|+|.+.+. .+...++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 455666665555432 24888999998642 123456799999999999 699999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||++|++|.++|... ..++.. +|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999653 345654 48899999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 643 (670)
... .....+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 322 23347899999999998754 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=255.39 Aligned_cols=185 Identities=17% Similarity=0.188 Sum_probs=147.2
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEecccc--------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..++||+|+||.||++.. .++.+++|+..... ....+.+.+|+.++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 67889999864311 112346899999999999999997777777888889999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++++|.+++.. ++.++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4579999999999999998 999999999999998 9999999999987543
Q ss_pred cccC-----CccccccccCcccccccCC--CCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 596 ETEG-----NTNRVVGTYGYMAPEYASD--GQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 596 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 1234679999999999977 568888999999999999998888863
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-23 Score=208.09 Aligned_cols=152 Identities=18% Similarity=0.127 Sum_probs=121.2
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccch------------------hchHHHHHHHHHHhcCCC
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQH 495 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H 495 (670)
........|.+.+.||+|+||.||+|...+++.||+|.++.... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445566778899999999999999997799999999864221 13456889999999999
Q ss_pred CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 496 ~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 556655433 55699999999999988 411 123469999999999999988 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 618 (670)
+ ++.+||+|||+++. +..++|||.+..
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9 99999999999864 345789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.2e-19 Score=176.42 Aligned_cols=137 Identities=16% Similarity=0.179 Sum_probs=106.3
Q ss_pred CcccceeeeecCceeEEEEEe-cCCcE--EEEEEecccchh------------------------chHHHHHHHHHHhcC
Q 005907 441 NFSINNKLGEGGFGPVYKGTL-VDGQE--IAVKRLSKISEQ------------------------GLKELKNEVILFSKL 493 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 493 (670)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 67888 999987542111 113678899999999
Q ss_pred CCCce--eeEEEEEEeCCeeEEEEEccCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 005907 494 QHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIH 565 (670)
Q Consensus 494 ~H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH 565 (670)
+|+++ ..++.. ...++||||+.+ | +|.+++.. .++.....++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 356899999942 3 67766532 123456679999999999999 887 999
Q ss_pred ccCCCCCEEEcCCCceEEEeecCceec
Q 005907 566 RDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 566 rDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
|||||.|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3e-16 Score=135.54 Aligned_cols=98 Identities=23% Similarity=0.423 Sum_probs=79.5
Q ss_pred CCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCC
Q 005907 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (670)
Q Consensus 24 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg 103 (670)
+.|+.+...+|.|..||+|+|.+. +++||++++... ....+|+|+++|||||++ + +.++||||+
T Consensus 13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d-~----~~~~W~S~~--------- 76 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS-G----SRAIWASNT--------- 76 (112)
T ss_dssp TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTS-CSSEEEEECTTSCEEEEE-T----TEEEEECCC---------
T ss_pred CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc-C----CEEEEECCc---------
Confidence 345555568899999999999987 899999987542 245789999999999998 2 368999993
Q ss_pred CccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEe-CCeeEEeeCCCCC
Q 005907 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNG 161 (670)
Q Consensus 104 ~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~~~~sg~~~g 161 (670)
+|++|.|++.++++|+ ++++. ...+||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567889999999998 55665 5789999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.7e-16 Score=134.28 Aligned_cols=102 Identities=23% Similarity=0.397 Sum_probs=79.7
Q ss_pred ceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCC
Q 005907 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDY 95 (670)
Q Consensus 16 t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~ 95 (670)
..+|..++-. . +...+|.+..||||||.+ .+++||++++... ....+++|+|+|||||++. .+.++||||
T Consensus 8 ~~L~~g~~l~-~-~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~~~----~~~~~W~S~-- 77 (110)
T 3a0c_A 8 NSLFTGHSLE-V-GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGL-GSGCRLTLHNNGNLVIYDQ----SNRVIWQTK-- 77 (110)
T ss_dssp CEECTTCEEE-E-TTTEEEEECTTSCEEEEE-TTEEEEECCCTTS-CSSCEEEECTTSCEEEECT----TCCEEEECC--
T ss_pred CEECCCCEEE-E-CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCC-CCcEEEEEeCCCCEEEECC----CCcEEEecC--
Confidence 4555555443 2 345889999999999998 5899999987543 2356899999999999986 467999999
Q ss_pred CCCcccCCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCCCC
Q 005907 96 PSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWN 160 (670)
Q Consensus 96 PtdtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~~~ 160 (670)
.+|++|.|++.++++|+ +++++. +||+++++.
T Consensus 78 -----------------------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~ 109 (110)
T 3a0c_A 78 -----------------------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSGP 109 (110)
T ss_dssp -----------------------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCCC
T ss_pred -----------------------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCcC
Confidence 34667899999999997 556665 899998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-16 Score=131.35 Aligned_cols=69 Identities=19% Similarity=0.390 Sum_probs=60.2
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
.++||+|||+.|.... +.|.++.||||||.|+++.+||+|+++.. ....+|+|+|+|||||+++ .||||
T Consensus 37 ~~~vW~ant~~~~~~~-~~L~l~~dGnLvL~d~~~~~vWss~t~~~-~~~~~l~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 37 STSTWASNTEIGGKSG-CSAVLQSDGNFVVYDSSGRSLWASHSTRG-SGNYILILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp TEEEEECCCCCTTCCS-CEEEECTTSCEEEECTTCCEEEECCCCCC-SSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred CEEEEEecCCCCCCcc-EEEEEeCCccEEEECCCcEEEEEecCCCC-CCCEEEEEeCCCeEEEECC-------cEecC
Confidence 4899999999998654 78999999999999999999999987643 3457899999999999974 59998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.6e-17 Score=167.78 Aligned_cols=142 Identities=13% Similarity=0.174 Sum_probs=100.7
Q ss_pred HhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccch--------------hchHH--------HHHHHHHHhcCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------------QGLKE--------LKNEVILFSKLQ 494 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l~~l~ 494 (670)
....-|.+.+.||+|+||.||+|...+|+.||||+++.... ..... ...|...|.++.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33344899999999999999999998999999998753110 00111 124556666665
Q ss_pred CCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 495 H~niv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
+.++.-...+.. ...+|||||+++++|..+.. . .....++.|++.+|.+||+.+ ||||||||.|||
T Consensus 172 ~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 172 EEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp HTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred hcCCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 444322111111 23379999999988866531 1 123457899999999999988 999999999999
Q ss_pred EcCCCc----------eEEEeecCceec
Q 005907 575 LDQDMN----------PKISDFGLVRTF 592 (670)
Q Consensus 575 l~~~~~----------~kl~DFGla~~~ 592 (670)
+++++. +.|+||+-+-..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 988773 899999976553
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=5.1e-15 Score=128.79 Aligned_cols=86 Identities=21% Similarity=0.327 Sum_probs=71.7
Q ss_pred ceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCccccccc
Q 005907 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (670)
Q Consensus 32 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~ 111 (670)
.+|.|..||+|+|.+. +++||++|+... .....|+|+|+|||||++. .+.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~d~----~~~~lW~S~------------------ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITN----ENVTVWQSP------------------ 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT----TCCEEEECS------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccC-CCceEEEEccCCEEEEEeC----CCcEEEcCC------------------
Confidence 6688999999999987 899999987543 2346899999999999986 567999999
Q ss_pred cccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 112 tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
.+|++|.|++.++++|+ +++++ .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 55666 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=126.29 Aligned_cols=90 Identities=22% Similarity=0.400 Sum_probs=74.4
Q ss_pred cceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCcccccc
Q 005907 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (670)
Q Consensus 31 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~ 110 (670)
...|.|..||||+|.+ .+++||++|+... ....+++|+++|||||++. .+.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~-~~~~~l~l~~~GnLvl~d~----~~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRR-GSGCRLTLLSDGNLVIYDH----NNNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTS-CSSCEEEECTTSCEEEECT----TCCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCC-CCceEEEECCCCcEEEECC----CceEEEEcCCC---------------
Confidence 4779999999999998 5889999987543 2346899999999999986 45799999997
Q ss_pred ccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCCCCC
Q 005907 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNG 161 (670)
Q Consensus 111 ~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~~~g 161 (670)
|++|.|++.++++|+ +++++. .||++++|..
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGC 110 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCB
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCC
Confidence 356789999999997 566754 8999999975
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4e-14 Score=121.52 Aligned_cols=73 Identities=29% Similarity=0.398 Sum_probs=61.3
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||.||++.|. ..+.+.|.+||||||.|.++.++|+|++... ....+++|+|+|||||++. ++||||+
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~-~g~~~l~l~~dGnlvl~~~-------~~W~S~~ 107 (110)
T 3a0c_A 38 GKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQDRNVVIYGP-------VVWATGS 107 (110)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCCC--CcEEEEEeCCCCEEEECCCCcEEEecCCCCC-CCCEEEEEeCCccEEEECC-------CEecCCC
Confidence 4899999998773 3478999999999999999999999986543 3456899999999999862 6999999
Q ss_pred CCC
Q 005907 95 YPS 97 (670)
Q Consensus 95 ~Pt 97 (670)
||.
T Consensus 108 ~~~ 110 (110)
T 3a0c_A 108 GPA 110 (110)
T ss_dssp CC-
T ss_pred cCC
Confidence 984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=119.42 Aligned_cols=74 Identities=22% Similarity=0.270 Sum_probs=62.5
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||+||++.|. ..+.|.|.++|||||.|.++.++|+|++... ....+++|+|+|||||++. ++||||.
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~-~g~~~l~l~~dGnlvl~~~-------~~W~S~~ 107 (115)
T 2dpf_A 38 GRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQKDGRFVIYGP-------VLWSLGP 107 (115)
T ss_dssp TEEEEECSCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEECS-------EEECSST
T ss_pred CEEEEeCCCCCCC--CceEEEECCCCcEEEECCCceEEEEcCCCCC-CCCEEEEEeCCCeEEEECC-------CEEECCC
Confidence 5899999999884 3578999999999999999999999986533 2356899999999999852 7999999
Q ss_pred CCCC
Q 005907 95 YPSD 98 (670)
Q Consensus 95 ~Ptd 98 (670)
+++.
T Consensus 108 ~~~~ 111 (115)
T 2dpf_A 108 NGCR 111 (115)
T ss_dssp TCBC
T ss_pred CCCc
Confidence 8764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.42 E-value=5.1e-13 Score=115.18 Aligned_cols=74 Identities=23% Similarity=0.412 Sum_probs=61.0
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||+||++.+ +..+.|.|.++|||||.| ++.++|+|++... ....+++|+++|||||++. .+.++||||+
T Consensus 37 ~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~-~g~~~l~l~~dGnlvl~~~----~~~~~W~S~~ 108 (112)
T 1xd5_A 37 NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQ-NGNYYLILQRDRNVVIYDN----SNNAIWATHT 108 (112)
T ss_dssp TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-TTEEEEECCCCCS-CCCCEEEECTTSCEEEECT----TSCEEEECCC
T ss_pred CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-CCEEEEECCccCC-CCCEEEEEeCCCcEEEECC----CCceEEECCC
Confidence 389999999863 345789999999999999 8899999986533 2346899999999999975 4568999999
Q ss_pred CC
Q 005907 95 YP 96 (670)
Q Consensus 95 ~P 96 (670)
+.
T Consensus 109 ~~ 110 (112)
T 1xd5_A 109 NV 110 (112)
T ss_dssp CC
T ss_pred cc
Confidence 85
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=113.65 Aligned_cols=69 Identities=20% Similarity=0.386 Sum_probs=58.0
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeec
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSF 93 (670)
.++||+|||+.| +..+.|.+.+||||||.|.++.++|+|++... ....+++|+|+|||||++. ++|||=
T Consensus 48 ~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~-~g~~~l~l~~~Gnlvl~~~-------~~W~Sg 116 (119)
T 1b2p_A 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGD-------ALWATQ 116 (119)
T ss_dssp TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEECSCCCC-SSCEEEEECTTSCEEEEES-------EEEECC
T ss_pred CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEcCCCCCC-CCCEEEEEECCCcEEEECc-------cEeCCC
Confidence 489999999977 33488999999999999999999999986533 2456899999999999872 799983
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=111.55 Aligned_cols=69 Identities=25% Similarity=0.358 Sum_probs=57.9
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeec
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSF 93 (670)
.++||+||++.+ +..+.|.|..||||||.|.++.++|++++... ....+|+|+|+|||||+++ ++|||=
T Consensus 37 ~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~-~~~~~~~L~ddGNlvly~~-------~~W~s~ 105 (109)
T 3dzw_A 37 DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQKDRNVVIYGT-------ARWATG 105 (109)
T ss_dssp TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECCCCCS-SSCEEEEECTTSCEEEEES-------CCCCCC
T ss_pred CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECCCCCC-CCCEEEEEeCCCEEEEECC-------CEEeCC
Confidence 389999999876 34578999999999999999999999987543 2356899999999999974 689984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=8.6e-12 Score=125.24 Aligned_cols=147 Identities=15% Similarity=0.057 Sum_probs=115.1
Q ss_pred HHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEE
Q 005907 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 436 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (670)
....+.|.+...++.|+.+.||++.. .++.+++|............+.+|+.+++.+. |..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456788888899999999999975 47889999986532233456889999999885 67788999999988899999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS----------------------------------- 559 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~----------------------------------- 559 (670)
|||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999987641 11123467889999999999811
Q ss_pred ---------------------CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 560 ---------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 560 ---------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999997654
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-11 Score=106.72 Aligned_cols=68 Identities=19% Similarity=0.321 Sum_probs=54.4
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
.++||.+|+..+- ..+.|.|.+||||||.|.++.++|++++... ....+|+|+|+|||||++. .+|+|
T Consensus 44 ~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~-~~~~~~~L~~dGnlvly~~-------~~W~s 111 (113)
T 3mez_B 44 TNIVWESGTSGRG--QHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAVVYGP-------AVWST 111 (113)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTSCEEEECSCCCS-SSCCEEEECTTSCEEEECS-------EEEES
T ss_pred CEEEEECCcccCC--cCEEEEEeCCCcEEEECCCCCEEEECCCcCC-CCCEEEEEcCCceEEEecC-------CEecC
Confidence 5789999998652 3478999999999999988899999987543 2346889999999999863 68987
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.6e-12 Score=106.49 Aligned_cols=66 Identities=26% Similarity=0.413 Sum_probs=54.8
Q ss_pred eEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 17 ~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
+||.+|++.. +..+.|.|.+||||||.|.++.++|++++... ....+|+|+|+|||||+++ .+|+|
T Consensus 43 ~vW~snt~~~--~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~-~~~~~~~L~~dGNlvly~~-------~~W~t 108 (110)
T 3r0e_B 43 YGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDGFGVIYGP-------AIFET 108 (110)
T ss_dssp SCEECCCTTS--SSSCEEEECTTSCEEEECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEECS-------EEEES
T ss_pred EEEECCCcCC--CcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCC-CCCEEEEEcCCccEEEecC-------CEecC
Confidence 7999999862 33478999999999999999999999987532 2346899999999999973 69987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.8e-11 Score=104.21 Aligned_cols=96 Identities=20% Similarity=0.267 Sum_probs=73.4
Q ss_pred CCCCCCCCcceEEEecCCcEEEECC-CCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCccc
Q 005907 23 RLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLL 101 (670)
Q Consensus 23 r~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlL 101 (670)
.+.|+.....+|.+..||||||.+. .++++|++++... .....++|+++|||||++. .+.++|||=.+-
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~-~~~~~l~l~~dGNLVl~d~----~~~~iW~S~t~~----- 86 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGR-GQHCFMRLGHSGELDITDD----RLNTVFVSNTVG----- 86 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTS-CSSCEEEECTTSCEEEECT----TSCEEEECSCCC-----
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccC-CcCEEEEEeCCCcEEEECC----CCCEEEECCCcC-----
Confidence 5677877778999999999999988 5899999987643 2356899999999999986 456899983310
Q ss_pred CCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 102 PGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 102 pg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
..|.|.+.++.+|+..+ +. .+.|.++|
T Consensus 87 --------------------------~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 87 --------------------------QEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp --------------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred --------------------------CCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 12457889999997554 43 57898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.17 E-value=8.8e-11 Score=100.62 Aligned_cols=97 Identities=14% Similarity=0.223 Sum_probs=71.3
Q ss_pred CCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccC
Q 005907 23 RLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLP 102 (670)
Q Consensus 23 r~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLp 102 (670)
.+.++.....+|.+..||||||.+.++ +|++++... .....++|+++|||||++.+ .+.++|||..+
T Consensus 13 ~g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~-~~~~~l~l~~dGNLVl~~~~---~~~~vW~S~t~------- 79 (111)
T 3mez_A 13 TDNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGR-GVDCTLRLNNRGQLEIHSAN---SNTPVWVYPRS------- 79 (111)
T ss_dssp TTCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTS-CSSCEEEECTTSCEEEECSS---CSSCSEEESSS-------
T ss_pred CCCEEecCCEEEEEccCCeEEEECCCC--EEECCcccC-CcCEEEEEcCCCcEEEEeCC---CCEEEEEeccc-------
Confidence 345565556889999999999999887 999987543 23478999999999999862 22359999731
Q ss_pred CCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 103 GMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 103 g~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
.....|.|.+.++.+|+..+ +. .++|.++.
T Consensus 80 ----------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp ----------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred ----------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 01124678999999997554 43 68898764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.16 E-value=8.5e-11 Score=100.37 Aligned_cols=65 Identities=18% Similarity=0.261 Sum_probs=54.3
Q ss_pred EEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 18 vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
+|.+|+..+ +..+.|.|.+||||||.|.++.++|++++... ....+|+|+|+|||||++. .+|+|
T Consensus 39 ~Wssnt~~~--~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~-~~~~~~~L~~dGNlvly~~-------~~W~s 103 (109)
T 3r0e_A 39 NWQSNTANN--GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSV-KGNYAAVVHPDGRLVVFGP-------SVFKI 103 (109)
T ss_dssp TEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECCCCCS-SSCCEEEEETTTEEEEECS-------EEEEE
T ss_pred eEEcCCCCC--CCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCC-CcCEEEEEcCCCeEEEEec-------CEECC
Confidence 699998865 33588999999999999999999999987542 3456899999999999963 69998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=9.9e-11 Score=117.06 Aligned_cols=139 Identities=17% Similarity=0.126 Sum_probs=102.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e 516 (670)
...+.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3456654343456669999998777888999987543 2356788999999886544 5668888887778899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------- 559 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~------------------------------------- 559 (670)
|++|.+|. .. . .+. ..++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~---~---~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SS---H---LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TS---C---CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cC---c---CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 21 1 121 246677788888888643
Q ss_pred ------------------CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 560 ------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 560 ------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
+..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876678999998754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.02 E-value=9e-10 Score=94.14 Aligned_cols=92 Identities=16% Similarity=0.310 Sum_probs=67.3
Q ss_pred CCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCC
Q 005907 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (670)
Q Consensus 24 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg 103 (670)
+.++......|.+..||||+|.+. .++|++++... .....++|+++|||||++. .+.++|||-.+-
T Consensus 18 g~~L~sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~-~~~~~l~l~~dGNLvl~d~----~~~~iW~S~t~~------- 83 (110)
T 3r0e_B 18 DGRLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGN-GEHCFLRLNHKGELIIKDD----DFKTIWSSRSSS------- 83 (110)
T ss_dssp TEEEECSSCEEEECTTSCEEEECS--SSCEECCCTTS-SSSCEEEECTTSCEEEECT----TCCEEEECCCCC-------
T ss_pred CCEEEeCCEEEEEcCCCeEEEECC--eEEEECCCcCC-CcCEEEEEeCCCcEEEEeC----CCCEEEEcCCcC-------
Confidence 344444558899999999999877 58999987643 2346899999999999986 457899986410
Q ss_pred CccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeC
Q 005907 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (670)
Q Consensus 104 ~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg 157 (670)
..|.|.+.++.+|+..+ +. .+.|.+|
T Consensus 84 ------------------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~ 109 (110)
T 3r0e_B 84 ------------------------KQGEYVLILQDDGFGVI--YG--PAIFETS 109 (110)
T ss_dssp ------------------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred ------------------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence 12347788998887553 44 3778876
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=1.7e-09 Score=92.33 Aligned_cols=86 Identities=19% Similarity=0.347 Sum_probs=64.4
Q ss_pred cceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCcccccc
Q 005907 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (670)
Q Consensus 31 ~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~ 110 (670)
...|.+..||||+|.+. +.++|++++... .....++|+++|||||++. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~----~~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSP----RNNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTS-SSSCEEEECTTSCEEEECT----TSCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccC-CCCEEEEEeCCCCEEEECC----CCCEEEECCCCC--------------
Confidence 47899999999999987 789999987543 2346899999999999986 457899986421
Q ss_pred ccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeC
Q 005907 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (670)
Q Consensus 111 ~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg 157 (670)
..+.|.+.++.+|+..+ ++. +.|.++
T Consensus 80 -----------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~ 105 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVI--YGT--ARWATG 105 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEE--EES--CCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEE--ECC--CEEeCC
Confidence 12457788998887543 443 567655
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.4e-09 Score=92.73 Aligned_cols=94 Identities=18% Similarity=0.366 Sum_probs=69.8
Q ss_pred cCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCccc
Q 005907 22 NRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLL 101 (670)
Q Consensus 22 Nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlL 101 (670)
..+.|+......|.+..||||||.++ +|+|++... .....++|+++|||||++. .+.++|+|-..
T Consensus 13 ~~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~-~~~~~l~l~~dGnLvl~d~----~~~~vWss~t~------ 77 (109)
T 3r0e_A 13 DTEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANN-GRDCKLTLTDYGELVIKNG----DGSTVWKSGAQ------ 77 (109)
T ss_dssp CTTCEEEETTEEEEECTTSCEEEETT----TEECCCTTS-CSSCEEEECTTSCEEEECT----TSCEEEECCCC------
T ss_pred CCCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCC-CCcEEEEEcCCCeEEEEeC----CCCEEEcCCCc------
Confidence 34566666668899999999999985 799987643 2356889999999999986 45689976210
Q ss_pred CCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCCC
Q 005907 102 PGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (670)
Q Consensus 102 pg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~~ 159 (670)
...+.|.+.++.+|+.. ++. .+.|.+++|
T Consensus 78 -------------------------~~~~~~~~~L~~dGNlv--ly~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 -------------------------SVKGNYAAVVHPDGRLV--VFG--PSVFKIDPW 106 (109)
T ss_dssp -------------------------CSSSCCEEEEETTTEEE--EEC--SEEEEECTT
T ss_pred -------------------------CCCcCEEEEEcCCCeEE--EEe--cCEECCCCc
Confidence 01345788999988654 344 688999887
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=92.95 Aligned_cols=66 Identities=18% Similarity=0.202 Sum_probs=53.5
Q ss_pred EEeccCCCCCCCCcceEEEecCCcEEEECCCCc-EEEeecCcc-CccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNI-VVWSAYLSK-EVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 18 vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~-~~Wst~~~~-~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
||.+|+..+ ...+.|.+..||||||.|.++. ++|+|++.. ......++.|+++|||||++ ..+|+|
T Consensus 40 vW~snt~~~--~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 40 GFQSNTHGR--GVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CEECCCTTS--CSSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred EEECCcccC--CcCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 999999876 2347899999999999999875 599998632 22345789999999999996 369997
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=3e-09 Score=111.85 Aligned_cols=142 Identities=17% Similarity=0.214 Sum_probs=106.0
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEec--ccc-hhchHHHHHHHHHHhcCC--CCceeeEEEEEEeC---CeeEEEE
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIY 515 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 515 (670)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999874 4678888775 321 123457788999999987 45678888888766 3478999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------ 559 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~------------------------------------ 559 (670)
||++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123567788889999999999999731
Q ss_pred -------------------CCCeEeccCCCCCEEEcCCCc--eEEEeecCcee
Q 005907 560 -------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (670)
Q Consensus 560 -------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 591 (670)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.4e-09 Score=109.86 Aligned_cols=186 Identities=18% Similarity=0.213 Sum_probs=120.4
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCc--eeeEEEEEEeCC---eeEEEEEccC
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN--LVKLLGCCIQGE---EKLLIYEFMP 519 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~~ 519 (670)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 579999999999863 56888886432 34567889999998873 333 345554433333 3478999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS---------------------------------------- 559 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 559 (670)
|.+|...... .++..++..++.++++.++.||+..
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988754321 2566777778888888888888621
Q ss_pred ---------------CCCeEeccCCCCCEEEcC--CCceEEEeecCceecCCCcccCCccc------------cccccCc
Q 005907 560 ---------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGDETEGNTNR------------VVGTYGY 610 (670)
Q Consensus 560 ---------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~------------~~gt~~y 610 (670)
...++|+|++|.||++++ ...+.|+||+.+..-........... .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 134899999999999998 55678999998875321100000000 0000011
Q ss_pred cc-ccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 611 MA-PEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 611 ~a-PE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.. |+.... .....+.|+++.++|++.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 112368999999999999999884
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=1.2e-08 Score=102.03 Aligned_cols=70 Identities=24% Similarity=0.457 Sum_probs=60.0
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.+++|.+++..+- . ..|.+..+|+|++.|.++.++|++++... ...+|+|+++|||||++. +++|||||
T Consensus 183 ~~~yW~Sgt~~~~--~-~~l~l~~dGnLvl~d~~~~~vWsS~t~~~--~~~rl~Ld~dGnLvly~~------~~~Wqsf~ 251 (276)
T 3m7h_A 183 GAATWNAGTQGKG--A-VRAVFQGDGNLVVYGAGNAVLWHSHTGGH--ASAVLRLQANGSIAILDE------KPVWARFG 251 (276)
T ss_dssp SSEEEECCCTTTT--C-CEEEECTTSCEEEECTTSCEEEECSCTTC--TTCEEEECTTSCEEEEEE------EEEEESSS
T ss_pred CeEEEECCCCCCc--c-EEEEEcCCCeEEEEeCCCcEEEEecCCCC--CCEEEEEcCCccEEEEcC------CCeEEccC
Confidence 4899999998762 2 78999999999999998899999986643 357899999999999973 47999999
Q ss_pred C
Q 005907 95 Y 95 (670)
Q Consensus 95 ~ 95 (670)
|
T Consensus 252 ~ 252 (276)
T 3m7h_A 252 F 252 (276)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.77 E-value=4.5e-08 Score=82.67 Aligned_cols=56 Identities=23% Similarity=0.379 Sum_probs=46.9
Q ss_pred ceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 32 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
-+|.+..||||||.+. +++||++|+.........+.|.++|||||+|. .+.++|.|
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~----~~~~vWss 76 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS----SGRSLWAS 76 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT----TCCEEEEC
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC----CcEEEEEe
Confidence 5788999999999975 58999999765444567899999999999987 56789986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.55 E-value=1.6e-07 Score=92.20 Aligned_cols=92 Identities=20% Similarity=0.250 Sum_probs=67.6
Q ss_pred CCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCC
Q 005907 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (670)
Q Consensus 24 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg 103 (670)
++|.++ .-+|.+..+|+|+|.+++ .++|++++... ....+++|+++||||+++. ++.++||||.+
T Consensus 145 ~d~s~G-~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~-~~~~~~~L~~~Gnl~ly~~----~~~~vw~s~~~-------- 209 (236)
T 1dlp_A 145 QSLQLS-PYRLSMETDCNLVLFDRD-DRVWSTNTAGK-GTGCRAVLQPNGRMDVLTN----QNIAVWTSGNS-------- 209 (236)
T ss_dssp CCCBCS-SCEEEEETTTEEEEEBTT-BCCSCCCCCSS-CSSCEEEEETTTEEEEEET----TTEEEEECCCC--------
T ss_pred cEeecC-cEEEEECCCCcEEEEcCC-EeEEeCCCcCC-CCceEEEECCCCcEEEEeC----CCcEEEEeCCC--------
Confidence 345434 367999999999999775 68999986533 2346789999999999985 45789999943
Q ss_pred CccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeC
Q 005907 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (670)
Q Consensus 104 ~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg 157 (670)
| ++|.|++.+|++|..+++ . ..||.+|
T Consensus 210 -----------------~------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 210 -----------------R------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp -----------------C------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred -----------------C------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 1 236789999999986654 3 3788764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=5.9e-06 Score=84.48 Aligned_cols=136 Identities=20% Similarity=0.149 Sum_probs=93.7
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCC---ceeeEEEEEE-eCCeeEEEEEccCC
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPN 520 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~ 520 (670)
.+.++.|....||+. +..+++|+... ......+..|..+++.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357888999999987 57788888532 23456788999999998752 3566666664 34457899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------------------------------------------ 558 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~------------------------------------------ 558 (670)
..|...... .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 123444444555555555555532
Q ss_pred ---------------CCCCeEeccCCCCCEEEcC---CCc-eEEEeecCcee
Q 005907 559 ---------------SRLRIIHRDLKASNVLLDQ---DMN-PKISDFGLVRT 591 (670)
Q Consensus 559 ---------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~ 591 (670)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 355 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.1e-05 Score=80.74 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=98.8
Q ss_pred CcccceeeeecCce-eEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEEc
Q 005907 441 NFSINNKLGEGGFG-PVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 441 ~~~~~~~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 3443 355666665 58988764 4567888976432 3456788999888874 33467888999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-------------------------------------- 559 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------- 559 (670)
+++.++.+..... ......+..+++..|..||+..
T Consensus 102 l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 102 IPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9998887765321 1122345566666677776431
Q ss_pred -----------------CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 560 -----------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 560 -----------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.5e-06 Score=87.28 Aligned_cols=80 Identities=6% Similarity=0.000 Sum_probs=55.6
Q ss_pred ceee-eecCceeEEEEEec-------CCcEEEEEEecccc---hhchHHHHHHHHHHhcCCC---CceeeEEEEEEeC--
Q 005907 445 NNKL-GEGGFGPVYKGTLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG-- 508 (670)
Q Consensus 445 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~-- 508 (670)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3577 88889999998764 26778888764322 1112467788888888742 3467788777654
Q ss_pred -CeeEEEEEccCCCCHH
Q 005907 509 -EEKLLIYEFMPNKSLD 524 (670)
Q Consensus 509 -~~~~lV~e~~~~g~L~ 524 (670)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.5e-05 Score=80.24 Aligned_cols=75 Identities=9% Similarity=0.158 Sum_probs=50.1
Q ss_pred ceeeeecCceeEEEEEec-CCcEEEEEEecccch-------hchHHHHHHHHHHhcCCC--Cc-eeeEEEEEEeCCeeEE
Q 005907 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQH--RN-LVKLLGCCIQGEEKLL 513 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 513 (670)
.+.||.|..+.||++... +++.++||....... .....+..|..+++.+.+ |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899998643211 123456788888887742 33 4455543 4556789
Q ss_pred EEEccCCC
Q 005907 514 IYEFMPNK 521 (670)
Q Consensus 514 V~e~~~~g 521 (670)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00012 Score=75.52 Aligned_cols=141 Identities=16% Similarity=0.212 Sum_probs=78.9
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-----CCceeeEE-E--EEEeCCeeEEEEEc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKLL-G--CCIQGEEKLLIYEF 517 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~e~ 517 (670)
+.|+.|....||+....++ .+++|+.... ..++..|+.+++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987544 5889988642 233344555555442 24443310 1 12346678899999
Q ss_pred cCCCCHH-----------HHH---hhcCC----C-------CCCCHHHH-------------------------------
Q 005907 518 MPNKSLD-----------SFI---FDQTR----R-------TLLDWSQR------------------------------- 541 (670)
Q Consensus 518 ~~~g~L~-----------~~l---~~~~~----~-------~~~~~~~~------------------------------- 541 (670)
++|..+. ..| +.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111 11000 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 542 FHIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 542 ~~i~~~ia~~l~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
..+...+..++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666653 0134599999999999998888999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00019 Score=72.36 Aligned_cols=80 Identities=16% Similarity=0.210 Sum_probs=58.4
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCC---ceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~e 516 (670)
....-.+.+|.|..+.||+.+..+|+.+++|+...........|..|+..|+.|... -+.+++++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 345566889999999999999999999999987544334445678899988887421 24455544 23478999
Q ss_pred ccCCCCH
Q 005907 517 FMPNKSL 523 (670)
Q Consensus 517 ~~~~g~L 523 (670)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00098 Score=67.82 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=92.3
Q ss_pred cceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
-.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346899999999999986 5778889986532 3457888988888874 35688888888888889999999998
Q ss_pred CCHH--------HHH---hhcCC-C------------------CCCCHHHHH---HHH----------------HHHHHH
Q 005907 521 KSLD--------SFI---FDQTR-R------------------TLLDWSQRF---HII----------------CGTARG 551 (670)
Q Consensus 521 g~L~--------~~l---~~~~~-~------------------~~~~~~~~~---~i~----------------~~ia~~ 551 (670)
..+. ..| +.... . -.-+|.... ++. ..+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 111 22111 0 012343321 111 111111
Q ss_pred -HHHHHh-CCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 552 -LLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 552 -l~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00056 Score=72.99 Aligned_cols=77 Identities=14% Similarity=0.120 Sum_probs=46.7
Q ss_pred CCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCCcccccc--ccCcccccccCCCC---CCccchHHHHHHHHH
Q 005907 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG--TYGYMAPEYASDGQ---FSIKSDVFSFGILLL 635 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvwSlGvil~ 635 (670)
..++|+|++|.|||++.++ ++|+||+.+..-.. ......... ...|.+|+...... -....++.+....+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998876 99999998765311 000000110 13466665543111 122345567777788
Q ss_pred HHHcCC
Q 005907 636 EIVSGK 641 (670)
Q Consensus 636 elltG~ 641 (670)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0082 Score=61.13 Aligned_cols=144 Identities=15% Similarity=0.123 Sum_probs=79.2
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc--eeeEEEE------EEeCCeeEEEEE
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e 516 (670)
.+.|+.|....+|+....++ .+++|..... .....+..|+.++..+.... +.+++.. ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677788899999987555 6888987642 12235566777776663211 2333311 123456789999
Q ss_pred ccCCCCHHH-----------H---HhhcCC----C--CCC---CHHHHHH------------HHHHHHHHHHHHHhC---
Q 005907 517 FMPNKSLDS-----------F---IFDQTR----R--TLL---DWSQRFH------------IICGTARGLLYLHQD--- 558 (670)
Q Consensus 517 ~~~~g~L~~-----------~---l~~~~~----~--~~~---~~~~~~~------------i~~~ia~~l~yLH~~--- 558 (670)
|++|..+.. . ++.... . ... .|...+. +...+.+.++.|+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865321 0 111100 0 001 1221110 001134455555532
Q ss_pred -CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 559 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 559 -~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134599999999999999876668999997754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0014 Score=66.31 Aligned_cols=71 Identities=10% Similarity=0.167 Sum_probs=44.6
Q ss_pred ceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEcc-CCCC
Q 005907 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKS 522 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~g~ 522 (670)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 56888887543221 1223567777776642222 455544 344457899999 6654
Q ss_pred H
Q 005907 523 L 523 (670)
Q Consensus 523 L 523 (670)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0011 Score=70.95 Aligned_cols=72 Identities=19% Similarity=0.319 Sum_probs=48.5
Q ss_pred eeeeecCceeEEEEEecC--------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEE
Q 005907 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 516 (670)
+.|+.|....+|++...+ ++.+++|+.... .....+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888889999998753 467888887431 111455678888888753333 56666543 2 28999
Q ss_pred ccCCCCH
Q 005907 517 FMPNKSL 523 (670)
Q Consensus 517 ~~~~g~L 523 (670)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.005 Score=63.18 Aligned_cols=141 Identities=14% Similarity=0.072 Sum_probs=71.8
Q ss_pred eeeeecCcee-EEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeeEEEEEccCCCC
Q 005907 446 NKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (670)
Q Consensus 446 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g~ 522 (670)
+.|+.|+... +|+....+++.+++|...... ...+..|+.+++.+.. -.+.+++.+.. ..-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3565554444 667765446677777643321 1334556666666532 23456666532 22378999998776
Q ss_pred HHHHHhhcC---------------------C--CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 005907 523 LDSFIFDQT---------------------R--RTLLDWSQRF-------H-I------------ICGTARGLLYLH--- 556 (670)
Q Consensus 523 L~~~l~~~~---------------------~--~~~~~~~~~~-------~-i------------~~~ia~~l~yLH--- 556 (670)
+.+++.... . ....+..... . + ...+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654432110 0 0111111100 0 0 001112222221
Q ss_pred hCCCCCeEeccCCCCCEEEcCC----CceEEEeecCcee
Q 005907 557 QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (670)
Q Consensus 557 ~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 591 (670)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0087 Score=61.14 Aligned_cols=142 Identities=14% Similarity=0.155 Sum_probs=80.4
Q ss_pred eeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCC--ceeeEEEE-----EEeCCeeEEEEEcc
Q 005907 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFM 518 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~e~~ 518 (670)
+.|+ |....||+....+|+.+++|..... ......+..|..+++.+... .+++++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 8888999987766778999998532 12335666777777766421 23444432 22345667899999
Q ss_pred CCCCHH-----H------HH---hhc----C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005907 519 PNKSLD-----S------FI---FDQ----T--RRTLLDWSQR----FHI---------------ICGTARGLLYLHQ-- 557 (670)
Q Consensus 519 ~~g~L~-----~------~l---~~~----~--~~~~~~~~~~----~~i---------------~~~ia~~l~yLH~-- 557 (670)
+|..+. . .| +.. . .....++... ..+ ...+...++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 11 110 0 0111222111 000 0011112223321
Q ss_pred --CCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 558 --DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 558 --~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999998 4 899999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0032 Score=65.80 Aligned_cols=141 Identities=17% Similarity=0.228 Sum_probs=80.7
Q ss_pred eeeeecCceeEEEEEecC--------CcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeEEEEE
Q 005907 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 516 (670)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|..+++.+. +.-..++++.+.+ -+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888899988642 467888886332 223456678988888774 2223566666533 28999
Q ss_pred ccCCCCHHH--------------HHhh-cCC----CCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 005907 517 FMPNKSLDS--------------FIFD-QTR----RTLLD--WSQRFHIICGTA-------------------RGLLYL- 555 (670)
Q Consensus 517 ~~~~g~L~~--------------~l~~-~~~----~~~~~--~~~~~~i~~~ia-------------------~~l~yL- 555 (670)
|++|..|.. .|.+ +.. ..... +.++.++..++. +.++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865531 1110 010 11122 334444443321 122333
Q ss_pred ---HhC-CCCCeEeccCCCCCEEEcCC----CceEEEeecCcee
Q 005907 556 ---HQD-SRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (670)
Q Consensus 556 ---H~~-~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 591 (670)
... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23458999999999999876 7899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.011 Score=63.55 Aligned_cols=73 Identities=15% Similarity=0.122 Sum_probs=47.2
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
+.|+.|-...+|++...+ +..+++|+....... ...-.+|..+++.|...++ .++++.+ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 578889899999998754 477888877432221 1122578888888865444 5667665 22 259999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0038 Score=65.18 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=43.6
Q ss_pred eeeeecCceeEEEEEecCC---------cEEEEEEecccchhchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeeEEEE
Q 005907 446 NKLGEGGFGPVYKGTLVDG---------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~~---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 515 (670)
+.|+.|..-.+|+....++ +.+++|+...... .......|..+++.+...+ ..++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 5778888889999986542 6788887654222 1223467888887774333 34666543 2 36899
Q ss_pred EccCCCCH
Q 005907 516 EFMPNKSL 523 (670)
Q Consensus 516 e~~~~g~L 523 (670)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.058 Score=55.38 Aligned_cols=31 Identities=26% Similarity=0.325 Sum_probs=27.6
Q ss_pred CCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 561 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.16 E-value=0.3 Score=51.58 Aligned_cols=73 Identities=18% Similarity=0.192 Sum_probs=46.9
Q ss_pred eeeeecCceeEEEEEecC--------CcEEEEEEecccchhchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeeEEEEE
Q 005907 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e 516 (670)
+.|..|-...+|+....+ ++.+++|+...... ......+|..+++.+...+ ..++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 577778888999988753 57788888644222 2223457888887774222 34555432 2 368999
Q ss_pred ccCCCCH
Q 005907 517 FMPNKSL 523 (670)
Q Consensus 517 ~~~~g~L 523 (670)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.90 E-value=0.44 Score=44.91 Aligned_cols=103 Identities=14% Similarity=0.059 Sum_probs=67.1
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccCC
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 600 (670)
-+|.++|.. ...++++++++.++.|.+++|.-+-... . -..+=+.|..|++..+|.|...+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 378898865 3456999999999999999987763211 1 12333457899999999887764 1110
Q ss_pred ccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 005907 601 TNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKN 643 (670)
Q Consensus 601 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 643 (670)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888763 3456788999999999998876555
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.63 E-value=0.82 Score=47.85 Aligned_cols=29 Identities=24% Similarity=0.390 Sum_probs=24.7
Q ss_pred eEeccCCCCCEEE------cCCCceEEEeecCcee
Q 005907 563 IIHRDLKASNVLL------DQDMNPKISDFGLVRT 591 (670)
Q Consensus 563 ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 591 (670)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4467799999998764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.16 E-value=13 Score=36.08 Aligned_cols=64 Identities=14% Similarity=0.201 Sum_probs=41.4
Q ss_pred ceEEeccCCCC--CC----CCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeC
Q 005907 16 EVVWVANRLNP--IN----DSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDE 80 (670)
Q Consensus 16 t~vW~ANr~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~ 80 (670)
+++|...+..+ +. .+.+.+.++.++.+...|++|..+|.-..... .....++.+.+||+++.+.
T Consensus 26 ~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~-~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 26 EIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAG-CEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTT-CEEEEEEECTTSCEEEEEE
T ss_pred eEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCC-ccccccEECCCCCEEEEec
Confidence 57899877642 11 12345555666667777888999999865321 1334567788898888765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.72 E-value=3.2 Score=38.92 Aligned_cols=116 Identities=11% Similarity=0.080 Sum_probs=77.9
Q ss_pred CCCCceeeEEEEEEeCCeeEEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 005907 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (670)
Q Consensus 493 l~H~niv~l~g~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~ 571 (670)
..||+++.. ..-.+.+.+.+.++.-+. -++.. + ..++...+++++.+|+....+++. =+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888866 455556666666665432 23333 2 126788999999999988866664 478889999
Q ss_pred CEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005907 572 NVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 572 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
||+++.++.+++.=.|+. .-++|.. .+...=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik-------------------~~l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQ-------------------NVVDPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEET-------------------TTBSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCc-------------------cCCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999755532 2244431 1222223367788899999988874
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=82.37 E-value=0.62 Score=36.29 Aligned_cols=25 Identities=32% Similarity=0.714 Sum_probs=22.2
Q ss_pred cccChHHHHHHhccCCceEEEeecc
Q 005907 305 KSMNLKECREGCLENSSCMAYTNSD 329 (670)
Q Consensus 305 ~~~s~~~C~~~Cl~~CsC~a~~~~~ 329 (670)
..+++++|+..|+.+=.|.||.|..
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~ 52 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV 52 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc
Confidence 3568999999999999999999963
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.35 E-value=0.2 Score=53.74 Aligned_cols=61 Identities=15% Similarity=0.189 Sum_probs=18.3
Q ss_pred cceeeeecCceeEEEEEecC-CcEEEE------EEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 005907 444 INNKLGEGGFGPVYKGTLVD-GQEIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (670)
+.+.|| ||.||+|.+.. ..+||+ |..+. ..++....+.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999854 367888 66543 223344578889999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 670 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 6e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 8e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-65
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+G + ++ ++ SL + T + + I TA+G+ YLH S
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA--- 616
IIHRDLK++N+ L +D+ KI DFGL ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGKK 642
+S +SDV++FGI+L E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 6e-63
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 495
D+F ++LG G G V+K + G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
+ +I+HRD+K SN+L++ K+ DFG+ + N VGT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
+S++SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-60
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 7/214 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L++EFM + L ++ Q + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + +PE S
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 620 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
++S KSDV+SFG+L+ E+ S K RS+++V
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 9/222 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
IHRDL+A+N+L+ ++ KI+DFGL R +E + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 620 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
F+IKSDV+SFGILL EIV+ + Y T +I ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLER 225
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-57
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 13/230 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
H+ D ++HRDLK +NV LD N K+ DFGL R D + VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYM 181
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+PE + ++ KSD++S G LL E+ + + + ++ L G + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIRE 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK + A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL ++ EF ++D+ + + R L SQ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H +IIHRDLKA N+L D + K++DFG+ ++ +GT +MAPE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 616 A-----SDGQFSIKSDVFSFGILLLEIVSGK 641
D + K+DV+S GI L+E+ +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 497
+++ + LGEG +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYAS 617
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 618 DGQF-SIKSDVFSFGILLLEIVSGK 641
+F + DV+S GI+L +++G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-57
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 9/222 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+ +HRDL A N L++ K+SDFGL R DE + + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 620 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+FS KSD+++FG+L+ EI S K Y T H+++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQ 216
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 8e-57
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNE 486
EL + FS ++G G FG VY + + + +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
V KL+H N ++ GC ++ L+ E+ + D + L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G +GL YLH +IHRD+KA N+LL + K+ DFG N VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 607 TYGYMAPEYA---SDGQFSIKSDVFSFGILLLEIVSGK 641
T +MAPE +GQ+ K DV+S GI +E+ K
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 9e-57
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
+HRDL A NVL+ +D K+SDFGL + + G + APE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 619 GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663
+FS KSDV+SFGILL EI S + Y +++ V K +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGY 217
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 9/224 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ +T + L Q + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
+ +HRDL+A+N+L+ +++ K++DFGL R +E + APE A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 620 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMH 663
+F+IKSDV+SFGILL E+ + + Y ++ V + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGY 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-56
Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 17/235 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+++L G LI E+ P ++ + ++ D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H R+IHRD+K N+LL KI+DFG + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 175
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670
K D++S G+L E + GK + ++T +S++ TF V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRVEFTFPDFV 227
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 62/230 (26%), Positives = 109/230 (47%), Gaps = 14/230 (6%)
Query: 438 ATDNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
DN I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRVVGTYGYM 611
YL + +HRDL A NVLL KISDFGL + G D++ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
APE + +FS +SDV+S+G+ + E +S + Y+ ++ + +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQ 227
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 1e-55
Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 33/259 (12%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKEL 483
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------- 535
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ + T+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 536 -------------LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
I+DFGL R + +M PE +++ +SDV+++G++L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 643 NRGFYRSDTKVNLIGHVSK 661
Y +I +V
Sbjct: 241 Q--PYYGMAHEEVIYYVRD 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 52/212 (24%), Positives = 111/212 (52%), Gaps = 10/212 (4%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ ++ N+V L + G+E ++ E++ SL + + D Q +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 181
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+MAPE + + K D++S GI+ +E++ G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 1e-54
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 9/223 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASD 618
+ IHRDL A N L+ ++ K++DFGL R GD + + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 619 GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+FSIKSDV++FG+LL EI + + Y + + K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEK 231
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 2e-54
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 430 FELATIANATDNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 475
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL 535
+E+ ++ +E + + H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
Q ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 596 ETEGNTNRVVG---TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
++ +G + APE +F+ SDV+S+GI++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 17/229 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQG-LKELKNEVILFSKLQH 495
+F N +G G FG VY GTL+D AVK L++I++ G + + E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 496 RNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N++ LLG C++ E L++ +M + L +FI ++T + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGTYGYMA 612
+ + + +HRDL A N +LD+ K++DFGL R E + N+ +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
E +F+ KSDV+SFG+LL E+++ Y ++ ++ +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ 249
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 500 KLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+ + L+ ++ + SL ++ R + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 556 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTY 608
H + + I HRDLK+ N+L+ ++ I+D GL D + N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 609 GYMAPEYASD------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
YMAPE D + ++D+++ G++ EI G +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 19/228 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 499 VKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+ + +L+ E M + +L +++ R ++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 555 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAP 613
LH + IIHRDLK N+ + + KI D GL V+GT +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 614 EYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
E + ++ DV++FG+ +LE+ + + + + V+
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTS 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 15/223 (6%)
Query: 445 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-RVVGTYGYMAPEYASD 618
+HRDL A NVLL KISDFGL + DE + APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 619 GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+FS KSDV+SFG+L+ E S + YR + + K
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEK 225
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-53
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------------FDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F+ + + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 602 NRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+MA E + ++ SDV+S+G+LL EIVS Y T L + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 9e-53
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 31/231 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+N LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR------------------ 533
L H N+V LLG C LI+E+ L +++ + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 534 --TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+L + A+G+ +L +HRDL A NVL+ KI DFGL R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
D +MAPE +G ++IKSDV+S+GILL EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 13/233 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
VKL E+ + N L +I D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
H IIHRDLK N+LL++DM+ +I+DFG + + + N VGT Y++PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
++ SD+++ G ++ ++V+G +R+ + + + K+ F
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIFQKIIKLEYDFPE 231
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 64/234 (27%), Positives = 92/234 (39%), Gaps = 26/234 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+ S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL---------------L 536
L H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D A+G+ +L IHRDL A N+LL KI DFGL R D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 650
+MAPE + ++ +SDV+S+GI L E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-52
Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 15/233 (6%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVI 488
I T+ F LG G FG VYKG + E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ + + + ++ +LLG C+ LI + MP L ++ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+MA E ++ +SDV+S+G+ + E+++ Y + + K
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEK 228
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 9e-51
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
+H DLK N++ + K+ DFGL ++ GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGK 641
+D++S G+L ++SG
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 14/211 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L HRNL++L G + K+ + E P SL + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTYGYM 611
YL R IHRDL A N+LL KI DFGL+R ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
APE FS SD + FG+ L E+ + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 12/221 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ ++ Q ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-NRVVGTYGYMA 612
YL + +HRDL A N+L++ ++ K+SDFGL R D T + + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 613 PEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 653
PE S +F+ SDV+SFGI++ E+++ + + S+ +V
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 4e-50
Identities = 61/236 (25%), Positives = 111/236 (47%), Gaps = 19/236 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S++ + S+ +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661
+M+PE DG F+ SDV+SFG++L EI + + Y+ + ++ V +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVME 250
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 4e-49
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 14/232 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L E +LI EF+ L I + + + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
I+H D+K N++ + KI DFGL DE T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
+D+++ G+L ++SG + + + + +V + F
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWEFDE 249
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
L R +HRD+ A NVL+ + K+ DFGL R + D T ++ +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKK 642
+ +F+ SDV+ FG+ + EI+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 62/225 (27%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 491
D + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 492 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQ-------------TRRTLLD 537
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
A+G+ +L + IHRDL A N+LL + KI DFGL R D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 598 EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK 642
+MAPE D ++I+SDV+SFG+LL EI S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-47
Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 28/247 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------------L 536
+ +H+N++ LLG C Q +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
ARG+ YL + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 656
T +MAPE D ++ +SDV+SFG+LL EI + + Y L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELF 247
Query: 657 GHVSKMH 663
+ + H
Sbjct: 248 KLLKEGH 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 7/212 (3%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 491
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
+ +H N++ + + + ++ + + ++ + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-NRVVGTYGY 610
L Y+H ++HRDLK SN+LL+ + KI DFGL R D V T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 611 MAPEYASDGQFSIKS-DVFSFGILLLEIVSGK 641
APE + + KS D++S G +L E++S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (410), Expect = 2e-45
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 18/235 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++++ G ++ +I +++ L S + R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
II+RDLK N+LLD++ + KI+DFG + + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670
S ++ D +SFGIL+ E+++G + + + F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT---PFYDSNTMKTYEKILNAELRFPPFF 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 4e-45
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 492
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+V + ++ I + M L + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMA 612
++H +++RDLK +N+LLD+ + +ISD GL F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 613 PEYASDGQ-FSIKSDVFSFGILLLEIVSGK 641
PE G + +D FS G +L +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 7e-45
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 15/212 (7%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 495 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTYG 609
L + H + IIHRD+K +N+++ K+ DFG+ R T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y++PE A +SDV+S G +L E+++G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-45
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 15/232 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
I H D++ N++ + KI +FG R + N + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
S +D++S G L+ ++SG + ++T +I ++ TF
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMNAEYTFDE 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 3e-44
Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 11/234 (4%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQ 494
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L G LI + + L I + +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH + + LD+D ISDFGL + + GT GY+APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
+ +S D +S G++ ++ G + + L + K F S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYEFDS 230
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 16/236 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 494
++F ++ LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H L + E + E++ L I + D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670
+++ D +SFG+LL E++ G+ + + L + + + +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHSIRMDNPFYPRWL 226
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 2e-43
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVIL 489
+N+ LG G V + +E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 490 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
K+ H N+++L L+++ M L ++ T + L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ LH +L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 609 GYMAPEYASDGQ------FSIKSDVFSFGILLLEIVSGK 641
Y+APE + + D++S G+++ +++G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 14/235 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+NF K+GEG +G VYK + G+ +A+K++ +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLL + L++EF+ D + T + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-Y 615
R++HRDLK N+L++ + K++DFGL R FG V T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670
+S D++S G + E+V+ + + D++++ + + + T +V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVV 226
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 19/240 (7%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
A + ++GEG +G V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 494 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS---FIFDQTRRTLLDWSQRFHIICG 547
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL +LH R++HRDLK N+L+ K++DFGL R + + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 608 YGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667
Y APE ++ D++S G + E+ K +R + V+ +G + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 2e-41
Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 14/232 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
+ + K+GEG +G VYK G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE-YA 616
R++HRDLK N+L++++ KI+DFGL R F + T Y AP+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
++S D++S G + E+V+G + ++ + + + ++ T +S
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNS 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (375), Expect = 9e-41
Identities = 39/234 (16%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + Q ++ + SL+ + R+ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 559 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN-----TNRVVGTY 608
+++RD+K N L+ + + + DFG+V+ + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 609 GYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKM 662
YM+ + S + D+ + G + + + G ++ T + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 18/230 (7%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 499
+ LGEG F VYK Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L+++FM + +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDG 619
I+HRDLK +N+LLD++ K++DFGL ++FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 620 Q-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
+ + + D+++ G +L E++ F D+ ++ + + + T +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTE 222
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 9e-40
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 499 VKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
V+L EK L+ +++P + L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYGYM 611
Y+H I HRD+K N+LLD D K+ DFG + E N + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRA 190
Query: 612 APEYASDGQFSIKSDVFSFGILLLEIVSGK 641
++ DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 23/243 (9%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L P KI DFGL +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 606 GTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665
GT ++APE + +++D++S G++ ++SG + DTK + +VS ++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYE 234
Query: 666 FSS 668
F
Sbjct: 235 FED 237
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 1e-39
Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 16/236 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + C + ++ + SL+ +R+ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 559 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLVRTFGGDETEGN-----TNRVVGTYGY 610
IHRD+K N L + I DFGL + + T + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666
+ + S + D+ S G +L+ G ++ TK +S+ +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 53/243 (21%), Positives = 104/243 (42%), Gaps = 23/243 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 497 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
N+V L+ C L+++F + + TL + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVG 606
L L+ R +I+HRD+KA+NVL+ +D K++DFGL R F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 607 TYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665
T Y PE + + D++ G ++ E+ + + +T+ + + +S++ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240
Query: 666 FSS 668
+
Sbjct: 241 ITP 243
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
L L + + E+ L + +R + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEY 615
+++RD+K N++LD+D + KI+DFGL + D GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 616 ASDGQFSIKSDVFSFGILLLEIVSGK 641
D + D + G+++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 20/213 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 492
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 493 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ +++LL + + +LI E T R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 610 YMAPEYASDGQF-SIKSDVFSFGILLLEIVSGK 641
Y PE+ ++ + V+S GILL ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 440 DNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 496
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 497 NLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
++V+++ L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLVRTFGGDETEGNTNRVVGTYG 609
YLH + I HRD+K N+L K++DFG + + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
Y+APE ++ D++S G+++ ++ G
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-37
Identities = 47/232 (20%), Positives = 93/232 (40%), Gaps = 12/232 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+GEG +G V+K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYA 616
++HRDLK N+L++++ K+++FGL R FG + VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174
Query: 617 SDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668
+S D++S G + E+ + R + + + + + ++ T +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTE 224
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 1e-36
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 22/273 (8%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT- 460
+ +E+ + ED E P A + D F LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 461 LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517
G A+K L K + + ++ NE + + LVKL ++ E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
+ + S + R YLH L +I+RDLK N+L+DQ
Sbjct: 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 578 DMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEI 637
+++DFG + +G T + GT +APE ++ D ++ G+L+ E+
Sbjct: 177 QGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 638 VSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSIV 670
+G + +D + + + F S
Sbjct: 232 AAGYP---PFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 497 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N++ LL E +F + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE- 614
H IIHRDLK N+ +++D KI DFGL R + + V T Y APE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 615 YASDGQFSIKSDVFSFGILLLEIVSGK 641
+ +++ D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 491
+NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 492 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
++ LV L + LI +++ L + + + R T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
+L L +L II+RD+K N+LLD + + ++DFGL + F DETE GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 611 MAPEYASDGQ--FSIKSDVFSFGILLLEIVSGK 641
MAP+ G D +S G+L+ E+++G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 497 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGY 610
G+ +LH IIHRDLK SN+++ D KI DFGL RT G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 611 MAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
APE + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 47/232 (20%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 497
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 498 LVKLLGCCIQGEEKL--LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ L + L++E + N L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPE 614
H + I+HRD+K NV++D + ++ D+GL + + N V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 615 YASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665
D Q + D++S G +L ++ K+ F+ + + ++K+ T
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGT 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 11/212 (5%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 491 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++H N++ LL + ++ + + + + + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYG 609
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T R +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184
Query: 610 YMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
+ ++ D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 8e-29
Identities = 40/215 (18%), Positives = 79/215 (36%), Gaps = 18/215 (8%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+ + KLG G F V+ +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 501 LLGCCIQGEEKLLIY-------------EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
KLL + F + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL Y+H+ R IIH D+K NVL++ D + + + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 607 TYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK 641
T Y +PE + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 5e-24
Identities = 38/205 (18%), Positives = 66/205 (32%), Gaps = 27/205 (13%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 492
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ R L KL G + +Y + N L I + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGTYGYM 611
+ I+H DL NVL+ + I DF G + R V Y
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 612 APEYASDGQFSIKSDVFSFGILLLE 636
+ Y + D+ S +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 65.4 bits (159), Expect = 1e-13
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ + W + Y
Sbjct: 92 DGNVVIYG-------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.9 bits (132), Expect = 8e-10
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 13/102 (12%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEV 61
+L + N ++P + + S L + NLVL + + V + K
Sbjct: 12 ILYSTQGNDNHP-----QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK-- 64
Query: 62 QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD--YPSDTLL 101
T L +G + + + W S + +
Sbjct: 65 GTGCRAVLQPNGRMDVLT----NQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.3 bits (94), Expect = 1e-04
Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ S+ V L
Sbjct: 50 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQP 106
Query: 72 SGNLVLRD 79
NL +
Sbjct: 107 DRNLAIYG 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 52.1 bits (124), Expect = 6e-09
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S + S + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSD 98
N+V+ D +S W + +
Sbjct: 90 DRNVVIYD----NSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 51.6 bits (123), Expect = 9e-09
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N F L + GNLV+ + SN +W++ + V L
Sbjct: 34 YDVDKPIWATNTGGLSRSCF--LSMQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQK 90
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W + +
Sbjct: 91 DRNVVIYGTD-------RWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.2 bits (117), Expect = 7e-08
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + V L L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYV-LVLQP 101
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W +
Sbjct: 102 DRNVVIYG-------DALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.0 bits (101), Expect = 8e-06
Identities = 16/75 (21%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 19 WVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLR 78
+ + S + NLVL S++ VW++ + T L G LV+
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG--ATGCRAVLQSDGLLVIL 71
Query: 79 DEHDGDSETYFWQSF 93
T W S
Sbjct: 72 T----AQNTIRWSSG 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.69 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.56 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.53 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.53 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.24 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.86 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.79 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.12 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.4 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.94 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.59 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 83.94 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 83.52 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=369.38 Aligned_cols=217 Identities=29% Similarity=0.422 Sum_probs=189.7
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 4889999998652 3345678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999996533 4899999999999999999999988 999999999999999999999999999875432
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
......||+.|||||++.+..++.++|||||||+||||++|+.||. ......++..+.+....+|+.
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~---~~~~~~~~~~i~~~~~~~p~~ 226 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFPDF 226 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHTTCCCCCTT
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC---CCCHHHHHHHHHcCCCCCCcc
Confidence 2234679999999999999999999999999999999999999975 344556777777777777653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=372.58 Aligned_cols=203 Identities=30% Similarity=0.429 Sum_probs=176.9
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||+|+.+ +++.||||++.... .+..+++.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999985 58899999986532 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.++|.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999853 345899999999999999999999988 9999999999999999999999999999875444
Q ss_pred ccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
........+||+.|||||++.+..+ +.++||||+||+||||+||+.||...
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 4444445789999999999988876 57899999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=374.33 Aligned_cols=221 Identities=27% Similarity=0.414 Sum_probs=188.5
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .+...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 5889999998652 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998653 34899999999999999999999998 999999999999999999999999999987654
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
.........+||+.|||||++.+..++.++||||+||+||||+||+.||. ..+...++..+.+....+|+.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~---~~~~~~~~~~i~~~~~~~p~~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLEYDFPEK 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHTTCCCCCTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC---CcCHHHHHHHHHcCCCCCCcc
Confidence 44444445689999999999999999999999999999999999999975 344556677777777666653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=371.73 Aligned_cols=199 Identities=27% Similarity=0.491 Sum_probs=179.6
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999874 58999999997665566778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999988542 4899999999999999999999998 99999999999999999999999999998753332
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 233467999999999999999999999999999999999999998543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=367.99 Aligned_cols=201 Identities=31% Similarity=0.449 Sum_probs=177.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
+.|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 58899999998766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|.+++.+. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999998653 245899999999999999999999998 9999999999999999999999999998753221
Q ss_pred CCccccccccCcccccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 599 GNTNRVVGTYGYMAPEYAS-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.......||+.|||||++. +..|+.++|||||||+||||+||+.||...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 1223467999999999984 556899999999999999999999997644
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=365.81 Aligned_cols=202 Identities=32% Similarity=0.521 Sum_probs=169.0
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||+|+.. ..||||+++. ......++|.+|+.++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467899999999999999999863 3599999864 34556678999999999999999999999875 456899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++... +..+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999653 345899999999999999999999987 9999999999999999999999999998875444
Q ss_pred ccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 4444445689999999999864 358999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=369.96 Aligned_cols=220 Identities=22% Similarity=0.309 Sum_probs=191.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
.++|++++.||+|+||.||+|+.+ +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999974 5899999999752 344567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999986543 4788999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSSI 669 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~~ 669 (670)
... .....+||+.|+|||++.+..|+.++||||+||+||||++|+.||.. .+...++..+.+....||..
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~---~~~~~~~~~i~~~~~~~p~~ 227 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFPRT 227 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCCCCCTT
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC---cCHHHHHHHHhcCCCCCCcc
Confidence 322 23347899999999999999999999999999999999999999653 44456667777777777654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=360.84 Aligned_cols=212 Identities=28% Similarity=0.475 Sum_probs=171.7
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccC
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 519 (670)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999988899999999753 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcccC
Q 005907 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (670)
Q Consensus 520 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 599 (670)
+|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999998653 345889999999999999999999988 999999999999999999999999999877543322
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCC-CCCCCCCcccchHhhhhhc
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~-p~~~~~~~~~~~l~~~i~~ 661 (670)
......||+.|+|||++.+..|+.++|||||||+||||+|+.. ||.. ....+++..+.+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDIST 217 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHh
Confidence 2233578999999999999999999999999999999999644 5433 233344444444
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=363.46 Aligned_cols=217 Identities=29% Similarity=0.428 Sum_probs=170.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 514 (670)
++|++.+.||+|+||.||+|+.+ +|+.||||++... .+...+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 5889999998653 34456678999999999999999999999865 4567899
Q ss_pred EEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 515 YEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 2456899999999999999999999864 13499999999999999999999999999988
Q ss_pred cCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
+..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+++..+.+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~ 228 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIRE 228 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHc
Confidence 753322 2234689999999999999999999999999999999999999976433 3344444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-43 Score=364.60 Aligned_cols=215 Identities=26% Similarity=0.404 Sum_probs=187.3
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++.+.||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 5899999999652 3345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999886533 4788888899999999999999988 999999999999999999999999999986432
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
....+||+.|||||++.+..|+.++||||+||+||||+||+.||. ..+...++..+.+....+|.
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~---~~~~~~~~~~i~~~~~~~p~ 222 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKILNAELRFPP 222 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHCCCCCCT
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC---CcCHHHHHHHHHcCCCCCCC
Confidence 223689999999999999999999999999999999999999975 34455666666666666554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=371.31 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=176.1
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+.++++++|||||++++++.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 5889999998653 33445688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
|+++|+|.+++.+.. .+++..+..++.|+++||.|||++ + |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999996543 488999999999999999999974 6 999999999999999999999999999876321
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223468999999999999999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.6e-43 Score=366.77 Aligned_cols=215 Identities=26% Similarity=0.396 Sum_probs=186.0
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999974 5899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCceEEEeecCceecCCC
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 595 (670)
+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999998542 345899999999999999999999998 999999999999964 578999999999987533
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceee
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHT 664 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~ 664 (670)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||... ...+++..+.+...
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDW 242 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCC
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCC
Confidence 2 233467999999999999999999999999999999999999997533 33445555554443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-43 Score=362.41 Aligned_cols=217 Identities=26% Similarity=0.377 Sum_probs=168.8
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc-hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
..+.|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999975 48899999987532 333457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCceEEEeecCceec
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF 592 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~ 592 (670)
||+++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999964 345899999999999999999999998 99999999999995 5789999999999876
Q ss_pred CCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeec
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTF 666 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~ 666 (670)
.... .....+||+.|||||++.+..|+.++||||+||+||||++|+.||.. .....+...+.+....+
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~~~~~~~ 228 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEF 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHTTCCCC
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHhccCCCC
Confidence 4322 22346799999999999999999999999999999999999999753 33344555555544443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=357.35 Aligned_cols=214 Identities=32% Similarity=0.493 Sum_probs=178.7
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.++||+|+||.||+|++++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578999999999999999999988889999999753 3445789999999999999999999998754 5678999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999875422 234899999999999999999999987 999999999999999999999999999987543322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
. .....||+.|||||++.+..++.++|||||||+||||+||..|+. ......+++..+.+
T Consensus 166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~--~~~~~~~~~~~i~~ 225 (272)
T d1qpca_ 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLER 225 (272)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHT
T ss_pred c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC--CCCCHHHHHHHHHh
Confidence 2 233578999999999999999999999999999999999766642 22233344444443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-43 Score=364.92 Aligned_cols=218 Identities=24% Similarity=0.371 Sum_probs=188.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999974 5899999999775555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCceEEEeecCceecCCC
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~ 595 (670)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988743 2345899999999999999999999988 99999999999998 5789999999999987543
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
. ......||+.|+|||++.+..++.++||||+||+||||+||+.||. ......++..+.+...+++
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~---~~~~~~~~~~i~~~~~~~~ 248 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFD 248 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC---CSSHHHHHHHHHHCCCCCC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCCCCC
Confidence 2 2334678999999999999999999999999999999999999975 3344556666666655554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=351.06 Aligned_cols=196 Identities=26% Similarity=0.423 Sum_probs=167.8
Q ss_pred cccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeeEEE
Q 005907 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 514 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 514 (670)
|++.++||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366678999999999999975 4789999998653 34456689999999999999999999999875 3457899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCceEEEeecCceecC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFG 593 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 593 (670)
|||+++|+|.+++... ..+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999654 34889999999999999999999874 3599999999999996 57899999999998643
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||..
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 22 2234689999999999865 599999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-44 Score=362.46 Aligned_cols=201 Identities=31% Similarity=0.496 Sum_probs=177.0
Q ss_pred hcCCcccceeeeecCceeEEEEEecC-CcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.++||+|+||.||+|.+.. ++.||||+++.. ....++|.+|+.++++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34679999999999999999999864 888999998653 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999997643 346899999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
.. ......|++.|+|||++.+..|+.++|||||||++|||++|+.|+
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 22 223356899999999999999999999999999999999987775
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=361.65 Aligned_cols=204 Identities=30% Similarity=0.480 Sum_probs=165.5
Q ss_pred CCcccceeeeecCceeEEEEEecC-C---cEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.++||+|+||+||+|+++. + ..||||++.. ......++|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998753 2 3589998865 3445567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988643 345899999999999999999999987 99999999999999999999999999988754
Q ss_pred CcccC---CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 595 DETEG---NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 33222 1222457899999999999999999999999999999998 899976443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=351.54 Aligned_cols=205 Identities=28% Similarity=0.434 Sum_probs=180.9
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.++||+|+||+||+|++++++.||||++++. ....++|++|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3689999999999999999999988889999999763 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|..++.... ..+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999975533 34789999999999999999999987 999999999999999999999999999876543332
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+.....
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 2333578999999999999999999999999999999998 89998765543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-43 Score=363.84 Aligned_cols=215 Identities=24% Similarity=0.323 Sum_probs=188.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (670)
++|++++.||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 5899999998642 3345677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 595 (670)
||+.+|+|..++.... .+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986543 4899999999999999999999988 999999999999999999999999999987432
Q ss_pred cccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 596 ETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 596 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
.....||+.|||||++.+..++.++|||||||+||||+||+.||. ......++..+.+....+|.
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~---~~~~~~~~~~i~~~~~~~p~ 259 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKVRFPS 259 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCCCCCT
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCCCc
Confidence 223679999999999999999999999999999999999999975 34456666777766666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=354.80 Aligned_cols=205 Identities=30% Similarity=0.506 Sum_probs=174.8
Q ss_pred CCcccce-eeeecCceeEEEEEec---CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|.+.+ +||+|+||.||+|.++ ++..||||+++.. .....++|.+|+.++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566767 4999999999999764 3457999999753 34456789999999999999999999999864 568899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++.. .+..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999854 3345899999999999999999999987 99999999999999999999999999998765
Q ss_pred Cccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 595 DETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 595 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 4332 22334568999999999999999999999999999999998 89998755433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=352.82 Aligned_cols=215 Identities=26% Similarity=0.381 Sum_probs=183.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc------hhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 58899999986521 12357899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----ceEEEeec
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG 587 (670)
++||||+++|+|.++|... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999654 34899999999999999999999998 99999999999998876 49999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeee
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTT 665 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~ 665 (670)
+++.+..... .....||+.|+|||++.+..++.++||||+||+||||++|+.||.. ....+++..+.+...+
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYE 234 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHTTCCC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC---CCHHHHHHHHHhcCCC
Confidence 9988743322 2335789999999999999999999999999999999999999753 3344455555554433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=356.25 Aligned_cols=218 Identities=27% Similarity=0.409 Sum_probs=187.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHh-cCCCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999985 5889999999752 2344556677777665 68999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCC
Q 005907 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 594 (670)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999996543 3788999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||. ......++..+....+.+|.
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~---~~~~~~~~~~i~~~~~~~p~ 224 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPFYPR 224 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCCCCCT
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC---CCCHHHHHHHHHcCCCCCCc
Confidence 322 2334679999999999999999999999999999999999999975 44556677777777666664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=362.23 Aligned_cols=208 Identities=32% Similarity=0.474 Sum_probs=176.0
Q ss_pred cCCcccceeeeecCceeEEEEEecCC------cEEEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (670)
.++|++.++||+|+||+||+|+.... ..||+|++.. ........+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46799999999999999999987532 3689999865 3344566889999999998 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTR--------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp 570 (670)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965422 235789999999999999999999987 99999999
Q ss_pred CCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 571 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333334678999999999999999999999999999999998 8999865443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-42 Score=361.99 Aligned_cols=220 Identities=25% Similarity=0.358 Sum_probs=183.6
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHH---HHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.++||+|+||.||+|+.. +|+.||||++.+. .......+. +|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999975 5899999998642 122223333 447778888999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
++||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999654 34788999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecCC
Q 005907 592 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFSS 668 (670)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~~ 668 (670)
+.... ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||......+...+...+......+|+
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 75332 234679999999999964 56899999999999999999999999766655555555555555555543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=353.37 Aligned_cols=196 Identities=31% Similarity=0.455 Sum_probs=166.4
Q ss_pred eeeeecCceeEEEEEecC---CcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005907 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 520 (670)
++||+|+||.||+|.+.+ ++.||||+++.. .+...++|.+|+.++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 467999998652 33345689999999999999999999999864 567899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc-C
Q 005907 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-G 599 (670)
Q Consensus 521 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 599 (670)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999999653 34899999999999999999999987 999999999999999999999999999987544332 2
Q ss_pred CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCC
Q 005907 600 NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYR 648 (670)
Q Consensus 600 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~ 648 (670)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 2334578999999999999999999999999999999998 899986544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=355.13 Aligned_cols=194 Identities=32% Similarity=0.489 Sum_probs=171.3
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
.|+..++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999874 5888999998653 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999998776442 35899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCCccccccccCcccccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASD---GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 223579999999999864 4689999999999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=349.50 Aligned_cols=200 Identities=30% Similarity=0.475 Sum_probs=166.0
Q ss_pred CCcccceeeeecCceeEEEEEecCC-----cEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
..|++.++||+|+||.||+|.++.. ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999987542 36999998653 34445679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999988653 345899999999999999999999988 9999999999999999999999999998875
Q ss_pred CCccc-CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005907 594 GDETE-GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNR 644 (670)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~ 644 (670)
..... .......||+.|||||++.+..++.++|||||||+||||++|..|+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 43322 2233356899999999999999999999999999999999976664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=348.71 Aligned_cols=214 Identities=30% Similarity=0.471 Sum_probs=174.2
Q ss_pred cCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEcc
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 518 (670)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3579999999999999999999988889999999653 344578999999999999999999999985 45678999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|..++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999886532 234899999999999999999999988 999999999999999999999999999876433322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
......||+.|+|||.+.+..++.++|||||||+||||+||++|+.. .....+++..+.+
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~ 229 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVER 229 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHT
T ss_pred -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHHHHh
Confidence 22335689999999999999999999999999999999998777432 2233444554443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=351.13 Aligned_cols=205 Identities=29% Similarity=0.500 Sum_probs=170.9
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc----EEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.+|++.++||+|+||+||+|.+.. |+ .||+|+++. ...+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998743 43 589998865 3445677899999999999999999999999865 5678
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
++||+.+++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999999988653 345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 650 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~ 650 (670)
............||+.|+|||++.+..++.++|||||||+||||+| |+.||......
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 5544444445678999999999999999999999999999999999 78887654443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-41 Score=342.71 Aligned_cols=202 Identities=24% Similarity=0.396 Sum_probs=168.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----e
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----E 510 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 510 (670)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999974 5899999999753 2334567899999999999999999999987654 3
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+++++|..++... ..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.++|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988653 34899999999999999999999988 9999999999999999999999999988
Q ss_pred ecCCCcc-cCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 591 TFGGDET-EGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 591 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
....... .......+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 7643322 2233346799999999999999999999999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-42 Score=350.49 Aligned_cols=220 Identities=27% Similarity=0.427 Sum_probs=182.4
Q ss_pred HhcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 005907 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (670)
Q Consensus 437 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (670)
...++|++.+.||+|+||.||+|+.+ +++.||||+++.. ..+..++|.+|+.++++++||||+++++++...+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34578999999999999999999864 3578999998753 3344678999999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDl 568 (670)
..++||||+++|+|.++|..... ...+++..++.++.|++.||+|||+++ ||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence 99999999999999999964321 234788999999999999999999988 999999
Q ss_pred CCCCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCCC
Q 005907 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK-KNRGFY 647 (670)
Q Consensus 569 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~p~~~~ 647 (670)
||+||||+.++.+||+|||+++.+.............||+.|+|||.+.+..|+.++|||||||+||||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998775444444444567899999999999999999999999999999999996 465443
Q ss_pred CCcccchHhhhhhce
Q 005907 648 RSDTKVNLIGHVSKM 662 (670)
Q Consensus 648 ~~~~~~~l~~~i~~~ 662 (670)
...+++..+.+.
T Consensus 247 ---~~~e~~~~v~~~ 258 (301)
T d1lufa_ 247 ---AHEEVIYYVRDG 258 (301)
T ss_dssp ---CHHHHHHHHHTT
T ss_pred ---CHHHHHHHHHcC
Confidence 333444444433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=347.36 Aligned_cols=218 Identities=22% Similarity=0.328 Sum_probs=185.0
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
..++|++.+.||+|+||+||+|... +++.||||+++... .....+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999975 58899999997643 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--CceEEEeecCceecCC
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGG 594 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~ 594 (670)
|+++++|.++|... ...+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999999542 335899999999999999999999988 9999999999999854 5899999999988643
Q ss_pred CcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhceeeecC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSKMHTTFS 667 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~~~~~~~ 667 (670)
.. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.. +....++..+.+....++
T Consensus 157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~ 223 (321)
T d1tkia_ 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHHTCCCCC
T ss_pred CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCCCC
Confidence 32 22346789999999999999999999999999999999999999754 334455566655554443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-41 Score=338.37 Aligned_cols=214 Identities=24% Similarity=0.354 Sum_probs=180.5
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccc---------hhchHHHHHHHHHHhcCC-CCceeeEEEEEEe
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 507 (670)
.++|++.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999974 58899999986532 112346889999999997 9999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
++..++||||+++|+|.++|... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999653 34899999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCC------CCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
+++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ....+...+.+
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~~~i~~ 229 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMIMS 229 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC---CHHHHHHHHHh
Confidence 9998754322 233679999999999853 45788999999999999999999997643 33344444444
Q ss_pred eee
Q 005907 662 MHT 664 (670)
Q Consensus 662 ~~~ 664 (670)
...
T Consensus 230 ~~~ 232 (277)
T d1phka_ 230 GNY 232 (277)
T ss_dssp TCC
T ss_pred CCC
Confidence 433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=339.46 Aligned_cols=213 Identities=26% Similarity=0.413 Sum_probs=167.8
Q ss_pred cCCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (670)
.++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998743 346899998653 3444567999999999999999999999985 467899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecC
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 593 (670)
||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987653 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhhc
Q 005907 594 GDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~~ 661 (670)
..... ......||+.|+|||++.+..++.++|||||||+||||+| |++||..... .+++..+.+
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~ 224 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN 224 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHT
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHc
Confidence 33322 2334568999999999999999999999999999999998 8999765443 334444443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=342.14 Aligned_cols=213 Identities=29% Similarity=0.439 Sum_probs=169.5
Q ss_pred HHHHHhcCCcccceeeeecCceeEEEEEecC------CcEEEEEEecc-cchhchHHHHHHHHHHhcC-CCCceeeEEEE
Q 005907 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGC 504 (670)
Q Consensus 433 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 504 (670)
.+++...++|++.++||+|+||.||+|+... ++.||||+++. ......+++.+|..++.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3333345789999999999999999998642 46899999875 3334456778888888776 68999999999
Q ss_pred EEeC-CeeEEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 005907 505 CIQG-EEKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (670)
Q Consensus 505 ~~~~-~~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp 570 (670)
+... ...++||||+++|+|.++|.... ....+++..++.++.||++||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8765 46799999999999999996532 1345889999999999999999999988 99999999
Q ss_pred CCEEEcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCCCC
Q 005907 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK-KNRGFYR 648 (670)
Q Consensus 571 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~p~~~~~ 648 (670)
+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876555444455578999999999999999999999999999999999975 5765443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=343.33 Aligned_cols=197 Identities=22% Similarity=0.306 Sum_probs=168.7
Q ss_pred cCCcccce-eeeecCceeEEEEEe-cCCcEEEEEEecccchhchHHHHHHHHHHhc-CCCCceeeEEEEEEe----CCee
Q 005907 439 TDNFSINN-KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 511 (670)
Q Consensus 439 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~ 511 (670)
.++|.+.. .||+|+||.||+|+. .+++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 599999999999997 4588999999864 2456789988665 489999999999875 3568
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeecC
Q 005907 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGl 588 (670)
++|||||++|+|.++|.... ...+++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 245899999999999999999999998 999999999999986 45799999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||...
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 998754332 23467999999999999999999999999999999999999998543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=340.63 Aligned_cols=195 Identities=29% Similarity=0.371 Sum_probs=164.5
Q ss_pred cceeeeecCceeEEEEEec-CCcEEEEEEecccch-----hchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 444 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 444 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
.+++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999975 488999999865321 1235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+.++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887766652 3345788899999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ....+||+.|+|||++.+ ..|+.++||||+||++|||+||+.||..
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 2 223579999999999865 4679999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=337.41 Aligned_cols=202 Identities=28% Similarity=0.409 Sum_probs=164.0
Q ss_pred CCcccceeeeecCceeEEEEEecC----CcEEEEEEeccc---chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (670)
++|++.+.||+|+||.||+|++.. ...||||++.+. .++..++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998643 237899998652 33445789999999999999999999999965 5678
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
+||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999988653 245899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCcccC-CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCC
Q 005907 593 GGDETEG-NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~ 647 (670)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 5443322 2333567889999999999999999999999999999998 89997643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=334.84 Aligned_cols=206 Identities=30% Similarity=0.480 Sum_probs=167.9
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 518 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 518 (670)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688899999999999999998 5788999999653 3457899999999999999999999998654 5679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++|+|.++|.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996532 234789999999999999999999987 999999999999999999999999999875322
Q ss_pred CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCCcccchHhhhhh
Q 005907 599 GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHVS 660 (670)
Q Consensus 599 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~i~ 660 (670)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+++..+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~ 214 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE 214 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH
Confidence 223467899999999999999999999999999999999 6777654333 34444443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=337.00 Aligned_cols=200 Identities=30% Similarity=0.456 Sum_probs=169.8
Q ss_pred CCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|+++++||+|+||.||+|+. .+++.||||+++.. .+...+++.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999997 45899999998653 23346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
|+.++ +..++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765 44444332 3345899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccCCccccccccCcccccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 2 233357999999999987765 47899999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=339.34 Aligned_cols=213 Identities=31% Similarity=0.478 Sum_probs=175.1
Q ss_pred CCcccceeeeecCceeEEEEEecC-Cc--EEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeeEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (670)
++|++.++||+|+||.||+|++++ +. .||||+++.. ..+..++|.+|+.++.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578999999999999999999865 33 5788887643 344567899999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCce
Q 005907 515 YEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (670)
Q Consensus 515 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 581 (670)
|||+++|+|.++|... .....+++..+++++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23456899999999999999999999988 9999999999999999999
Q ss_pred EEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCC-CCCCCCCcccchHhhhhh
Q 005907 582 KISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHVS 660 (670)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~-p~~~~~~~~~~~l~~~i~ 660 (670)
||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||. ......++..+.
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~---~~~~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC---CCCHHHHHHHHH
Confidence 99999999865322 22234568999999999999999999999999999999999765 544 334445555554
Q ss_pred c
Q 005907 661 K 661 (670)
Q Consensus 661 ~ 661 (670)
+
T Consensus 241 ~ 241 (309)
T d1fvra_ 241 Q 241 (309)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=338.16 Aligned_cols=208 Identities=32% Similarity=0.468 Sum_probs=175.6
Q ss_pred cCCcccceeeeecCceeEEEEEecC--------CcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (670)
.++|++.++||+|+||.||+|+... +..||||++++. ......++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998643 247999999763 334567888999999888 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 005907 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (670)
Q Consensus 509 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl 575 (670)
+..++||||+++|+|.++|..... ...+++..++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965431 245899999999999999999999998 9999999999999
Q ss_pred cCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCCCCC
Q 005907 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRS 649 (670)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~p~~~~~~ 649 (670)
+.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |+.||+....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999998765555545555778999999999999999999999999999999998 6888764443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=337.51 Aligned_cols=207 Identities=31% Similarity=0.440 Sum_probs=178.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (670)
..++|++.++||+|+||.||+|++. .++.||||+++.. ......+|.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468999999999999999999863 3568999999753 334456789999999999 6999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQT---------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NIL 574 (670)
..++||||+++|+|.++|+... ....+++..++.++.||++||+|||+++ |+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999997543 2235889999999999999999999998 999999999999
Q ss_pred EcCCCceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcC-CCCCCCC
Q 005907 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSG-KKNRGFY 647 (670)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~p~~~~ 647 (670)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+ ++|+...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654444444456899999999999999999999999999999999995 5555433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=337.97 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=178.1
Q ss_pred cCCcccceeeeecCceeEEEEEec------CCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCee
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (670)
.++|++.++||+|+||.||+|.+. .++.||||+++.. ..+....|.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468899999999999999999864 2578999999753 344456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 512 LLIYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 512 ~lV~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
++||||+++|+|.+++... .....+++..++.++.|+++||.|||+++ |+||||||+||||+.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998542 22344789999999999999999999987 9999999999999999999999
Q ss_pred eecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCC
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGK-KNRGF 646 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~p~~~ 646 (670)
|||+++.+.............||+.|+|||.+.+..++.++||||||++||||+||. .||..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 999998875544444444567899999999999999999999999999999999985 66544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-39 Score=332.53 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=171.2
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.++||+|+||+||+|+.++++.||||+++.. .+...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999988999999998653 334467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCcc
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 597 (670)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877766653 2355899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 598 EGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 598 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
......|++.|+|||.+.+. .++.++||||+||+||||++|+.||..
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 22335689999999998764 568999999999999999999999753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=332.79 Aligned_cols=197 Identities=31% Similarity=0.508 Sum_probs=169.2
Q ss_pred ceeeeecCceeEEEEEecCC----cEEEEEEecc-cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005907 445 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 518 (670)
Q Consensus 445 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 518 (670)
.++||+|+||+||+|++.++ ..||||++++ ......++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 2589999975 3455667899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCccc
Q 005907 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (670)
Q Consensus 519 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 598 (670)
++++|.+++... ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998653 345778889999999999999999988 999999999999999999999999999887543322
Q ss_pred C--CccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 599 G--NTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 599 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
. ......||+.|+|||.+.+..++.++||||||++||||+||+.||..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 1 22335689999999999999999999999999999999998888653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=329.89 Aligned_cols=198 Identities=26% Similarity=0.395 Sum_probs=168.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccch------hchHHHHHHHHHHhcCC--CCceeeEEEEEEeCC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 509 (670)
.++|++.++||+|+||.||+|+.. +++.||||++.+... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999974 589999999865211 12345678999999986 899999999999999
Q ss_pred eeEEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CceEEEeec
Q 005907 510 EKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (670)
Q Consensus 510 ~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG 587 (670)
..++||||+.+ +++.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5788887543 34899999999999999999999998 9999999999999854 799999999
Q ss_pred CceecCCCcccCCccccccccCcccccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCC
Q 005907 588 LVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99875332 2234679999999999987765 5779999999999999999999863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=332.30 Aligned_cols=200 Identities=27% Similarity=0.404 Sum_probs=163.0
Q ss_pred CCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 515 (670)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3577889999999999999997 689999999864322 1222334555667889999999999998654 578999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
||+++|+|.++|.+. .+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999653 3889999999999999999999741 2359999999999999999999999999999
Q ss_pred ecCCCccc--CCccccccccCcccccccCCCC------CCccchHHHHHHHHHHHHcCCCCCC
Q 005907 591 TFGGDETE--GNTNRVVGTYGYMAPEYASDGQ------FSIKSDVFSFGILLLEIVSGKKNRG 645 (670)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltG~~p~~ 645 (670)
.+...... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|++
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 87543322 2334467999999999987643 6778999999999999999998864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=331.47 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=167.7
Q ss_pred cCCcccceeeeecCceeEEEEEec-C-CcEEEEEEeccc--chhchHHHHHHHHHHhcC---CCCceeeEEEEEEe----
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ---- 507 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 507 (670)
.++|+++++||+|+||+||+|++. + ++.||||+++.. .+.....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 567999998652 223344566787777665 79999999999864
Q ss_pred -CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEee
Q 005907 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (670)
Q Consensus 508 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 586 (670)
....+++|||+.++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999988877655432 3455889999999999999999999998 999999999999999999999999
Q ss_pred cCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 587 GLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 998765322 22334679999999999999999999999999999999999999986433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-38 Score=323.50 Aligned_cols=211 Identities=18% Similarity=0.297 Sum_probs=177.4
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeeEEEEE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 516 (670)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999975 58899999885532 23467889999999975 899999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-----CCceEEEeecCcee
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRT 591 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~ 591 (670)
|+ +++|.+++.... ..++...+..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689999886533 35889999999999999999999988 999999999999974 57899999999998
Q ss_pred cCCCccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhh
Q 005907 592 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 657 (670)
Q Consensus 592 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~ 657 (670)
+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||...........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 7533221 12334679999999999999999999999999999999999999997665554443333
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=325.65 Aligned_cols=203 Identities=25% Similarity=0.381 Sum_probs=168.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEe--------
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 507 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 507 (670)
.++|+++++||+|+||+||+|+.. +|+.||||++.. ..+...+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999974 689999999854 234456778999999999999999999999855
Q ss_pred CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeec
Q 005907 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (670)
Q Consensus 508 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 587 (670)
....++||||++++.+..+.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999998877765542 3345788999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCccc--CCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 588 LVRTFGGDETE--GNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 588 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
+++.+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 99877543322 222335799999999998765 6899999999999999999999997543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=325.90 Aligned_cols=205 Identities=26% Similarity=0.384 Sum_probs=174.3
Q ss_pred CCcccceeeeecCceeEEEEEec----CCcEEEEEEeccc----chhchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCe
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 510 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 510 (670)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998652 23445678899999999976 899999999999999
Q ss_pred eEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCce
Q 005907 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (670)
Q Consensus 511 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 590 (670)
.++||||+.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999996644 3678888999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccCCccccccccCcccccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCCCCCcc
Q 005907 591 TFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 651 (670)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~p~~~~~~~~ 651 (670)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 76433222 23346799999999999765 46889999999999999999999986554433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-38 Score=327.39 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=164.3
Q ss_pred CcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CeeEE
Q 005907 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 513 (670)
Q Consensus 441 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 513 (670)
+|+..++||+|+||+||+|++. +++.||||++.+... .+.+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999985 588999999965322 234799999999999999999998643 24689
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceec
Q 005907 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (670)
Q Consensus 514 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~ 592 (670)
||||++++.+..+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444332334456899999999999999999999988 99999999999999775 8999999999887
Q ss_pred CCCcccCCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 593 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 543322 23578999999998865 578999999999999999999999986443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=316.46 Aligned_cols=212 Identities=24% Similarity=0.369 Sum_probs=178.9
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCCeeEEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 516 (670)
++|+++++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999974 5788999998643 33456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceecCCCc
Q 005907 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (670)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 596 (670)
++.+++|..++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887754 344789999999999999999999988 9999999999999999999999999999875433
Q ss_pred ccCCccccccccCcccccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCCCCCcccchHhhhhhc
Q 005907 597 TEGNTNRVVGTYGYMAPEYASDGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHVSK 661 (670)
Q Consensus 597 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~i~~ 661 (670)
.. .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.|| +...+..+.+..+..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~--~~~~~~~~~~~~~~~ 217 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFR 217 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS--CCCSSHHHHHHHHHH
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC--CCCCCHHHHHHHHHh
Confidence 22 22345788899999987665 689999999999999999999996 334444444444443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-38 Score=326.27 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=167.9
Q ss_pred cCCcccceeeeecCceeEEEEEe-cCCcEEEEEEeccc-chhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eeE
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKL 512 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 512 (670)
.++|+++++||+|+||+||+|.. .+++.||||++.+. .....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 46899999999753 3344568899999999999999999999987643 335
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCceec
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 592 (670)
++++|+.+++|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 556677799999999643 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-CCccccccccCcccccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 593 GGDETE-GNTNRVVGTYGYMAPEYASD-GQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 443222 22344679999999999854 56789999999999999999999997543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-37 Score=318.22 Aligned_cols=208 Identities=22% Similarity=0.336 Sum_probs=166.8
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeEEEEEc
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 517 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 517 (670)
++|++.+.||+|+||.||+|++. +++.||||++.... ...++..|++++++++|+|+ +.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 58899999876532 33568899999999987765 5555666788889999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCceEEEeecCceecCC
Q 005907 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFGG 594 (670)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 594 (670)
+ +++|...+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 45666665432 345899999999999999999999998 999999999999864 45799999999998754
Q ss_pred Cccc-----CCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCCCCcccchH
Q 005907 595 DETE-----GNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 655 (670)
Q Consensus 595 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~~~~~~~~l 655 (670)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.||...........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 3321 123346799999999999999999999999999999999999999976655544433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=325.72 Aligned_cols=197 Identities=28% Similarity=0.424 Sum_probs=164.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEecc--cchhchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (670)
..++|+++++||+|+||.||+|... +|+.||||++++ ......+.+.+|+.+|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3468999999999999999999974 589999999975 23344568899999999999999999999997654
Q ss_pred -eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecC
Q 005907 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (670)
Q Consensus 510 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 588 (670)
..++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 5678777643 34899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 589 VRTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 9876432 2235789999999998764 5689999999999999999999997543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-36 Score=316.15 Aligned_cols=194 Identities=22% Similarity=0.388 Sum_probs=167.2
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CeeEEEE
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 515 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 515 (670)
++|+++++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 5889999998653 3467889999999995 99999999999754 4689999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-ceEEEeecCceecCC
Q 005907 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (670)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 594 (670)
||+.+++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997664 23889999999999999999999998 99999999999998655 699999999988653
Q ss_pred CcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCCCC
Q 005907 595 DETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYR 648 (670)
Q Consensus 595 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~~~ 648 (670)
... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 322 2345789999999998765 57999999999999999999999986443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=316.67 Aligned_cols=196 Identities=28% Similarity=0.344 Sum_probs=159.3
Q ss_pred cCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEe------CC
Q 005907 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 509 (670)
Q Consensus 439 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 509 (670)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 5899999999652 34445678999999999999999999999964 36
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..++||||+.++.+..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999766554432 23789999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 8754322 23345789999999999999999999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=316.95 Aligned_cols=197 Identities=27% Similarity=0.410 Sum_probs=165.1
Q ss_pred hcCCcccceeeeecCceeEEEEEec-CCcEEEEEEeccc--chhchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----C
Q 005907 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 509 (670)
Q Consensus 438 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 509 (670)
..++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999974 5899999999753 334456788999999999999999999998643 3
Q ss_pred eeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEEeecCc
Q 005907 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (670)
Q Consensus 510 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 589 (670)
..+++|+|+.+++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 44677788889999999843 34899999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccCCccccccccCcccccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCC
Q 005907 590 RTFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSIKSDVFSFGILLLEIVSGKKNRGF 646 (670)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p~~~ 646 (670)
..... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 76432 12235789999999987765 468999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1e-31 Score=282.82 Aligned_cols=199 Identities=20% Similarity=0.247 Sum_probs=160.0
Q ss_pred CCcccceeeeecCceeEEEEEec-CCcEEEEEEecccchhchHHHHHHHHHHhcCC-----------CCceeeEEEEEEe
Q 005907 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 507 (670)
Q Consensus 440 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 507 (670)
++|+++++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 58999999997532 23457788988888775 5789999988764
Q ss_pred --CCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCC-----
Q 005907 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDM----- 579 (670)
Q Consensus 508 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrDlkp~NILl~~~~----- 579 (670)
....+++|+++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566777776665444333333445568889999999999999999998 55 99999999999998665
Q ss_pred -ceEEEeecCceecCCCcccCCccccccccCcccccccCCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 005907 580 -NPKISDFGLVRTFGGDETEGNTNRVVGTYGYMAPEYASDGQFSIKSDVFSFGILLLEIVSGKKNRGFY 647 (670)
Q Consensus 580 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p~~~~ 647 (670)
.++|+|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3899999998865322 23357999999999999999999999999999999999999998644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=192.55 Aligned_cols=163 Identities=19% Similarity=0.178 Sum_probs=120.2
Q ss_pred ccceeeeecCceeEEEEEecCCcEEEEEEecccch------------------hchHHHHHHHHHHhcCCCCceeeEEEE
Q 005907 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQHRNLVKLLGC 504 (670)
Q Consensus 443 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 504 (670)
.+.++||+|+||.||+|+..+|+.||||+++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998653100 012344568889999999999988765
Q ss_pred EEeCCeeEEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCceEEE
Q 005907 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (670)
Q Consensus 505 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 584 (670)
. ..+++|||+++..+..+ +......++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 23799999988765432 22334568999999999999988 9999999999999865 58999
Q ss_pred eecCceecCCCcccCCccccccccCccc------ccccCCCCCCccchHHHHHHHH
Q 005907 585 DFGLVRTFGGDETEGNTNRVVGTYGYMA------PEYASDGQFSIKSDVFSFGILL 634 (670)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlGvil 634 (670)
|||+|.....+... .|.. .|. ..+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999875322111 1111 111 236778899999975443
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.69 E-value=2.5e-17 Score=141.13 Aligned_cols=101 Identities=19% Similarity=0.246 Sum_probs=82.8
Q ss_pred CccCCCCCCCCCCCceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCC
Q 005907 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEH 81 (670)
Q Consensus 2 ~~~~~~~~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~ 81 (670)
|||++.+++ +++|++|++.|+....-+|.+..||||+|.+. +.++|++++... .....|+|+++|||||++.
T Consensus 12 il~~~~~~~-----~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~- 83 (120)
T d1dlpa2 12 ILYSTQGND-----NHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTN- 83 (120)
T ss_dssp ECCCC--CC-----CCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSS-CSSCEEEEETTTEEEEEET-
T ss_pred EEEcCCCCC-----CcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccC-CCcEEEEEeCCeeEEEEcC-
Confidence 688877776 78899999999988778999999999999986 678999986543 3457899999999999997
Q ss_pred CCCCcceEEeecCCCCCcccCCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceE
Q 005907 82 DGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEV 144 (670)
Q Consensus 82 ~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~ 144 (670)
.+.++||||. +.++|.|.+.++++|+.-+
T Consensus 84 ---~~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 84 ---QNIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp ---TTEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred ---CCCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 5689999983 2356788999999997654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.58 E-value=2.7e-15 Score=126.06 Aligned_cols=72 Identities=21% Similarity=0.363 Sum_probs=61.9
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||+||++.|+... +.|.|.+||+|+|.|++|.+||+|+++.. ....+|+|+|+|||||+++ .+|||+-
T Consensus 37 ~~~vW~ant~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~s~t~~~-~~~~~l~L~ddGNlvly~~-------~~W~S~t 107 (109)
T d1kj1a_ 37 STSVWASNTGILGKKG-CKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYGS-------DIWSTGT 107 (109)
T ss_dssp TEEEEECCCCCTTCCC-CEEEECTTSCEEEECSSSCEEEECCCCCC-SSCCEEEECTTSCEEEECC-------EEEECCC
T ss_pred CEEEEEeCCCCCCcee-EEEEEcCCceEEEEeCCCcEEEEEeeECC-CCCEEEEEeCCCcEEEECC-------CEecCCC
Confidence 4789999999998664 78999999999999999999999986643 3456899999999999964 4999986
Q ss_pred C
Q 005907 95 Y 95 (670)
Q Consensus 95 ~ 95 (670)
|
T Consensus 108 ~ 108 (109)
T d1kj1a_ 108 Y 108 (109)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=1.4e-15 Score=128.57 Aligned_cols=110 Identities=17% Similarity=0.246 Sum_probs=89.2
Q ss_pred CccCCCCCCCCCCCceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCC
Q 005907 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEH 81 (670)
Q Consensus 2 ~~~~~~~~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~ 81 (670)
|||-.-+++ +..|+.+.+.|+.....+|.+..||||||.++ +.++|++++... ....+.|+++|||||++.
T Consensus 3 ~~~~~~~~~-----~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~- 73 (115)
T d1dlpa1 3 ILFGLSHEG-----SHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA--TGCRAVLQSDGLLVILTA- 73 (115)
T ss_dssp CCBCSSSSS-----CSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSC--SCCBCCBCSSSCBCCBCT-
T ss_pred EEEecCCCC-----CCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCC--CceEEEEeccCCEEEEcc-
Confidence 567666666 66689999999988778999999999999984 678999987643 567889999999999986
Q ss_pred CCCCcceEEeecCCCCCcccCCCccccccccccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 82 DGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 82 ~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
.+.+||||+. +.++|.|.+.|+++|+.. ++ +.++|.+|.
T Consensus 74 ---~~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt 112 (115)
T d1dlpa1 74 ---QNTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT 112 (115)
T ss_dssp ---TTCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred ---CCCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence 5678999873 345789999999999854 44 347898874
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.53 E-value=1.1e-14 Score=123.47 Aligned_cols=76 Identities=21% Similarity=0.422 Sum_probs=62.7
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||.||++.|... +.|.|..||+|+|.|. +.++|+++++.. ....+|+|+|+|||||++. ++.++|||+.
T Consensus 37 ~~~vW~s~~~~~~~~--~~l~l~~dGnLvl~~~-~~~~w~s~t~~~-~~~~~l~L~ddGNlvly~~----~~~~~W~S~t 108 (112)
T d1xd5a_ 37 NRAVWASGTNGKASG--CVLKMQNDGNLVIYSG-SRAIWASNTNRQ-NGNYYLILQRDRNVVIYDN----SNNAIWATHT 108 (112)
T ss_dssp TEEEEECCCTTSCSS--EEEEECTTSCEEEEET-TEEEEECCCCCS-CCCCEEEECTTSCEEEECT----TSCEEEECCC
T ss_pred CcEEEEccCccCCCC--cEEEEeccccEEEEec-CCeEEEEeeccC-CCceEEEEcCCCCEEEECC----CCcEEecCCC
Confidence 489999999988543 6899999999999987 456777765433 3556899999999999986 5678999999
Q ss_pred CCCC
Q 005907 95 YPSD 98 (670)
Q Consensus 95 ~Ptd 98 (670)
+|+|
T Consensus 109 ~~~n 112 (112)
T d1xd5a_ 109 NVGN 112 (112)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 9986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.53 E-value=1e-14 Score=122.47 Aligned_cols=71 Identities=23% Similarity=0.338 Sum_probs=60.0
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||.||++.|. +.+.|.+..+|+|+|.+++|.+||+|++... ....+|+|+|+|||||++. .+||||+
T Consensus 37 ~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~-~~~~~l~L~ddGNlVly~~-------~~W~S~t 106 (108)
T d1jpca_ 37 DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQ-NGNYVCILQKDRNVVIYGT-------DRWATGT 106 (108)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCS-CSCEEEEECTTSCEEEEEC-------CCCCCCC
T ss_pred CceeeEeCCCCCC--CccEEEEeccceEEEECCCccceEEccccCC-CCcEEEEEcCCCCEEEeCC-------CcccCCC
Confidence 4789999999884 3468999999999999999999999986543 3455789999999999974 3899998
Q ss_pred C
Q 005907 95 Y 95 (670)
Q Consensus 95 ~ 95 (670)
|
T Consensus 107 ~ 107 (108)
T d1jpca_ 107 H 107 (108)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=1.4e-11 Score=104.38 Aligned_cols=70 Identities=21% Similarity=0.373 Sum_probs=58.5
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||.||+..|.. .+.|.|..||+|+|.|++|.+||++++... ....+|+|+|+|||||+++ .+|||-.
T Consensus 48 ~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~-~~~~~l~Lq~DGNlvlYg~-------~~W~S~T 117 (119)
T d1b2pa_ 48 NNPIWATNTGGLGN--GCRAVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGD-------ALWATQT 117 (119)
T ss_dssp TEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEECSCCCC-SSCEEEEECTTSCEEEEES-------EEEECCC
T ss_pred CeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCCcEEEECCCcCC-CCceEEEEcCCCCEEEECC-------CEeccCC
Confidence 47899999987753 378999999999999999999999986543 3455789999999999864 6999964
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.86 E-value=8.6e-09 Score=85.65 Aligned_cols=87 Identities=20% Similarity=0.381 Sum_probs=65.4
Q ss_pred ceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCccccccc
Q 005907 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (670)
Q Consensus 32 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~ 111 (670)
-.|.+-.||||+|.+ .+.+||++++.........+.|.++|||||+++ .+.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~s~------------------ 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA----EGRSLWASH------------------ 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS----SSCEEEECC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC----CCcEEEEEe------------------
Confidence 668889999999986 567999998765445567899999999999987 567899871
Q ss_pred cccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 112 tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
...+.|.|.+.|+++|+.-+ ++ .+.|.|+.
T Consensus 78 -------------t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t 107 (109)
T d1kj1a_ 78 -------------SVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGT 107 (109)
T ss_dssp -------------CCCCSSCCEEEECTTSCEEE--EC--CEEEECCC
T ss_pred -------------eECCCCCEEEEEeCCCcEEE--EC--CCEecCCC
Confidence 01124568889999997543 43 46787764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.83 E-value=1e-08 Score=86.33 Aligned_cols=85 Identities=19% Similarity=0.314 Sum_probs=63.8
Q ss_pred eEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCcccccccc
Q 005907 33 FLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (670)
Q Consensus 33 ~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~t 112 (670)
.|.+-.||||||.++ +.++|++++... .....+.|.++|||||++. .+.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~d~----~g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITN----ENVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT----TCCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCC-CcceEEEEEeCCCEEEECC----CCcEEEECCC------------------
Confidence 477789999999876 568999987543 3457899999999999987 5678998632
Q ss_pred ccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeCC
Q 005907 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (670)
Q Consensus 113 g~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg~ 158 (670)
.-+.|.|.+.|+.+|+..+ + +.+.|.|+.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvl--Y--g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVI--Y--GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEE--E--ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEE--E--CCCEeccCC
Confidence 1135678899999997654 4 346888764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.79 E-value=1.2e-08 Score=84.71 Aligned_cols=85 Identities=20% Similarity=0.401 Sum_probs=62.3
Q ss_pred ceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCccccccc
Q 005907 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (670)
Q Consensus 32 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~ 111 (670)
-+|.+..||||||.+. +.+||++++... .....+.|.++|||||++. .+.++|.|=
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~----~g~~vWsS~------------------ 76 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGL-SRSCFLSMQTDGNLVVYNP----SNKPIWASN------------------ 76 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT----TCCEEEECC------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCC-CCccEEEEeccceEEEECC----CccceEEcc------------------
Confidence 5788999999999874 578999986543 2346799999999999987 567899861
Q ss_pred cccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeCCeeEEeeC
Q 005907 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (670)
Q Consensus 112 tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~sg 157 (670)
....++.|.+.|+.+|+.-+ +. .+.|.|+
T Consensus 77 -------------t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~ 105 (108)
T d1jpca_ 77 -------------TGGQNGNYVCILQKDRNVVI--YG--TDRWATG 105 (108)
T ss_dssp -------------CCCSCSCEEEEECTTSCEEE--EE--CCCCCCC
T ss_pred -------------ccCCCCcEEEEEcCCCCEEE--eC--CCcccCC
Confidence 11134567888998897543 43 3456654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.76 E-value=1.8e-09 Score=90.41 Aligned_cols=69 Identities=20% Similarity=0.280 Sum_probs=55.5
Q ss_pred CceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecC
Q 005907 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (670)
Q Consensus 15 ~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd 94 (670)
.++||.+|... ...+++.+..+|||||.|.++.+||++++... ...-+++|+++|||||++. .+|+|-.
T Consensus 44 ~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~-~g~y~l~Lq~DGNlvlY~~-------~~Wssgt 112 (115)
T d1dlpa1 44 DVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYGP-------GLWDSGT 112 (115)
T ss_dssp SSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEECS-------EEEECSC
T ss_pred CeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEEcCCCCC-CCCEEEEECCCCcEEEeCC-------CeecCCC
Confidence 36899999753 23478999999999999999999999986543 3445789999999999853 6899854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.71 E-value=8.1e-09 Score=87.28 Aligned_cols=67 Identities=21% Similarity=0.372 Sum_probs=53.2
Q ss_pred ceEEeccCCCCCCCCcceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEee
Q 005907 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (670)
Q Consensus 16 t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqS 92 (670)
.+||.+|- +..+..+.+.|.++|||||.|.++.++|++++... ....++.|.++|||||++. .+|.|
T Consensus 54 ~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~-~~~~~l~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 54 DRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp BCCSCCCC--CSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCS-SSCCEEEECSSSCEEEECC-------CCCBC
T ss_pred cEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCC-CCcEEEEECCCCcEEEeCC-------CcccC
Confidence 57898874 34445578999999999999999999999987543 2345789999999999953 47875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2.3e-07 Score=90.13 Aligned_cols=149 Identities=15% Similarity=0.073 Sum_probs=103.3
Q ss_pred HHHHhcCCcccceeeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeeE
Q 005907 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 512 (670)
Q Consensus 434 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 512 (670)
++......|++.+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444556777766655555678999864 56778889886655555556788888887764 434677888888888999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005907 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--------------------------------- 559 (670)
Q Consensus 513 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~--------------------------------- 559 (670)
+||+++++.++....... .. ...++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886554211 11 2224555566666666421
Q ss_pred -----------------------CCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 560 -----------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 560 -----------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12278999999999999877677999997654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.46 E-value=6.7e-07 Score=74.46 Aligned_cols=88 Identities=23% Similarity=0.430 Sum_probs=63.2
Q ss_pred ceEEEecCCcEEEECCCCcEEEeecCccCccCceEEEEecCCCEEEeeCCCCCCcceEEeecCCCCCcccCCCccccccc
Q 005907 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (670)
Q Consensus 32 ~~l~~~~~g~l~l~~~~~~~~Wst~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~~~~WqSFd~PtdtlLpg~~l~~~~~ 111 (670)
-.|.+..||||||.+ .+.+||+++.... .....+.|..+|||||++. ++.+|-|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~-~~~~~l~l~~dGnLvl~~~-----~~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG-----SRAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTS-CSSEEEEECTTSCEEEEET-----TEEEEEC-------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccC-CCCcEEEEeccccEEEEec-----CCeEEEE-------------------
Confidence 678899999999986 4679999986543 3456899999999999984 3456654
Q ss_pred cccceeEEEeccCCCCCCcceEEEEecCCCceEEEEeC-CeeEEeeCCC
Q 005907 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKG-SRKFYRTGPW 159 (670)
Q Consensus 112 tg~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~~~~sg~~ 159 (670)
...-..|.+.+.|+.+|+.- +++. ..+.|.|+..
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHTN 109 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCCC
T ss_pred ------------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCCc
Confidence 11112456888999999754 3433 4678987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=2.6e-05 Score=74.72 Aligned_cols=131 Identities=19% Similarity=0.173 Sum_probs=85.1
Q ss_pred eeeecCc-eeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005907 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (670)
Q Consensus 447 ~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g~L 523 (670)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555553 67899988778888889765432 2356777777776643 3367778888888888999999988765
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005907 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH----------------------------------------------- 556 (670)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~yLH----------------------------------------------- 556 (670)
.+.. .... .++.++++.|+-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 1111 11122222333333
Q ss_pred ----hC----CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 557 ----QD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 557 ----~~----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
+. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112379999999999999877778999997654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00046 Score=70.32 Aligned_cols=75 Identities=11% Similarity=0.178 Sum_probs=48.6
Q ss_pred eeeeecCceeEEEEEecC-CcEEEEEEeccc----c---hhchHHHHHHHHHHhcCC-C--CceeeEEEEEEeCCeeEEE
Q 005907 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLLI 514 (670)
Q Consensus 446 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 514 (670)
+.||.|..-.||++...+ ++.++||..... . +....+...|...|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998754 678899975321 1 112344566777777652 2 345566544 55667899
Q ss_pred EEccCCCC
Q 005907 515 YEFMPNKS 522 (670)
Q Consensus 515 ~e~~~~g~ 522 (670)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.76 E-value=0.0022 Score=63.29 Aligned_cols=69 Identities=10% Similarity=0.015 Sum_probs=45.9
Q ss_pred ceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCce--eeEE-----EEEEeCCeeEEEEEccCCCC
Q 005907 453 FGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL--VKLL-----GCCIQGEEKLLIYEFMPNKS 522 (670)
Q Consensus 453 fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~e~~~~g~ 522 (670)
.=.||++...+|+.+++|+.+.. ....+++..|...+..|....+ +..+ .....+...+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 35799999989999999987642 3345677788888877643222 1111 12244667788999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.89 E-value=0.0067 Score=61.39 Aligned_cols=75 Identities=20% Similarity=0.333 Sum_probs=48.9
Q ss_pred cccceeeeecCceeEEEEEecCC--------cEEEEEEecccchhchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeeE
Q 005907 442 FSINNKLGEGGFGPVYKGTLVDG--------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKL 512 (670)
Q Consensus 442 ~~~~~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~ 512 (670)
+++ +.|+.|-.=.+|++...++ +.|.+++... ........+|..+++.+.-.++ .++++++.. .
T Consensus 45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 444 5788888889999987543 3466666542 2233455678888888753344 467776532 5
Q ss_pred EEEEccCCCCH
Q 005907 513 LIYEFMPNKSL 523 (670)
Q Consensus 513 lV~e~~~~g~L 523 (670)
+|+||+++..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.12 E-value=0.032 Score=54.11 Aligned_cols=156 Identities=14% Similarity=0.053 Sum_probs=78.3
Q ss_pred HHHHHhcCCcccce-----eeeecCceeEEEEEecCCcEEEEEEecccchhchHHHHHHHHHHhcCCCCc-----eeeEE
Q 005907 433 ATIANATDNFSINN-----KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-----LVKLL 502 (670)
Q Consensus 433 ~~~~~~~~~~~~~~-----~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-----iv~l~ 502 (670)
.++.....+|.+.+ .|..|---+.|+....+| .+++|+.... ...+++..|+.++..+.+.+ .+...
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceec
Confidence 44555556666533 344566677899887554 5899987542 12345556676776664322 11110
Q ss_pred ---EEEEeCCeeEEEEEccCCCCHHH-----------HH---hhc------CCCCCCC------------------HHHH
Q 005907 503 ---GCCIQGEEKLLIYEFMPNKSLDS-----------FI---FDQ------TRRTLLD------------------WSQR 541 (670)
Q Consensus 503 ---g~~~~~~~~~lV~e~~~~g~L~~-----------~l---~~~------~~~~~~~------------------~~~~ 541 (670)
.+.........++.++.+..... .+ +.. ....... ....
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 01223445566777766543210 00 000 0000000 0011
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCceEEEeecCcee
Q 005907 542 FHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (670)
Q Consensus 542 ~~i~~~ia~~l~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 591 (670)
...+..+...+.-.+.. -+.++||+|+.++||+++.+...-|.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11122222222222221 134599999999999999887778999998754
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.40 E-value=0.01 Score=35.70 Aligned_cols=32 Identities=34% Similarity=0.784 Sum_probs=25.8
Q ss_pred CCCCcCCCCCCCcccccC-CCCccccccccccCC
Q 005907 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPKS 263 (670)
Q Consensus 231 ~~C~~~~~CG~~giC~~~-~~~~C~C~~Gf~~~~ 263 (670)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 7899999998 6899743 344599999999865
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.94 E-value=0.059 Score=34.72 Aligned_cols=32 Identities=38% Similarity=0.761 Sum_probs=25.1
Q ss_pred CCCCc-CCCCCCCcccccC-CCCccccccccccC
Q 005907 231 DQCDT-YGLCGAYGICIIG-QSPVCQCLKGFKPK 262 (670)
Q Consensus 231 ~~C~~-~~~CG~~giC~~~-~~~~C~C~~Gf~~~ 262 (670)
|+|.. ...|..+|.|... ..-.|.|++||+-.
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 67875 5789999999854 44579999999743
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.59 E-value=0.14 Score=32.15 Aligned_cols=32 Identities=41% Similarity=0.881 Sum_probs=24.6
Q ss_pred CCCCcCCCCCCCcccccC-CCCccccccccccCC
Q 005907 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPKS 263 (670)
Q Consensus 231 ~~C~~~~~CG~~giC~~~-~~~~C~C~~Gf~~~~ 263 (670)
|+|. ...|...|.|... ..-.|.|++||+-..
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 4675 5789999999854 456799999998543
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.94 E-value=0.22 Score=31.30 Aligned_cols=32 Identities=19% Similarity=0.543 Sum_probs=24.3
Q ss_pred CCCCcCCCCCCCcccccC-CCCccccccccccCC
Q 005907 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPKS 263 (670)
Q Consensus 231 ~~C~~~~~CG~~giC~~~-~~~~C~C~~Gf~~~~ 263 (670)
|+|. ...|...|.|... ..-.|.|++||+-..
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~~ 34 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGVH 34 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESSS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccCc
Confidence 5664 4789999999854 456799999997543
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.52 E-value=0.19 Score=31.58 Aligned_cols=32 Identities=38% Similarity=0.616 Sum_probs=25.2
Q ss_pred CCCCCcCCCCCCCcccccC-CCCccccccccccC
Q 005907 230 RDQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPK 262 (670)
Q Consensus 230 ~~~C~~~~~CG~~giC~~~-~~~~C~C~~Gf~~~ 262 (670)
.|+|. +..|...|.|... ..-.|.|++||+-.
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 46786 5889999999743 55679999999754
|